data_6r8d_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6r8d _Structure_validation_residue.Date_analyzed 2020-05-29 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.645 0.259 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -60.72 -40.49 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.326 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.18 -40.68 86.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.86 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.2 83.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.46 -42.1 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.188 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.81 -38.54 88.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.9 mtt -71.13 -38.6 72.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.971 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.72 -44.61 73.66 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -64.28 -45.93 85.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.499 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -63.25 -34.06 76.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.376 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.83 80.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.741 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.75 85.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.812 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.93 -53.16 58.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.068 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.8 -34.87 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.747 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -58.89 -43.47 90.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.245 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -83.23 -40.5 19.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.591 . . . . 0.0 111.684 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -69.85 -41.86 74.32 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -72.94 -15.62 61.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.145 0.498 . . . . 0.0 110.442 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.8 tt -115.35 142.21 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.547 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -83.58 113.71 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -67.87 -38.62 14.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.787 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 60.0 Cg_exo -52.68 -31.78 51.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.878 1.719 . . . . 0.0 112.616 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -60.5 -37.26 80.51 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.891 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.9 mt -79.85 -20.1 46.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 109.856 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.47 5.45 82.12 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.2 ttt -167.07 154.8 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.55 142.91 33.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.034 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 157.17 16.27 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.0 m -121.15 143.28 49.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.23 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.33 118.08 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 110.131 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -63.32 -36.16 82.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.313 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.63 161.52 10.44 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.64 151.35 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.812 0.339 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.17 142.59 48.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.0 mtt -102.2 142.28 33.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.003 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.7 t -73.79 152.2 40.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.087 0.47 . . . . 0.0 110.588 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -55.98 -31.75 63.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.993 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.71 -3.87 57.05 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.326 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.8 mt 58.8 20.11 7.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.06 -41.37 6.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.945 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.62 147.28 40.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 141.31 49.18 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.94 0.4 . . . . 0.0 110.474 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -109.04 127.55 54.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.81 133.11 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -112.84 130.46 56.08 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.91 147.65 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.892 0.377 . . . . 0.0 110.716 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -126.37 125.7 42.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.96 131.6 55.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.5 tp -70.89 -25.93 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.436 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 60' ' ' LYS . 19.6 m120 -81.09 2.57 26.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -60.75 -16.85 44.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 58' ' ' ASN . 14.7 mtpp -69.0 -35.56 76.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -89.71 119.32 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.378 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.71 -32.31 70.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.75 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.7 -40.24 76.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.308 0.575 . . . . 0.0 110.415 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.09 74.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.955 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.83 -34.37 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.257 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -64.69 -42.92 94.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 109.641 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.64 75.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.343 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.37 51.66 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.997 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.5 mm -57.98 -42.93 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.666 0.27 . . . . 0.0 111.038 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.01 -35.73 80.57 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.04 -45.2 71.01 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.106 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 tp -70.98 -36.68 72.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.416 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.6 -45.46 71.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.43 -37.08 74.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.43 59.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.28 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 t -55.67 -51.07 68.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.241 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.09 93.22 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -65.94 -41.27 91.54 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.11 -41.43 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.342 0.592 . . . . 0.0 109.969 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 93' ' ' PRO . 37.4 ttt85 -62.9 -47.15 84.51 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.42 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 t -70.95 -36.45 72.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.707 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.46 -39.91 77.44 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.787 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.35 -49.22 51.62 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.43 -42.26 99.73 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.407 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -68.8 -39.86 79.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.375 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.851 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.08 -14.07 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 93.7 mtt-85 56.91 35.78 26.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.52 141.35 34.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.782 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -102.12 -10.94 19.22 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.498 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.8 pt -88.4 13.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.09 121.94 86.39 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 94.7 Cg_endo -78.06 166.06 25.32 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.701 1.601 . . . . 0.0 111.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.01 138.41 58.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.4 mm? -97.56 128.31 44.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.074 0.464 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.4 m -118.57 129.35 55.29 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.67 129.12 49.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.198 0.523 . . . . 0.0 111.498 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.1 t80 -123.25 144.97 49.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.738 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 21.4 m-85 -109.22 132.56 54.0 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.932 0.396 . . . . 0.0 110.241 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.936 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -62.02 -43.06 99.64 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.65 -37.74 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.164 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.96 81.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -64.67 -41.78 95.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.29 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.57 -38.75 88.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 90.4 mtp -71.1 -38.8 72.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.71 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.5 -42.38 78.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.537 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -63.0 -45.42 92.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.11 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.13 -34.85 78.49 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.708 0.766 . . . . 0.0 109.715 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.63 -41.51 77.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.485 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.51 84.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.194 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.56 -52.99 62.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.577 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.9 mt -69.87 -34.26 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.395 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.33 -41.96 76.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.016 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.3 tt0 -82.92 -41.64 18.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 111.442 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -70.35 -38.81 74.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.122 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -72.39 -14.86 61.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.071 0.462 . . . . 0.0 110.336 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 24' ' ' GLN . 19.9 tt -119.9 141.64 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.554 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -86.54 113.06 22.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -67.77 -38.75 15.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.489 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.59 -28.69 46.93 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.012 1.808 . . . . 0.0 112.559 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -59.38 -38.2 79.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.527 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 mt -88.37 -19.45 26.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.138 0.494 . . . . 0.0 109.8 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.71 5.0 89.84 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 90.7 mmm -143.74 162.22 36.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.838 0.351 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.6 ttp -96.79 134.54 39.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.952 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.0 p -92.0 158.04 16.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 t -135.56 159.66 40.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.17 127.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.999 0.428 . . . . 0.0 110.085 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 m -72.19 -34.2 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.42 157.44 8.48 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.76 150.69 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.074 0.464 . . . . 0.0 111.488 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.1 141.86 50.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.074 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.1 mtt -108.11 142.07 38.87 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 p -75.47 152.84 37.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.058 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -63.06 -34.81 78.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.443 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.92 -3.11 57.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.376 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.4 mt 62.03 13.67 5.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.11 58.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.177 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.2 165.49 29.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.256 0.55 . . . . 0.0 111.764 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.54 142.3 35.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.257 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -112.41 120.01 40.19 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.208 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.8 133.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.907 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -109.67 136.19 49.41 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.79 146.98 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 0.0 111.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 t -144.65 152.48 40.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 11.0 p90 -150.24 159.73 44.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.123 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.18 -27.03 68.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.02 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.412 ' C ' ' N ' ' A' ' 60' ' ' LYS . 73.5 m-20 -80.23 5.78 13.67 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 68.9 m-20 -61.02 -16.71 46.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 58' ' ' ASN . 63.9 tttp -68.87 -39.97 79.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.82 114.12 26.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.167 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -60.46 -33.0 71.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.04 -38.72 89.09 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.447 0.641 . . . . 0.0 109.386 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.55 83.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 82.6 t -68.76 -37.87 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.913 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.4 -45.47 79.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.595 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.27 -44.55 68.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.496 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.85 41.38 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.484 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.8 -34.5 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.214 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -66.4 -41.31 89.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.38 0.61 . . . . 0.0 109.506 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.36 75.09 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.95 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -69.62 -36.63 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.404 ' O ' ' OG ' ' A' ' 76' ' ' SER . 63.5 tt0 -68.48 -44.49 74.67 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.192 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -69.35 -37.07 77.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.091 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.72 -10.52 59.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.333 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 59.8 p -58.67 -49.41 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.243 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.7 91.88 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -64.49 -43.6 93.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.623 0.249 . . . . 0.0 111.452 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.73 -42.84 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 110.808 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -63.11 -47.1 84.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.48 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.1 t -70.98 -37.76 72.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.866 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -66.45 -37.8 85.95 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.778 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.75 -43.32 76.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.956 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.0 -38.4 74.21 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -66.26 -43.12 87.36 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -0.726 . . . . 0.0 111.921 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.58 83.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.7 mtt -84.29 -17.21 40.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' GLY . 41.3 ttt85 59.44 35.35 22.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.656 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.35 142.05 33.32 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.034 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.58 -10.54 19.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.668 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 pt -82.62 18.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.201 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.97 122.5 87.81 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.91 158.97 31.09 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.545 1.496 . . . . 0.0 111.374 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.81 128.7 37.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.5 mt -95.58 131.37 41.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.228 0.537 . . . . 0.0 111.313 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -115.61 127.25 55.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.98 126.9 52.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -119.11 141.64 48.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.768 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 23.3 p90 -106.83 132.02 53.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.905 0.383 . . . . 0.0 110.337 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -63.31 -43.2 98.52 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.016 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.07 -37.1 78.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.291 0.567 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.8 -39.54 83.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -71.59 -46.42 59.32 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.519 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.37 -37.15 84.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 57.3 mtt -71.62 -40.72 69.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.982 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -54.49 -42.33 70.63 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -63.3 -46.79 85.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.366 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.35 -33.48 75.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.608 0.718 . . . . 0.0 109.824 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.26 -42.92 78.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.962 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.17 86.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.58 -51.82 65.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.389 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.27 -34.1 64.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.7 -41.02 97.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -82.65 -27.8 31.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -82.83 -45.26 14.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.773 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.05 -17.39 62.02 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.24 133.92 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.009 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.97 121.96 28.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 10.7 t70 -46.14 -58.48 6.36 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.302 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.61 -22.93 18.24 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.805 1.67 . . . . 0.0 113.13 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.18 -38.36 76.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.763 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.8 mt -100.7 -13.79 18.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.05 0.453 . . . . 0.0 109.801 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.66 5.68 89.68 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.3 tpt -160.88 158.75 28.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.404 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.442 ' SD ' ' OD1' ' A' ' 29' ' ' ASP . 94.1 mmm -80.45 137.93 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 p -86.08 150.33 24.52 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.872 0.368 . . . . 0.0 111.029 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.4 m -125.98 141.71 51.84 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.911 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -100.24 120.97 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.012 0.434 . . . . 0.0 110.169 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -68.84 -33.94 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.17 158.19 8.79 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 m -127.16 148.62 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 111.193 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -126.1 138.29 53.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.952 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.487 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -113.73 143.24 44.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.559 ' HG ' ' H ' ' A' ' 49' ' ' TYR . 94.7 p -73.2 156.4 38.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.233 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.953 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 55.3 p30 -83.91 -0.86 53.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.5 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.27 31.94 21.57 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' A' ' 46' ' ' ASP . . . -105.56 -46.44 4.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.79 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.559 ' H ' ' HG ' ' A' ' 44' ' ' SER . 66.0 m-85 -116.02 145.55 42.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.829 0.347 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.88 142.17 40.69 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -122.05 127.49 50.28 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.5 134.74 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -109.96 133.17 53.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.74 149.85 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.167 0.508 . . . . 0.0 111.55 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -143.36 151.77 40.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.41 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 7.2 p90 -156.03 158.52 37.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 111.397 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.01 -14.67 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.75 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -80.6 3.42 21.94 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.519 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 64.6 m-20 -61.88 -16.64 52.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.37 -39.43 85.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.135 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.62 117.26 29.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.037 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -60.3 -36.57 78.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.427 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.06 -37.92 89.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.471 0.653 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.84 84.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.1 -44.32 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -66.83 -39.83 87.78 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.47 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.83 76.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.59 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.42 -51.2 38.78 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.41 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.37 -41.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.612 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.46 -35.27 80.4 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.57 86.21 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.936 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.35 -35.89 73.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.851 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -67.78 -45.96 73.33 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.47 -37.18 71.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.5 -3.97 54.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.286 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -55.24 -50.3 69.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.317 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.76 93.02 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.232 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -66.41 -42.65 87.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.32 -39.52 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.638 0.732 . . . . 0.0 110.087 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -63.74 -45.02 91.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.09 -36.95 78.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.521 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.52 -38.77 90.63 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.935 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.87 -49.5 57.74 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.515 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -59.45 -43.0 97.83 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.692 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.053 0.454 . . . . 0.0 111.824 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.65 98.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.474 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -94.5 -9.17 36.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 89.5 mtm-85 55.13 36.67 27.49 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.72 141.2 33.93 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.977 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -99.22 -14.69 19.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 pt -86.91 29.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.57 118.36 67.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.91 160.82 27.25 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.547 1.498 . . . . 0.0 111.61 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.29 136.2 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.8 mt -100.84 130.76 46.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 110.947 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -119.65 124.88 47.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.996 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.73 129.11 47.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.452 . . . . 0.0 111.231 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 37.7 t80 -119.64 139.8 51.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 44.6 p90 -104.67 133.6 49.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.964 0.412 . . . . 0.0 110.484 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.56 0.219 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -59.77 -43.21 94.47 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 m -65.5 -36.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.847 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.33 85.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.811 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.33 -40.71 96.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.3 -37.62 83.89 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.55 -42.18 68.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.886 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.36 -43.74 79.43 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -63.52 -48.14 78.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.069 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.83 -32.25 72.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.246 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.03 -41.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.86 85.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.8 tp -64.34 -52.01 60.5 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.22 -33.92 60.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -57.96 -42.21 84.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.4 mt-30 -82.46 -41.87 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.384 0.611 . . . . 0.0 111.358 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -70.54 -37.6 74.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.827 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -72.12 -17.42 61.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.176 0.512 . . . . 0.0 110.125 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 19.2 tt -118.7 141.09 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.815 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -66.52 -38.69 21.0 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.437 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.5 Cg_exo -55.28 -31.91 78.7 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.004 1.802 . . . . 0.0 112.521 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.51 -38.22 80.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.704 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.9 -20.02 28.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.951 0.405 . . . . 0.0 110.002 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 7.39 87.19 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.8 mtt -138.85 167.15 22.64 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.962 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.8 mtp -98.29 151.2 20.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.444 ' CG2' ' CE1' ' A' ' 56' ' ' PHE . 88.0 m -109.09 142.36 39.94 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -122.41 157.36 32.05 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.732 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -105.54 116.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.152 0.501 . . . . 0.0 110.2 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -34.46 78.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.006 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.11 152.59 6.37 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.5 t -126.09 137.92 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.679 0.276 . . . . 0.0 110.454 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -128.23 140.35 51.95 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.993 0.425 . . . . 0.0 110.779 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.6 mtt -111.36 142.47 43.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.475 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.1 p -73.44 155.31 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.822 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.25 -32.54 71.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.565 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.57 -3.54 56.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.377 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.31 27.12 16.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.37 -41.29 5.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -118.07 142.75 47.07 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.872 0.367 . . . . 0.0 110.885 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.07 141.73 48.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.13 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.97 129.13 55.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.77 133.36 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.415 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -118.74 128.76 54.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.33 149.73 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.225 0.536 . . . . 0.0 111.452 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -123.7 134.68 53.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 36' ' ' THR . 97.6 m-85 -121.39 146.55 46.76 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.426 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.3 mt -76.03 -12.06 60.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 81.9 m-20 -80.68 -2.43 46.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.834 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 100' ' ' ASP . 98.4 m-20 -62.94 -21.2 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.88 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -69.88 -38.43 76.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.562 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -99.1 109.51 22.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.03 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.11 -38.17 82.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.05 -38.03 89.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.84 82.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.51 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.43 -35.53 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -66.2 -43.75 85.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.228 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.81 72.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.346 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -50.4 32.18 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.717 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.7 tp -59.22 -36.74 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.682 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -68.35 -38.05 81.09 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.551 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.35 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.61 -36.88 76.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.658 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.76 -44.95 72.65 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.09 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.75 -36.95 79.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.236 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.26 -12.16 60.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.436 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 22.5 t -58.0 -49.53 76.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.461 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.15 86.02 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.161 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.09 -44.63 88.24 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.333 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.44 -39.6 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.543 0.687 . . . . 0.0 110.501 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -63.48 -45.02 92.7 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.736 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.56 -36.55 76.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.0 mt -66.43 -36.49 82.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.237 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.12 -48.6 64.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.909 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.17 -43.1 65.08 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.603 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.86 -43.11 80.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.258 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.14 83.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.54 -21.38 30.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 84' ' ' GLY . 49.0 ttp85 64.21 37.15 8.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.992 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.28 141.46 28.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -98.7 -14.56 19.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.8 pt -97.7 34.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -73.25 119.87 78.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.98 160.35 30.37 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.418 1.412 . . . . 0.0 111.352 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.37 132.67 54.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.05 126.82 51.47 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.819 0.342 . . . . 0.0 110.304 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 m -117.11 133.68 55.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.512 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CD2' ' OG ' ' A' ' 76' ' ' SER . 92.8 m-85 -107.28 128.52 54.52 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -119.58 137.53 53.79 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 38.3 p90 -109.63 123.59 49.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.932 0.396 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.417 ' O ' ' OD2' ' A' ' 59' ' ' ASP . 60.4 t0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.648 0.261 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -58.71 -41.57 86.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.53 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.2 -39.38 78.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.757 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.07 96.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.914 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -61.38 -39.37 90.41 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.379 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.56 -37.33 83.44 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.32 -41.87 69.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.599 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.66 -41.5 95.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.574 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -64.63 -51.33 63.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.215 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.74 -34.92 79.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.941 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.0 mt -71.07 -39.96 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.109 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -36.85 85.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.25 -53.31 46.18 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.81 -34.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.76 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.35 -38.96 81.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.945 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 27' ' ' ILE . 48.5 tt0 -81.88 -44.46 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.988 0.423 . . . . 0.0 111.15 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -71.15 -36.64 72.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -73.27 -14.31 61.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.291 0.567 . . . . 0.0 109.906 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 24' ' ' GLN . 15.0 tt -121.67 149.47 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -76.03 113.02 13.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -70.14 -38.55 9.02 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.86 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 46.0 Cg_exo -56.57 -37.4 97.56 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.078 1.852 . . . . 0.0 112.781 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -59.94 -37.43 79.5 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.121 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 61.7 mt -92.45 -3.88 54.54 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.76 0.314 . . . . 0.0 110.6 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 35' ' ' MET . . . 90.05 5.39 70.65 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ttt 65.46 0.38 1.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.415 ' H ' ' C ' ' A' ' 33' ' ' GLY . 84.4 mmm -79.32 10.29 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.692 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.3 m -78.75 130.68 36.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.067 0.46 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.9 m -131.27 145.91 52.09 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.3 t -94.47 119.11 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.379 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.98 163.68 11.3 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 m -127.42 148.8 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.637 0.256 . . . . 0.0 110.386 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.93 130.55 56.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 58.3 mmm -100.65 142.27 32.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -73.52 151.27 41.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 0.0 110.585 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -57.92 -36.12 72.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.428 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -83.92 -0.14 50.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.421 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 59.38 30.17 19.83 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.61 -47.41 4.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.187 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -118.19 145.02 45.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.903 0.383 . . . . 0.0 111.055 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.4 141.79 46.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.06 130.13 56.27 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.14 133.47 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.593 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -116.51 128.9 55.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.722 0.296 . . . . 0.0 110.355 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.82 147.34 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.83 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -132.61 144.2 50.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 5.5 p90 -150.3 150.17 31.12 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.159 0.504 . . . . 0.0 111.058 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.08 -33.75 75.01 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 17.0 m120 -80.89 -2.46 47.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 36.0 t0 -61.68 -14.83 34.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -67.6 -38.2 83.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.28 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.09 126.71 35.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.068 0.461 . . . . 0.0 110.428 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.3 -35.41 75.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.136 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.9 -40.28 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 109.976 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.66 81.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.054 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.74 -39.27 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 0.0 109.279 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.663 ' HZ2' ' NZ ' ' A' ' 70' ' ' LYS . 22.0 tptp -64.31 -43.32 95.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.534 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.9 62.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.804 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.64 -52.08 32.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.747 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.34 -36.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.568 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.663 ' NZ ' ' HZ2' ' A' ' 66' ' ' LYS . 3.1 ttmp? -66.03 -39.94 90.62 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.43 -42.06 83.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.834 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.11 -36.24 74.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.116 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 76' ' ' SER . 61.0 tp60 -69.0 -45.5 70.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.59 -36.96 73.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.227 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.13 -8.78 59.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.218 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 81.9 p -57.15 -49.06 77.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.293 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.36 87.09 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.07 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -66.08 -44.52 84.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.464 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.29 -40.37 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 110.149 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -63.46 -45.55 90.32 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -68.88 -37.09 78.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.44 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.11 -38.36 90.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.254 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.92 -47.24 66.27 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.67 -42.15 72.53 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.722 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.43 -43.01 78.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.351 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.32 87.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.008 0.432 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 39.8 mtt -86.21 -17.6 34.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 70.8 mtp85 53.51 37.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -94.64 139.44 31.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.412 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 92' ' ' VAL . 94.6 mtt180 -86.65 -39.0 16.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.033 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.9 pt -76.22 33.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 90' ' ' ARG . 7.3 p -72.59 114.61 31.61 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -80.33 162.13 22.61 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.694 1.596 . . . . 0.0 112.036 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.67 133.29 50.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.19 131.41 44.57 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.104 0.478 . . . . 0.0 110.882 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.6 m -120.88 131.79 54.6 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.389 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.74 127.28 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.004 0.431 . . . . 0.0 110.98 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -126.04 146.16 50.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.0 p90 -109.54 132.48 54.1 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.788 0.328 . . . . 0.0 111.313 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.89 178.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.673 0.273 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -59.24 -39.85 84.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.995 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.1 t -58.02 -39.74 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.69 95.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.86 -40.35 96.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.697 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.97 -36.46 81.52 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.47 -40.96 63.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.47 -47.91 82.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.135 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -67.48 -37.83 83.46 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -64.19 -42.37 96.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.311 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.78 -40.65 86.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.33 87.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.082 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.59 -51.88 65.59 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.32 -34.41 68.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.766 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 tp -60.34 -40.42 90.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -83.07 -27.57 30.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.783 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -79.61 -46.45 17.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.38 -15.39 61.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 24' ' ' GLN . 31.7 mt -114.15 133.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -84.48 112.73 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -65.93 -39.15 27.88 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.235 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.2 Cg_exo -55.28 -34.39 88.21 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.021 1.814 . . . . 0.0 112.36 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.49 -37.89 79.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.445 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 63.7 mt -80.91 -20.26 42.54 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.89 4.27 90.1 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 57.1 mtt -151.62 167.15 29.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.833 0.349 . . . . 0.0 110.513 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -92.06 139.8 30.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.0 p -87.17 152.02 22.69 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 110.965 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -126.81 141.8 51.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.286 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.11 122.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -66.2 -35.22 79.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.237 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.67 160.69 10.02 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.34 146.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 111.1 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -121.43 139.4 53.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.609 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.3 mmm -109.39 139.97 43.68 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 89.3 p -73.99 153.64 39.64 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.418 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 56.9 t0 -82.45 -3.3 55.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.058 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.3 mp 56.38 23.31 7.2 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.42 -37.01 9.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.45 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.406 ' O ' ' OG ' ' A' ' 44' ' ' SER . 83.6 m-85 -123.14 150.79 42.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.21 141.9 35.9 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.305 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -119.63 125.09 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.598 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.26 134.58 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.285 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -108.8 135.8 49.42 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.57 147.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.255 0.55 . . . . 0.0 111.464 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 t -146.32 152.04 38.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.34 151.32 24.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.209 0.528 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.58 -25.55 68.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.833 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.493 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 84.9 m-20 -79.91 5.26 14.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.9 p30 -64.5 -15.4 60.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 15.2 ptpt -70.03 -33.88 72.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -90.22 116.67 28.38 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.82 -33.4 71.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.385 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.5 -39.12 91.5 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.448 0.642 . . . . 0.0 109.619 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.93 87.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.98 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.72 -38.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -66.76 -47.03 73.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.044 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.58 77.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.473 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.53 -50.72 24.47 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.572 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.7 tt -59.67 -36.71 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.768 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -68.14 -37.51 81.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.24 92.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.241 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' O ' ' OG ' ' A' ' 76' ' ' SER . 56.6 tp -68.35 -36.43 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.882 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -69.44 -45.81 68.25 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.3 -36.92 71.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.31 58.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.286 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 72' ' ' LEU . 20.7 m -56.5 -50.05 72.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.69 93.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.252 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.22 -42.99 87.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.727 0.298 . . . . 0.0 111.506 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.42 -40.8 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.352 0.596 . . . . 0.0 110.783 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -64.27 -45.35 88.42 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.259 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -69.45 -36.84 76.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.632 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.01 -37.54 81.54 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.66 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.32 -50.49 53.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.578 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.41 -43.87 96.14 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.596 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -70.83 -42.22 70.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.8 98.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.25 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtm -89.5 -15.82 32.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.831 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' GLY . 96.8 mtt180 53.42 36.65 23.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -94.74 139.1 31.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.04 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -82.69 -44.7 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.531 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 pt -75.79 40.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.917 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.74 114.59 31.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 72.8 Cg_endo -79.91 157.64 24.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.643 1.562 . . . . 0.0 112.256 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.97 138.07 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -94.97 127.9 41.37 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.11 0.481 . . . . 0.0 110.753 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -115.72 120.85 40.7 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.86 132.05 44.5 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 0.0 111.727 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -119.14 138.86 52.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -102.43 115.87 31.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -59.79 -39.62 85.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.86 -40.8 83.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.08 94.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.024 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -60.9 -39.6 89.92 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.993 0.425 . . . . 0.0 110.328 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.62 -37.33 83.57 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.1 -40.9 67.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.824 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.1 -42.43 80.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.455 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -63.02 -47.56 82.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.925 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -61.99 -34.57 76.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.579 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.62 -40.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.795 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 -37.35 87.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.42 -52.22 62.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.654 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.94 -34.63 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.43 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.7 mt -64.39 -33.66 76.38 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.061 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.584 ' NE2' ' SD ' ' A' ' 35' ' ' MET . 94.8 mt-30 -82.76 -27.71 30.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 0.0 111.346 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -87.65 -46.19 9.74 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.48 -12.55 60.83 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.508 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.24 132.11 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.21 109.98 17.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 8.8 t0 -65.32 -36.63 15.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.398 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 31.9 Cg_exo -58.82 -38.55 88.01 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.497 1.465 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -61.89 -38.58 88.85 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.216 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.5 mt -87.63 -19.77 27.28 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.68 5.42 89.98 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.3 ttm -163.9 151.91 12.91 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.584 ' SD ' ' NE2' ' A' ' 24' ' ' GLN . 58.7 ttp -83.24 141.49 31.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.09 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -81.48 153.86 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 111.01 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.5 m -122.92 143.84 49.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.11 118.96 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.001 0.429 . . . . 0.0 110.589 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.454 ' HG ' ' HG1' ' A' ' 55' ' ' THR . 32.0 m -66.51 -34.33 77.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.278 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.65 153.94 6.99 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -126.59 135.78 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.774 0.321 . . . . 0.0 111.081 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.74 137.96 52.99 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.3 mtt -112.57 142.34 45.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.413 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 p -76.91 152.43 35.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.182 0.515 . . . . 0.0 110.388 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -64.08 -32.86 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.677 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.47 -3.25 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.404 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.42 14.36 5.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.82 62.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.84 164.28 35.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.514 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.12 35.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.486 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -104.11 127.57 51.7 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.6 133.11 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.42 134.92 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -129.82 145.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 120.997 0.427 . . . . 0.0 110.537 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.454 ' HG1' ' HG ' ' A' ' 39' ' ' SER . 61.0 m -139.9 137.44 34.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.057 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.35 149.37 29.25 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.892 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.66 -15.34 63.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.531 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -81.12 -2.31 47.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.07 -15.3 62.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.426 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.88 -36.05 77.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.76 115.74 28.08 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -34.0 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.517 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.65 -38.69 91.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.376 0.607 . . . . 0.0 109.49 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.54 83.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.878 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.18 -41.05 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.84 -42.17 86.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.57 -46.12 64.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.65 -50.59 41.64 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.3 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.2 tt -59.48 -34.5 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.197 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -66.73 -41.18 88.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.81 78.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.802 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -69.48 -36.57 76.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.08 -45.01 71.37 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.212 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.51 -36.93 74.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.01 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.19 -7.05 56.61 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.141 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.8 t -55.57 -50.04 71.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.3 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -38.27 91.19 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.221 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -65.87 -43.58 87.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.593 0.235 . . . . 0.0 111.545 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.78 -39.72 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.56 0.695 . . . . 0.0 110.31 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -63.51 -46.26 86.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.272 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.1 t -70.22 -37.02 74.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.646 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.44 -37.45 86.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.345 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -68.45 -49.88 56.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -63.1 -43.88 98.07 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.349 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.67 -39.53 73.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 0.0 111.807 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.66 94.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.571 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.3 mtm -92.44 -13.55 29.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.485 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 30.9 mmt180 57.34 42.92 24.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.767 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.79 141.2 29.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.824 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -92.93 -16.86 24.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 pt -96.7 43.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.3 t -72.8 114.57 31.67 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 156.19 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.459 1.439 . . . . 0.0 111.433 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.47 125.99 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.3 mt -94.18 131.84 39.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.411 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -119.78 128.24 53.54 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.033 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.43 131.23 53.12 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 111.345 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.404 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.8 t80 -119.49 142.3 48.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.512 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 44.8 p90 -105.45 133.79 49.63 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.958 0.408 . . . . 0.0 110.292 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.79 0.329 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -59.22 -38.8 80.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.398 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.62 -40.39 79.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.14 93.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.221 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -64.84 -40.07 94.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.6 -37.85 85.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.24 -42.87 68.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.81 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.71 -41.79 82.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -64.06 -50.23 69.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -63.29 -34.77 78.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.727 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.26 -42.19 78.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.132 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.94 85.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.64 -52.92 61.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.53 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.33 -35.77 74.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.054 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.447 ' O ' ' CG2' ' A' ' 27' ' ' ILE . 9.6 tt -63.13 -37.25 86.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.284 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -74.38 -41.15 61.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 111.038 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -75.19 -42.5 55.59 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -73.08 -16.23 61.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.748 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 23' ' ' LEU . 12.6 tt -107.19 134.01 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -86.15 108.78 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -66.68 -38.61 19.67 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 35.9 Cg_exo -58.02 -33.69 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.479 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -59.38 -37.87 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.579 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.5 mt -82.36 -20.4 37.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.137 0.494 . . . . 0.0 109.692 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.62 3.85 90.35 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.399 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 94.3 mmm -147.85 171.17 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.897 0.38 . . . . 0.0 109.995 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.1 mtt -94.99 157.15 16.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.7 t -125.05 150.24 46.98 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -129.45 148.81 51.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.844 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 t -94.0 123.91 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.8 p -73.27 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.92 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.4 157.37 8.13 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.37 151.97 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.374 . . . . 0.0 110.771 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -135.96 142.21 44.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.9 mtt -96.95 139.02 33.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.257 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 86.5 p -73.88 160.73 31.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.269 0.557 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.441 ' CD ' ' N ' ' A' ' 45' ' ' ARG . 1.1 mpt_? -59.59 -32.35 70.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.694 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.2 m-20 -83.06 -4.34 58.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.098 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.8 mt 60.08 5.6 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -95.94 -22.94 17.1 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.972 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.418 ' O ' ' OG ' ' A' ' 44' ' ' SER . 97.6 m-85 -124.13 143.96 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.65 141.94 49.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.09 120.15 37.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.74 133.68 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.251 0.548 . . . . 0.0 109.798 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.77 136.19 50.2 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.298 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.99 147.09 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.04 0.448 . . . . 0.0 111.141 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -140.29 151.33 45.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.273 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.65 160.77 42.48 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.182 0.515 . . . . 0.0 111.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.0 mm? -67.34 -18.91 65.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.643 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -80.96 1.96 28.86 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.1 p30 -64.33 -15.08 59.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 60.9 tttm -69.09 -39.97 78.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.334 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -93.43 115.96 28.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.449 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.99 -35.95 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.29 -39.17 93.38 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.1 83.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.73 -39.14 83.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.16 -45.54 91.36 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.95 -36.38 77.86 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.3 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.44 52.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.737 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.7 -39.98 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.299 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.52 -36.96 83.98 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.907 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.9 77.53 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.53 -36.45 73.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.207 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.424 ' O ' ' OG ' ' A' ' 76' ' ' SER . 51.1 tt0 -69.57 -45.64 68.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.155 0.502 . . . . 0.0 110.475 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.24 -37.01 74.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.244 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.48 -12.83 60.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 58.0 p -58.0 -49.16 77.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.56 86.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.245 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -66.61 -44.57 81.73 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.535 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.29 -40.81 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.556 0.693 . . . . 0.0 110.559 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.523 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 62.3 ttt180 -63.88 -46.6 84.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.551 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 t -68.7 -37.29 79.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.646 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 27.6 mt -65.58 -35.98 82.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.493 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.3 -48.44 64.93 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.831 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.92 -41.2 73.04 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -70.72 -43.76 68.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.391 -0.904 . . . . 0.0 112.173 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' LEU . . . -63.21 -43.37 98.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.7 mtt -85.42 -15.42 43.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 81.4 mtm180 59.95 26.1 15.33 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.531 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.37 150.31 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.382 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' VAL . 70.5 mtp85 -100.87 -9.58 21.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.248 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 tt -59.07 -2.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 90' ' ' ARG . 27.3 m -70.36 116.09 41.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 172.5 14.45 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.841 1.694 . . . . 0.0 111.942 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.523 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 77.2 mm-40 -59.85 134.53 57.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.9 mt -100.65 128.32 46.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.957 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -113.26 127.32 56.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.52 129.06 55.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.195 0.522 . . . . 0.0 112.097 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -118.53 137.32 53.29 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 46.1 p90 -110.27 132.78 53.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.421 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.528 0.204 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HE ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -59.93 -39.69 86.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.213 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.73 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.299 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.96 81.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.107 0.479 . . . . 0.0 110.338 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.78 -46.81 62.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.652 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.38 -36.87 85.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.054 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.5 mtt -71.93 -40.89 68.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -54.86 -45.87 74.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.22 -45.8 86.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.26 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 85.2 tt0 -61.65 -33.89 74.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.2 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.97 -42.6 77.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.29 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -36.62 84.78 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.67 -52.94 54.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.076 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.0 mt -70.1 -35.03 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.65 -41.74 95.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.779 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -82.58 -41.29 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.313 0.578 . . . . 0.0 111.286 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -70.3 -40.8 74.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.57 -16.71 61.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.333 0.587 . . . . 0.0 110.195 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 24' ' ' GLN . 17.8 tt -116.05 149.48 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.326 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -67.3 122.85 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 110.059 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.07 -61.87 4.33 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.956 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.17 -27.63 57.21 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.727 1.618 . . . . 0.0 112.814 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -59.5 -38.04 79.86 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.215 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 70.4 mt -103.79 -2.18 26.76 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.0 5.86 72.79 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.4 ttt 63.03 8.44 3.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.2 mmm -81.35 18.4 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.1 m -76.03 128.05 34.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.319 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -132.7 143.06 49.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.967 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.5 t -98.72 120.35 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.944 0.402 . . . . 0.0 109.972 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 m -63.95 -36.14 82.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.256 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.72 155.84 7.45 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 m -127.39 152.27 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.957 0.408 . . . . 0.0 110.819 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -132.79 141.9 48.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.226 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.3 mtt -113.79 142.27 46.28 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 73.5 m -73.51 151.92 40.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.012 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -63.71 -29.58 70.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.337 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -83.6 -3.84 58.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 mt 60.38 24.54 14.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 -45.98 5.82 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.307 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.424 ' O ' ' OG ' ' A' ' 44' ' ' SER . 88.5 m-85 -119.65 146.75 45.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.15 0.5 . . . . 0.0 111.124 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.45 142.23 41.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.159 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.41 124.21 43.96 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.33 134.52 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.038 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -113.91 138.27 50.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.26 148.17 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.28 0.562 . . . . 0.0 111.187 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 m -141.67 132.8 26.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -135.93 146.44 47.31 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 178.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 7.0 mp -64.29 -23.03 67.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 83.8 m-20 -81.13 -7.0 59.47 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.33 -16.03 51.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -66.65 -33.09 74.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -89.91 117.96 29.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.29 -39.75 94.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.482 0.658 . . . . 0.0 109.432 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.76 -36.01 81.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.47 -39.7 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.5 -41.41 88.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.05 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -47.14 62.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.84 -50.46 41.44 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.274 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.39 -34.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.493 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.79 -41.21 87.98 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.381 0.61 . . . . 0.0 109.522 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 -40.88 75.09 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.041 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -70.31 -37.67 74.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.43 ' O ' ' OG ' ' A' ' 76' ' ' SER . 7.6 tt0 -68.64 -45.11 72.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.278 0.561 . . . . 0.0 110.163 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -69.79 -37.18 76.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.908 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -9.2 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 82.0 p -57.42 -50.67 72.26 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.89 93.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.52 -41.53 84.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.62 -39.72 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.645 0.736 . . . . 0.0 109.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -63.31 -46.01 88.68 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.523 ' OG ' ' NZ ' ' A' ' 85' ' ' LYS . 19.6 t -68.37 -36.64 79.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.434 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.57 -38.75 87.71 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.094 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 mt -68.99 -50.46 48.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.709 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.81 -44.13 97.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.54 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.523 ' NZ ' ' OG ' ' A' ' 81' ' ' SER . 47.4 mttp -71.3 -42.2 68.95 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.81 97.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.96 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 63.4 mtm -87.29 -19.49 28.19 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 84' ' ' GLY . 50.9 ttm-85 61.61 41.84 11.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.479 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.9 141.16 29.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.994 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -88.22 -26.34 22.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.532 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -89.75 45.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.569 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 114.2 28.65 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.133 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 78.6 Cg_endo -80.61 163.31 21.47 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.613 1.542 . . . . 0.0 111.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -72.39 130.75 41.45 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.6 mm? -93.17 128.18 39.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.155 0.502 . . . . 0.0 110.894 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 m -114.98 121.28 42.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -101.02 129.71 46.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.086 0.47 . . . . 0.0 111.818 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -119.77 138.95 53.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.393 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -102.0 132.3 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.579 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.408 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.0 mp0 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.78 0.324 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.25 -39.7 83.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.397 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.24 -40.84 84.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.54 86.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -65.88 -43.02 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.17 -37.37 84.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt -73.55 -36.04 65.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.9 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.03 -47.73 80.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -66.46 -37.34 84.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.984 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.4 tt0 -65.78 -40.39 91.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.28 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.35 -42.27 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 -38.12 89.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.282 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.07 -52.26 63.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.129 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.42 -33.48 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 60.7 tp -57.67 -36.33 71.77 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.375 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -84.4 -36.02 22.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -76.98 -47.74 19.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -75.45 -3.89 36.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.113 0.482 . . . . 0.0 110.346 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 47.5 mm -114.29 126.68 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.946 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -82.46 102.86 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 1.3 m-20 -78.34 -36.76 1.33 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.496 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 84.1 Cg_exo -48.47 -38.19 34.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.635 1.557 . . . . 0.0 113.323 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.41 -37.6 87.9 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.771 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.45 -20.18 34.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 109.795 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.55 84.84 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.2 mtt -147.89 156.25 42.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 110.313 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.2 mtm -97.69 148.04 23.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 p -87.63 156.05 19.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 p -124.13 160.93 26.71 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.26 128.71 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.829 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t -88.54 -14.91 36.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.7 148.54 5.16 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.58 128.84 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.43 139.98 53.38 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.979 0.418 . . . . 0.0 110.778 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.4 mtt -117.1 142.59 46.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.66 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 69.2 m -73.34 152.16 41.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.238 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -59.48 -31.67 69.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.528 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.4 -3.82 57.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.287 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.63 29.21 18.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.22 -49.17 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.031 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.426 ' O ' ' OG ' ' A' ' 44' ' ' SER . 84.7 m-85 -117.17 144.48 44.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.924 0.392 . . . . 0.0 111.021 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.99 141.08 50.22 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.615 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -122.59 117.84 26.79 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.382 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.9 135.41 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 120.708 0.289 . . . . 0.0 110.87 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.0 135.48 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 m -133.27 149.83 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.122 0.487 . . . . 0.0 111.379 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -131.35 156.43 45.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.948 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -157.5 153.57 27.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 111.814 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 59' ' ' ASP . 74.0 mt -76.65 -12.27 59.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.659 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -80.08 3.65 19.69 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 57' ' ' LEU . 24.2 p-10 -66.16 -15.6 63.27 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.87 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -67.87 -39.97 83.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.431 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -92.45 115.14 27.83 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.173 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.41 -34.54 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.57 -38.72 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.5 80.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.54 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.25 -46.15 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.601 . . . . 0.0 109.899 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -67.98 -47.77 67.65 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.86 -45.36 64.6 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.555 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -51.94 53.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.899 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 69' ' ' ILE . 97.4 mt -61.14 -34.84 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.021 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.35 -40.75 96.47 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.94 87.03 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.529 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.8 -36.78 81.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.358 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -68.15 -45.08 74.53 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.343 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.42 -36.99 74.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.254 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.06 -8.29 57.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.053 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -55.18 -48.64 73.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.426 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.37 -38.26 90.03 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.084 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.56 -42.17 92.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.604 0.24 . . . . 0.0 111.308 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.65 -42.62 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 63.3 ttt180 -63.12 -46.71 86.02 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.346 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 t -70.28 -36.94 74.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.375 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.63 -35.56 80.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.435 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -68.4 -50.4 53.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.97 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.5 -43.56 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.236 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.72 -40.84 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.179 0.514 . . . . 0.0 111.713 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.76 99.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.48 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 58.3 mtm -93.94 -8.89 38.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 91.9 mtt-85 54.86 36.03 25.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.62 141.13 32.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -97.73 -10.76 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.29 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -94.53 30.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.23 118.46 68.82 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 161.93 30.58 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.505 1.47 . . . . 0.0 111.834 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 78.1 mm-40 -60.08 136.17 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.53 130.85 47.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 0.0 111.059 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.3 m -120.79 128.39 52.84 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.87 126.25 54.9 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.994 0.426 . . . . 0.0 111.644 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -119.96 138.67 53.33 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -110.22 129.78 55.66 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.282 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.246 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.625 0.25 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.09 -37.86 78.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.652 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -38.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 0.0 110.274 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.8 82.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.455 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -71.62 -46.38 59.29 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.952 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -62.64 -36.55 83.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.9 ttm -70.51 -40.57 73.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.09 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.03 -41.96 75.79 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -62.64 -45.04 94.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.018 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.61 -33.18 75.04 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.469 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.23 -42.41 78.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.413 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.79 85.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.098 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.92 -52.49 64.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.602 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.2 mt -68.67 -33.9 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.128 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.3 tp -56.17 -43.29 78.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.848 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.1 mt-30 -83.1 -40.05 20.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 111.809 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -70.05 -39.96 75.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -72.56 -14.99 61.76 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.076 0.465 . . . . 0.0 110.377 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLN . 20.1 tt -119.23 143.34 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -83.45 115.11 21.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -69.99 -38.19 8.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.58 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.42 -37.28 81.72 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.816 1.677 . . . . 0.0 112.242 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -59.94 -37.8 80.57 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.362 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -78.24 -20.93 50.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.38 5.34 87.18 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm -171.82 154.69 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.655 0.264 . . . . 0.0 110.475 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.9 mtp -83.24 138.11 33.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -88.42 158.07 18.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -122.87 143.7 49.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.543 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.52 122.76 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -65.39 -36.09 82.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.08 159.17 9.13 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.18 148.83 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.896 0.379 . . . . 0.0 110.925 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -122.91 142.1 51.17 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.1 mmm -109.42 142.29 40.6 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.86 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 57.9 m -73.11 155.01 40.14 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 110.372 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -58.31 -34.25 70.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.499 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -83.69 -4.57 58.72 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 110.807 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.61 32.99 21.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.84 -46.59 3.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.609 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' O ' ' OG ' ' A' ' 44' ' ' SER . 83.9 m-85 -116.89 140.85 48.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.426 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.23 141.62 51.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.907 0.384 . . . . 0.0 110.801 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.29 130.59 55.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.169 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.66 134.34 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.002 0.429 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.05 133.87 53.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -131.14 147.17 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.345 0.593 . . . . 0.0 112.062 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -146.29 150.52 35.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.371 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.91 155.65 29.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.844 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 59' ' ' ASP . 60.8 mt -72.85 -14.77 61.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.744 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -81.07 3.43 23.3 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 50.4 p30 -66.37 -15.85 63.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.115 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -68.62 -36.4 78.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.355 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -91.03 117.09 29.31 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.14 -34.94 74.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.35 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.07 -38.32 90.41 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.44 0.638 . . . . 0.0 109.454 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.45 83.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.842 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.69 -41.93 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 109.584 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.68 -42.7 86.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.584 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.7 -44.77 66.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.012 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.98 -51.11 48.1 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.185 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 -37.15 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.002 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -65.39 -40.03 92.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.57 -41.76 83.65 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.554 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.1 -36.43 81.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.397 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.95 -45.95 69.42 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.148 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -71.29 -37.11 71.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.261 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.2 -6.31 54.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.505 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.5 p -58.9 -52.52 65.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.193 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.64 92.88 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.643 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -66.79 -44.38 81.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -68.11 -38.21 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.116 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -64.21 -47.16 80.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.558 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -71.09 -37.85 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.814 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.66 -36.99 85.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.407 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.14 -48.52 62.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.67 -42.32 99.74 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.11 -40.38 74.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.051 0.453 . . . . 0.0 111.598 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.74 96.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.157 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.1 mtt -88.22 -17.35 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.482 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 84' ' ' GLY . 72.7 mtm180 54.18 36.99 26.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.09 139.62 30.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.012 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 92' ' ' VAL . 89.0 mtt180 -92.36 -38.53 11.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.91 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.9 pt -73.55 26.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 90' ' ' ARG . 60.0 t -73.22 114.13 28.42 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 119.289 -0.386 . . . . 0.0 109.975 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.4 159.63 25.89 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.54 1.493 . . . . 0.0 111.632 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.45 137.38 58.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.56 130.01 46.57 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.223 0.535 . . . . 0.0 111.001 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.4 m -123.78 135.38 53.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.85 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -117.08 139.79 50.29 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.452 0.644 . . . . 0.0 112.134 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -121.66 153.94 37.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.728 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -109.15 134.07 52.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.649 -179.324 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.898 0.38 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -59.37 -37.9 79.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.099 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.92 -40.39 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.66 88.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.55 -39.94 94.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.484 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.57 -37.2 82.98 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.18 -42.76 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.525 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -55.75 -44.68 77.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.452 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -64.32 -46.8 81.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.542 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.71 -33.62 74.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.917 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.14 -42.44 79.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.61 84.87 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.106 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.15 -53.4 57.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.037 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.78 -33.52 56.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.455 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.52 -44.37 76.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.855 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.8 mt-30 -82.1 -40.91 21.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 111.686 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -69.65 -37.58 76.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.126 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 45.5 tp10 -71.99 -17.09 62.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.205 0.526 . . . . 0.0 109.974 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.7 pt -118.54 150.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.796 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -81.93 115.14 20.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -70.8 -37.85 6.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -179.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 44.2 Cg_exo -56.87 -38.15 96.53 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.839 1.693 . . . . 0.0 112.499 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -60.1 -37.54 80.3 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.14 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.526 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 64.9 mt -92.36 -8.02 46.16 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.558 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.79 28.61 50.39 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mtm 56.17 -126.21 2.01 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.464 -0.199 . . . . 0.0 110.464 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.8 mtm 45.24 48.2 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.618 0.247 . . . . 0.0 111.037 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.5 m -120.24 130.45 54.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.855 0.359 . . . . 0.0 110.386 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -132.94 145.15 50.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.6 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.78 118.64 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.2 m -65.75 -35.4 80.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.587 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.42 152.31 6.23 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.47 134.41 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.922 0.392 . . . . 0.0 110.95 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.52 141.43 49.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.039 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.3 mmm -111.45 141.85 44.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.521 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 73.7 m -73.45 151.76 40.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -60.67 -30.46 69.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.322 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 57.7 t0 -82.62 -3.86 56.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.4 mp 56.57 29.75 16.09 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.31 -49.02 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.737 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' O ' ' OG ' ' A' ' 44' ' ' SER . 85.8 m-85 -116.92 143.56 45.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.74 141.59 51.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.434 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -113.08 127.77 56.3 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.21 132.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.309 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -119.77 127.38 52.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 150.71 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.246 0.546 . . . . 0.0 111.798 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 149.87 52.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.895 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' A' ' 59' ' ' ASP . 6.3 p90 -156.2 155.34 32.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.358 0.599 . . . . 0.0 111.606 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.3 -13.58 59.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.602 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 71.3 m-20 -80.91 0.18 36.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 7.3 m-20 -61.93 -19.53 62.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -68.22 -34.94 77.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.103 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.78 115.74 27.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.048 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 51.0 mp0 -59.69 -34.27 72.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.35 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.97 -37.34 87.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.376 0.608 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.17 83.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.554 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.72 -47.04 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.16 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.98 -46.33 71.64 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.357 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.06 -46.34 65.18 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.213 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.44 -51.41 48.86 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.455 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.5 tp -60.12 -34.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.473 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -67.1 -40.23 86.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.251 0.548 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.19 -41.86 76.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.843 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 76' ' ' SER . 52.7 tp -70.3 -36.65 74.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.136 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -68.78 -45.38 71.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.243 0.544 . . . . 0.0 110.316 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -70.6 -37.08 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.35 -8.63 57.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.544 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 72' ' ' LEU . 48.7 m -56.12 -50.46 71.02 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.036 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.69 94.31 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CE1' ' OE2' ' A' ' 26' ' ' GLU . 35.4 t80 -63.4 -43.15 98.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.64 -39.44 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.421 0.629 . . . . 0.0 110.359 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.522 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 74.2 ttt-85 -60.95 -46.16 91.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.937 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -70.21 -37.75 75.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.533 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.63 -37.84 76.97 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.82 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.78 -46.43 68.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.078 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -60.32 -42.48 98.83 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.99 -36.48 75.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.465 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.83 95.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.508 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.0 mtm -101.52 -3.91 27.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 53.41 43.77 30.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.505 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.1 mt -100.55 141.07 33.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.142 0.496 . . . . 0.0 111.701 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -97.99 -10.82 23.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.95 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.3 pt -98.56 21.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.814 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.7 116.46 50.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.05 160.63 26.84 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.713 1.608 . . . . 0.0 112.068 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.522 ' CD ' ' HE ' ' A' ' 80' ' ' ARG . 78.3 mm-40 -60.42 137.45 58.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.5 mt -100.37 130.15 46.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.961 0.41 . . . . 0.0 110.676 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.7 m -119.95 127.48 52.7 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -108.0 126.41 52.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.144 0.497 . . . . 0.0 111.308 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -120.93 138.26 54.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.333 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 37.7 p90 -107.74 113.85 27.39 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.866 0.365 . . . . 0.0 110.318 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.9 t0 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.935 179.654 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.756 0.312 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -59.5 -39.93 85.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.53 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.56 -40.23 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.92 91.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.183 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -63.86 -39.9 95.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.368 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.5 -37.64 84.42 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.2 -43.77 66.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.925 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.31 -42.44 77.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.337 0.589 . . . . 0.0 109.842 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.92 -49.82 71.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.228 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.66 -35.34 80.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.306 0.574 . . . . 0.0 110.747 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.155 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.284 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.57 -53.36 58.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.345 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.3 mt -70.23 -34.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.442 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.8 tp -55.95 -45.53 78.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.785 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 12.5 pt20 -84.49 -42.03 15.97 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.973 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 24' ' ' GLN . 50.7 mtp180 -70.45 -33.76 71.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -72.25 -15.75 61.92 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.452 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.8 pt -119.4 149.68 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.669 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.36 117.26 29.85 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -74.12 -38.12 3.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.496 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.2 Cg_exo -55.61 -31.61 79.94 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.108 1.872 . . . . 0.0 112.554 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.54 -37.72 79.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.684 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 mt -81.51 -20.06 40.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.979 0.419 . . . . 0.0 109.918 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.35 5.52 89.51 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.3 mtt -143.95 168.78 19.17 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.2 mtp -113.02 158.08 20.74 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 55' ' ' THR . 13.2 t -128.74 153.71 47.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.529 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.6 m -127.57 148.04 50.35 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.84 118.59 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.4 p -67.8 -30.51 69.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.14 157.41 8.04 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.57 152.82 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -130.36 141.05 50.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -103.75 141.66 35.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.936 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 67.5 m -73.06 154.69 40.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.639 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -58.21 -32.47 68.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.572 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -82.93 -3.99 57.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.449 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 58.87 26.58 15.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -104.86 -47.91 3.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.849 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.432 ' O ' ' OG ' ' A' ' 44' ' ' SER . 87.5 m-85 -114.69 143.7 44.62 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.885 0.374 . . . . 0.0 110.541 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.22 141.39 51.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -108.41 128.57 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.991 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.33 133.39 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.6 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.86 132.26 55.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' CG1' ' CZ ' ' A' ' 56' ' ' PHE . 22.0 t -131.13 148.03 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.345 0.593 . . . . 0.0 111.874 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 36' ' ' THR . 37.5 m -119.2 129.34 54.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.838 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CZ ' ' CG1' ' A' ' 54' ' ' VAL . 84.8 m-85 -119.67 142.01 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.897 0.379 . . . . 0.0 111.778 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.67 -13.54 57.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 82.1 m-20 -81.34 -0.41 41.04 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.9 p30 -66.03 -15.01 62.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.96 177.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 61.2 tttp -67.37 -39.86 85.7 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.544 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -109.28 117.7 34.78 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -58.34 -35.86 72.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.85 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.36 -38.0 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.685 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.0 -45.56 73.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.64 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.35 -33.41 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.37 . . . . 0.0 111.149 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.08 -40.52 94.75 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.39 -46.1 64.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.35 -50.23 39.94 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.533 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.26 -34.67 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.247 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.47 -41.52 88.88 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.86 76.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.909 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.04 -36.61 75.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.637 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.15 -44.34 76.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.218 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.85 -36.57 80.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.281 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.12 -9.0 58.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.256 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.4 m -55.82 -45.99 78.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.159 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.75 -38.29 91.67 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -64.87 -42.91 94.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.019 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -58.22 -39.62 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.592 0.71 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -61.42 -44.76 96.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 t -70.12 -36.75 75.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.617 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.37 -41.43 76.55 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.58 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 tt -69.05 -48.48 62.73 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.633 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -65.68 -44.02 93.25 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.553 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.72 -37.89 73.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 112.024 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.73 98.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 74.7 mtm -99.83 -5.95 27.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.836 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' GLY . 66.4 mtt85 49.52 40.88 20.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.43 138.7 31.37 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.626 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -92.49 -38.4 11.97 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.223 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 pt -78.46 19.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.519 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -72.67 114.42 30.05 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.98 157.88 30.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.501 1.468 . . . . 0.0 112.099 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 38.0 mp0 -60.96 139.87 57.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.99 132.81 46.22 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.014 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.2 m -119.0 128.03 54.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.91 127.32 51.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.282 0.563 . . . . 0.0 111.426 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 52.0 t80 -126.91 147.73 50.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 51.1 p90 -101.28 129.13 47.19 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.767 0.318 . . . . 0.0 110.223 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.791 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -59.02 -37.24 76.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.298 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.57 -40.51 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.042 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.54 87.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.592 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.85 -43.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.597 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.32 -39.32 92.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mmt -66.98 -42.17 85.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.442 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.88 -41.92 88.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.783 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -63.48 -47.36 82.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.095 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -62.96 -35.33 79.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.07 -42.88 79.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.58 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.41 84.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.471 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.7 tp -60.76 -53.38 58.11 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.26 -34.48 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.514 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.11 -45.87 79.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.905 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.3 mt-30 -83.23 -39.33 21.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.114 0.483 . . . . 0.0 112.068 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -69.79 -38.76 76.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.05 -16.1 62.03 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.907 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 24' ' ' GLN . 9.6 pt -116.58 149.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.304 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -86.61 125.8 34.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.51 -63.0 1.05 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.612 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -56.94 -23.82 53.53 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -58.94 -37.1 75.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.199 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -77.62 -20.55 53.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.43 5.09 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 62.4 mtt -146.73 167.8 22.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.812 0.339 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -104.9 152.49 22.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.625 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -130.68 155.29 46.85 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.798 0.332 . . . . 0.0 110.752 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -137.4 159.03 43.1 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.423 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.12 123.11 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.42 ' OG ' ' OD2' ' A' ' 100' ' ' ASP . 86.7 p -69.93 -28.7 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.26 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.71 153.89 6.48 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.2 148.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.744 0.307 . . . . 0.0 110.454 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -129.26 139.69 51.72 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.5 mmt -105.81 142.41 35.58 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.8 t -73.76 151.94 40.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.136 0.493 . . . . 0.0 110.343 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.24 -29.99 66.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.623 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.7 -3.36 57.71 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.546 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? 56.51 29.9 16.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.79 -48.41 3.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.789 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -116.78 141.57 48.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.46 51.86 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.452 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.69 127.7 54.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.34 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.48 133.27 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.623 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.08 133.66 55.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.27 149.79 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.442 0.639 . . . . 0.0 111.84 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -129.67 135.98 49.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.49 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -146.02 154.77 42.24 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.546 0.689 . . . . 0.0 112.22 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.3 mm? -80.08 -11.26 59.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.592 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.488 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 88.1 m-20 -79.49 -0.25 32.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.0 p30 -68.09 -14.84 63.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 35.1 ttpt -69.27 -38.51 78.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.541 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.59 119.03 38.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.018 0.437 . . . . 0.0 110.114 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 50.7 mp0 -59.48 -32.97 70.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.22 -39.02 75.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.254 0.549 . . . . 0.0 110.794 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.05 74.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.748 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.93 -33.58 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.448 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.75 -44.51 85.7 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.22 -44.77 67.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.39 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.8 -50.73 39.76 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.485 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.3 tt -59.46 -34.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.922 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -66.1 -42.19 89.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -40.72 87.25 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.649 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.92 -36.26 79.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -68.92 -45.63 70.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.083 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.15 -37.08 72.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.95 -8.91 58.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.177 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -57.09 -50.09 73.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.122 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.38 90.78 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.33 -43.6 94.13 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.269 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -58.61 -41.57 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 109.744 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 94' ' ' GLU . 39.8 ttm180 -63.14 -46.76 85.7 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -70.64 -38.04 73.83 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.98 -38.58 79.41 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.002 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.94 -40.61 83.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.157 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.89 -34.54 71.52 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -67.53 -43.29 81.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.392 -0.904 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.19 85.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.594 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtt -85.68 -17.19 36.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.5 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 84' ' ' GLY . 73.9 mtp180 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.244 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.3 mt -101.15 141.55 33.88 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.124 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -97.43 -14.95 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.559 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.69 21.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.773 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.85 114.14 27.8 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.141 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 89.3 Cg_endo -77.66 161.59 30.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.298 1.332 . . . . 0.0 111.098 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 80' ' ' ARG . 79.0 mm-40 -64.62 136.49 57.04 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.249 -0.581 . . . . 0.0 109.521 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' PRO . 7.1 mp -98.94 129.87 45.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.062 0.458 . . . . 0.0 110.365 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -117.9 127.63 54.04 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.28 126.65 51.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.126 0.489 . . . . 0.0 111.157 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 48.1 t80 -126.17 146.14 50.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.475 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 47.9 p90 -99.8 129.02 45.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.855 0.36 . . . . 0.0 110.435 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 56.3 p-10 . . . . . 0 N--CA 1.474 0.772 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.378 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.823 0.344 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -59.29 -38.18 79.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.152 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.77 -40.79 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.81 88.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.146 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.48 -40.88 96.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.607 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.44 -36.96 81.83 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.3 -39.09 65.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.268 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -49.11 76.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.548 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -67.18 -37.71 84.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.099 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.1 tt0 -68.76 -39.94 80.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.43 -42.78 97.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.36 86.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.9 tp -60.68 -52.92 63.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.25 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -69.14 -34.01 61.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.22 -42.31 85.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.577 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -82.43 -41.89 19.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.307 0.575 . . . . 0.0 111.337 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -70.23 -37.15 74.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.35 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.22 -15.28 61.94 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.181 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 pt -113.89 150.42 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.18 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -78.5 130.52 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.028 0.442 . . . . 0.0 110.342 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.59 -62.0 3.31 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.962 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.74 -28.18 55.89 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.714 1.609 . . . . 0.0 112.725 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.31 -37.77 78.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.447 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 72.2 mt -99.02 -1.94 38.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.143 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.9 9.16 62.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm 58.97 60.79 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.571 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.2 mtt -150.6 72.8 1.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.4 p -126.04 140.92 52.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.6 m -139.71 142.78 36.85 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.208 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.76 117.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 m -68.21 -31.19 70.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.63 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.53 6.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.41 133.0 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -131.73 141.25 49.48 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.6 mpt? -111.44 143.17 42.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.412 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.5 t -72.63 151.86 42.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.662 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -56.29 -35.01 67.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.383 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.07 -4.98 58.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.695 0.283 . . . . 0.0 110.757 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 tp 60.01 34.45 21.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.61 -48.23 3.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.674 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -117.79 139.13 51.5 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.428 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.84 141.11 52.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.804 0.335 . . . . 0.0 110.226 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -119.58 118.79 31.94 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.96 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -119.43 134.66 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.014 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -108.56 136.35 48.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.058 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.33 150.82 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.1 0.476 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -140.95 152.06 44.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.023 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -156.04 146.77 21.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.392 0.615 . . . . 0.0 111.646 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -66.05 -18.67 65.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.411 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 25.3 m120 -80.4 2.48 24.83 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.7 p30 -65.64 -15.12 62.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -70.22 -35.61 74.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.502 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -90.51 119.83 31.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.755 0.312 . . . . 0.0 110.368 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.6 -37.47 81.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.679 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -63.5 -38.92 92.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.483 0.658 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.08 82.33 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.96 -47.08 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.352 0.596 . . . . 0.0 109.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.52 -38.48 84.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.659 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.24 65.43 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.206 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.54 -52.71 15.02 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.045 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.91 -39.68 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.248 0.524 . . . . 0.0 112.064 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.37 -35.82 80.12 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.048 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.16 68.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.739 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 76' ' ' SER . 36.7 tp -71.11 -36.99 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.765 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.25 -45.49 73.07 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.33 0.586 . . . . 0.0 110.261 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.95 -36.93 75.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.082 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.66 -7.24 59.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.655 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 72' ' ' LEU . 75.5 m -55.55 -50.01 71.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.685 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.15 -35.62 85.02 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -64.93 -45.98 83.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.88 -39.54 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.512 0.673 . . . . 0.0 110.123 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -62.03 -45.07 95.2 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.526 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -71.01 -38.25 72.63 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.28 -42.41 75.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.73 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.88 -39.72 83.66 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.763 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.77 -39.46 76.63 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -68.38 -38.02 80.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.189 -1.005 . . . . 0.0 111.347 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.9 99.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.558 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 69.0 mtm -98.34 -6.92 29.86 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 98.8 mtt180 49.59 38.27 14.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 109.316 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 37.1 tp -90.98 140.4 29.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.968 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -90.08 -38.59 13.45 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.731 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 pt -78.28 34.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.731 0.3 . . . . 0.0 111.744 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.3 t -73.46 115.31 40.09 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.8 161.31 30.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.366 1.377 . . . . 0.0 111.884 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.27 138.36 58.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.24 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -122.23 131.23 53.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.397 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -108.54 130.33 55.29 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.048 0.451 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -119.43 141.23 49.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -97.77 118.62 34.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 111.524 -179.014 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -57.58 -37.23 72.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.215 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.56 -38.82 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.612 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -63.05 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.99 -36.11 80.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.4 mtt -73.17 -38.99 66.0 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.987 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.4 -49.06 78.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.087 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -67.8 -40.77 83.85 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.071 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.98 -38.66 86.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.63 -44.06 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -37.04 86.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.3 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.29 -53.32 58.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.043 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.71 -34.27 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.716 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.99 -41.9 84.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -83.3 -38.16 22.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.209 0.528 . . . . 0.0 111.909 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -71.16 -43.87 66.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.1 -13.82 61.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.52 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.1 tt -112.17 142.44 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -80.25 117.15 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 6.8 t70 -73.2 -35.6 2.83 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.8 Cg_exo -55.66 -29.82 72.46 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.966 1.778 . . . . 0.0 113.176 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -59.99 -36.64 77.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.742 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.36 -20.02 55.39 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.368 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.66 5.79 74.14 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.594 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 14.8 ptp -174.75 175.7 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.5 mtm -89.14 161.23 16.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.268 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -124.07 155.15 38.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.656 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.0 p -121.35 160.9 23.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.943 0.402 . . . . 0.0 110.96 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.43 123.75 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.828 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.436 ' CB ' ' OD2' ' A' ' 100' ' ' ASP . 23.2 t -68.31 -35.55 77.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.6 158.49 8.28 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.15 147.01 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 110.986 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -119.51 138.14 53.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.522 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.9 mmm -108.62 142.26 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 54.8 m -72.93 152.01 41.61 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -63.59 -30.5 71.61 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.409 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 56.4 p30 -83.68 -2.64 56.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.118 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.6 32.86 21.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -108.75 -47.66 3.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.174 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.429 ' O ' ' OG ' ' A' ' 44' ' ' SER . 91.6 m-85 -117.28 139.02 51.34 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.0 0.428 . . . . 0.0 111.179 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.53 141.5 51.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -113.67 130.03 56.47 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.188 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.69 133.82 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.705 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.84 132.44 56.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.9 151.06 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.098 0.475 . . . . 0.0 111.857 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -144.19 149.86 37.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 59' ' ' ASP . 6.9 p90 -159.21 159.95 34.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.29 0.567 . . . . 0.0 111.577 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.95 -25.76 66.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.401 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.594 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 27.6 m120 -80.31 0.93 30.78 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.891 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 13.8 m-20 -63.43 -15.1 56.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -69.44 -36.7 76.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.049 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -91.09 113.9 26.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.19 -35.99 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.81 -38.1 89.85 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.42 0.629 . . . . 0.0 109.458 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.59 84.24 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.51 -38.48 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 109.921 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -66.43 -40.75 89.7 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.03 66.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.72 -50.07 32.66 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.644 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.67 -38.7 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.663 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.27 -36.18 79.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.58 80.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.719 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.35 -36.56 74.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.962 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -68.8 -45.36 71.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.138 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.9 -37.09 72.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.955 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.62 -7.8 57.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.067 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 t -57.85 -52.86 63.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.565 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.45 93.86 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.954 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.74 -44.56 85.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -68.86 -37.29 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.174 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.74 -46.45 88.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.666 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 t -67.62 -38.12 83.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.1 tp -68.93 -34.38 75.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.262 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.83 -46.79 74.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.744 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -58.61 -40.97 95.36 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.851 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.58 -40.8 93.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.94 0.4 . . . . 0.0 111.212 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.77 99.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtt -82.21 -17.3 46.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' GLY . 83.1 mtp180 57.85 34.01 23.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.261 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.08 141.44 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.737 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -97.93 -10.23 24.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.453 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pp -106.96 34.21 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.27 124.77 90.89 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ALA . 88.8 Cg_endo -75.52 157.97 40.36 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.436 1.424 . . . . 0.0 112.304 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 39.3 mp0 -61.43 138.73 58.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.7 130.55 48.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.478 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 m -121.98 131.37 53.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.727 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.87 128.83 54.96 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.223 0.535 . . . . 0.0 111.015 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 41.5 t80 -129.64 152.28 49.32 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.7 p90 -104.81 132.43 51.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.658 0.266 . . . . 0.0 110.53 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' CB ' ' A' ' 39' ' ' SER . 56.3 p30 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.626 0.25 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -58.29 -40.5 82.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.386 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 p -59.41 -38.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.729 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' GLN . . . -62.13 -39.12 91.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -66.06 -42.66 89.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.15 -39.52 92.91 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.5 mtt -74.06 -35.61 64.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.107 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . 49.4 tt0 -57.33 -48.8 78.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.563 . . . . 0.0 110.617 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -68.7 -36.46 78.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.075 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.03 -41.42 86.59 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.659 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -69.56 -36.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.517 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.555 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.24 -52.93 51.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.759 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.54 -33.58 57.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.044 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.2 -40.08 84.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.577 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.84 -44.07 19.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.397 0.618 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -69.85 -35.12 74.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.849 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -72.04 -14.34 61.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.016 0.436 . . . . 0.0 109.988 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.85 149.86 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.083 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.79 107.61 19.48 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.53 -41.92 93.07 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.93 -178.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 34.3 Cg_exo -61.69 -33.96 84.89 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.185 1.923 . . . . 0.0 112.815 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.98 -39.51 85.93 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.55 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 mt -104.91 -19.76 13.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 69.83 16.99 72.89 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 ttp -108.04 145.77 33.51 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.634 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -103.04 144.46 31.25 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.122 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.6 m -110.7 132.06 54.52 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -128.88 156.44 43.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 116.22 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.914 0.387 . . . . 0.0 110.544 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.9 t -70.63 -30.69 67.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.602 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.64 156.14 8.37 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.37 132.18 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.692 0.282 . . . . 0.0 110.846 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -127.17 137.84 53.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.176 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtt -109.86 143.71 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.8 t -77.29 151.09 35.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.117 0.484 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -60.97 -31.05 70.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.939 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.6 m-20 -83.17 -3.62 57.55 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.43 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 58.87 11.07 1.73 Allowed 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -75.02 -36.02 61.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -150.76 166.66 29.77 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.56 141.83 43.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -101.04 125.47 47.66 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.34 133.55 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 120.944 0.402 . . . . 0.0 110.476 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.42 149.37 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 121.248 0.547 . . . . 0.0 111.095 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 m -133.27 135.64 45.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' A' ' 59' ' ' ASP . 35.4 m-85 -123.06 153.13 40.29 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.3 tp -72.26 -35.71 68.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.632 0.73 . . . . 0.0 110.397 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -81.27 8.13 9.76 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.8 p30 -60.96 -20.13 61.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 25.8 pttm -68.99 -30.04 68.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -90.7 117.2 29.15 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.31 -34.87 74.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.714 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.02 -38.81 89.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.455 0.645 . . . . 0.0 109.576 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.75 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.12 -38.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -66.37 -45.67 79.33 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.489 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.97 -43.01 72.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.823 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.6 28.58 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.589 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.7 tp -59.09 -37.63 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.719 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.09 -35.9 78.91 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.876 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.4 78.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.002 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' SER . 79.8 mt -71.22 -36.35 71.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.533 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.38 -45.55 75.92 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.291 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -71.18 -37.11 72.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.28 -3.55 57.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.392 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 72' ' ' LEU . 22.9 t -55.44 -51.16 67.83 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.899 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.56 92.64 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -63.04 -43.87 97.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.581 -0.309 . . . . 0.0 111.275 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.8 -40.21 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.372 0.606 . . . . 0.0 110.787 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.77 -46.02 89.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.048 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.5 m -70.48 -36.95 74.14 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.571 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -69.31 -37.94 78.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.542 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.27 -42.41 79.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.879 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.91 -41.9 71.01 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -66.21 -39.41 89.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.289 -0.956 . . . . 0.0 112.128 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.18 87.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.247 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.1 mtm -97.69 -5.39 35.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.44 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.9 mtm180 49.31 41.98 21.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 110.056 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.9 tp -92.04 140.32 29.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.416 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -95.09 -41.29 9.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.7 pt -71.43 29.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.601 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 90' ' ' ARG . 88.6 t -73.45 114.2 29.47 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.276 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 160.62 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.5 1.467 . . . . 0.0 110.838 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.38 127.27 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.9 mt -94.2 131.02 40.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.207 0.527 . . . . 0.0 111.512 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.9 m -120.18 130.5 54.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.201 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -104.74 127.32 52.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.938 0.399 . . . . 0.0 110.752 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 39.9 t80 -132.23 151.72 51.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.002 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 51.0 p90 -105.61 132.51 51.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.969 0.414 . . . . 0.0 111.191 -179.54 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.09 -37.71 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.254 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.0 t -58.08 -40.04 75.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.09 93.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.083 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -63.83 -39.23 93.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.333 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.84 -36.3 80.77 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.8 mtt -72.84 -39.93 66.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.534 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.59 -47.41 79.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.774 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -66.49 -36.87 83.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.229 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -65.48 -41.69 93.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.67 -41.28 87.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.28 86.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.299 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.2 tp -60.92 -51.89 67.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.209 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.58 -34.44 65.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.24 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -59.17 -40.85 86.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.841 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -82.24 -41.31 20.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.354 0.597 . . . . 0.0 111.481 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -70.59 -41.57 72.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.04 -15.74 61.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.173 0.511 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.3 tt -114.42 148.2 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.75 119.4 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 30.9 t0 -78.89 -35.68 1.09 Allowed Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 47.4 Cg_exo -56.52 -34.49 95.15 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.766 1.644 . . . . 0.0 112.763 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -60.07 -38.01 81.58 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.267 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.81 -20.88 45.07 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.78 88.62 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.662 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.417 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 47.5 ttm -171.94 154.8 3.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.593 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -79.48 140.98 37.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.7 p -89.18 165.51 14.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.2 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -127.14 156.2 42.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.57 125.41 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.966 0.413 . . . . 0.0 110.393 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -67.54 -34.08 76.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.41 159.94 9.53 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.51 148.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.933 0.396 . . . . 0.0 111.262 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -124.08 138.09 54.48 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.748 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 mmm -113.14 142.33 45.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -73.85 150.76 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.734 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -60.6 -33.52 72.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.248 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.99 -3.54 57.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.408 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.0 mt 60.19 30.57 19.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.61 -48.21 3.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.888 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.6 144.36 44.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.953 0.406 . . . . 0.0 110.952 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.64 142.03 45.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.549 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -122.06 125.43 46.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.28 134.46 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.69 139.71 41.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.061 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.47 146.32 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.266 0.555 . . . . 0.0 111.467 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -133.6 139.39 46.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.318 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -149.2 143.9 26.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.96 0.41 . . . . 0.0 110.026 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.487 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 1.2 pt? -77.66 -12.15 59.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.834 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.78 3.22 20.15 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 57' ' ' LEU . 54.5 t0 -61.5 -16.53 48.27 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -69.64 -36.76 76.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 63' ' ' ASP . 65.2 t0 -90.84 114.01 26.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.722 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.26 -35.03 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.73 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 3.4 p30 -67.01 -33.52 75.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.133 0.492 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -67.98 -37.15 81.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.74 -44.7 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.341 0.591 . . . . 0.0 109.986 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.46 -41.0 85.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.018 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.48 -46.16 64.3 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.688 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.98 -51.73 27.35 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.472 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 mm -59.14 -37.79 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.567 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.39 -39.84 92.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.68 -41.81 74.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.939 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.1 tp -70.38 -36.52 74.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.67 -45.0 69.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.308 0.575 . . . . 0.0 110.386 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -36.86 74.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.028 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.38 -7.86 55.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 t -55.07 -50.55 68.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.11 -39.04 93.89 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -66.94 -40.33 87.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.41 -41.43 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 109.833 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.9 -47.19 81.58 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.535 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -70.93 -36.23 72.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.821 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.81 -34.56 76.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.063 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.36 -46.08 74.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.545 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -66.52 -36.93 92.17 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.985 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.58 -43.55 89.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.72 -0.74 . . . . 0.0 111.714 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.26 -43.73 66.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.798 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.7 mtt -80.65 -17.96 49.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 84' ' ' GLY . 40.5 ttp180 61.47 29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.487 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.58 141.66 35.04 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.217 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -97.38 -11.91 23.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.094 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -84.03 24.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.33 119.13 73.11 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.34 161.48 31.78 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.447 1.432 . . . . 0.0 111.882 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.04 134.11 56.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.6 mt -99.76 131.04 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.085 0.469 . . . . 0.0 110.883 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -118.6 123.13 44.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -102.69 131.11 49.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 54.4 t80 -119.03 141.92 48.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.603 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.412 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 43.2 p90 -106.87 134.53 49.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 -179.817 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.639 0.256 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -60.31 -43.31 96.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 p -65.6 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.721 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.09 79.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.45 -40.42 95.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.24 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -38.38 87.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 91.1 mmm -70.66 -40.13 73.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.513 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.562 HE21 ' H ' ' A' ' 41' ' ' VAL . 51.2 tt0 -55.32 -43.21 74.69 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.551 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -62.73 -45.35 93.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.182 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.59 -34.66 78.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.788 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.5 mt -70.5 -42.3 78.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.69 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.77 85.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.034 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.53 -53.06 61.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.641 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.5 mt -69.81 -33.94 58.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.503 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.7 tp -56.67 -41.56 77.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.813 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.4 tt0 -82.11 -42.8 18.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.285 0.564 . . . . 0.0 111.267 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.39 -36.62 76.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.94 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -71.81 -17.05 62.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.214 0.53 . . . . 0.0 109.909 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.2 pt -119.44 150.54 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.067 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.2 120.52 24.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -73.13 -39.09 4.89 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.4 Cg_exo -52.91 -38.35 78.94 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.012 1.808 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -63.93 -37.73 88.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 mt -99.7 -9.79 22.68 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.719 0.295 . . . . 0.0 110.514 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 35' ' ' MET . . . 81.01 17.88 71.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.3 ttp 60.61 3.01 0.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.334 0.588 . . . . 0.0 109.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 33' ' ' GLY . 64.9 mtt -58.29 -28.02 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.781 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -65.98 129.42 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -131.39 148.39 52.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.898 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.93 117.75 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 0.0 109.788 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 m -66.48 -35.9 81.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.508 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 160.58 10.04 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.562 ' H ' HE21 ' A' ' 16' ' ' GLN . 5.4 m -127.14 152.78 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -132.79 139.9 47.75 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.42 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.2 mtt -97.16 140.3 31.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' HG ' ' H ' ' A' ' 49' ' ' TYR . 97.7 p -73.66 160.14 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.955 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.8 ttm105 -58.01 -32.78 68.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.507 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -82.6 -3.88 56.81 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.271 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.0 mt 59.17 15.26 4.03 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.13 -36.79 8.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.901 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.455 ' H ' ' HG ' ' A' ' 44' ' ' SER . 85.4 m-85 -115.6 146.25 41.95 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.724 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.19 141.75 47.17 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.787 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -108.88 128.08 54.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.299 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.1 133.38 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.292 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.44 130.16 56.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.14 148.68 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.007 0.432 . . . . 0.0 110.94 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 t -135.43 151.55 50.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -144.63 141.85 29.69 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.275 0.56 . . . . 0.0 111.037 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.9 tp -68.74 -22.49 64.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -80.3 5.57 14.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 53.7 p30 -61.85 -17.43 56.41 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 48.1 mtmt -68.88 -35.85 77.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.339 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -89.73 118.57 29.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.011 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.1 -35.49 75.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.907 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.78 -39.57 93.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.608 0.718 . . . . 0.0 109.275 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.53 80.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.588 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.44 -42.83 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.679 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.15 -47.68 70.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.258 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.45 69.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.826 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -51.27 37.34 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.857 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.03 -40.98 81.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.223 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.79 -35.02 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.951 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.4 76.82 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.335 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.11 -36.82 72.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.198 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 76' ' ' SER . 67.9 tp60 -70.02 -45.38 67.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.347 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.67 -37.06 73.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.487 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.62 -12.06 60.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.345 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 92.5 p -55.66 -50.2 70.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.503 -177.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.83 95.06 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.485 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.72 -41.44 92.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.39 -39.84 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.321 0.582 . . . . 0.0 110.622 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.36 -47.74 80.84 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.023 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.1 m -71.45 -38.37 71.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.211 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.5 tp -68.07 -37.79 81.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.311 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.35 -41.33 80.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.73 -36.04 74.52 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -70.05 -43.68 70.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.529 -0.835 . . . . 0.0 111.614 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.61 89.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.522 . . . . 0.0 109.909 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.8 mtt -84.9 -17.69 37.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.15 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' GLY . 39.7 mmm-85 59.52 25.32 14.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.99 141.77 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.108 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.71 -10.45 19.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.413 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.1 pt -75.21 7.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.353 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.55 122.21 86.92 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.75 163.68 28.72 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.616 1.544 . . . . 0.0 111.749 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.02 133.47 56.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.31 129.73 44.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -119.38 127.96 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.51 129.85 52.5 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.181 0.515 . . . . 0.0 111.468 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -119.11 138.69 52.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.568 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 24.6 p90 -102.69 128.69 49.29 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.935 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.46 0.059 0 CA-C-O 120.771 0.319 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -58.93 -37.63 77.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' SD ' ' A' ' 15' ' ' MET . 66.3 t -58.57 -41.01 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.762 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.26 90.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.063 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.86 -39.2 93.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.116 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.73 -36.52 81.21 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -73.06 -41.1 64.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.035 178.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.11 -45.62 92.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -67.25 -41.1 86.16 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.24 -41.9 89.37 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.772 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.23 -41.35 86.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.281 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 -37.65 88.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.122 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.53 -52.32 63.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.311 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.34 -32.78 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.305 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.36 -40.96 71.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.478 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ILE . 26.2 mt-30 -82.51 -43.73 16.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.696 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.83 -32.68 69.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -71.7 -16.54 62.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.45 0.643 . . . . 0.0 109.343 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.6 pt -118.69 149.34 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -95.0 123.92 38.75 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -47.39 -59.7 5.13 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -52.11 -23.23 16.81 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.966 1.777 . . . . 0.0 113.513 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.45 -38.11 76.81 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.559 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -100.33 -12.24 19.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.85 61.42 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 mtt -146.71 163.91 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.542 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.6 mtp -96.19 148.08 23.08 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.807 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -114.35 152.5 31.37 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.131 0.491 . . . . 0.0 111.004 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.0 m -129.03 145.7 51.19 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -92.73 124.08 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.5 p -78.33 -23.19 47.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.744 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.95 155.09 6.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.46 153.53 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -135.12 142.51 46.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 mmt -103.36 142.36 34.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.778 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' A' ' 49' ' ' TYR . 88.3 p -73.54 161.6 30.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.186 0.517 . . . . 0.0 110.5 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -59.55 -35.16 73.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 44' ' ' SER . 55.4 p30 -83.68 -2.94 57.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.417 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp 59.89 22.48 11.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.71 -37.53 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.46 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.597 ' H ' ' HG ' ' A' ' 44' ' ' SER . 89.9 m-85 -116.19 143.66 45.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.42 141.97 46.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -115.93 125.72 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.301 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.65 134.77 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.087 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -109.54 131.95 54.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 m -131.59 149.53 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.062 0.458 . . . . 0.0 111.04 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -140.96 152.01 44.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.285 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CG ' ' OD1' ' A' ' 59' ' ' ASP . 19.2 p90 -151.98 161.07 43.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.474 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -27.76 68.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.486 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 60' ' ' LYS . 15.9 t-20 -80.56 2.03 27.2 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.529 ' OD1' ' CG ' ' A' ' 56' ' ' PHE . 3.3 m-20 -61.53 -15.48 38.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 58' ' ' ASN . 48.9 mtmt -67.64 -37.13 82.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -90.52 114.46 26.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.778 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.34 -33.26 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.64 -38.88 92.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.48 0.657 . . . . 0.0 109.486 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.65 84.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.763 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.61 -39.53 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.212 0.529 . . . . 0.0 109.977 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -65.86 -41.22 91.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.07 70.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.38 -51.39 52.89 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.254 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.6 -38.83 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.203 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.43 -39.98 95.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.254 0.55 . . . . 0.0 109.634 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.82 71.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.325 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 tp -70.32 -37.57 74.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.429 ' O ' ' OG ' ' A' ' 76' ' ' SER . 81.6 mm-40 -69.35 -44.76 70.93 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.09 -37.03 78.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.936 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.86 -10.14 59.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 82.9 p -57.76 -49.6 76.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.63 -36.79 87.29 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.09 -45.38 85.46 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.425 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.2 mt -60.72 -39.23 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.468 0.651 . . . . 0.0 110.608 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -61.43 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.84 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -70.4 -35.65 73.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.478 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -40.58 97.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.113 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.63 -51.11 45.72 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.88 -44.31 94.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.176 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.58 -42.63 70.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.33 92.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtm -89.19 -17.15 29.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.12 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 84' ' ' GLY . 48.1 mmm-85 54.42 37.61 28.01 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 tp -93.9 139.87 30.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.689 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -89.35 -38.56 14.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -77.76 21.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.673 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.35 114.8 32.91 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -83.24 168.61 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.903 1.735 . . . . 0.0 112.284 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -74.32 142.46 45.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.15 128.13 44.48 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.189 0.518 . . . . 0.0 111.324 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 m -110.24 118.95 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 130.25 44.66 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 112.334 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.37 138.67 52.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.095 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -105.71 133.81 49.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.731 0.301 . . . . 0.0 110.653 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.98 0.419 . . . . 0.0 110.184 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo . . . . . 0 N--CA 1.498 1.745 0 CA-C-O 120.792 0.247 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -58.5 -37.07 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -60.72 -40.49 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.326 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.18 -40.68 86.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.86 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.2 83.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.46 -42.1 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.188 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.81 -38.54 88.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.9 mtt -71.13 -38.6 72.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.971 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.72 -44.61 73.66 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -64.28 -45.93 85.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.499 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -63.25 -34.06 76.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.376 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.83 80.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.741 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.75 85.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.812 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.93 -53.16 58.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.068 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.8 -34.87 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.747 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -58.89 -43.47 90.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.245 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -83.23 -40.5 19.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.591 . . . . 0.0 111.684 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -69.85 -41.86 74.32 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -72.94 -15.62 61.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.145 0.498 . . . . 0.0 110.442 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.8 tt -115.35 142.21 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.547 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -83.58 113.71 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -67.87 -38.62 14.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.787 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 60.0 Cg_exo -52.68 -31.78 51.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.878 1.719 . . . . 0.0 112.616 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -60.5 -37.26 80.51 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.891 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.9 mt -79.85 -20.1 46.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 109.856 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.47 5.45 82.12 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.2 ttt -167.07 154.8 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.65 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.55 142.91 33.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.034 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 157.17 16.27 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.0 m -121.15 143.28 49.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.23 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.33 118.08 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 110.131 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -63.32 -36.16 82.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.313 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.63 161.52 10.44 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.64 151.35 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.812 0.339 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.17 142.59 48.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.0 mtt -102.2 142.28 33.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.003 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.7 t -73.79 152.2 40.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.087 0.47 . . . . 0.0 110.588 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -55.98 -31.75 63.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.993 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.71 -3.87 57.05 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.326 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.8 mt 58.8 20.11 7.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.06 -41.37 6.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.945 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.62 147.28 40.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 141.31 49.18 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.94 0.4 . . . . 0.0 110.474 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -109.04 127.55 54.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.81 133.11 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -112.84 130.46 56.08 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.91 147.65 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.892 0.377 . . . . 0.0 110.716 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -126.37 125.7 42.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.96 131.6 55.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.5 tp -70.89 -25.93 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.436 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 60' ' ' LYS . 19.6 m120 -81.09 2.57 26.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -60.75 -16.85 44.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 58' ' ' ASN . 14.7 mtpp -69.0 -35.56 76.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -89.71 119.32 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.378 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.71 -32.31 70.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.75 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.7 -40.24 76.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.308 0.575 . . . . 0.0 110.415 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.09 74.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.955 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.83 -34.37 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.257 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -64.69 -42.92 94.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 109.641 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.64 75.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.343 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.37 51.66 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.997 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.5 mm -57.98 -42.93 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.666 0.27 . . . . 0.0 111.038 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.01 -35.73 80.57 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.04 -45.2 71.01 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.106 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 tp -70.98 -36.68 72.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.416 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.6 -45.46 71.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.43 -37.08 74.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.43 59.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.28 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 t -55.67 -51.07 68.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.241 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.09 93.22 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -65.94 -41.27 91.54 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.11 -41.43 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.342 0.592 . . . . 0.0 109.969 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 93' ' ' PRO . 37.4 ttt85 -62.9 -47.15 84.51 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.42 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 t -70.95 -36.45 72.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.707 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.46 -39.91 77.44 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.787 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.35 -49.22 51.62 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.43 -42.26 99.73 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.407 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -68.8 -39.86 79.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.375 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.851 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.08 -14.07 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 93.7 mtt-85 56.91 35.78 26.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.52 141.35 34.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.782 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -102.12 -10.94 19.22 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.498 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.8 pt -88.4 13.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.09 121.94 86.39 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 94.7 Cg_endo -78.06 166.06 25.32 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.701 1.601 . . . . 0.0 111.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.01 138.41 58.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.4 mm? -97.56 128.31 44.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.074 0.464 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.4 m -118.57 129.35 55.29 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.67 129.12 49.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.198 0.523 . . . . 0.0 111.498 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.1 t80 -123.25 144.97 49.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.738 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 21.4 m-85 -109.22 132.56 54.0 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.932 0.396 . . . . 0.0 110.241 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.936 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo . . . . . 0 N--CA 1.501 1.951 0 CA-C-O 120.592 0.164 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.2 -37.87 81.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.73 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -62.02 -43.06 99.64 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.65 -37.74 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.164 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.96 81.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -64.67 -41.78 95.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.29 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.57 -38.75 88.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 90.4 mtp -71.1 -38.8 72.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.71 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.5 -42.38 78.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.537 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -63.0 -45.42 92.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.11 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.13 -34.85 78.49 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.708 0.766 . . . . 0.0 109.715 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.63 -41.51 77.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.485 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.51 84.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.194 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.56 -52.99 62.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.577 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.9 mt -69.87 -34.26 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.395 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.33 -41.96 76.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.016 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.3 tt0 -82.92 -41.64 18.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 111.442 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -70.35 -38.81 74.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.122 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -72.39 -14.86 61.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.071 0.462 . . . . 0.0 110.336 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 24' ' ' GLN . 19.9 tt -119.9 141.64 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.554 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -86.54 113.06 22.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -67.77 -38.75 15.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.489 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.59 -28.69 46.93 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.012 1.808 . . . . 0.0 112.559 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -59.38 -38.2 79.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.527 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 mt -88.37 -19.45 26.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.138 0.494 . . . . 0.0 109.8 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.71 5.0 89.84 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 90.7 mmm -143.74 162.22 36.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.838 0.351 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.6 ttp -96.79 134.54 39.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.952 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.0 p -92.0 158.04 16.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 t -135.56 159.66 40.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.17 127.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.999 0.428 . . . . 0.0 110.085 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 m -72.19 -34.2 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.42 157.44 8.48 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.76 150.69 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.074 0.464 . . . . 0.0 111.488 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.1 141.86 50.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.074 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.1 mtt -108.11 142.07 38.87 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 p -75.47 152.84 37.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.058 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -63.06 -34.81 78.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.443 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.92 -3.11 57.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.376 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.4 mt 62.03 13.67 5.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.11 58.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.177 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.2 165.49 29.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.256 0.55 . . . . 0.0 111.764 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.54 142.3 35.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.257 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -112.41 120.01 40.19 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.208 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.8 133.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.907 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -109.67 136.19 49.41 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.79 146.98 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 0.0 111.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 t -144.65 152.48 40.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 11.0 p90 -150.24 159.73 44.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.123 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.18 -27.03 68.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.02 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.412 ' C ' ' N ' ' A' ' 60' ' ' LYS . 73.5 m-20 -80.23 5.78 13.67 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 68.9 m-20 -61.02 -16.71 46.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 58' ' ' ASN . 63.9 tttp -68.87 -39.97 79.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.82 114.12 26.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.167 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -60.46 -33.0 71.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.04 -38.72 89.09 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.447 0.641 . . . . 0.0 109.386 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.55 83.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 82.6 t -68.76 -37.87 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.913 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.4 -45.47 79.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.595 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.27 -44.55 68.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.496 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.85 41.38 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.484 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.0 tt -59.8 -34.5 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.214 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -66.4 -41.31 89.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.38 0.61 . . . . 0.0 109.506 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.36 75.09 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.95 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -69.62 -36.63 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.404 ' O ' ' OG ' ' A' ' 76' ' ' SER . 63.5 tt0 -68.48 -44.49 74.67 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.192 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -69.35 -37.07 77.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.091 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.72 -10.52 59.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.333 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 59.8 p -58.67 -49.41 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.243 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.7 91.88 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -64.49 -43.6 93.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.623 0.249 . . . . 0.0 111.452 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.73 -42.84 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 110.808 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -63.11 -47.1 84.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.48 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.1 t -70.98 -37.76 72.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.866 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -66.45 -37.8 85.95 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.778 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.75 -43.32 76.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.956 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.0 -38.4 74.21 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -66.26 -43.12 87.36 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -0.726 . . . . 0.0 111.921 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.58 83.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.7 mtt -84.29 -17.21 40.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' GLY . 41.3 ttt85 59.44 35.35 22.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.656 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.35 142.05 33.32 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.034 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.58 -10.54 19.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.668 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 pt -82.62 18.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.201 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.97 122.5 87.81 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.91 158.97 31.09 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.545 1.496 . . . . 0.0 111.374 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.81 128.7 37.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.5 mt -95.58 131.37 41.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.228 0.537 . . . . 0.0 111.313 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -115.61 127.25 55.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.98 126.9 52.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -119.11 141.64 48.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.768 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 23.3 p90 -106.83 132.02 53.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.905 0.383 . . . . 0.0 110.337 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.341 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.497 1.722 0 CA-C-O 120.746 0.227 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -63.31 -43.2 98.52 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.016 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.07 -37.1 78.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.291 0.567 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.8 -39.54 83.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -71.59 -46.42 59.32 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.519 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.37 -37.15 84.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 57.3 mtt -71.62 -40.72 69.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.982 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -54.49 -42.33 70.63 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -63.3 -46.79 85.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.366 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.35 -33.48 75.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.608 0.718 . . . . 0.0 109.824 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.26 -42.92 78.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.962 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.17 86.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.58 -51.82 65.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.389 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.27 -34.1 64.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.7 -41.02 97.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -82.65 -27.8 31.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -82.83 -45.26 14.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.773 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.05 -17.39 62.02 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 mt -112.24 133.92 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.009 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.97 121.96 28.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 10.7 t70 -46.14 -58.48 6.36 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.302 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.61 -22.93 18.24 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.805 1.67 . . . . 0.0 113.13 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.18 -38.36 76.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.763 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.8 mt -100.7 -13.79 18.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.05 0.453 . . . . 0.0 109.801 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.66 5.68 89.68 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.3 tpt -160.88 158.75 28.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.404 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.442 ' SD ' ' OD1' ' A' ' 29' ' ' ASP . 94.1 mmm -80.45 137.93 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 p -86.08 150.33 24.52 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.872 0.368 . . . . 0.0 111.029 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.4 m -125.98 141.71 51.84 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.911 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -100.24 120.97 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.012 0.434 . . . . 0.0 110.169 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -68.84 -33.94 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.17 158.19 8.79 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 m -127.16 148.62 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 111.193 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -126.1 138.29 53.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.952 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.487 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -113.73 143.24 44.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.559 ' HG ' ' H ' ' A' ' 49' ' ' TYR . 94.7 p -73.2 156.4 38.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.233 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.953 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 55.3 p30 -83.91 -0.86 53.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.5 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.27 31.94 21.57 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' A' ' 46' ' ' ASP . . . -105.56 -46.44 4.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.79 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.559 ' H ' ' HG ' ' A' ' 44' ' ' SER . 66.0 m-85 -116.02 145.55 42.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.829 0.347 . . . . 0.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.88 142.17 40.69 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -122.05 127.49 50.28 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.5 134.74 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -109.96 133.17 53.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.74 149.85 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.167 0.508 . . . . 0.0 111.55 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -143.36 151.77 40.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.41 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 7.2 p90 -156.03 158.52 37.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 111.397 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.01 -14.67 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.75 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -80.6 3.42 21.94 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.519 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 64.6 m-20 -61.88 -16.64 52.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.37 -39.43 85.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.135 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.62 117.26 29.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.037 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -60.3 -36.57 78.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.427 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.06 -37.92 89.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.471 0.653 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.84 84.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.1 -44.32 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -66.83 -39.83 87.78 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.47 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.83 76.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.59 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.42 -51.2 38.78 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.41 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.37 -41.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.612 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.46 -35.27 80.4 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.57 86.21 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.936 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.35 -35.89 73.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.851 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -67.78 -45.96 73.33 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.47 -37.18 71.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.5 -3.97 54.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.286 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -55.24 -50.3 69.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.317 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.76 93.02 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.232 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -66.41 -42.65 87.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.32 -39.52 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.638 0.732 . . . . 0.0 110.087 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -63.74 -45.02 91.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.09 -36.95 78.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.521 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.52 -38.77 90.63 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.935 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.87 -49.5 57.74 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.515 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -59.45 -43.0 97.83 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.692 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.053 0.454 . . . . 0.0 111.824 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.65 98.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.474 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -94.5 -9.17 36.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 89.5 mtm-85 55.13 36.67 27.49 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.72 141.2 33.93 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.977 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -99.22 -14.69 19.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 pt -86.91 29.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.57 118.36 67.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.91 160.82 27.25 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.547 1.498 . . . . 0.0 111.61 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.29 136.2 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.8 mt -100.84 130.76 46.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 110.947 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -119.65 124.88 47.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.996 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.73 129.11 47.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.452 . . . . 0.0 111.231 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 37.7 t80 -119.64 139.8 51.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 44.6 p90 -104.67 133.6 49.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.964 0.412 . . . . 0.0 110.484 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.502 1.986 0 CA-C-O 120.758 0.232 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.37 -34.4 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.288 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -59.77 -43.21 94.47 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 m -65.5 -36.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.847 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.33 85.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.811 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.33 -40.71 96.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.3 -37.62 83.89 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.55 -42.18 68.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.886 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.36 -43.74 79.43 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -63.52 -48.14 78.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.069 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.83 -32.25 72.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.246 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.03 -41.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.86 85.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.8 tp -64.34 -52.01 60.5 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.22 -33.92 60.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -57.96 -42.21 84.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.4 mt-30 -82.46 -41.87 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.384 0.611 . . . . 0.0 111.358 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -70.54 -37.6 74.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.827 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -72.12 -17.42 61.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.176 0.512 . . . . 0.0 110.125 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 19.2 tt -118.7 141.09 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.815 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -66.52 -38.69 21.0 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.437 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.5 Cg_exo -55.28 -31.91 78.7 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.004 1.802 . . . . 0.0 112.521 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.51 -38.22 80.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.704 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.9 -20.02 28.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.951 0.405 . . . . 0.0 110.002 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 7.39 87.19 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.8 mtt -138.85 167.15 22.64 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.962 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.8 mtp -98.29 151.2 20.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.444 ' CG2' ' CE1' ' A' ' 56' ' ' PHE . 88.0 m -109.09 142.36 39.94 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -122.41 157.36 32.05 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.732 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -105.54 116.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.152 0.501 . . . . 0.0 110.2 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -34.46 78.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.006 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.11 152.59 6.37 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.5 t -126.09 137.92 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.679 0.276 . . . . 0.0 110.454 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -128.23 140.35 51.95 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.993 0.425 . . . . 0.0 110.779 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.6 mtt -111.36 142.47 43.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.475 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.1 p -73.44 155.31 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.822 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.25 -32.54 71.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.565 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.57 -3.54 56.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.377 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.31 27.12 16.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.37 -41.29 5.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -118.07 142.75 47.07 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.872 0.367 . . . . 0.0 110.885 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.07 141.73 48.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.13 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.97 129.13 55.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.77 133.36 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.415 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -118.74 128.76 54.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.33 149.73 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.225 0.536 . . . . 0.0 111.452 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -123.7 134.68 53.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 36' ' ' THR . 97.6 m-85 -121.39 146.55 46.76 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.426 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.3 mt -76.03 -12.06 60.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 81.9 m-20 -80.68 -2.43 46.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.834 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 100' ' ' ASP . 98.4 m-20 -62.94 -21.2 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.88 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -69.88 -38.43 76.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.562 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -99.1 109.51 22.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.03 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.11 -38.17 82.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.05 -38.03 89.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.84 82.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.51 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.43 -35.53 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -66.2 -43.75 85.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.228 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.81 72.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.346 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -50.4 32.18 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.717 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.7 tp -59.22 -36.74 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.682 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -68.35 -38.05 81.09 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.551 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.35 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.61 -36.88 76.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.658 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.76 -44.95 72.65 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.09 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.75 -36.95 79.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.236 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.26 -12.16 60.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.436 ' OG ' ' CD2' ' A' ' 97' ' ' PHE . 22.5 t -58.0 -49.53 76.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.461 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.15 86.02 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.161 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.09 -44.63 88.24 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.333 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.44 -39.6 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.543 0.687 . . . . 0.0 110.501 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -63.48 -45.02 92.7 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.736 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.56 -36.55 76.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.0 mt -66.43 -36.49 82.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.237 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.12 -48.6 64.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.909 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.17 -43.1 65.08 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.603 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.86 -43.11 80.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.258 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.14 83.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.6 mtt -84.54 -21.38 30.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.465 ' N ' ' O ' ' A' ' 84' ' ' GLY . 49.0 ttp85 64.21 37.15 8.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.992 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.28 141.46 28.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -98.7 -14.56 19.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.8 pt -97.7 34.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.641 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -73.25 119.87 78.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.98 160.35 30.37 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.418 1.412 . . . . 0.0 111.352 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.37 132.67 54.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.05 126.82 51.47 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.819 0.342 . . . . 0.0 110.304 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 m -117.11 133.68 55.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.512 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.436 ' CD2' ' OG ' ' A' ' 76' ' ' SER . 92.8 m-85 -107.28 128.52 54.52 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -119.58 137.53 53.79 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 38.3 p90 -109.63 123.59 49.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.932 0.396 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.417 ' O ' ' OD2' ' A' ' 59' ' ' ASP . 60.4 t0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.497 1.721 0 CA-C-O 121.028 0.345 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -65.03 -29.81 70.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.632 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -58.71 -41.57 86.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.53 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.2 -39.38 78.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.757 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.07 96.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.914 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -61.38 -39.37 90.41 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.379 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.56 -37.33 83.44 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.32 -41.87 69.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.599 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.66 -41.5 95.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.574 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -64.63 -51.33 63.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.215 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.74 -34.92 79.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.941 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.0 mt -71.07 -39.96 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.109 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -36.85 85.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.25 -53.31 46.18 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.81 -34.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.76 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.35 -38.96 81.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.945 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 27' ' ' ILE . 48.5 tt0 -81.88 -44.46 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.988 0.423 . . . . 0.0 111.15 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -71.15 -36.64 72.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -73.27 -14.31 61.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.291 0.567 . . . . 0.0 109.906 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 24' ' ' GLN . 15.0 tt -121.67 149.47 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -76.03 113.02 13.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -70.14 -38.55 9.02 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.86 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 46.0 Cg_exo -56.57 -37.4 97.56 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.078 1.852 . . . . 0.0 112.781 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -59.94 -37.43 79.5 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.121 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 61.7 mt -92.45 -3.88 54.54 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.76 0.314 . . . . 0.0 110.6 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 35' ' ' MET . . . 90.05 5.39 70.65 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ttt 65.46 0.38 1.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.415 ' H ' ' C ' ' A' ' 33' ' ' GLY . 84.4 mmm -79.32 10.29 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.692 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.3 m -78.75 130.68 36.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.067 0.46 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.9 m -131.27 145.91 52.09 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.3 t -94.47 119.11 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.379 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.98 163.68 11.3 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 m -127.42 148.8 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.637 0.256 . . . . 0.0 110.386 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.93 130.55 56.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 58.3 mmm -100.65 142.27 32.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -73.52 151.27 41.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 0.0 110.585 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -57.92 -36.12 72.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.428 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -83.92 -0.14 50.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.421 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 59.38 30.17 19.83 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.61 -47.41 4.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.187 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -118.19 145.02 45.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.903 0.383 . . . . 0.0 111.055 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.4 141.79 46.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.06 130.13 56.27 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.14 133.47 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.593 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -116.51 128.9 55.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.722 0.296 . . . . 0.0 110.355 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.82 147.34 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.83 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -132.61 144.2 50.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 5.5 p90 -150.3 150.17 31.12 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.159 0.504 . . . . 0.0 111.058 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.08 -33.75 75.01 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 17.0 m120 -80.89 -2.46 47.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 36.0 t0 -61.68 -14.83 34.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -67.6 -38.2 83.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.28 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.09 126.71 35.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.068 0.461 . . . . 0.0 110.428 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.3 -35.41 75.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.136 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.9 -40.28 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 109.976 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.66 81.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.054 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.74 -39.27 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 0.0 109.279 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.663 ' HZ2' ' NZ ' ' A' ' 70' ' ' LYS . 22.0 tptp -64.31 -43.32 95.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.534 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.9 62.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.804 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.64 -52.08 32.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.747 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.34 -36.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.568 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.663 ' NZ ' ' HZ2' ' A' ' 66' ' ' LYS . 3.1 ttmp? -66.03 -39.94 90.62 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.43 -42.06 83.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.834 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.11 -36.24 74.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.116 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 76' ' ' SER . 61.0 tp60 -69.0 -45.5 70.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.59 -36.96 73.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.227 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.13 -8.78 59.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.218 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 81.9 p -57.15 -49.06 77.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.293 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.36 87.09 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.07 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -66.08 -44.52 84.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.464 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.29 -40.37 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 110.149 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -63.46 -45.55 90.32 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -68.88 -37.09 78.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.44 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.11 -38.36 90.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.254 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.92 -47.24 66.27 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.67 -42.15 72.53 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.722 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.43 -43.01 78.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.351 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.32 87.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.008 0.432 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 39.8 mtt -86.21 -17.6 34.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 70.8 mtp85 53.51 37.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -94.64 139.44 31.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.412 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 92' ' ' VAL . 94.6 mtt180 -86.65 -39.0 16.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.033 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.9 pt -76.22 33.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 90' ' ' ARG . 7.3 p -72.59 114.61 31.61 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -80.33 162.13 22.61 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.694 1.596 . . . . 0.0 112.036 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.67 133.29 50.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.19 131.41 44.57 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.104 0.478 . . . . 0.0 110.882 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.6 m -120.88 131.79 54.6 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.389 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.74 127.28 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.004 0.431 . . . . 0.0 110.98 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -126.04 146.16 50.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.0 p90 -109.54 132.48 54.1 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.788 0.328 . . . . 0.0 111.313 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.89 178.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.982 0.326 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.55 -33.37 74.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.314 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -59.24 -39.85 84.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.995 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.1 t -58.02 -39.74 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.69 95.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.86 -40.35 96.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.697 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.97 -36.46 81.52 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.47 -40.96 63.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.47 -47.91 82.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.135 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -67.48 -37.83 83.46 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -64.19 -42.37 96.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.311 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.78 -40.65 86.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.33 87.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.082 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.59 -51.88 65.59 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.32 -34.41 68.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.766 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 tp -60.34 -40.42 90.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.383 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -83.07 -27.57 30.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.783 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -79.61 -46.45 17.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.38 -15.39 61.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 24' ' ' GLN . 31.7 mt -114.15 133.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -84.48 112.73 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -65.93 -39.15 27.88 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.235 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.2 Cg_exo -55.28 -34.39 88.21 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.021 1.814 . . . . 0.0 112.36 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.49 -37.89 79.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.445 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 63.7 mt -80.91 -20.26 42.54 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.89 4.27 90.1 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 57.1 mtt -151.62 167.15 29.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.833 0.349 . . . . 0.0 110.513 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -92.06 139.8 30.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.0 p -87.17 152.02 22.69 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 110.965 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -126.81 141.8 51.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.286 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.11 122.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -66.2 -35.22 79.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.237 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.67 160.69 10.02 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.34 146.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 111.1 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -121.43 139.4 53.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.609 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.3 mmm -109.39 139.97 43.68 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 89.3 p -73.99 153.64 39.64 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.964 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.418 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 56.9 t0 -82.45 -3.3 55.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.058 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.3 mp 56.38 23.31 7.2 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.42 -37.01 9.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.45 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.406 ' O ' ' OG ' ' A' ' 44' ' ' SER . 83.6 m-85 -123.14 150.79 42.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.21 141.9 35.9 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.305 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -119.63 125.09 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.598 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.26 134.58 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.285 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -108.8 135.8 49.42 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.57 147.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.255 0.55 . . . . 0.0 111.464 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 t -146.32 152.04 38.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.34 151.32 24.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.209 0.528 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.58 -25.55 68.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.833 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.493 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 84.9 m-20 -79.91 5.26 14.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.9 p30 -64.5 -15.4 60.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 15.2 ptpt -70.03 -33.88 72.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -90.22 116.67 28.38 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.82 -33.4 71.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.385 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.5 -39.12 91.5 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.448 0.642 . . . . 0.0 109.619 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.93 87.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.98 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.72 -38.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -66.76 -47.03 73.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.044 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.58 77.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.473 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.53 -50.72 24.47 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.572 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.7 tt -59.67 -36.71 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.768 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -68.14 -37.51 81.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.24 92.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.241 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' O ' ' OG ' ' A' ' 76' ' ' SER . 56.6 tp -68.35 -36.43 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.882 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -69.44 -45.81 68.25 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.3 -36.92 71.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.31 58.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.286 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 72' ' ' LEU . 20.7 m -56.5 -50.05 72.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.69 93.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.252 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.22 -42.99 87.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.727 0.298 . . . . 0.0 111.506 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.42 -40.8 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.352 0.596 . . . . 0.0 110.783 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -64.27 -45.35 88.42 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.259 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -69.45 -36.84 76.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.632 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.01 -37.54 81.54 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.66 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.32 -50.49 53.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.578 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.41 -43.87 96.14 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.596 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -70.83 -42.22 70.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.8 98.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.25 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtm -89.5 -15.82 32.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.831 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' GLY . 96.8 mtt180 53.42 36.65 23.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -94.74 139.1 31.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.04 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -82.69 -44.7 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.531 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 pt -75.79 40.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.917 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.74 114.59 31.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 72.8 Cg_endo -79.91 157.64 24.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.643 1.562 . . . . 0.0 112.256 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.97 138.07 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -94.97 127.9 41.37 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.11 0.481 . . . . 0.0 110.753 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -115.72 120.85 40.7 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.86 132.05 44.5 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 0.0 111.727 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -119.14 138.86 52.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -102.43 115.87 31.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo . . . . . 0 N--CA 1.496 1.622 0 CA-C-O 120.848 0.27 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -35.9 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -59.79 -39.62 85.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.86 -40.8 83.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.08 94.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.024 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -60.9 -39.6 89.92 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.993 0.425 . . . . 0.0 110.328 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.62 -37.33 83.57 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.1 -40.9 67.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.824 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.1 -42.43 80.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.455 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -63.02 -47.56 82.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.925 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -61.99 -34.57 76.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.579 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.62 -40.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.795 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 -37.35 87.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.42 -52.22 62.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.654 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.94 -34.63 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.43 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.7 mt -64.39 -33.66 76.38 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.061 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.584 ' NE2' ' SD ' ' A' ' 35' ' ' MET . 94.8 mt-30 -82.76 -27.71 30.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 0.0 111.346 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -87.65 -46.19 9.74 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.48 -12.55 60.83 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.508 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.24 132.11 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.21 109.98 17.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 8.8 t0 -65.32 -36.63 15.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.398 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 31.9 Cg_exo -58.82 -38.55 88.01 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.497 1.465 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -61.89 -38.58 88.85 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.216 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.5 mt -87.63 -19.77 27.28 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.68 5.42 89.98 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.3 ttm -163.9 151.91 12.91 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.584 ' SD ' ' NE2' ' A' ' 24' ' ' GLN . 58.7 ttp -83.24 141.49 31.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.09 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -81.48 153.86 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 111.01 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.5 m -122.92 143.84 49.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.11 118.96 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.001 0.429 . . . . 0.0 110.589 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.454 ' HG ' ' HG1' ' A' ' 55' ' ' THR . 32.0 m -66.51 -34.33 77.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.278 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.65 153.94 6.99 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -126.59 135.78 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.774 0.321 . . . . 0.0 111.081 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.74 137.96 52.99 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.3 mtt -112.57 142.34 45.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.413 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 p -76.91 152.43 35.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.182 0.515 . . . . 0.0 110.388 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -64.08 -32.86 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.677 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.47 -3.25 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.404 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.42 14.36 5.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.82 62.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.84 164.28 35.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.514 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.12 35.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.486 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -104.11 127.57 51.7 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.6 133.11 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.42 134.92 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -129.82 145.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 120.997 0.427 . . . . 0.0 110.537 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.454 ' HG1' ' HG ' ' A' ' 39' ' ' SER . 61.0 m -139.9 137.44 34.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.057 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.35 149.37 29.25 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.892 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.66 -15.34 63.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.531 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -81.12 -2.31 47.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.07 -15.3 62.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.426 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.88 -36.05 77.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.76 115.74 28.08 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -34.0 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.517 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.65 -38.69 91.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.376 0.607 . . . . 0.0 109.49 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.54 83.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.878 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.18 -41.05 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.84 -42.17 86.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.57 -46.12 64.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.65 -50.59 41.64 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.3 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.2 tt -59.48 -34.5 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.197 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -66.73 -41.18 88.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.81 78.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.802 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -69.48 -36.57 76.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.08 -45.01 71.37 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.212 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.51 -36.93 74.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.01 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.19 -7.05 56.61 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.141 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.8 t -55.57 -50.04 71.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.3 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -38.27 91.19 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.221 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -65.87 -43.58 87.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.593 0.235 . . . . 0.0 111.545 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.78 -39.72 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.56 0.695 . . . . 0.0 110.31 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -63.51 -46.26 86.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.272 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.1 t -70.22 -37.02 74.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.646 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.44 -37.45 86.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.345 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -68.45 -49.88 56.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -63.1 -43.88 98.07 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.349 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.67 -39.53 73.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 0.0 111.807 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.66 94.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.571 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.3 mtm -92.44 -13.55 29.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.485 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 30.9 mmt180 57.34 42.92 24.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.767 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.79 141.2 29.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.824 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -92.93 -16.86 24.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 pt -96.7 43.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.3 t -72.8 114.57 31.67 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 156.19 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.459 1.439 . . . . 0.0 111.433 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.47 125.99 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.3 mt -94.18 131.84 39.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.411 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -119.78 128.24 53.54 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.033 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.43 131.23 53.12 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 111.345 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.404 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.8 t80 -119.49 142.3 48.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.512 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 44.8 p90 -105.45 133.79 49.63 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.958 0.408 . . . . 0.0 110.292 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 120.868 0.278 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -59.47 -31.46 69.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -59.22 -38.8 80.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.398 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.62 -40.39 79.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.14 93.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.221 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -64.84 -40.07 94.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.6 -37.85 85.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.24 -42.87 68.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.81 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.71 -41.79 82.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -64.06 -50.23 69.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -63.29 -34.77 78.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.727 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.26 -42.19 78.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.132 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.94 85.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.64 -52.92 61.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.53 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.33 -35.77 74.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.054 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.447 ' O ' ' CG2' ' A' ' 27' ' ' ILE . 9.6 tt -63.13 -37.25 86.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.284 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -74.38 -41.15 61.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 111.038 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -75.19 -42.5 55.59 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -73.08 -16.23 61.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.748 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 23' ' ' LEU . 12.6 tt -107.19 134.01 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -86.15 108.78 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -66.68 -38.61 19.67 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 35.9 Cg_exo -58.02 -33.69 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.479 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -59.38 -37.87 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.579 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.5 mt -82.36 -20.4 37.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.137 0.494 . . . . 0.0 109.692 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.62 3.85 90.35 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.399 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 94.3 mmm -147.85 171.17 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.897 0.38 . . . . 0.0 109.995 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.1 mtt -94.99 157.15 16.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.7 t -125.05 150.24 46.98 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -129.45 148.81 51.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.844 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 t -94.0 123.91 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.8 p -73.27 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.92 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.4 157.37 8.13 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.37 151.97 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.374 . . . . 0.0 110.771 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -135.96 142.21 44.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.9 mtt -96.95 139.02 33.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.257 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 86.5 p -73.88 160.73 31.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.269 0.557 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' CD ' ' N ' ' A' ' 45' ' ' ARG . 1.1 mpt_? -59.59 -32.35 70.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.694 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.2 m-20 -83.06 -4.34 58.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.098 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.8 mt 60.08 5.6 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -95.94 -22.94 17.1 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.972 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.418 ' O ' ' OG ' ' A' ' 44' ' ' SER . 97.6 m-85 -124.13 143.96 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.65 141.94 49.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.09 120.15 37.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.74 133.68 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.251 0.548 . . . . 0.0 109.798 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.77 136.19 50.2 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.298 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.99 147.09 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.04 0.448 . . . . 0.0 111.141 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -140.29 151.33 45.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.273 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.65 160.77 42.48 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.182 0.515 . . . . 0.0 111.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.0 mm? -67.34 -18.91 65.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.643 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -80.96 1.96 28.86 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.1 p30 -64.33 -15.08 59.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 60.9 tttm -69.09 -39.97 78.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.334 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -93.43 115.96 28.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.449 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.99 -35.95 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.29 -39.17 93.38 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.1 83.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.73 -39.14 83.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.16 -45.54 91.36 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.95 -36.38 77.86 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.3 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.44 52.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.737 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.7 -39.98 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.299 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.52 -36.96 83.98 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.907 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.9 77.53 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.53 -36.45 73.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.207 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.424 ' O ' ' OG ' ' A' ' 76' ' ' SER . 51.1 tt0 -69.57 -45.64 68.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.155 0.502 . . . . 0.0 110.475 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.24 -37.01 74.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.244 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.48 -12.83 60.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 58.0 p -58.0 -49.16 77.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.56 86.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.245 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -66.61 -44.57 81.73 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.535 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.29 -40.81 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.556 0.693 . . . . 0.0 110.559 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.523 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 62.3 ttt180 -63.88 -46.6 84.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.551 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 t -68.7 -37.29 79.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.646 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 27.6 mt -65.58 -35.98 82.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.493 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.3 -48.44 64.93 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.831 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.92 -41.2 73.04 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -70.72 -43.76 68.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.391 -0.904 . . . . 0.0 112.173 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' LEU . . . -63.21 -43.37 98.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.7 mtt -85.42 -15.42 43.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 81.4 mtm180 59.95 26.1 15.33 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.531 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.37 150.31 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.382 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' VAL . 70.5 mtp85 -100.87 -9.58 21.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.248 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 tt -59.07 -2.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 90' ' ' ARG . 27.3 m -70.36 116.09 41.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 172.5 14.45 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.841 1.694 . . . . 0.0 111.942 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.523 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 77.2 mm-40 -59.85 134.53 57.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.9 mt -100.65 128.32 46.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.957 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -113.26 127.32 56.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.52 129.06 55.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.195 0.522 . . . . 0.0 112.097 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -118.53 137.32 53.29 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 46.1 p90 -110.27 132.78 53.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.421 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.493 1.489 0 CA-C-O 120.708 0.212 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -55.37 -31.6 61.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.658 ' HE ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -59.93 -39.69 86.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.213 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.73 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.299 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.96 81.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.107 0.479 . . . . 0.0 110.338 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.78 -46.81 62.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.652 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.38 -36.87 85.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.054 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.5 mtt -71.93 -40.89 68.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -54.86 -45.87 74.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.22 -45.8 86.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.26 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 85.2 tt0 -61.65 -33.89 74.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.2 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.97 -42.6 77.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.29 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -36.62 84.78 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.67 -52.94 54.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.076 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.0 mt -70.1 -35.03 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.65 -41.74 95.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.779 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -82.58 -41.29 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.313 0.578 . . . . 0.0 111.286 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -70.3 -40.8 74.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.57 -16.71 61.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.333 0.587 . . . . 0.0 110.195 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 24' ' ' GLN . 17.8 tt -116.05 149.48 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.326 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -67.3 122.85 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 110.059 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.07 -61.87 4.33 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.956 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.17 -27.63 57.21 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.727 1.618 . . . . 0.0 112.814 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -59.5 -38.04 79.86 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.215 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 70.4 mt -103.79 -2.18 26.76 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.0 5.86 72.79 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.4 ttt 63.03 8.44 3.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.2 mmm -81.35 18.4 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.1 m -76.03 128.05 34.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.319 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -132.7 143.06 49.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.967 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.5 t -98.72 120.35 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.944 0.402 . . . . 0.0 109.972 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 m -63.95 -36.14 82.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.256 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.72 155.84 7.45 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 m -127.39 152.27 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.957 0.408 . . . . 0.0 110.819 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -132.79 141.9 48.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.226 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.3 mtt -113.79 142.27 46.28 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 73.5 m -73.51 151.92 40.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.012 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -63.71 -29.58 70.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.337 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -83.6 -3.84 58.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 mt 60.38 24.54 14.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 -45.98 5.82 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.307 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.424 ' O ' ' OG ' ' A' ' 44' ' ' SER . 88.5 m-85 -119.65 146.75 45.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.15 0.5 . . . . 0.0 111.124 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.45 142.23 41.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.159 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.41 124.21 43.96 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.33 134.52 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.038 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -113.91 138.27 50.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.26 148.17 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.28 0.562 . . . . 0.0 111.187 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 m -141.67 132.8 26.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -135.93 146.44 47.31 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 178.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 7.0 mp -64.29 -23.03 67.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 83.8 m-20 -81.13 -7.0 59.47 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.33 -16.03 51.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -66.65 -33.09 74.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -89.91 117.96 29.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.29 -39.75 94.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.482 0.658 . . . . 0.0 109.432 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.76 -36.01 81.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.47 -39.7 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.5 -41.41 88.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.05 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -47.14 62.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.84 -50.46 41.44 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.274 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.39 -34.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.493 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.79 -41.21 87.98 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.381 0.61 . . . . 0.0 109.522 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 -40.88 75.09 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.041 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -70.31 -37.67 74.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.43 ' O ' ' OG ' ' A' ' 76' ' ' SER . 7.6 tt0 -68.64 -45.11 72.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.278 0.561 . . . . 0.0 110.163 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -69.79 -37.18 76.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.908 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -9.2 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 82.0 p -57.42 -50.67 72.26 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.89 93.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.52 -41.53 84.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.62 -39.72 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.645 0.736 . . . . 0.0 109.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -63.31 -46.01 88.68 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.523 ' OG ' ' NZ ' ' A' ' 85' ' ' LYS . 19.6 t -68.37 -36.64 79.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.434 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.57 -38.75 87.71 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.094 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 mt -68.99 -50.46 48.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.709 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.81 -44.13 97.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.54 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.523 ' NZ ' ' OG ' ' A' ' 81' ' ' SER . 47.4 mttp -71.3 -42.2 68.95 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.81 97.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.96 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 63.4 mtm -87.29 -19.49 28.19 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 84' ' ' GLY . 50.9 ttm-85 61.61 41.84 11.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.479 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.9 141.16 29.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.994 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -88.22 -26.34 22.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.532 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -89.75 45.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.569 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 114.2 28.65 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.133 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 78.6 Cg_endo -80.61 163.31 21.47 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.613 1.542 . . . . 0.0 111.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -72.39 130.75 41.45 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.6 mm? -93.17 128.18 39.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.155 0.502 . . . . 0.0 110.894 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 m -114.98 121.28 42.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -101.02 129.71 46.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.086 0.47 . . . . 0.0 111.818 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -119.77 138.95 53.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.393 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -102.0 132.3 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.579 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 CA-C-O 120.809 0.254 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.408 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.0 mp0 -58.08 -35.16 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.384 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.25 -39.7 83.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.397 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.24 -40.84 84.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.54 86.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -65.88 -43.02 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.17 -37.37 84.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt -73.55 -36.04 65.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.9 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.03 -47.73 80.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -66.46 -37.34 84.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.984 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.4 tt0 -65.78 -40.39 91.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.28 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.35 -42.27 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 -38.12 89.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.282 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.07 -52.26 63.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.129 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.42 -33.48 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 60.7 tp -57.67 -36.33 71.77 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.375 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -84.4 -36.02 22.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -76.98 -47.74 19.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -75.45 -3.89 36.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.113 0.482 . . . . 0.0 110.346 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 47.5 mm -114.29 126.68 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.946 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -82.46 102.86 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 1.3 m-20 -78.34 -36.76 1.33 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.496 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 84.1 Cg_exo -48.47 -38.19 34.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.635 1.557 . . . . 0.0 113.323 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.41 -37.6 87.9 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.771 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.45 -20.18 34.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 109.795 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.55 84.84 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.2 mtt -147.89 156.25 42.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 110.313 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.2 mtm -97.69 148.04 23.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 p -87.63 156.05 19.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 p -124.13 160.93 26.71 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.7 t -106.26 128.71 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.829 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t -88.54 -14.91 36.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.7 148.54 5.16 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.58 128.84 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.43 139.98 53.38 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.979 0.418 . . . . 0.0 110.778 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.4 mtt -117.1 142.59 46.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.66 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 69.2 m -73.34 152.16 41.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.238 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -59.48 -31.67 69.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.528 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.4 -3.82 57.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.287 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.63 29.21 18.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.22 -49.17 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.031 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.426 ' O ' ' OG ' ' A' ' 44' ' ' SER . 84.7 m-85 -117.17 144.48 44.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.924 0.392 . . . . 0.0 111.021 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.99 141.08 50.22 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.615 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -122.59 117.84 26.79 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.382 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.9 135.41 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 120.708 0.289 . . . . 0.0 110.87 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.0 135.48 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 m -133.27 149.83 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.122 0.487 . . . . 0.0 111.379 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -131.35 156.43 45.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.948 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -157.5 153.57 27.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 111.814 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 59' ' ' ASP . 74.0 mt -76.65 -12.27 59.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.659 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -80.08 3.65 19.69 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 57' ' ' LEU . 24.2 p-10 -66.16 -15.6 63.27 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.87 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -67.87 -39.97 83.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.431 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -92.45 115.14 27.83 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.173 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.41 -34.54 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.57 -38.72 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.5 80.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.54 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.25 -46.15 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.601 . . . . 0.0 109.899 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -67.98 -47.77 67.65 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.86 -45.36 64.6 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.555 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -51.94 53.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.899 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 69' ' ' ILE . 97.4 mt -61.14 -34.84 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.021 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.35 -40.75 96.47 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.94 87.03 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.529 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.8 -36.78 81.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.358 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -68.15 -45.08 74.53 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.343 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.42 -36.99 74.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.254 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.06 -8.29 57.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.053 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -55.18 -48.64 73.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.426 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.37 -38.26 90.03 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.084 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.56 -42.17 92.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.604 0.24 . . . . 0.0 111.308 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.65 -42.62 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 63.3 ttt180 -63.12 -46.71 86.02 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.346 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 t -70.28 -36.94 74.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.375 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.63 -35.56 80.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.435 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -68.4 -50.4 53.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.97 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.5 -43.56 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.236 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.72 -40.84 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.179 0.514 . . . . 0.0 111.713 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.76 99.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.48 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 58.3 mtm -93.94 -8.89 38.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 91.9 mtt-85 54.86 36.03 25.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.62 141.13 32.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -97.73 -10.76 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.29 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -94.53 30.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.23 118.46 68.82 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 161.93 30.58 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.505 1.47 . . . . 0.0 111.834 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 78.1 mm-40 -60.08 136.17 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.53 130.85 47.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 0.0 111.059 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.3 m -120.79 128.39 52.84 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.87 126.25 54.9 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.994 0.426 . . . . 0.0 111.644 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -119.96 138.67 53.33 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -110.22 129.78 55.66 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.282 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.246 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 N--CA 1.495 1.566 0 CA-C-O 120.848 0.27 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.77 -33.23 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.09 -37.86 78.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.652 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -38.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 0.0 110.274 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.8 82.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.455 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -71.62 -46.38 59.29 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.952 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -62.64 -36.55 83.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.9 ttm -70.51 -40.57 73.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.09 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.03 -41.96 75.79 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -62.64 -45.04 94.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.018 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.61 -33.18 75.04 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.469 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.23 -42.41 78.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.413 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.79 85.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.098 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.92 -52.49 64.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.602 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.2 mt -68.67 -33.9 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.128 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.3 tp -56.17 -43.29 78.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.848 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.1 mt-30 -83.1 -40.05 20.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 111.809 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -70.05 -39.96 75.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -72.56 -14.99 61.76 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.076 0.465 . . . . 0.0 110.377 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLN . 20.1 tt -119.23 143.34 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -83.45 115.11 21.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -69.99 -38.19 8.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.58 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.42 -37.28 81.72 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.816 1.677 . . . . 0.0 112.242 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -59.94 -37.8 80.57 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.362 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -78.24 -20.93 50.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.38 5.34 87.18 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm -171.82 154.69 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.655 0.264 . . . . 0.0 110.475 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.9 mtp -83.24 138.11 33.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -88.42 158.07 18.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -122.87 143.7 49.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.543 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.52 122.76 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -65.39 -36.09 82.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.08 159.17 9.13 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.18 148.83 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.896 0.379 . . . . 0.0 110.925 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -122.91 142.1 51.17 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.1 mmm -109.42 142.29 40.6 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.86 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 57.9 m -73.11 155.01 40.14 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 110.372 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -58.31 -34.25 70.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.499 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -83.69 -4.57 58.72 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 110.807 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.61 32.99 21.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.84 -46.59 3.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.609 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' O ' ' OG ' ' A' ' 44' ' ' SER . 83.9 m-85 -116.89 140.85 48.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.426 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.23 141.62 51.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.907 0.384 . . . . 0.0 110.801 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.29 130.59 55.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.169 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.66 134.34 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.002 0.429 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.05 133.87 53.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -131.14 147.17 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.345 0.593 . . . . 0.0 112.062 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -146.29 150.52 35.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.371 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.91 155.65 29.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.844 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 59' ' ' ASP . 60.8 mt -72.85 -14.77 61.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.744 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -81.07 3.43 23.3 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 50.4 p30 -66.37 -15.85 63.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.115 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -68.62 -36.4 78.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.355 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -91.03 117.09 29.31 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.14 -34.94 74.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.35 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.07 -38.32 90.41 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.44 0.638 . . . . 0.0 109.454 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.45 83.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.842 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.69 -41.93 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 109.584 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.68 -42.7 86.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.584 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.7 -44.77 66.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.012 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.98 -51.11 48.1 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.185 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 -37.15 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.002 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -65.39 -40.03 92.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.57 -41.76 83.65 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.554 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.1 -36.43 81.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.397 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.95 -45.95 69.42 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.148 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -71.29 -37.11 71.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.261 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.2 -6.31 54.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.505 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.5 p -58.9 -52.52 65.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.193 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.64 92.88 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.643 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -66.79 -44.38 81.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -68.11 -38.21 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.116 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -64.21 -47.16 80.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.558 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -71.09 -37.85 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.814 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.66 -36.99 85.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.407 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.14 -48.52 62.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.67 -42.32 99.74 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.11 -40.38 74.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.051 0.453 . . . . 0.0 111.598 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.74 96.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.157 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.1 mtt -88.22 -17.35 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.482 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 84' ' ' GLY . 72.7 mtm180 54.18 36.99 26.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.09 139.62 30.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.012 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 92' ' ' VAL . 89.0 mtt180 -92.36 -38.53 11.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.91 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.9 pt -73.55 26.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 90' ' ' ARG . 60.0 t -73.22 114.13 28.42 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 119.289 -0.386 . . . . 0.0 109.975 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.4 159.63 25.89 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.54 1.493 . . . . 0.0 111.632 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.45 137.38 58.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.56 130.01 46.57 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.223 0.535 . . . . 0.0 111.001 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.4 m -123.78 135.38 53.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.85 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -117.08 139.79 50.29 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.452 0.644 . . . . 0.0 112.134 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -121.66 153.94 37.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.728 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -109.15 134.07 52.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.649 -179.324 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo . . . . . 0 N--CA 1.495 1.598 0 CA-C-O 120.925 0.302 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -60.08 -31.48 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -59.37 -37.9 79.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.099 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.92 -40.39 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.66 88.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.55 -39.94 94.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.484 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.57 -37.2 82.98 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.18 -42.76 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.525 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -55.75 -44.68 77.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.452 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -64.32 -46.8 81.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.542 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.71 -33.62 74.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.917 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.14 -42.44 79.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.61 84.87 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.106 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.15 -53.4 57.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.037 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.78 -33.52 56.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.455 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.52 -44.37 76.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.855 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.8 mt-30 -82.1 -40.91 21.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 111.686 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -69.65 -37.58 76.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.126 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 45.5 tp10 -71.99 -17.09 62.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.205 0.526 . . . . 0.0 109.974 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.7 pt -118.54 150.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.796 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -81.93 115.14 20.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -70.8 -37.85 6.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -179.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 44.2 Cg_exo -56.87 -38.15 96.53 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.839 1.693 . . . . 0.0 112.499 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -60.1 -37.54 80.3 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.14 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 64.9 mt -92.36 -8.02 46.16 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.558 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.79 28.61 50.39 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mtm 56.17 -126.21 2.01 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.464 -0.199 . . . . 0.0 110.464 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.8 mtm 45.24 48.2 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.618 0.247 . . . . 0.0 111.037 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.5 m -120.24 130.45 54.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.855 0.359 . . . . 0.0 110.386 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -132.94 145.15 50.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.6 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.78 118.64 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.2 m -65.75 -35.4 80.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.587 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.42 152.31 6.23 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.47 134.41 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.922 0.392 . . . . 0.0 110.95 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.52 141.43 49.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.039 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.3 mmm -111.45 141.85 44.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.521 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 73.7 m -73.45 151.76 40.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.585 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -60.67 -30.46 69.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.322 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 57.7 t0 -82.62 -3.86 56.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.4 mp 56.57 29.75 16.09 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.31 -49.02 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.737 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' O ' ' OG ' ' A' ' 44' ' ' SER . 85.8 m-85 -116.92 143.56 45.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.74 141.59 51.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.434 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -113.08 127.77 56.3 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.21 132.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.309 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -119.77 127.38 52.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 150.71 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.246 0.546 . . . . 0.0 111.798 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 149.87 52.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.895 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' A' ' 59' ' ' ASP . 6.3 p90 -156.2 155.34 32.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.358 0.599 . . . . 0.0 111.606 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.3 -13.58 59.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.602 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 71.3 m-20 -80.91 0.18 36.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 7.3 m-20 -61.93 -19.53 62.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -68.22 -34.94 77.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.103 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.78 115.74 27.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.048 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 51.0 mp0 -59.69 -34.27 72.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.35 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.97 -37.34 87.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.376 0.608 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.17 83.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.554 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.72 -47.04 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.16 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.98 -46.33 71.64 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.357 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.06 -46.34 65.18 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.213 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.44 -51.41 48.86 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.455 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.5 tp -60.12 -34.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.473 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -67.1 -40.23 86.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.251 0.548 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.19 -41.86 76.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.843 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 76' ' ' SER . 52.7 tp -70.3 -36.65 74.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.136 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -68.78 -45.38 71.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.243 0.544 . . . . 0.0 110.316 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -70.6 -37.08 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.35 -8.63 57.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.544 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 72' ' ' LEU . 48.7 m -56.12 -50.46 71.02 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.036 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.69 94.31 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CE1' ' OE2' ' A' ' 26' ' ' GLU . 35.4 t80 -63.4 -43.15 98.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.64 -39.44 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.421 0.629 . . . . 0.0 110.359 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.522 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 74.2 ttt-85 -60.95 -46.16 91.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.937 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -70.21 -37.75 75.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.533 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.63 -37.84 76.97 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.82 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.78 -46.43 68.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.078 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -60.32 -42.48 98.83 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.99 -36.48 75.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.465 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.83 95.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.508 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.0 mtm -101.52 -3.91 27.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 53.41 43.77 30.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.505 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.1 mt -100.55 141.07 33.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.142 0.496 . . . . 0.0 111.701 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -97.99 -10.82 23.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.95 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.3 pt -98.56 21.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.814 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.7 116.46 50.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.05 160.63 26.84 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.713 1.608 . . . . 0.0 112.068 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.522 ' CD ' ' HE ' ' A' ' 80' ' ' ARG . 78.3 mm-40 -60.42 137.45 58.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.5 mt -100.37 130.15 46.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.961 0.41 . . . . 0.0 110.676 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.7 m -119.95 127.48 52.7 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -108.0 126.41 52.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.144 0.497 . . . . 0.0 111.308 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -120.93 138.26 54.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.333 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 37.7 p90 -107.74 113.85 27.39 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.866 0.365 . . . . 0.0 110.318 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.9 t0 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.935 179.654 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.498 1.751 0 CA-C-O 120.793 0.247 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.58 -37.37 75.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -59.5 -39.93 85.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.53 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.56 -40.23 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.92 91.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.183 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -63.86 -39.9 95.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.368 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.5 -37.64 84.42 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.2 -43.77 66.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.925 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.31 -42.44 77.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.337 0.589 . . . . 0.0 109.842 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.92 -49.82 71.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.228 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.66 -35.34 80.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.306 0.574 . . . . 0.0 110.747 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.155 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.284 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.57 -53.36 58.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.345 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.3 mt -70.23 -34.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.442 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.8 tp -55.95 -45.53 78.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.785 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 12.5 pt20 -84.49 -42.03 15.97 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.973 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 24' ' ' GLN . 50.7 mtp180 -70.45 -33.76 71.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -72.25 -15.75 61.92 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.452 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.8 pt -119.4 149.68 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.669 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.36 117.26 29.85 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -74.12 -38.12 3.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.496 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.2 Cg_exo -55.61 -31.61 79.94 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.108 1.872 . . . . 0.0 112.554 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.54 -37.72 79.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.684 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 mt -81.51 -20.06 40.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.979 0.419 . . . . 0.0 109.918 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.35 5.52 89.51 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.3 mtt -143.95 168.78 19.17 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.2 mtp -113.02 158.08 20.74 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 55' ' ' THR . 13.2 t -128.74 153.71 47.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.529 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.6 m -127.57 148.04 50.35 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.84 118.59 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.4 p -67.8 -30.51 69.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.14 157.41 8.04 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.57 152.82 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -130.36 141.05 50.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -103.75 141.66 35.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.936 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 67.5 m -73.06 154.69 40.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.639 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -58.21 -32.47 68.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.572 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -82.93 -3.99 57.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.449 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 58.87 26.58 15.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -104.86 -47.91 3.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.849 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.432 ' O ' ' OG ' ' A' ' 44' ' ' SER . 87.5 m-85 -114.69 143.7 44.62 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.885 0.374 . . . . 0.0 110.541 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.22 141.39 51.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -108.41 128.57 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.991 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.33 133.39 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.6 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.86 132.26 55.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' CG1' ' CZ ' ' A' ' 56' ' ' PHE . 22.0 t -131.13 148.03 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.345 0.593 . . . . 0.0 111.874 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 36' ' ' THR . 37.5 m -119.2 129.34 54.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.838 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.433 ' CZ ' ' CG1' ' A' ' 54' ' ' VAL . 84.8 m-85 -119.67 142.01 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.897 0.379 . . . . 0.0 111.778 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.67 -13.54 57.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 82.1 m-20 -81.34 -0.41 41.04 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.9 p30 -66.03 -15.01 62.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.96 177.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 61.2 tttp -67.37 -39.86 85.7 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.544 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -109.28 117.7 34.78 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -58.34 -35.86 72.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.85 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.36 -38.0 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.685 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.0 -45.56 73.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.64 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.35 -33.41 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.37 . . . . 0.0 111.149 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.08 -40.52 94.75 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.39 -46.1 64.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.35 -50.23 39.94 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.533 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.26 -34.67 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.247 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.47 -41.52 88.88 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.86 76.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.909 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.04 -36.61 75.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.637 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.15 -44.34 76.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.218 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.85 -36.57 80.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.281 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.12 -9.0 58.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.256 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.4 m -55.82 -45.99 78.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.159 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.75 -38.29 91.67 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -64.87 -42.91 94.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.019 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -58.22 -39.62 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.592 0.71 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -61.42 -44.76 96.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 t -70.12 -36.75 75.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.617 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.37 -41.43 76.55 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.58 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 tt -69.05 -48.48 62.73 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.633 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -65.68 -44.02 93.25 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.553 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.72 -37.89 73.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 112.024 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.73 98.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 74.7 mtm -99.83 -5.95 27.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.836 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' GLY . 66.4 mtt85 49.52 40.88 20.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.43 138.7 31.37 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.626 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -92.49 -38.4 11.97 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.223 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 pt -78.46 19.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.519 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 p -72.67 114.42 30.05 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.98 157.88 30.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.501 1.468 . . . . 0.0 112.099 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 38.0 mp0 -60.96 139.87 57.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.99 132.81 46.22 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.014 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.2 m -119.0 128.03 54.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.91 127.32 51.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.282 0.563 . . . . 0.0 111.426 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 52.0 t80 -126.91 147.73 50.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 51.1 p90 -101.28 129.13 47.19 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.767 0.318 . . . . 0.0 110.223 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.791 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 N--CA 1.498 1.754 0 CA-C-O 120.565 0.152 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -51.04 -23.74 3.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -59.02 -37.24 76.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.298 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.57 -40.51 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.042 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.54 87.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.592 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.85 -43.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.597 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.32 -39.32 92.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mmt -66.98 -42.17 85.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.442 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.88 -41.92 88.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.783 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -63.48 -47.36 82.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.095 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -62.96 -35.33 79.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.07 -42.88 79.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.58 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.41 84.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.471 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.7 tp -60.76 -53.38 58.11 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.26 -34.48 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.514 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.11 -45.87 79.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.905 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.3 mt-30 -83.23 -39.33 21.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.114 0.483 . . . . 0.0 112.068 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -69.79 -38.76 76.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.05 -16.1 62.03 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.907 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 24' ' ' GLN . 9.6 pt -116.58 149.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.304 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -86.61 125.8 34.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.51 -63.0 1.05 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.612 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -56.94 -23.82 53.53 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -58.94 -37.1 75.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.199 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -77.62 -20.55 53.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.43 5.09 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 62.4 mtt -146.73 167.8 22.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.812 0.339 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -104.9 152.49 22.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.625 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -130.68 155.29 46.85 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.798 0.332 . . . . 0.0 110.752 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -137.4 159.03 43.1 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.423 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -98.12 123.11 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.42 ' OG ' ' OD2' ' A' ' 100' ' ' ASP . 86.7 p -69.93 -28.7 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.26 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.71 153.89 6.48 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.2 148.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.744 0.307 . . . . 0.0 110.454 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -129.26 139.69 51.72 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.5 mmt -105.81 142.41 35.58 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.8 t -73.76 151.94 40.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.136 0.493 . . . . 0.0 110.343 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.24 -29.99 66.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.623 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.7 -3.36 57.71 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.546 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? 56.51 29.9 16.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.79 -48.41 3.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.789 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -116.78 141.57 48.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.46 51.86 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.452 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.69 127.7 54.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.34 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.48 133.27 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.623 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.08 133.66 55.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.27 149.79 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.442 0.639 . . . . 0.0 111.84 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -129.67 135.98 49.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.49 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -146.02 154.77 42.24 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.546 0.689 . . . . 0.0 112.22 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.3 mm? -80.08 -11.26 59.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.592 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.488 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 88.1 m-20 -79.49 -0.25 32.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.0 p30 -68.09 -14.84 63.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 35.1 ttpt -69.27 -38.51 78.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.541 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.59 119.03 38.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.018 0.437 . . . . 0.0 110.114 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 50.7 mp0 -59.48 -32.97 70.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.22 -39.02 75.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.254 0.549 . . . . 0.0 110.794 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.05 74.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.748 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -69.93 -33.58 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.448 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.75 -44.51 85.7 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.22 -44.77 67.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.39 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.8 -50.73 39.76 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.485 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.3 tt -59.46 -34.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.922 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -66.1 -42.19 89.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -40.72 87.25 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.649 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.92 -36.26 79.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -68.92 -45.63 70.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.083 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.15 -37.08 72.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.95 -8.91 58.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.177 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -57.09 -50.09 73.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.122 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.38 90.78 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.33 -43.6 94.13 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.269 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -58.61 -41.57 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 109.744 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 94' ' ' GLU . 39.8 ttm180 -63.14 -46.76 85.7 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -70.64 -38.04 73.83 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.98 -38.58 79.41 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.002 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.94 -40.61 83.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.157 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.89 -34.54 71.52 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -67.53 -43.29 81.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.392 -0.904 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.19 85.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.594 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtt -85.68 -17.19 36.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.5 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 84' ' ' GLY . 73.9 mtp180 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.244 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.3 mt -101.15 141.55 33.88 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.124 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -97.43 -14.95 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.559 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.69 21.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.773 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.85 114.14 27.8 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.141 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 89.3 Cg_endo -77.66 161.59 30.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.298 1.332 . . . . 0.0 111.098 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 80' ' ' ARG . 79.0 mm-40 -64.62 136.49 57.04 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.249 -0.581 . . . . 0.0 109.521 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' PRO . 7.1 mp -98.94 129.87 45.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.062 0.458 . . . . 0.0 110.365 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -117.9 127.63 54.04 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.28 126.65 51.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.126 0.489 . . . . 0.0 111.157 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 48.1 t80 -126.17 146.14 50.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.475 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 47.9 p90 -99.8 129.02 45.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.855 0.36 . . . . 0.0 110.435 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 56.3 p-10 . . . . . 0 N--CA 1.474 0.772 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.378 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo . . . . . 0 N--CA 1.494 1.502 0 CA-C-O 120.878 0.282 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -60.01 -31.76 70.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.81 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -59.29 -38.18 79.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.152 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.77 -40.79 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.81 88.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.146 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.48 -40.88 96.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.607 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.44 -36.96 81.83 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.3 -39.09 65.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.268 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -49.11 76.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.548 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -67.18 -37.71 84.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.099 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.1 tt0 -68.76 -39.94 80.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.43 -42.78 97.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.36 86.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.9 tp -60.68 -52.92 63.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.25 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -69.14 -34.01 61.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.22 -42.31 85.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.577 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -82.43 -41.89 19.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.307 0.575 . . . . 0.0 111.337 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.6 ttm180 -70.23 -37.15 74.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.35 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.22 -15.28 61.94 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.181 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 pt -113.89 150.42 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.18 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -78.5 130.52 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.028 0.442 . . . . 0.0 110.342 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.59 -62.0 3.31 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.962 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.74 -28.18 55.89 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.714 1.609 . . . . 0.0 112.725 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.31 -37.77 78.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.447 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 72.2 mt -99.02 -1.94 38.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.143 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.9 9.16 62.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm 58.97 60.79 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.571 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.2 mtt -150.6 72.8 1.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.4 p -126.04 140.92 52.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.6 m -139.71 142.78 36.85 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.208 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -95.76 117.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 m -68.21 -31.19 70.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.63 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.53 6.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.41 133.0 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -131.73 141.25 49.48 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.6 mpt? -111.44 143.17 42.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.412 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.5 t -72.63 151.86 42.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.662 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -56.29 -35.01 67.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.383 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.07 -4.98 58.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.695 0.283 . . . . 0.0 110.757 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.9 tp 60.01 34.45 21.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.61 -48.23 3.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.674 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -117.79 139.13 51.5 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.428 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.84 141.11 52.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.804 0.335 . . . . 0.0 110.226 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -119.58 118.79 31.94 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.96 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -119.43 134.66 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.014 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -108.56 136.35 48.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.058 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.33 150.82 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.1 0.476 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -140.95 152.06 44.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.023 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -156.04 146.77 21.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.392 0.615 . . . . 0.0 111.646 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 32.4 tp -66.05 -18.67 65.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.411 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 25.3 m120 -80.4 2.48 24.83 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.7 p30 -65.64 -15.12 62.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -70.22 -35.61 74.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.502 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -90.51 119.83 31.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.755 0.312 . . . . 0.0 110.368 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.6 -37.47 81.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.679 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -63.5 -38.92 92.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.483 0.658 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.08 82.33 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.96 -47.08 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.352 0.596 . . . . 0.0 109.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.52 -38.48 84.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.659 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.24 65.43 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.206 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.54 -52.71 15.02 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.045 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.91 -39.68 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.248 0.524 . . . . 0.0 112.064 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.37 -35.82 80.12 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.048 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.16 68.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.739 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 76' ' ' SER . 36.7 tp -71.11 -36.99 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.765 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.25 -45.49 73.07 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.33 0.586 . . . . 0.0 110.261 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.95 -36.93 75.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.082 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.66 -7.24 59.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.655 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 72' ' ' LEU . 75.5 m -55.55 -50.01 71.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.685 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.15 -35.62 85.02 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -64.93 -45.98 83.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.88 -39.54 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.512 0.673 . . . . 0.0 110.123 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -62.03 -45.07 95.2 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.526 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -71.01 -38.25 72.63 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -69.28 -42.41 75.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.73 -178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.88 -39.72 83.66 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.763 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.77 -39.46 76.63 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -68.38 -38.02 80.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.189 -1.005 . . . . 0.0 111.347 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.9 99.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.558 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 69.0 mtm -98.34 -6.92 29.86 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 98.8 mtt180 49.59 38.27 14.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 109.316 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 37.1 tp -90.98 140.4 29.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.968 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -90.08 -38.59 13.45 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.731 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 pt -78.28 34.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.731 0.3 . . . . 0.0 111.744 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.3 t -73.46 115.31 40.09 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.8 161.31 30.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.366 1.377 . . . . 0.0 111.884 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.27 138.36 58.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.24 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -122.23 131.23 53.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.397 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -108.54 130.33 55.29 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.048 0.451 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -119.43 141.23 49.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -97.77 118.62 34.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 111.524 -179.014 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.87 0.279 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.74 -22.8 25.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.425 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -57.58 -37.23 72.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.215 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.56 -38.82 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.612 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -63.05 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.99 -36.11 80.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.4 mtt -73.17 -38.99 66.0 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.987 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.4 -49.06 78.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.087 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -67.8 -40.77 83.85 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.071 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.98 -38.66 86.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.63 -44.06 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -37.04 86.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.3 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.29 -53.32 58.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.043 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.1 mt -69.71 -34.27 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.716 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.99 -41.9 84.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -83.3 -38.16 22.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.209 0.528 . . . . 0.0 111.909 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -71.16 -43.87 66.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.1 -13.82 61.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.52 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.1 tt -112.17 142.44 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -80.25 117.15 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 6.8 t70 -73.2 -35.6 2.83 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.8 Cg_exo -55.66 -29.82 72.46 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.966 1.778 . . . . 0.0 113.176 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -59.99 -36.64 77.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.742 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.36 -20.02 55.39 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.368 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.66 5.79 74.14 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.594 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 14.8 ptp -174.75 175.7 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.5 mtm -89.14 161.23 16.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.268 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -124.07 155.15 38.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.656 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.0 p -121.35 160.9 23.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.943 0.402 . . . . 0.0 110.96 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.43 123.75 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.828 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.436 ' CB ' ' OD2' ' A' ' 100' ' ' ASP . 23.2 t -68.31 -35.55 77.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.6 158.49 8.28 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.15 147.01 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 110.986 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -119.51 138.14 53.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.522 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.9 mmm -108.62 142.26 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 54.8 m -72.93 152.01 41.61 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -63.59 -30.5 71.61 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.409 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 56.4 p30 -83.68 -2.64 56.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.118 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.6 32.86 21.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -108.75 -47.66 3.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.174 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.429 ' O ' ' OG ' ' A' ' 44' ' ' SER . 91.6 m-85 -117.28 139.02 51.34 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.0 0.428 . . . . 0.0 111.179 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.53 141.5 51.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -113.67 130.03 56.47 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.188 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.69 133.82 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.705 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.84 132.44 56.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.9 151.06 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.098 0.475 . . . . 0.0 111.857 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -144.19 149.86 37.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 59' ' ' ASP . 6.9 p90 -159.21 159.95 34.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.29 0.567 . . . . 0.0 111.577 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.95 -25.76 66.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.401 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.594 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 27.6 m120 -80.31 0.93 30.78 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.891 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 13.8 m-20 -63.43 -15.1 56.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -69.44 -36.7 76.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.049 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -91.09 113.9 26.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.19 -35.99 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.81 -38.1 89.85 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.42 0.629 . . . . 0.0 109.458 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.59 84.24 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.51 -38.48 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 109.921 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -66.43 -40.75 89.7 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.03 66.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.72 -50.07 32.66 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.644 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.8 tp -58.67 -38.7 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.663 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.27 -36.18 79.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.58 80.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.719 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.35 -36.56 74.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.962 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -68.8 -45.36 71.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.138 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.9 -37.09 72.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.955 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.62 -7.8 57.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.067 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 t -57.85 -52.86 63.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.565 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.45 93.86 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.954 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.74 -44.56 85.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -68.86 -37.29 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.174 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.74 -46.45 88.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.666 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 t -67.62 -38.12 83.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.1 tp -68.93 -34.38 75.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.262 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.83 -46.79 74.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.744 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -58.61 -40.97 95.36 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.851 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.58 -40.8 93.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.94 0.4 . . . . 0.0 111.212 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.77 99.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtt -82.21 -17.3 46.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' GLY . 83.1 mtp180 57.85 34.01 23.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.261 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.08 141.44 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.737 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -97.93 -10.23 24.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.453 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 pp -106.96 34.21 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.27 124.77 90.89 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ALA . 88.8 Cg_endo -75.52 157.97 40.36 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.436 1.424 . . . . 0.0 112.304 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 39.3 mp0 -61.43 138.73 58.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.7 130.55 48.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.478 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 m -121.98 131.37 53.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.727 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.87 128.83 54.96 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.223 0.535 . . . . 0.0 111.015 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 41.5 t80 -129.64 152.28 49.32 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.7 p90 -104.81 132.43 51.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.658 0.266 . . . . 0.0 110.53 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' CB ' ' A' ' 39' ' ' SER . 56.3 p30 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 CA-C-O 120.832 0.263 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -54.28 -24.03 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.468 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -58.29 -40.5 82.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.386 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 p -59.41 -38.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.729 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' GLN . . . -62.13 -39.12 91.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -66.06 -42.66 89.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.15 -39.52 92.91 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.5 mtt -74.06 -35.61 64.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.107 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . 49.4 tt0 -57.33 -48.8 78.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.563 . . . . 0.0 110.617 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -68.7 -36.46 78.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.075 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.03 -41.42 86.59 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.659 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 pt -69.56 -36.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.517 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.555 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.24 -52.93 51.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.759 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.54 -33.58 57.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.044 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.2 -40.08 84.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.577 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.84 -44.07 19.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.397 0.618 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -69.85 -35.12 74.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.849 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -72.04 -14.34 61.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.016 0.436 . . . . 0.0 109.988 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.85 149.86 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.083 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.79 107.61 19.48 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.53 -41.92 93.07 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.93 -178.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 34.3 Cg_exo -61.69 -33.96 84.89 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.185 1.923 . . . . 0.0 112.815 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.98 -39.51 85.93 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.55 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 mt -104.91 -19.76 13.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 69.83 16.99 72.89 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 ttp -108.04 145.77 33.51 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.634 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -103.04 144.46 31.25 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.122 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.6 m -110.7 132.06 54.52 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -128.88 156.44 43.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 116.22 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.914 0.387 . . . . 0.0 110.544 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.9 t -70.63 -30.69 67.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.602 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.64 156.14 8.37 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.37 132.18 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.692 0.282 . . . . 0.0 110.846 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -127.17 137.84 53.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.176 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtt -109.86 143.71 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.8 t -77.29 151.09 35.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.117 0.484 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -60.97 -31.05 70.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.939 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.6 m-20 -83.17 -3.62 57.55 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.43 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 58.87 11.07 1.73 Allowed 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -75.02 -36.02 61.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -150.76 166.66 29.77 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.56 141.83 43.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -101.04 125.47 47.66 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.34 133.55 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 120.944 0.402 . . . . 0.0 110.476 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.42 149.37 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 121.248 0.547 . . . . 0.0 111.095 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 m -133.27 135.64 45.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' A' ' 59' ' ' ASP . 35.4 m-85 -123.06 153.13 40.29 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.3 tp -72.26 -35.71 68.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.632 0.73 . . . . 0.0 110.397 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -81.27 8.13 9.76 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.8 p30 -60.96 -20.13 61.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 25.8 pttm -68.99 -30.04 68.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -90.7 117.2 29.15 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.31 -34.87 74.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.714 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.02 -38.81 89.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.455 0.645 . . . . 0.0 109.576 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.75 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.12 -38.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -66.37 -45.67 79.33 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.489 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.97 -43.01 72.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.823 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.6 28.58 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.589 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.7 tp -59.09 -37.63 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.719 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.09 -35.9 78.91 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.876 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.4 78.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.002 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' SER . 79.8 mt -71.22 -36.35 71.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.533 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.38 -45.55 75.92 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.291 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -71.18 -37.11 72.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.28 -3.55 57.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.392 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 72' ' ' LEU . 22.9 t -55.44 -51.16 67.83 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.899 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.56 92.64 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -63.04 -43.87 97.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.581 -0.309 . . . . 0.0 111.275 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.8 -40.21 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.372 0.606 . . . . 0.0 110.787 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.77 -46.02 89.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.048 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.5 m -70.48 -36.95 74.14 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.571 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -69.31 -37.94 78.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.542 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.27 -42.41 79.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.879 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.91 -41.9 71.01 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -66.21 -39.41 89.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.289 -0.956 . . . . 0.0 112.128 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.18 87.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.247 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.1 mtm -97.69 -5.39 35.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.44 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.9 mtm180 49.31 41.98 21.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 110.056 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.9 tp -92.04 140.32 29.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.416 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -95.09 -41.29 9.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.7 pt -71.43 29.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.601 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 90' ' ' ARG . 88.6 t -73.45 114.2 29.47 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.276 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 160.62 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.5 1.467 . . . . 0.0 110.838 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.38 127.27 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.9 mt -94.2 131.02 40.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.207 0.527 . . . . 0.0 111.512 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.9 m -120.18 130.5 54.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.201 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -104.74 127.32 52.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.938 0.399 . . . . 0.0 110.752 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 39.9 t80 -132.23 151.72 51.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.002 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 51.0 p90 -105.61 132.51 51.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.969 0.414 . . . . 0.0 111.191 -179.54 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 120.854 0.272 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.386 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.09 -37.71 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.254 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.0 t -58.08 -40.04 75.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.09 93.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.083 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -63.83 -39.23 93.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.333 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.84 -36.3 80.77 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.8 mtt -72.84 -39.93 66.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.534 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.59 -47.41 79.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.774 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -66.49 -36.87 83.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.229 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -65.48 -41.69 93.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.67 -41.28 87.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.28 86.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.299 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.2 tp -60.92 -51.89 67.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.209 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.58 -34.44 65.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.24 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -59.17 -40.85 86.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.841 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -82.24 -41.31 20.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.354 0.597 . . . . 0.0 111.481 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -70.59 -41.57 72.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.04 -15.74 61.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.173 0.511 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.3 tt -114.42 148.2 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.75 119.4 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 30.9 t0 -78.89 -35.68 1.09 Allowed Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 47.4 Cg_exo -56.52 -34.49 95.15 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.766 1.644 . . . . 0.0 112.763 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -60.07 -38.01 81.58 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.267 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.81 -20.88 45.07 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.78 88.62 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.662 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.417 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 47.5 ttm -171.94 154.8 3.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.593 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -79.48 140.98 37.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.7 p -89.18 165.51 14.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.2 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -127.14 156.2 42.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.57 125.41 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.966 0.413 . . . . 0.0 110.393 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -67.54 -34.08 76.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.41 159.94 9.53 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.51 148.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.933 0.396 . . . . 0.0 111.262 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -124.08 138.09 54.48 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.748 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 mmm -113.14 142.33 45.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -73.85 150.76 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.734 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -60.6 -33.52 72.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.248 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.99 -3.54 57.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.408 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.0 mt 60.19 30.57 19.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.61 -48.21 3.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.888 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.6 144.36 44.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.953 0.406 . . . . 0.0 110.952 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.64 142.03 45.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.549 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -122.06 125.43 46.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.28 134.46 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.69 139.71 41.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.061 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.47 146.32 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.266 0.555 . . . . 0.0 111.467 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -133.6 139.39 46.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.318 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -149.2 143.9 26.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.96 0.41 . . . . 0.0 110.026 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.487 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 1.2 pt? -77.66 -12.15 59.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.834 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.78 3.22 20.15 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 57' ' ' LEU . 54.5 t0 -61.5 -16.53 48.27 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -69.64 -36.76 76.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 63' ' ' ASP . 65.2 t0 -90.84 114.01 26.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.722 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.26 -35.03 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.73 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 3.4 p30 -67.01 -33.52 75.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.133 0.492 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -67.98 -37.15 81.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.74 -44.7 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.341 0.591 . . . . 0.0 109.986 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.46 -41.0 85.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.018 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.48 -46.16 64.3 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.688 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.98 -51.73 27.35 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.472 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 mm -59.14 -37.79 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.567 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.39 -39.84 92.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.68 -41.81 74.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.939 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.1 tp -70.38 -36.52 74.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.67 -45.0 69.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.308 0.575 . . . . 0.0 110.386 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -36.86 74.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.028 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.38 -7.86 55.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 t -55.07 -50.55 68.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.11 -39.04 93.89 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -66.94 -40.33 87.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.41 -41.43 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 109.833 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.9 -47.19 81.58 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.535 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -70.93 -36.23 72.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.821 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.81 -34.56 76.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.063 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.36 -46.08 74.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.545 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -66.52 -36.93 92.17 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.985 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.58 -43.55 89.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.72 -0.74 . . . . 0.0 111.714 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.26 -43.73 66.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.798 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.7 mtt -80.65 -17.96 49.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 84' ' ' GLY . 40.5 ttp180 61.47 29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.487 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.58 141.66 35.04 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.217 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -97.38 -11.91 23.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.094 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -84.03 24.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.33 119.13 73.11 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.34 161.48 31.78 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.447 1.432 . . . . 0.0 111.882 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.04 134.11 56.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.6 mt -99.76 131.04 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.085 0.469 . . . . 0.0 110.883 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -118.6 123.13 44.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -102.69 131.11 49.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 54.4 t80 -119.03 141.92 48.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.603 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.412 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 43.2 p90 -106.87 134.53 49.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 -179.817 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 121.057 0.357 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -64.4 -35.08 79.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.335 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -60.31 -43.31 96.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 p -65.6 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.721 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.09 79.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.45 -40.42 95.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.24 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -38.38 87.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 91.1 mmm -70.66 -40.13 73.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.513 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.562 HE21 ' H ' ' A' ' 41' ' ' VAL . 51.2 tt0 -55.32 -43.21 74.69 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.551 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -62.73 -45.35 93.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.182 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.59 -34.66 78.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.788 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.5 mt -70.5 -42.3 78.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.69 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.77 85.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.034 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.53 -53.06 61.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.641 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.5 mt -69.81 -33.94 58.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.503 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.7 tp -56.67 -41.56 77.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.813 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.4 tt0 -82.11 -42.8 18.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.285 0.564 . . . . 0.0 111.267 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.39 -36.62 76.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.94 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -71.81 -17.05 62.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.214 0.53 . . . . 0.0 109.909 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.2 pt -119.44 150.54 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.067 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.2 120.52 24.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -73.13 -39.09 4.89 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.4 Cg_exo -52.91 -38.35 78.94 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.012 1.808 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -63.93 -37.73 88.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 mt -99.7 -9.79 22.68 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.719 0.295 . . . . 0.0 110.514 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 35' ' ' MET . . . 81.01 17.88 71.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.3 ttp 60.61 3.01 0.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.334 0.588 . . . . 0.0 109.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 33' ' ' GLY . 64.9 mtt -58.29 -28.02 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.781 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -65.98 129.42 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -131.39 148.39 52.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.898 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.93 117.75 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 0.0 109.788 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 m -66.48 -35.9 81.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.508 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 160.58 10.04 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.562 ' H ' HE21 ' A' ' 16' ' ' GLN . 5.4 m -127.14 152.78 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -132.79 139.9 47.75 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.42 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.2 mtt -97.16 140.3 31.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' HG ' ' H ' ' A' ' 49' ' ' TYR . 97.7 p -73.66 160.14 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.955 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.8 ttm105 -58.01 -32.78 68.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.507 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -82.6 -3.88 56.81 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.271 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.0 mt 59.17 15.26 4.03 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.13 -36.79 8.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.901 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.455 ' H ' ' HG ' ' A' ' 44' ' ' SER . 85.4 m-85 -115.6 146.25 41.95 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.724 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.19 141.75 47.17 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.787 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -108.88 128.08 54.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.299 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.1 133.38 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.292 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.44 130.16 56.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.14 148.68 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.007 0.432 . . . . 0.0 110.94 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 t -135.43 151.55 50.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -144.63 141.85 29.69 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.275 0.56 . . . . 0.0 111.037 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.9 tp -68.74 -22.49 64.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -80.3 5.57 14.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 53.7 p30 -61.85 -17.43 56.41 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 48.1 mtmt -68.88 -35.85 77.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.339 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -89.73 118.57 29.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.011 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.1 -35.49 75.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.907 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.78 -39.57 93.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.608 0.718 . . . . 0.0 109.275 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.53 80.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.588 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.44 -42.83 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.679 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.15 -47.68 70.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.258 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.45 69.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.826 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -51.27 37.34 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.857 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.03 -40.98 81.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.223 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.79 -35.02 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.951 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.4 76.82 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.335 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.11 -36.82 72.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.198 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.413 ' O ' ' OG ' ' A' ' 76' ' ' SER . 67.9 tp60 -70.02 -45.38 67.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.347 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.67 -37.06 73.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.487 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.62 -12.06 60.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.345 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 92.5 p -55.66 -50.2 70.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.503 -177.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.83 95.06 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.485 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.72 -41.44 92.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.39 -39.84 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.321 0.582 . . . . 0.0 110.622 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.36 -47.74 80.84 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.023 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.1 m -71.45 -38.37 71.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.211 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.5 tp -68.07 -37.79 81.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.311 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.35 -41.33 80.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.73 -36.04 74.52 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -70.05 -43.68 70.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.529 -0.835 . . . . 0.0 111.614 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.61 89.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.522 . . . . 0.0 109.909 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.8 mtt -84.9 -17.69 37.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.15 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' GLY . 39.7 mmm-85 59.52 25.32 14.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.99 141.77 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.108 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.71 -10.45 19.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.413 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.1 pt -75.21 7.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.353 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.55 122.21 86.92 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.75 163.68 28.72 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.616 1.544 . . . . 0.0 111.749 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.02 133.47 56.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.31 129.73 44.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -119.38 127.96 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.51 129.85 52.5 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.181 0.515 . . . . 0.0 111.468 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -119.11 138.69 52.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.568 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 24.6 p90 -102.69 128.69 49.29 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.935 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 CA-C-O 120.856 0.273 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -51.94 -23.72 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.797 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -58.93 -37.63 77.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' SD ' ' A' ' 15' ' ' MET . 66.3 t -58.57 -41.01 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.762 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.26 90.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.063 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.86 -39.2 93.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.116 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.73 -36.52 81.21 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -73.06 -41.1 64.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.035 178.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.11 -45.62 92.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -67.25 -41.1 86.16 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.24 -41.9 89.37 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.772 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.23 -41.35 86.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.281 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 -37.65 88.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.122 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.53 -52.32 63.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.311 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.34 -32.78 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.305 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.36 -40.96 71.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.478 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ILE . 26.2 mt-30 -82.51 -43.73 16.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.696 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.83 -32.68 69.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -71.7 -16.54 62.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.45 0.643 . . . . 0.0 109.343 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.6 pt -118.69 149.34 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -95.0 123.92 38.75 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -47.39 -59.7 5.13 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -52.11 -23.23 16.81 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.966 1.777 . . . . 0.0 113.513 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.45 -38.11 76.81 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.559 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -100.33 -12.24 19.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.85 61.42 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 mtt -146.71 163.91 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.542 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.6 mtp -96.19 148.08 23.08 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.807 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -114.35 152.5 31.37 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.131 0.491 . . . . 0.0 111.004 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.0 m -129.03 145.7 51.19 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -92.73 124.08 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.5 p -78.33 -23.19 47.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.744 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.95 155.09 6.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.46 153.53 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -135.12 142.51 46.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 mmt -103.36 142.36 34.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.778 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' A' ' 49' ' ' TYR . 88.3 p -73.54 161.6 30.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.186 0.517 . . . . 0.0 110.5 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -59.55 -35.16 73.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' OG ' ' A' ' 44' ' ' SER . 55.4 p30 -83.68 -2.94 57.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.417 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp 59.89 22.48 11.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.71 -37.53 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.46 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.597 ' H ' ' HG ' ' A' ' 44' ' ' SER . 89.9 m-85 -116.19 143.66 45.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.42 141.97 46.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -115.93 125.72 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.301 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.65 134.77 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.087 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -109.54 131.95 54.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 m -131.59 149.53 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.062 0.458 . . . . 0.0 111.04 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -140.96 152.01 44.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.285 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CG ' ' OD1' ' A' ' 59' ' ' ASP . 19.2 p90 -151.98 161.07 43.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.474 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -27.76 68.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.486 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 60' ' ' LYS . 15.9 t-20 -80.56 2.03 27.2 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.529 ' OD1' ' CG ' ' A' ' 56' ' ' PHE . 3.3 m-20 -61.53 -15.48 38.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 58' ' ' ASN . 48.9 mtmt -67.64 -37.13 82.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -90.52 114.46 26.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.778 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.34 -33.26 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.64 -38.88 92.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.48 0.657 . . . . 0.0 109.486 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.65 84.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.763 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.61 -39.53 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.212 0.529 . . . . 0.0 109.977 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -65.86 -41.22 91.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.07 70.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.38 -51.39 52.89 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.254 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.6 -38.83 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.203 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.43 -39.98 95.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.254 0.55 . . . . 0.0 109.634 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.82 71.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.325 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 tp -70.32 -37.57 74.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.429 ' O ' ' OG ' ' A' ' 76' ' ' SER . 81.6 mm-40 -69.35 -44.76 70.93 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.09 -37.03 78.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.936 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.86 -10.14 59.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 73' ' ' GLN . 82.9 p -57.76 -49.6 76.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.63 -36.79 87.29 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.09 -45.38 85.46 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.425 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.2 mt -60.72 -39.23 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.468 0.651 . . . . 0.0 110.608 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -61.43 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.84 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -70.4 -35.65 73.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.478 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -40.58 97.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.113 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.63 -51.11 45.72 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.88 -44.31 94.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.176 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.58 -42.63 70.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.33 92.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtm -89.19 -17.15 29.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.12 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 84' ' ' GLY . 48.1 mmm-85 54.42 37.61 28.01 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 tp -93.9 139.87 30.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.689 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -89.35 -38.56 14.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -77.76 21.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.673 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.35 114.8 32.91 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -83.24 168.61 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.903 1.735 . . . . 0.0 112.284 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -74.32 142.46 45.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.15 128.13 44.48 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.189 0.518 . . . . 0.0 111.324 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 m -110.24 118.95 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 130.25 44.66 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 112.334 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.37 138.67 52.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.095 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -105.71 133.81 49.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.731 0.301 . . . . 0.0 110.653 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.98 0.419 . . . . 0.0 110.184 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.645 0.259 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -60.72 -40.49 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.326 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.18 -40.68 86.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.86 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.2 83.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.46 -42.1 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.188 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.81 -38.54 88.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.9 mtt -71.13 -38.6 72.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.971 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.72 -44.61 73.66 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -64.28 -45.93 85.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.499 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -63.25 -34.06 76.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.376 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.83 80.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.741 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.75 85.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.812 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.93 -53.16 58.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.068 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.8 -34.87 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.747 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.0 tp -58.89 -43.47 90.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.245 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -83.23 -40.5 19.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.591 . . . . 0.0 111.684 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -69.85 -41.86 74.32 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -72.94 -15.62 61.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.145 0.498 . . . . 0.0 110.442 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 23' ' ' LEU . 18.8 tt -115.35 142.21 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.547 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -83.58 113.71 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -67.87 -38.62 14.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.787 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 60.0 Cg_exo -52.68 -31.78 51.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.878 1.719 . . . . 0.0 112.616 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -60.5 -37.26 80.51 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.891 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.9 mt -79.85 -20.1 46.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 109.856 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.47 5.45 82.12 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.401 ' SD ' HD23 ' A' ' 57' ' ' LEU . 25.2 ttt -167.07 154.8 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.65 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.55 142.91 33.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.034 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 157.17 16.27 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.0 m -121.15 143.28 49.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.23 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.33 118.08 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 110.131 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -63.32 -36.16 82.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.313 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.63 161.52 10.44 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.64 151.35 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.812 0.339 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.17 142.59 48.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.0 mtt -102.2 142.28 33.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.003 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.7 t -73.79 152.2 40.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.087 0.47 . . . . 0.0 110.588 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -55.98 -31.75 63.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.993 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.71 -3.87 57.05 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.326 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.8 mt 58.8 20.11 7.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.06 -41.37 6.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.945 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.62 147.28 40.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 141.31 49.18 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.94 0.4 . . . . 0.0 110.474 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -109.04 127.55 54.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.81 133.11 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -112.84 130.46 56.08 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.91 147.65 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.892 0.377 . . . . 0.0 110.716 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -126.37 125.7 42.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.96 131.6 55.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' SD ' ' A' ' 34' ' ' MET . 30.5 tp -70.89 -25.93 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.436 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 60' ' ' LYS . 19.6 m120 -81.09 2.57 26.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -60.75 -16.85 44.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 58' ' ' ASN . 14.7 mtpp -69.0 -35.56 76.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -89.71 119.32 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.378 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.71 -32.31 70.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.75 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.7 -40.24 76.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.308 0.575 . . . . 0.0 110.415 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.09 74.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.955 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.83 -34.37 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.257 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -64.69 -42.92 94.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 109.641 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.64 75.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.343 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.37 51.66 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.997 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.58 HD13 ' CZ ' ' A' ' 99' ' ' TYR . 5.5 mm -57.98 -42.93 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.666 0.27 . . . . 0.0 111.038 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.01 -35.73 80.57 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.04 -45.2 71.01 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.106 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 tp -70.98 -36.68 72.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.416 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.6 -45.46 71.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.43 -37.08 74.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.43 59.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.28 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 t -55.67 -51.07 68.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.241 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.09 93.22 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -65.94 -41.27 91.54 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.11 -41.43 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.342 0.592 . . . . 0.0 109.969 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 93' ' ' PRO . 37.4 ttt85 -62.9 -47.15 84.51 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.42 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 t -70.95 -36.45 72.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.707 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.46 -39.91 77.44 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.787 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.35 -49.22 51.62 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.43 -42.26 99.73 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.407 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -68.8 -39.86 79.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.375 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.851 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.08 -14.07 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 93.7 mtt-85 56.91 35.78 26.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.52 141.35 34.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.782 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -102.12 -10.94 19.22 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.498 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 91' ' ' ILE . 36.8 pt -88.4 13.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -73.09 121.94 86.39 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 94.7 Cg_endo -78.06 166.06 25.32 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.701 1.601 . . . . 0.0 111.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.01 138.41 58.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.4 mm? -97.56 128.31 44.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.074 0.464 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.4 m -118.57 129.35 55.29 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.67 129.12 49.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.198 0.523 . . . . 0.0 111.498 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.1 t80 -123.25 144.97 49.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.738 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 21.4 m-85 -109.22 132.56 54.0 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.932 0.396 . . . . 0.0 110.241 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.936 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -62.02 -43.06 99.64 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.65 -37.74 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.164 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.96 81.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -64.67 -41.78 95.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.29 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.57 -38.75 88.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 90.4 mtp -71.1 -38.8 72.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.71 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.5 -42.38 78.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.537 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -63.0 -45.42 92.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.11 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.13 -34.85 78.49 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.708 0.766 . . . . 0.0 109.715 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.63 -41.51 77.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.485 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.51 84.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.194 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.56 -52.99 62.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.577 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.9 mt -69.87 -34.26 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.395 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 27' ' ' ILE . 36.8 tp -56.33 -41.96 76.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.016 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' ILE . 59.4 tt0 -82.92 -41.64 18.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 111.442 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -70.35 -38.81 74.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.122 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -72.39 -14.86 61.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.071 0.462 . . . . 0.0 110.336 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.9 tt -119.9 141.64 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.554 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -86.54 113.06 22.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -67.77 -38.75 15.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.489 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.59 -28.69 46.93 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.012 1.808 . . . . 0.0 112.559 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -59.38 -38.2 79.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.527 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 mt -88.37 -19.45 26.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.138 0.494 . . . . 0.0 109.8 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.71 5.0 89.84 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 90.7 mmm -143.74 162.22 36.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.838 0.351 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.6 ttp -96.79 134.54 39.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.952 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.0 p -92.0 158.04 16.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 t -135.56 159.66 40.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p -108.17 127.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.999 0.428 . . . . 0.0 110.085 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 m -72.19 -34.2 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.42 157.44 8.48 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.76 150.69 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.074 0.464 . . . . 0.0 111.488 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.1 141.86 50.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.074 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.1 mtt -108.11 142.07 38.87 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 p -75.47 152.84 37.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.058 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -63.06 -34.81 78.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.443 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.92 -3.11 57.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.376 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.4 mt 62.03 13.67 5.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.11 58.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.177 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.2 165.49 29.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.256 0.55 . . . . 0.0 111.764 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.54 142.3 35.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.257 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -112.41 120.01 40.19 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.208 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.8 133.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.907 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -109.67 136.19 49.41 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.79 146.98 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 0.0 111.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 t -144.65 152.48 40.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 11.0 p90 -150.24 159.73 44.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.123 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.18 -27.03 68.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.02 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.412 ' C ' ' N ' ' A' ' 60' ' ' LYS . 73.5 m-20 -80.23 5.78 13.67 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 68.9 m-20 -61.02 -16.71 46.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 58' ' ' ASN . 63.9 tttp -68.87 -39.97 79.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.82 114.12 26.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.167 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -60.46 -33.0 71.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.04 -38.72 89.09 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.447 0.641 . . . . 0.0 109.386 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.55 83.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 69' ' ' ILE . 82.6 t -68.76 -37.87 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.913 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.4 -45.47 79.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.595 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.27 -44.55 68.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.496 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.85 41.38 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.484 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.0 tt -59.8 -34.5 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.214 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -66.4 -41.31 89.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.38 0.61 . . . . 0.0 109.506 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.36 75.09 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.95 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -69.62 -36.63 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -68.48 -44.49 74.67 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.192 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -69.35 -37.07 77.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.091 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.72 -10.52 59.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.333 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.8 p -58.67 -49.41 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.243 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.7 91.88 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -64.49 -43.6 93.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.623 0.249 . . . . 0.0 111.452 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.73 -42.84 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 110.808 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -63.11 -47.1 84.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.48 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.1 t -70.98 -37.76 72.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.866 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -66.45 -37.8 85.95 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.778 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.75 -43.32 76.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.956 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.0 -38.4 74.21 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -66.26 -43.12 87.36 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -0.726 . . . . 0.0 111.921 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.58 83.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.7 mtt -84.29 -17.21 40.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' GLY . 41.3 ttt85 59.44 35.35 22.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.656 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.35 142.05 33.32 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.034 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.58 -10.54 19.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.668 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 pt -82.62 18.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.201 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.97 122.5 87.81 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.91 158.97 31.09 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.545 1.496 . . . . 0.0 111.374 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.81 128.7 37.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.5 mt -95.58 131.37 41.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.228 0.537 . . . . 0.0 111.313 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -115.61 127.25 55.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.98 126.9 52.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -119.11 141.64 48.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.768 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 23.3 p90 -106.83 132.02 53.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.905 0.383 . . . . 0.0 110.337 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.341 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -63.31 -43.2 98.52 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.016 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.07 -37.1 78.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.291 0.567 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.8 -39.54 83.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -71.59 -46.42 59.32 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.519 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.37 -37.15 84.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 57.3 mtt -71.62 -40.72 69.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.982 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -54.49 -42.33 70.63 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -63.3 -46.79 85.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.366 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.35 -33.48 75.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.608 0.718 . . . . 0.0 109.824 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.26 -42.92 78.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.962 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.17 86.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.58 -51.82 65.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.389 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.27 -34.1 64.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.7 -41.02 97.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -82.65 -27.8 31.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -82.83 -45.26 14.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.773 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.05 -17.39 62.02 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 72' ' ' LEU . 35.5 mt -112.24 133.92 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.009 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.97 121.96 28.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 10.7 t70 -46.14 -58.48 6.36 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.302 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.61 -22.93 18.24 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.805 1.67 . . . . 0.0 113.13 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.18 -38.36 76.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.763 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.8 mt -100.7 -13.79 18.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.05 0.453 . . . . 0.0 109.801 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.66 5.68 89.68 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.3 tpt -160.88 158.75 28.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.404 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.442 ' SD ' ' OD1' ' A' ' 29' ' ' ASP . 94.1 mmm -80.45 137.93 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 p -86.08 150.33 24.52 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.872 0.368 . . . . 0.0 111.029 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.4 m -125.98 141.71 51.84 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.911 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -100.24 120.97 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.012 0.434 . . . . 0.0 110.169 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -68.84 -33.94 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.17 158.19 8.79 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 m -127.16 148.62 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 111.193 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -126.1 138.29 53.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.952 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.487 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -113.73 143.24 44.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 94.7 p -73.2 156.4 38.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.233 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.953 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 55.3 p30 -83.91 -0.86 53.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.5 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.27 31.94 21.57 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' A' ' 46' ' ' ASP . . . -105.56 -46.44 4.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.79 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -116.02 145.55 42.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.829 0.347 . . . . 0.0 110.641 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.88 142.17 40.69 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -122.05 127.49 50.28 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.5 134.74 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -109.96 133.17 53.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.74 149.85 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.167 0.508 . . . . 0.0 111.55 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -143.36 151.77 40.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.41 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 7.2 p90 -156.03 158.52 37.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 111.397 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.01 -14.67 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.75 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.6 3.42 21.94 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.519 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 64.6 m-20 -61.88 -16.64 52.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.37 -39.43 85.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.135 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.62 117.26 29.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.037 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -60.3 -36.57 78.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.427 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.06 -37.92 89.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.471 0.653 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.84 84.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.1 -44.32 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -66.83 -39.83 87.78 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.47 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.83 76.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.59 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.42 -51.2 38.78 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.41 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.37 -41.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.612 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.46 -35.27 80.4 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.57 86.21 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.936 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' CD2' HD11 ' A' ' 27' ' ' ILE . 84.7 mt -70.35 -35.89 73.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.851 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -67.78 -45.96 73.33 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.47 -37.18 71.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.5 -3.97 54.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.286 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -55.24 -50.3 69.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.317 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.76 93.02 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.232 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -66.41 -42.65 87.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.32 -39.52 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.638 0.732 . . . . 0.0 110.087 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -63.74 -45.02 91.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.09 -36.95 78.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.521 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.52 -38.77 90.63 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.935 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.87 -49.5 57.74 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.515 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -59.45 -43.0 97.83 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.692 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.053 0.454 . . . . 0.0 111.824 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.65 98.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.474 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -94.5 -9.17 36.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 89.5 mtm-85 55.13 36.67 27.49 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.72 141.2 33.93 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.977 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -99.22 -14.69 19.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 pt -86.91 29.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 92' ' ' VAL . 35.9 m -72.57 118.36 67.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.91 160.82 27.25 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.547 1.498 . . . . 0.0 111.61 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.29 136.2 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.8 mt -100.84 130.76 46.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 110.947 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -119.65 124.88 47.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.996 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.73 129.11 47.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.452 . . . . 0.0 111.231 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 37.7 t80 -119.64 139.8 51.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 44.6 p90 -104.67 133.6 49.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.964 0.412 . . . . 0.0 110.484 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.56 0.219 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -59.77 -43.21 94.47 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 m -65.5 -36.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.847 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.33 85.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.811 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.33 -40.71 96.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.3 -37.62 83.89 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.55 -42.18 68.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.886 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.36 -43.74 79.43 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -63.52 -48.14 78.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.069 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.83 -32.25 72.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.246 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.03 -41.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.86 85.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.8 tp -64.34 -52.01 60.5 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.22 -33.92 60.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 27' ' ' ILE . 56.4 tp -57.96 -42.21 84.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.4 mt-30 -82.46 -41.87 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.384 0.611 . . . . 0.0 111.358 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -70.54 -37.6 74.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.827 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -72.12 -17.42 61.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.176 0.512 . . . . 0.0 110.125 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.2 tt -118.7 141.09 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.815 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -66.52 -38.69 21.0 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.437 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.5 Cg_exo -55.28 -31.91 78.7 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.004 1.802 . . . . 0.0 112.521 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.51 -38.22 80.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.704 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.9 -20.02 28.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.951 0.405 . . . . 0.0 110.002 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 7.39 87.19 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.8 mtt -138.85 167.15 22.64 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.962 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.8 mtp -98.29 151.2 20.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.444 ' CG2' ' CE1' ' A' ' 56' ' ' PHE . 88.0 m -109.09 142.36 39.94 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -122.41 157.36 32.05 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.732 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p -105.54 116.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.152 0.501 . . . . 0.0 110.2 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -34.46 78.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.006 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.11 152.59 6.37 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 52' ' ' VAL . 32.5 t -126.09 137.92 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.679 0.276 . . . . 0.0 110.454 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -128.23 140.35 51.95 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.993 0.425 . . . . 0.0 110.779 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.6 mtt -111.36 142.47 43.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.475 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.1 p -73.44 155.31 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.822 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.25 -32.54 71.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.565 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.57 -3.54 56.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.377 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.31 27.12 16.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.37 -41.29 5.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -118.07 142.75 47.07 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.872 0.367 . . . . 0.0 110.885 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.07 141.73 48.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.13 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.97 129.13 55.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 41' ' ' VAL . 97.0 t -117.77 133.36 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.415 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -118.74 128.76 54.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.33 149.73 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.225 0.536 . . . . 0.0 111.452 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -123.7 134.68 53.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 36' ' ' THR . 97.6 m-85 -121.39 146.55 46.76 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.426 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.3 mt -76.03 -12.06 60.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 81.9 m-20 -80.68 -2.43 46.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.834 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 100' ' ' ASP . 98.4 m-20 -62.94 -21.2 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.88 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -69.88 -38.43 76.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.562 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -99.1 109.51 22.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.03 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.11 -38.17 82.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.05 -38.03 89.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.84 82.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.51 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' ILE . 76.7 t -66.43 -35.53 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -66.2 -43.75 85.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.228 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.81 72.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.346 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -50.4 32.18 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.717 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.22 -36.74 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.682 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -68.35 -38.05 81.09 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.551 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.35 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.61 -36.88 76.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.658 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.76 -44.95 72.65 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.09 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.75 -36.95 79.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.236 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.26 -12.16 60.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.0 -49.53 76.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.461 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.15 86.02 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.161 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.09 -44.63 88.24 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.333 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.44 -39.6 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.543 0.687 . . . . 0.0 110.501 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -63.48 -45.02 92.7 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.736 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.56 -36.55 76.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.0 mt -66.43 -36.49 82.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.237 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.12 -48.6 64.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.909 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.17 -43.1 65.08 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.603 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.86 -43.11 80.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.258 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.14 83.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.429 ' HB3' HD23 ' A' ' 89' ' ' LEU . 56.6 mtt -84.54 -21.38 30.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 84' ' ' GLY . 49.0 ttp85 64.21 37.15 8.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.992 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.6 mm? -90.28 141.46 28.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.984 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -98.7 -14.56 19.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.422 ' CG1' HD12 ' A' ' 89' ' ' LEU . 34.8 pt -97.7 34.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 92' ' ' VAL . 34.2 m -73.25 119.87 78.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.98 160.35 30.37 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.418 1.412 . . . . 0.0 111.352 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.37 132.67 54.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.05 126.82 51.47 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.819 0.342 . . . . 0.0 110.304 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 m -117.11 133.68 55.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.512 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.28 128.52 54.52 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -119.58 137.53 53.79 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 38.3 p90 -109.63 123.59 49.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.932 0.396 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.417 ' O ' ' OD2' ' A' ' 59' ' ' ASP . 60.4 t0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.648 0.261 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -58.71 -41.57 86.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.53 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.2 -39.38 78.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.757 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.07 96.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.914 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -61.38 -39.37 90.41 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.379 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.56 -37.33 83.44 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.32 -41.87 69.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.599 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HG2' HG22 ' A' ' 41' ' ' VAL . 94.7 mt-30 -60.66 -41.5 95.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.574 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -64.63 -51.33 63.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.215 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.74 -34.92 79.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.941 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.0 mt -71.07 -39.96 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.109 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -36.85 85.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.25 -53.31 46.18 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.81 -34.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.76 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 27' ' ' ILE . 37.0 tp -59.35 -38.96 81.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.945 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 27' ' ' ILE . 48.5 tt0 -81.88 -44.46 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.988 0.423 . . . . 0.0 111.15 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -71.15 -36.64 72.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -73.27 -14.31 61.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.291 0.567 . . . . 0.0 109.906 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 23' ' ' LEU . 15.0 tt -121.67 149.47 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -76.03 113.02 13.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -70.14 -38.55 9.02 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.86 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 46.0 Cg_exo -56.57 -37.4 97.56 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.078 1.852 . . . . 0.0 112.781 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -59.94 -37.43 79.5 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.121 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 61.7 mt -92.45 -3.88 54.54 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.76 0.314 . . . . 0.0 110.6 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.05 5.39 70.65 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ttt 65.46 0.38 1.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mmm -79.32 10.29 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.692 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.3 m -78.75 130.68 36.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.067 0.46 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.9 m -131.27 145.91 52.09 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.3 t -94.47 119.11 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.379 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.98 163.68 11.3 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 16' ' ' GLN . 2.2 m -127.42 148.8 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.637 0.256 . . . . 0.0 110.386 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.93 130.55 56.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 58.3 mmm -100.65 142.27 32.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -73.52 151.27 41.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 0.0 110.585 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -57.92 -36.12 72.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.428 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -83.92 -0.14 50.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.421 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 59.38 30.17 19.83 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.61 -47.41 4.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.187 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -118.19 145.02 45.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.903 0.383 . . . . 0.0 111.055 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.4 141.79 46.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.06 130.13 56.27 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.14 133.47 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.593 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -116.51 128.9 55.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.722 0.296 . . . . 0.0 110.355 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.82 147.34 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.83 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -132.61 144.2 50.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 5.5 p90 -150.3 150.17 31.12 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.159 0.504 . . . . 0.0 111.058 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.08 -33.75 75.01 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 17.0 m120 -80.89 -2.46 47.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 36.0 t0 -61.68 -14.83 34.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -67.6 -38.2 83.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.28 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.09 126.71 35.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.068 0.461 . . . . 0.0 110.428 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.3 -35.41 75.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.136 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.9 -40.28 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 109.976 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.66 81.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.054 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.74 -39.27 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 0.0 109.279 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HZ3' ' CE ' ' A' ' 70' ' ' LYS . 22.0 tptp -64.31 -43.32 95.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.534 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.9 62.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.804 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.64 -52.08 32.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.747 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.34 -36.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.568 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' CE ' ' HZ3' ' A' ' 66' ' ' LYS . 3.1 ttmp? -66.03 -39.94 90.62 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.43 -42.06 83.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.834 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.11 -36.24 74.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.116 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -69.0 -45.5 70.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.59 -36.96 73.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.227 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.13 -8.78 59.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.218 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -57.15 -49.06 77.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.293 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.36 87.09 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.07 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -66.08 -44.52 84.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.464 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.29 -40.37 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 110.149 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -63.46 -45.55 90.32 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -68.88 -37.09 78.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.44 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.11 -38.36 90.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.254 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.92 -47.24 66.27 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.67 -42.15 72.53 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.722 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.43 -43.01 78.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.351 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.32 87.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.008 0.432 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 39.8 mtt -86.21 -17.6 34.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 70.8 mtp85 53.51 37.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -94.64 139.44 31.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.412 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -86.65 -39.0 16.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.033 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.9 pt -76.22 33.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -72.59 114.61 31.61 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -80.33 162.13 22.61 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.694 1.596 . . . . 0.0 112.036 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.67 133.29 50.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.19 131.41 44.57 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.104 0.478 . . . . 0.0 110.882 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.6 m -120.88 131.79 54.6 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.389 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.74 127.28 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.004 0.431 . . . . 0.0 110.98 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -126.04 146.16 50.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.0 p90 -109.54 132.48 54.1 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.788 0.328 . . . . 0.0 111.313 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.89 178.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.673 0.273 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -59.24 -39.85 84.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.995 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.1 t -58.02 -39.74 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.69 95.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.86 -40.35 96.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.697 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.97 -36.46 81.52 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.47 -40.96 63.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.47 -47.91 82.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.135 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -67.48 -37.83 83.46 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -64.19 -42.37 96.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.311 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.78 -40.65 86.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.33 87.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.082 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.59 -51.88 65.59 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.32 -34.41 68.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.766 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 72' ' ' LEU . 13.3 tp -60.34 -40.42 90.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.383 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -83.07 -27.57 30.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.783 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -79.61 -46.45 17.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.38 -15.39 61.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 24' ' ' GLN . 31.7 mt -114.15 133.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -84.48 112.73 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -65.93 -39.15 27.88 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.235 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.2 Cg_exo -55.28 -34.39 88.21 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.021 1.814 . . . . 0.0 112.36 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.49 -37.89 79.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.445 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.7 mt -80.91 -20.26 42.54 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.89 4.27 90.1 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.644 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 57.1 mtt -151.62 167.15 29.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.833 0.349 . . . . 0.0 110.513 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -92.06 139.8 30.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.0 p -87.17 152.02 22.69 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 110.965 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -126.81 141.8 51.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.286 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.11 122.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -66.2 -35.22 79.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.237 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.67 160.69 10.02 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.34 146.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 111.1 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -121.43 139.4 53.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.609 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.3 mmm -109.39 139.97 43.68 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.3 p -73.99 153.64 39.64 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.964 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.418 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 56.9 t0 -82.45 -3.3 55.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.058 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 47' ' ' LEU . 9.3 mp 56.38 23.31 7.2 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.42 -37.01 9.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.45 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -123.14 150.79 42.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.21 141.9 35.9 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.305 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -119.63 125.09 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.598 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.26 134.58 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.285 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -108.8 135.8 49.42 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.57 147.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.255 0.55 . . . . 0.0 111.464 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 t -146.32 152.04 38.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.34 151.32 24.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.209 0.528 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.58 -25.55 68.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.833 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.644 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 9.5 m120 -79.91 5.26 14.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.9 p30 -64.5 -15.4 60.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 15.2 ptpt -70.03 -33.88 72.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -90.22 116.67 28.38 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.82 -33.4 71.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.385 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.5 -39.12 91.5 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.448 0.642 . . . . 0.0 109.619 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.93 87.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.98 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.72 -38.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -66.76 -47.03 73.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.044 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.58 77.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.473 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.53 -50.72 24.47 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.572 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.7 tt -59.67 -36.71 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.768 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -68.14 -37.51 81.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.24 92.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.241 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 23' ' ' LEU . 56.6 tp -68.35 -36.43 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.882 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -69.44 -45.81 68.25 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.3 -36.92 71.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.31 58.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.286 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 m -56.5 -50.05 72.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.69 93.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.252 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.22 -42.99 87.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.727 0.298 . . . . 0.0 111.506 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.42 -40.8 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.352 0.596 . . . . 0.0 110.783 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -64.27 -45.35 88.42 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.259 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -69.45 -36.84 76.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.632 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.01 -37.54 81.54 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.66 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.32 -50.49 53.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.578 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.41 -43.87 96.14 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.596 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -70.83 -42.22 70.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.8 98.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.25 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtm -89.5 -15.82 32.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.831 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' GLY . 96.8 mtt180 53.42 36.65 23.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -94.74 139.1 31.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.04 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -82.69 -44.7 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.531 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 pt -75.79 40.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.917 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.0 p -72.74 114.59 31.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 72.8 Cg_endo -79.91 157.64 24.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.643 1.562 . . . . 0.0 112.256 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.97 138.07 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -94.97 127.9 41.37 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.11 0.481 . . . . 0.0 110.753 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -115.72 120.85 40.7 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.86 132.05 44.5 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 0.0 111.727 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -119.14 138.86 52.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -102.43 115.87 31.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -59.79 -39.62 85.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.86 -40.8 83.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.08 94.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.024 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -60.9 -39.6 89.92 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.993 0.425 . . . . 0.0 110.328 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.62 -37.33 83.57 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.1 -40.9 67.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.824 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.1 -42.43 80.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.455 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -63.02 -47.56 82.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.925 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -61.99 -34.57 76.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.579 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.62 -40.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.795 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 -37.35 87.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.42 -52.22 62.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.654 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.94 -34.63 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.43 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.7 mt -64.39 -33.66 76.38 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.061 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.584 ' NE2' ' SD ' ' A' ' 35' ' ' MET . 94.8 mt-30 -82.76 -27.71 30.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 0.0 111.346 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -87.65 -46.19 9.74 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.48 -12.55 60.83 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.508 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.24 132.11 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.21 109.98 17.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 8.8 t0 -65.32 -36.63 15.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.398 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 31.9 Cg_exo -58.82 -38.55 88.01 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.497 1.465 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -61.89 -38.58 88.85 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.216 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.5 mt -87.63 -19.77 27.28 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.68 5.42 89.98 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.3 ttm -163.9 151.91 12.91 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.584 ' SD ' ' NE2' ' A' ' 24' ' ' GLN . 58.7 ttp -83.24 141.49 31.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.09 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -81.48 153.86 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 111.01 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.5 m -122.92 143.84 49.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.11 118.96 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.001 0.429 . . . . 0.0 110.589 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 m -66.51 -34.33 77.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.278 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.65 153.94 6.99 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 52' ' ' VAL . 29.3 t -126.59 135.78 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.774 0.321 . . . . 0.0 111.081 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.74 137.96 52.99 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.3 mtt -112.57 142.34 45.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.413 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 p -76.91 152.43 35.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.182 0.515 . . . . 0.0 110.388 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -64.08 -32.86 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.677 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.47 -3.25 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.404 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.42 14.36 5.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.82 62.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.84 164.28 35.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.514 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.12 35.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.486 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -104.11 127.57 51.7 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 41' ' ' VAL . 72.3 t -117.6 133.11 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.42 134.92 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -129.82 145.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 120.997 0.427 . . . . 0.0 110.537 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.0 m -139.9 137.44 34.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.057 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.35 149.37 29.25 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.892 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.66 -15.34 63.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.531 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -81.12 -2.31 47.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.07 -15.3 62.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.426 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.88 -36.05 77.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.76 115.74 28.08 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -34.0 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.517 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.65 -38.69 91.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.376 0.607 . . . . 0.0 109.49 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.54 83.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.878 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 69' ' ' ILE . 79.2 t -67.18 -41.05 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.84 -42.17 86.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.57 -46.12 64.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.65 -50.59 41.64 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.3 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.2 tt -59.48 -34.5 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -66.73 -41.18 88.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.81 78.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.802 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -69.48 -36.57 76.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.08 -45.01 71.37 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.212 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.51 -36.93 74.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.01 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.19 -7.05 56.61 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.141 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.8 t -55.57 -50.04 71.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.3 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -38.27 91.19 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.221 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -65.87 -43.58 87.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.593 0.235 . . . . 0.0 111.545 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.78 -39.72 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.56 0.695 . . . . 0.0 110.31 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -63.51 -46.26 86.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.272 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.1 t -70.22 -37.02 74.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.646 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.44 -37.45 86.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.345 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -68.45 -49.88 56.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -63.1 -43.88 98.07 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.349 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.67 -39.53 73.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 0.0 111.807 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.66 94.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.571 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.3 mtm -92.44 -13.55 29.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.485 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 30.9 mmt180 57.34 42.92 24.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.767 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.79 141.2 29.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.824 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -92.93 -16.86 24.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 pt -96.7 43.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.3 t -72.8 114.57 31.67 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 156.19 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.459 1.439 . . . . 0.0 111.433 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.47 125.99 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.3 mt -94.18 131.84 39.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.411 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -119.78 128.24 53.54 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.033 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.43 131.23 53.12 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 111.345 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.404 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.8 t80 -119.49 142.3 48.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.512 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 44.8 p90 -105.45 133.79 49.63 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.958 0.408 . . . . 0.0 110.292 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.79 0.329 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -59.22 -38.8 80.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.398 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.62 -40.39 79.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.14 93.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.221 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -64.84 -40.07 94.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.6 -37.85 85.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.24 -42.87 68.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.81 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.71 -41.79 82.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -64.06 -50.23 69.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -63.29 -34.77 78.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.727 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.26 -42.19 78.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.132 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.94 85.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 ' HE ' ' A' ' 25' ' ' ARG . 42.9 tp -62.64 -52.92 61.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.53 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.33 -35.77 74.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.054 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.6 tt -63.13 -37.25 86.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.284 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -74.38 -41.15 61.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 111.038 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HE ' HD11 ' A' ' 21' ' ' LEU . 89.3 mtt-85 -75.19 -42.5 55.59 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -73.08 -16.23 61.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.748 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 23' ' ' LEU . 12.6 tt -107.19 134.01 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -86.15 108.78 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -66.68 -38.61 19.67 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 35.9 Cg_exo -58.02 -33.69 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.479 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -59.38 -37.87 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.579 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.5 mt -82.36 -20.4 37.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.137 0.494 . . . . 0.0 109.692 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.62 3.85 90.35 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.399 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 94.3 mmm -147.85 171.17 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.897 0.38 . . . . 0.0 109.995 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.1 mtt -94.99 157.15 16.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.7 t -125.05 150.24 46.98 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -129.45 148.81 51.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.844 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 t -94.0 123.91 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.8 p -73.27 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.92 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.4 157.37 8.13 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.37 151.97 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.374 . . . . 0.0 110.771 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -135.96 142.21 44.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.9 mtt -96.95 139.02 33.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.257 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.5 p -73.88 160.73 31.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.269 0.557 . . . . 0.0 110.782 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 45' ' ' ARG . 1.1 mpt_? -59.59 -32.35 70.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.694 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.2 m-20 -83.06 -4.34 58.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.098 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.8 mt 60.08 5.6 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -95.94 -22.94 17.1 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.972 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -124.13 143.96 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.65 141.94 49.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.09 120.15 37.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.74 133.68 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.251 0.548 . . . . 0.0 109.798 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.77 136.19 50.2 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.298 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.99 147.09 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.04 0.448 . . . . 0.0 111.141 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -140.29 151.33 45.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.273 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.65 160.77 42.48 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.182 0.515 . . . . 0.0 111.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.0 mm? -67.34 -18.91 65.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.643 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -80.96 1.96 28.86 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.1 p30 -64.33 -15.08 59.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 60.9 tttm -69.09 -39.97 78.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.334 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -93.43 115.96 28.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.449 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.99 -35.95 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.29 -39.17 93.38 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.1 83.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.73 -39.14 83.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.16 -45.54 91.36 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.95 -36.38 77.86 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.3 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.44 52.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.737 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.7 -39.98 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.299 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.52 -36.96 83.98 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.907 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.9 77.53 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.53 -36.45 73.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.207 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.57 -45.64 68.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.155 0.502 . . . . 0.0 110.475 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.24 -37.01 74.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.244 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.48 -12.83 60.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -49.16 77.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.56 86.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.245 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -66.61 -44.57 81.73 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.535 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.29 -40.81 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.556 0.693 . . . . 0.0 110.559 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.523 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 62.3 ttt180 -63.88 -46.6 84.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.551 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 t -68.7 -37.29 79.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.646 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 27.6 mt -65.58 -35.98 82.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.493 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.3 -48.44 64.93 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.831 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.92 -41.2 73.04 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -70.72 -43.76 68.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.391 -0.904 . . . . 0.0 112.173 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' LEU . . . -63.21 -43.37 98.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.7 mtt -85.42 -15.42 43.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 81.4 mtm180 59.95 26.1 15.33 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.531 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.37 150.31 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.382 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' A' ' 92' ' ' VAL . 70.5 mtp85 -100.87 -9.58 21.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.248 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 tt -59.07 -2.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 92' ' ' VAL . 27.3 m -70.36 116.09 41.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 172.5 14.45 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.841 1.694 . . . . 0.0 111.942 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.523 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 77.2 mm-40 -59.85 134.53 57.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.9 mt -100.65 128.32 46.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.957 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -113.26 127.32 56.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.52 129.06 55.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.195 0.522 . . . . 0.0 112.097 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -118.53 137.32 53.29 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 46.1 p90 -110.27 132.78 53.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.421 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.87 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HB2' ' HE ' ' A' ' 10' ' ' ARG . 99.2 mm-40 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.528 0.204 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.671 ' HE ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -59.93 -39.69 86.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.213 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.73 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.299 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.96 81.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.107 0.479 . . . . 0.0 110.338 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -70.78 -46.81 62.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.652 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.38 -36.87 85.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.054 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.5 mtt -71.93 -40.89 68.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.429 HE22 HG11 ' A' ' 38' ' ' VAL . 37.7 tp60 -54.86 -45.87 74.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.22 -45.8 86.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.26 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 85.2 tt0 -61.65 -33.89 74.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.2 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.97 -42.6 77.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.29 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -36.62 84.78 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.67 -52.94 54.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.076 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.0 mt -70.1 -35.03 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.4 tp -60.65 -41.74 95.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.779 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -82.58 -41.29 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.313 0.578 . . . . 0.0 111.286 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -70.3 -40.8 74.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.57 -16.71 61.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.333 0.587 . . . . 0.0 110.195 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 23' ' ' LEU . 17.8 tt -116.05 149.48 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.326 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -67.3 122.85 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 110.059 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.07 -61.87 4.33 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.956 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.17 -27.63 57.21 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.727 1.618 . . . . 0.0 112.814 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -59.5 -38.04 79.86 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.215 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 70.4 mt -103.79 -2.18 26.76 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.0 5.86 72.79 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.4 ttt 63.03 8.44 3.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.2 mmm -81.35 18.4 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.1 m -76.03 128.05 34.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.319 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -132.7 143.06 49.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.967 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.429 HG11 HE22 ' A' ' 16' ' ' GLN . 40.5 t -98.72 120.35 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.944 0.402 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 m -63.95 -36.14 82.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.256 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.72 155.84 7.45 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 m -127.39 152.27 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.957 0.408 . . . . 0.0 110.819 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -132.79 141.9 48.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.226 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.3 mtt -113.79 142.27 46.28 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.5 m -73.51 151.92 40.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -63.71 -29.58 70.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.337 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -83.6 -3.84 58.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 mt 60.38 24.54 14.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 -45.98 5.82 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.307 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -119.65 146.75 45.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.15 0.5 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.45 142.23 41.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.159 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.41 124.21 43.96 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.33 134.52 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.038 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -113.91 138.27 50.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.26 148.17 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.28 0.562 . . . . 0.0 111.187 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 m -141.67 132.8 26.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -135.93 146.44 47.31 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 178.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 57' ' ' LEU . 7.0 mp -64.29 -23.03 67.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 83.8 m-20 -81.13 -7.0 59.47 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.33 -16.03 51.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -66.65 -33.09 74.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -89.91 117.96 29.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.29 -39.75 94.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.482 0.658 . . . . 0.0 109.432 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.76 -36.01 81.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 69' ' ' ILE . 73.3 t -64.47 -39.7 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.5 -41.41 88.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.05 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -47.14 62.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.84 -50.46 41.44 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.274 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.7 tt -59.39 -34.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.493 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.79 -41.21 87.98 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.381 0.61 . . . . 0.0 109.522 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 -40.88 75.09 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.041 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -70.31 -37.67 74.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -68.64 -45.11 72.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.278 0.561 . . . . 0.0 110.163 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -69.79 -37.18 76.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.908 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -9.2 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.0 p -57.42 -50.67 72.26 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.89 93.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.52 -41.53 84.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.62 -39.72 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.645 0.736 . . . . 0.0 109.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -63.31 -46.01 88.68 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.6 t -68.37 -36.64 79.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.434 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.57 -38.75 87.71 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.094 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 mt -68.99 -50.46 48.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.709 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.81 -44.13 97.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.54 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -71.3 -42.2 68.95 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.81 97.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.96 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 63.4 mtm -87.29 -19.49 28.19 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 84' ' ' GLY . 50.9 ttm-85 61.61 41.84 11.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.479 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.5 mm? -90.9 141.16 29.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.994 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -88.22 -26.34 22.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.532 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -89.75 45.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.569 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 114.2 28.65 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.133 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 78.6 Cg_endo -80.61 163.31 21.47 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.613 1.542 . . . . 0.0 111.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -72.39 130.75 41.45 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 1.6 mm? -93.17 128.18 39.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.155 0.502 . . . . 0.0 110.894 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 m -114.98 121.28 42.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -101.02 129.71 46.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.086 0.47 . . . . 0.0 111.818 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -119.77 138.95 53.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.393 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -102.0 132.3 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.579 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.78 0.324 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.25 -39.7 83.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.397 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.24 -40.84 84.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.54 86.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -65.88 -43.02 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.17 -37.37 84.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt -73.55 -36.04 65.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.9 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.03 -47.73 80.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -66.46 -37.34 84.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.984 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.4 tt0 -65.78 -40.39 91.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.28 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.35 -42.27 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 -38.12 89.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.282 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.07 -52.26 63.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.129 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.42 -33.48 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 60.7 tp -57.67 -36.33 71.77 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.375 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -84.4 -36.02 22.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -76.98 -47.74 19.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -75.45 -3.89 36.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.113 0.482 . . . . 0.0 110.346 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 47.5 mm -114.29 126.68 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.946 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -82.46 102.86 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 1.3 m-20 -78.34 -36.76 1.33 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.496 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 84.1 Cg_exo -48.47 -38.19 34.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.635 1.557 . . . . 0.0 113.323 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.41 -37.6 87.9 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.771 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.45 -20.18 34.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 109.795 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.55 84.84 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.2 mtt -147.89 156.25 42.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 110.313 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.2 mtm -97.69 148.04 23.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 p -87.63 156.05 19.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 p -124.13 160.93 26.71 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' GLY . 47.7 t -106.26 128.71 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.829 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t -88.54 -14.91 36.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' H ' HG12 ' A' ' 38' ' ' VAL . . . 157.7 148.54 5.16 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG13 HG12 ' A' ' 52' ' ' VAL . 22.0 t -124.58 128.84 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.43 139.98 53.38 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.979 0.418 . . . . 0.0 110.778 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.4 mtt -117.1 142.59 46.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.66 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.2 m -73.34 152.16 41.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -59.48 -31.67 69.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.528 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.4 -3.82 57.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.287 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.63 29.21 18.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.22 -49.17 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.031 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -117.17 144.48 44.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.924 0.392 . . . . 0.0 111.021 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.99 141.08 50.22 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.615 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -122.59 117.84 26.79 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.382 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 HG13 ' A' ' 41' ' ' VAL . 1.7 m -120.9 135.41 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 120.708 0.289 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.0 135.48 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 m -133.27 149.83 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.122 0.487 . . . . 0.0 111.379 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -131.35 156.43 45.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.948 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -157.5 153.57 27.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 111.814 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.65 -12.27 59.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -80.08 3.65 19.69 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -66.16 -15.6 63.27 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.87 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -67.87 -39.97 83.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.431 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -92.45 115.14 27.83 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.173 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.41 -34.54 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.57 -38.72 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.5 80.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.54 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.25 -46.15 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.601 . . . . 0.0 109.899 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -67.98 -47.77 67.65 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.86 -45.36 64.6 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.555 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -51.94 53.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.899 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.14 -34.84 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.021 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.35 -40.75 96.47 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.94 87.03 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.529 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.8 -36.78 81.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.358 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -68.15 -45.08 74.53 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.343 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.42 -36.99 74.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.254 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.06 -8.29 57.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.053 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -55.18 -48.64 73.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.426 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.37 -38.26 90.03 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.084 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.56 -42.17 92.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.604 0.24 . . . . 0.0 111.308 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.65 -42.62 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 63.3 ttt180 -63.12 -46.71 86.02 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.346 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 t -70.28 -36.94 74.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.375 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.63 -35.56 80.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.435 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -68.4 -50.4 53.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.97 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.5 -43.56 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.236 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.72 -40.84 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.179 0.514 . . . . 0.0 111.713 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.76 99.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.48 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 58.3 mtm -93.94 -8.89 38.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 91.9 mtt-85 54.86 36.03 25.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.62 141.13 32.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -97.73 -10.76 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.29 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -94.53 30.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -73.23 118.46 68.82 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 161.93 30.58 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.505 1.47 . . . . 0.0 111.834 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 78.1 mm-40 -60.08 136.17 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.53 130.85 47.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 0.0 111.059 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.3 m -120.79 128.39 52.84 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.87 126.25 54.9 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.994 0.426 . . . . 0.0 111.644 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -119.96 138.67 53.33 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -110.22 129.78 55.66 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.282 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.246 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.625 0.25 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.09 -37.86 78.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.652 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -38.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 0.0 110.274 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.8 82.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.455 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -71.62 -46.38 59.29 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.952 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -62.64 -36.55 83.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.9 ttm -70.51 -40.57 73.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.09 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.03 -41.96 75.79 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -62.64 -45.04 94.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.018 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.61 -33.18 75.04 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.469 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.23 -42.41 78.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.413 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.79 85.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.098 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.92 -52.49 64.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.602 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.2 mt -68.67 -33.9 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.128 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.3 tp -56.17 -43.29 78.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.1 mt-30 -83.1 -40.05 20.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 111.809 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -70.05 -39.96 75.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -72.56 -14.99 61.76 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.076 0.465 . . . . 0.0 110.377 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -119.23 143.34 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -83.45 115.11 21.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -69.99 -38.19 8.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.58 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.42 -37.28 81.72 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.816 1.677 . . . . 0.0 112.242 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -59.94 -37.8 80.57 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.362 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -78.24 -20.93 50.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.38 5.34 87.18 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm -171.82 154.69 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.655 0.264 . . . . 0.0 110.475 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.9 mtp -83.24 138.11 33.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -88.42 158.07 18.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -122.87 143.7 49.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.543 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.52 122.76 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -65.39 -36.09 82.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.08 159.17 9.13 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.18 148.83 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.896 0.379 . . . . 0.0 110.925 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -122.91 142.1 51.17 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.1 mmm -109.42 142.29 40.6 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.86 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -73.11 155.01 40.14 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 110.372 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -58.31 -34.25 70.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.499 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -83.69 -4.57 58.72 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 110.807 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.61 32.99 21.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.84 -46.59 3.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.609 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.89 140.85 48.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.426 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.23 141.62 51.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.907 0.384 . . . . 0.0 110.801 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.29 130.59 55.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.169 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.66 134.34 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.002 0.429 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.05 133.87 53.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -131.14 147.17 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.345 0.593 . . . . 0.0 112.062 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -146.29 150.52 35.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.371 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.91 155.65 29.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.844 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.8 mt -72.85 -14.77 61.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.744 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -81.07 3.43 23.3 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 50.4 p30 -66.37 -15.85 63.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.115 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -68.62 -36.4 78.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.355 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -91.03 117.09 29.31 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.14 -34.94 74.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.35 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.07 -38.32 90.41 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.44 0.638 . . . . 0.0 109.454 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.45 83.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.842 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.69 -41.93 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 109.584 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.68 -42.7 86.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.584 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.7 -44.77 66.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.012 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.98 -51.11 48.1 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.185 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 -37.15 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.002 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -65.39 -40.03 92.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.57 -41.76 83.65 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.554 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.1 -36.43 81.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.397 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.95 -45.95 69.42 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.148 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -71.29 -37.11 71.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.261 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.2 -6.31 54.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.505 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.5 p -58.9 -52.52 65.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.193 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.64 92.88 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.643 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -66.79 -44.38 81.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -68.11 -38.21 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.116 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -64.21 -47.16 80.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.558 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -71.09 -37.85 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.814 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.66 -36.99 85.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.407 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 ' SD ' ' A' ' 87' ' ' MET . 6.2 tt -69.14 -48.52 62.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.806 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.67 -42.32 99.74 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.11 -40.38 74.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.051 0.453 . . . . 0.0 111.598 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.74 96.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.157 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.432 ' SD ' HD21 ' A' ' 83' ' ' LEU . 62.1 mtt -88.22 -17.35 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.482 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 84' ' ' GLY . 72.7 mtm180 54.18 36.99 26.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.09 139.62 30.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.012 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 92' ' ' VAL . 89.0 mtt180 -92.36 -38.53 11.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.91 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.9 pt -73.55 26.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 90' ' ' ARG . 60.0 t -73.22 114.13 28.42 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 119.289 -0.386 . . . . 0.0 109.975 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.4 159.63 25.89 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.54 1.493 . . . . 0.0 111.632 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.45 137.38 58.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.56 130.01 46.57 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.223 0.535 . . . . 0.0 111.001 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.4 m -123.78 135.38 53.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.85 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -117.08 139.79 50.29 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.452 0.644 . . . . 0.0 112.134 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -121.66 153.94 37.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.728 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -109.15 134.07 52.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.649 -179.324 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.898 0.38 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -59.37 -37.9 79.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.099 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.92 -40.39 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.66 88.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.55 -39.94 94.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.484 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.57 -37.2 82.98 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.18 -42.76 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.525 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -55.75 -44.68 77.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.452 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -64.32 -46.8 81.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.542 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.71 -33.62 74.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.917 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.14 -42.44 79.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.61 84.87 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.106 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HH11 ' A' ' 25' ' ' ARG . 43.0 tp -61.15 -53.4 57.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.037 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.78 -33.52 56.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.455 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.52 -44.37 76.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.855 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.8 mt-30 -82.1 -40.91 21.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 111.686 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.541 HH11 HD11 ' A' ' 21' ' ' LEU . 24.7 ttm180 -69.65 -37.58 76.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.126 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 45.5 tp10 -71.99 -17.09 62.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.205 0.526 . . . . 0.0 109.974 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.7 pt -118.54 150.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.796 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -81.93 115.14 20.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -70.8 -37.85 6.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -179.08 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 44.2 Cg_exo -56.87 -38.15 96.53 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.839 1.693 . . . . 0.0 112.499 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -60.1 -37.54 80.3 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.14 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.526 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 64.9 mt -92.36 -8.02 46.16 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.558 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.79 28.61 50.39 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mtm 56.17 -126.21 2.01 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.464 -0.199 . . . . 0.0 110.464 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.409 ' SD ' HD12 ' A' ' 57' ' ' LEU . 71.8 mtm 45.24 48.2 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.618 0.247 . . . . 0.0 111.037 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.5 m -120.24 130.45 54.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.855 0.359 . . . . 0.0 110.386 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -132.94 145.15 50.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.6 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -92.78 118.64 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 55' ' ' THR . 44.2 m -65.75 -35.4 80.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.587 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.42 152.31 6.23 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 52' ' ' VAL . 43.3 t -125.47 134.41 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.922 0.392 . . . . 0.0 110.95 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.52 141.43 49.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.039 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.3 mmm -111.45 141.85 44.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.521 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.7 m -73.45 151.76 40.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.585 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -60.67 -30.46 69.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.322 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 57.7 t0 -82.62 -3.86 56.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 9.4 mp 56.57 29.75 16.09 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.31 -49.02 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.737 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -116.92 143.56 45.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.74 141.59 51.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.434 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -113.08 127.77 56.3 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 41' ' ' VAL . 55.2 t -118.21 132.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.309 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -119.77 127.38 52.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 150.71 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.246 0.546 . . . . 0.0 111.798 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.501 HG23 ' OG ' ' A' ' 39' ' ' SER . 22.2 p -131.01 149.87 52.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.895 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' A' ' 59' ' ' ASP . 6.3 p90 -156.2 155.34 32.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.358 0.599 . . . . 0.0 111.606 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 HD12 ' SD ' ' A' ' 35' ' ' MET . 64.7 mt -77.3 -13.58 59.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.602 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 71.3 m-20 -80.91 0.18 36.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 7.3 m-20 -61.93 -19.53 62.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -68.22 -34.94 77.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.103 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.78 115.74 27.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.048 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 51.0 mp0 -59.69 -34.27 72.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.35 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.97 -37.34 87.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.376 0.608 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.17 83.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.554 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 69' ' ' ILE . 78.1 t -69.72 -47.04 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.16 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.98 -46.33 71.64 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.357 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.06 -46.34 65.18 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.213 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.44 -51.41 48.86 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.455 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.5 tp -60.12 -34.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.473 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -67.1 -40.23 86.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.251 0.548 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.19 -41.86 76.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.843 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.3 -36.65 74.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.136 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -68.78 -45.38 71.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.243 0.544 . . . . 0.0 110.316 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -70.6 -37.08 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.35 -8.63 57.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.544 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.7 m -56.12 -50.46 71.02 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.036 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.69 94.31 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CE1' ' OE2' ' A' ' 26' ' ' GLU . 35.4 t80 -63.4 -43.15 98.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.64 -39.44 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.421 0.629 . . . . 0.0 110.359 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 74.2 ttt-85 -60.95 -46.16 91.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.937 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -70.21 -37.75 75.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.533 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.63 -37.84 76.97 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.82 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD21 ' CE ' ' A' ' 87' ' ' MET . 8.4 tt -68.78 -46.43 68.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.078 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -60.32 -42.48 98.83 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.99 -36.48 75.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.465 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.83 95.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.508 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 83' ' ' LEU . 66.0 mtm -101.52 -3.91 27.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 53.41 43.77 30.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.505 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.1 mt -100.55 141.07 33.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.142 0.496 . . . . 0.0 111.701 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -97.99 -10.82 23.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.95 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 91' ' ' ILE . 22.3 pt -98.56 21.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -72.7 116.46 50.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.05 160.63 26.84 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.713 1.608 . . . . 0.0 112.068 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' A' ' 80' ' ' ARG . 78.3 mm-40 -60.42 137.45 58.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.5 mt -100.37 130.15 46.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.961 0.41 . . . . 0.0 110.676 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.7 m -119.95 127.48 52.7 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -108.0 126.41 52.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.144 0.497 . . . . 0.0 111.308 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -120.93 138.26 54.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.333 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 99' ' ' TYR . 37.7 p90 -107.74 113.85 27.39 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.866 0.365 . . . . 0.0 110.318 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.9 t0 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.935 179.654 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.756 0.312 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -59.5 -39.93 85.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.53 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.56 -40.23 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.92 91.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.183 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -63.86 -39.9 95.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.368 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.5 -37.64 84.42 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.2 -43.77 66.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.925 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.31 -42.44 77.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.337 0.589 . . . . 0.0 109.842 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.92 -49.82 71.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.228 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.66 -35.34 80.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.306 0.574 . . . . 0.0 110.747 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.155 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.284 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.57 -53.36 58.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.345 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.3 mt -70.23 -34.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.442 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.8 tp -55.95 -45.53 78.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.785 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 12.5 pt20 -84.49 -42.03 15.97 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.973 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 24' ' ' GLN . 50.7 mtp180 -70.45 -33.76 71.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -72.25 -15.75 61.92 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.452 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.8 pt -119.4 149.68 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.669 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.36 117.26 29.85 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -74.12 -38.12 3.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.496 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.2 Cg_exo -55.61 -31.61 79.94 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.108 1.872 . . . . 0.0 112.554 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.54 -37.72 79.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.684 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 mt -81.51 -20.06 40.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.979 0.419 . . . . 0.0 109.918 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.35 5.52 89.51 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.3 mtt -143.95 168.78 19.17 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.2 mtp -113.02 158.08 20.74 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 55' ' ' THR . 13.2 t -128.74 153.71 47.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.529 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.6 m -127.57 148.04 50.35 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.84 118.59 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.4 p -67.8 -30.51 69.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.14 157.41 8.04 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.57 152.82 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -130.36 141.05 50.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -103.75 141.66 35.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.936 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 67.5 m -73.06 154.69 40.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.639 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -58.21 -32.47 68.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.572 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -82.93 -3.99 57.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.449 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 58.87 26.58 15.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -104.86 -47.91 3.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.849 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.418 ' O ' ' OG ' ' A' ' 44' ' ' SER . 87.5 m-85 -114.69 143.7 44.62 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.885 0.374 . . . . 0.0 110.541 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.22 141.39 51.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -108.41 128.57 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.991 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.33 133.39 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.6 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.86 132.26 55.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 22.0 t -131.13 148.03 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.345 0.593 . . . . 0.0 111.874 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 36' ' ' THR . 37.5 m -119.2 129.34 54.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.838 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CZ ' HG11 ' A' ' 54' ' ' VAL . 84.8 m-85 -119.67 142.01 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.897 0.379 . . . . 0.0 111.778 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.67 -13.54 57.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 82.1 m-20 -81.34 -0.41 41.04 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.9 p30 -66.03 -15.01 62.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.96 177.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 61.2 tttp -67.37 -39.86 85.7 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.544 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -109.28 117.7 34.78 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -58.34 -35.86 72.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.85 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.36 -38.0 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.685 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.0 -45.56 73.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.64 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 69' ' ' ILE . 7.4 p -73.35 -33.41 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.37 . . . . 0.0 111.149 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.08 -40.52 94.75 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.39 -46.1 64.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.35 -50.23 39.94 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.533 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.8 tt -59.26 -34.67 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.247 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.47 -41.52 88.88 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.86 76.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.909 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.04 -36.61 75.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.637 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.15 -44.34 76.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.218 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.85 -36.57 80.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.281 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.12 -9.0 58.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.256 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.4 m -55.82 -45.99 78.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.159 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.75 -38.29 91.67 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -64.87 -42.91 94.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.019 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -58.22 -39.62 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.592 0.71 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 94' ' ' GLU . 75.3 ttt-85 -61.42 -44.76 96.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.442 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 t -70.12 -36.75 75.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.617 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -69.37 -41.43 76.55 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.58 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 tt -69.05 -48.48 62.73 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.633 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -65.68 -44.02 93.25 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.553 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.72 -37.89 73.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 112.024 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' LEU . . . -60.94 -42.73 98.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 74.7 mtm -99.83 -5.95 27.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.836 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' GLY . 66.4 mtt85 49.52 40.88 20.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.43 138.7 31.37 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.626 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -92.49 -38.4 11.97 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.223 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 pt -78.46 19.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.519 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.9 p -72.67 114.42 30.05 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.98 157.88 30.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.501 1.468 . . . . 0.0 112.099 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 38.0 mp0 -60.96 139.87 57.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.99 132.81 46.22 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.014 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.2 m -119.0 128.03 54.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.91 127.32 51.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.282 0.563 . . . . 0.0 111.426 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 52.0 t80 -126.91 147.73 50.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 51.1 p90 -101.28 129.13 47.19 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.767 0.318 . . . . 0.0 110.223 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.791 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -59.02 -37.24 76.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.298 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.57 -40.51 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.042 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.54 87.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.592 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.85 -43.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.597 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.32 -39.32 92.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mmt -66.98 -42.17 85.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.442 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.88 -41.92 88.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.783 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -63.48 -47.36 82.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.095 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -62.96 -35.33 79.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.07 -42.88 79.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.58 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.41 84.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.471 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.7 tp -60.76 -53.38 58.11 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.26 -34.48 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.514 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.11 -45.87 79.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.905 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.3 mt-30 -83.23 -39.33 21.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.114 0.483 . . . . 0.0 112.068 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -69.79 -38.76 76.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.05 -16.1 62.03 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.907 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 24' ' ' GLN . 9.6 pt -116.58 149.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.304 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -86.61 125.8 34.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.51 -63.0 1.05 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.612 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -56.94 -23.82 53.53 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -58.94 -37.1 75.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.199 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -77.62 -20.55 53.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.43 5.09 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 62.4 mtt -146.73 167.8 22.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.812 0.339 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -104.9 152.49 22.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.625 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -130.68 155.29 46.85 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.798 0.332 . . . . 0.0 110.752 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -137.4 159.03 43.1 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.423 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 38' ' ' VAL . 11.7 p -98.12 123.11 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.7 p -69.93 -28.7 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.26 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.71 153.89 6.48 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.2 148.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.744 0.307 . . . . 0.0 110.454 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -129.26 139.69 51.72 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.5 mmt -105.81 142.41 35.58 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.8 t -73.76 151.94 40.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.136 0.493 . . . . 0.0 110.343 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.24 -29.99 66.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.623 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.7 -3.36 57.71 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.546 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? 56.51 29.9 16.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.79 -48.41 3.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.789 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -116.78 141.57 48.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.46 51.86 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.452 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.69 127.7 54.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.34 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.48 133.27 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.623 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.08 133.66 55.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.27 149.79 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.442 0.639 . . . . 0.0 111.84 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -129.67 135.98 49.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.49 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 65' ' ' VAL . 15.7 p90 -146.02 154.77 42.24 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.546 0.689 . . . . 0.0 112.22 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.3 mm? -80.08 -11.26 59.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.592 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.488 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 88.1 m-20 -79.49 -0.25 32.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.0 p30 -68.09 -14.84 63.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 35.1 ttpt -69.27 -38.51 78.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.541 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.59 119.03 38.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.018 0.437 . . . . 0.0 110.114 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 50.7 mp0 -59.48 -32.97 70.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.22 -39.02 75.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.254 0.549 . . . . 0.0 110.794 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.05 74.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.748 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 69' ' ' ILE . 14.5 p -69.93 -33.58 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.448 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.75 -44.51 85.7 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.22 -44.77 67.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.39 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.8 -50.73 39.76 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.485 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.3 tt -59.46 -34.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.922 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -66.1 -42.19 89.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -40.72 87.25 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.649 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.92 -36.26 79.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -68.92 -45.63 70.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.083 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.15 -37.08 72.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.95 -8.91 58.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.177 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -57.09 -50.09 73.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.122 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.38 90.78 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.33 -43.6 94.13 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.269 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -58.61 -41.57 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 109.744 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 94' ' ' GLU . 39.8 ttm180 -63.14 -46.76 85.7 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -70.64 -38.04 73.83 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.98 -38.58 79.41 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.002 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.94 -40.61 83.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.157 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.89 -34.54 71.52 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -67.53 -43.29 81.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.392 -0.904 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.19 85.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.594 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtt -85.68 -17.19 36.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.5 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 84' ' ' GLY . 73.9 mtp180 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.244 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 92' ' ' VAL . 86.3 mt -101.15 141.55 33.88 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.124 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -97.43 -14.95 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.559 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 91' ' ' ILE . 37.7 pt -86.69 21.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 89' ' ' LEU . 59.4 t -72.85 114.14 27.8 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.141 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 89.3 Cg_endo -77.66 161.59 30.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.298 1.332 . . . . 0.0 111.098 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 80' ' ' ARG . 79.0 mm-40 -64.62 136.49 57.04 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.249 -0.581 . . . . 0.0 109.521 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' PRO . 7.1 mp -98.94 129.87 45.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.062 0.458 . . . . 0.0 110.365 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -117.9 127.63 54.04 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.28 126.65 51.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.126 0.489 . . . . 0.0 111.157 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 48.1 t80 -126.17 146.14 50.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.475 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 47.9 p90 -99.8 129.02 45.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.855 0.36 . . . . 0.0 110.435 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 56.3 p-10 . . . . . 0 N--CA 1.474 0.772 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.378 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.823 0.344 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -59.29 -38.18 79.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.152 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.77 -40.79 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.81 88.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.146 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.48 -40.88 96.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.607 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.44 -36.96 81.83 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.3 -39.09 65.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.268 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -49.11 76.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.548 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HG2' ' HZ3' ' A' ' 17' ' ' LYS . 1.5 ptpp? -67.18 -37.71 84.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.099 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.1 tt0 -68.76 -39.94 80.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.43 -42.78 97.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.36 86.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 HH11 ' A' ' 25' ' ' ARG . 27.9 tp -60.68 -52.92 63.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.25 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -69.14 -34.01 61.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.22 -42.31 85.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.577 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -82.43 -41.89 19.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.307 0.575 . . . . 0.0 111.337 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.523 HH11 HD11 ' A' ' 21' ' ' LEU . 24.6 ttm180 -70.23 -37.15 74.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.35 -177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.22 -15.28 61.94 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.181 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 27' ' ' ILE . 13.1 pt -113.89 150.42 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.18 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -78.5 130.52 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.028 0.442 . . . . 0.0 110.342 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.59 -62.0 3.31 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.962 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.74 -28.18 55.89 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.714 1.609 . . . . 0.0 112.725 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.31 -37.77 78.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.447 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 72.2 mt -99.02 -1.94 38.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.143 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.9 9.16 62.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm 58.97 60.79 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.571 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.423 ' SD ' HD23 ' A' ' 57' ' ' LEU . 62.2 mtt -150.6 72.8 1.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.555 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.4 p -126.04 140.92 52.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.6 m -139.71 142.78 36.85 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.208 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.2 p -95.76 117.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 m -68.21 -31.19 70.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.63 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.53 6.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 52' ' ' VAL . 17.1 t -125.41 133.0 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -131.73 141.25 49.48 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.6 mpt? -111.44 143.17 42.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.412 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.5 t -72.63 151.86 42.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.662 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -56.29 -35.01 67.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.383 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.07 -4.98 58.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.695 0.283 . . . . 0.0 110.757 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 91' ' ' ILE . 7.9 tp 60.01 34.45 21.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.61 -48.23 3.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.674 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -117.79 139.13 51.5 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.428 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.84 141.11 52.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.804 0.335 . . . . 0.0 110.226 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -119.58 118.79 31.94 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.96 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 41' ' ' VAL . 1.2 m -119.43 134.66 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.014 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -108.56 136.35 48.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.058 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.33 150.82 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.1 0.476 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -140.95 152.06 44.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.023 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -156.04 146.77 21.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.392 0.615 . . . . 0.0 111.646 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.423 HD23 ' SD ' ' A' ' 35' ' ' MET . 32.4 tp -66.05 -18.67 65.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.411 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 25.3 m120 -80.4 2.48 24.83 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.7 p30 -65.64 -15.12 62.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -70.22 -35.61 74.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.502 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -90.51 119.83 31.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.755 0.312 . . . . 0.0 110.368 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.6 -37.47 81.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.679 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -63.5 -38.92 92.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.483 0.658 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.08 82.33 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.96 -47.08 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.352 0.596 . . . . 0.0 109.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.52 -38.48 84.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.659 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.24 65.43 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.206 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.54 -52.71 15.02 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.045 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 99' ' ' TYR . 79.0 mt -59.91 -39.68 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.248 0.524 . . . . 0.0 112.064 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.37 -35.82 80.12 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.048 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.16 68.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.739 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.11 -36.99 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.765 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.25 -45.49 73.07 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.33 0.586 . . . . 0.0 110.261 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.95 -36.93 75.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.082 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.66 -7.24 59.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.655 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.5 m -55.55 -50.01 71.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.685 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.15 -35.62 85.02 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -64.93 -45.98 83.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.88 -39.54 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.512 0.673 . . . . 0.0 110.123 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -62.03 -45.07 95.2 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.526 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -71.01 -38.25 72.63 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 82' ' ' LEU . 1.1 tm? -69.28 -42.41 75.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.73 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.88 -39.72 83.66 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.763 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.77 -39.46 76.63 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -68.38 -38.02 80.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.189 -1.005 . . . . 0.0 111.347 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.9 99.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.558 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 69.0 mtm -98.34 -6.92 29.86 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 98.8 mtt180 49.59 38.27 14.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 109.316 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.1 tp -90.98 140.4 29.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.968 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -90.08 -38.59 13.45 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.731 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.412 HD12 ' CD2' ' A' ' 47' ' ' LEU . 25.8 pt -78.28 34.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.731 0.3 . . . . 0.0 111.744 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 89' ' ' LEU . 88.3 t -73.46 115.31 40.09 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.8 161.31 30.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.366 1.377 . . . . 0.0 111.884 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.27 138.36 58.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.24 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -122.23 131.23 53.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.397 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -108.54 130.33 55.29 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.048 0.451 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -119.43 141.23 49.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' HG23 ' A' ' 69' ' ' ILE . 2.9 m-85 -97.77 118.62 34.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 111.524 -179.014 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -57.58 -37.23 72.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.215 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.56 -38.82 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.612 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -63.05 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.99 -36.11 80.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.4 mtt -73.17 -38.99 66.0 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.987 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.4 -49.06 78.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.087 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -67.8 -40.77 83.85 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.071 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.98 -38.66 86.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.63 -44.06 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -37.04 86.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.3 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD11 HH11 ' A' ' 25' ' ' ARG . 31.8 tp -61.29 -53.32 58.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.043 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 83' ' ' LEU . 81.1 mt -69.71 -34.27 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.716 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.7 tp -57.99 -41.9 84.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -83.3 -38.16 22.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.209 0.528 . . . . 0.0 111.909 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.546 HH11 HD11 ' A' ' 21' ' ' LEU . 30.5 ttm180 -71.16 -43.87 66.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.1 -13.82 61.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.52 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -112.17 142.44 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -80.25 117.15 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 6.8 t70 -73.2 -35.6 2.83 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.8 Cg_exo -55.66 -29.82 72.46 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.966 1.778 . . . . 0.0 113.176 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -59.99 -36.64 77.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.742 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.36 -20.02 55.39 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.368 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.66 5.79 74.14 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.594 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 14.8 ptp -174.75 175.7 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.5 mtm -89.14 161.23 16.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.268 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -124.07 155.15 38.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.656 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.0 p -121.35 160.9 23.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.943 0.402 . . . . 0.0 110.96 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -108.43 123.75 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.828 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.436 ' CB ' ' OD2' ' A' ' 100' ' ' ASP . 23.2 t -68.31 -35.55 77.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.6 158.49 8.28 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.15 147.01 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 110.986 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -119.51 138.14 53.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.522 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.9 mmm -108.62 142.26 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 m -72.93 152.01 41.61 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -63.59 -30.5 71.61 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.409 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -83.68 -2.64 56.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.118 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.6 32.86 21.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -108.75 -47.66 3.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.174 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -117.28 139.02 51.34 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.0 0.428 . . . . 0.0 111.179 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.53 141.5 51.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -113.67 130.03 56.47 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.188 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.69 133.82 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.705 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.84 132.44 56.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.9 151.06 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.098 0.475 . . . . 0.0 111.857 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -144.19 149.86 37.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 59' ' ' ASP . 6.9 p90 -159.21 159.95 34.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.29 0.567 . . . . 0.0 111.577 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.95 -25.76 66.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.401 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.594 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 27.6 m120 -80.31 0.93 30.78 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.891 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 13.8 m-20 -63.43 -15.1 56.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -69.44 -36.7 76.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.049 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -91.09 113.9 26.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.19 -35.99 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.81 -38.1 89.85 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.42 0.629 . . . . 0.0 109.458 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.59 84.24 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 69' ' ' ILE . 69.9 t -67.51 -38.48 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -66.43 -40.75 89.7 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.03 66.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.72 -50.07 32.66 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.644 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.8 tp -58.67 -38.7 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.663 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.27 -36.18 79.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.58 80.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.719 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.35 -36.56 74.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.962 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -68.8 -45.36 71.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.138 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.9 -37.09 72.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.955 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.62 -7.8 57.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.067 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 t -57.85 -52.86 63.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.565 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.45 93.86 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.954 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.74 -44.56 85.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -68.86 -37.29 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.174 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.74 -46.45 88.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.666 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 t -67.62 -38.12 83.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.1 tp -68.93 -34.38 75.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.262 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 HD12 ' A' ' 22' ' ' ILE . 13.6 tp -66.83 -46.79 74.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.744 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -58.61 -40.97 95.36 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.851 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.58 -40.8 93.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.94 0.4 . . . . 0.0 111.212 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.77 99.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtt -82.21 -17.3 46.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' GLY . 83.1 mtp180 57.85 34.01 23.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.261 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.08 141.44 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.737 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -97.93 -10.23 24.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.453 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 91' ' ' ILE . 2.6 pp -106.96 34.21 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.4 p -73.27 124.77 90.89 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ALA . 88.8 Cg_endo -75.52 157.97 40.36 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.436 1.424 . . . . 0.0 112.304 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 39.3 mp0 -61.43 138.73 58.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.7 130.55 48.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.478 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 m -121.98 131.37 53.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.727 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.87 128.83 54.96 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.223 0.535 . . . . 0.0 111.015 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 41.5 t80 -129.64 152.28 49.32 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.7 p90 -104.81 132.43 51.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.658 0.266 . . . . 0.0 110.53 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' CB ' ' A' ' 39' ' ' SER . 56.3 p30 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.626 0.25 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -58.29 -40.5 82.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.386 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 p -59.41 -38.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.729 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' GLN . . . -62.13 -39.12 91.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -66.06 -42.66 89.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.15 -39.52 92.91 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 19' ' ' ILE . 58.5 mtt -74.06 -35.61 64.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.107 177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . 49.4 tt0 -57.33 -48.8 78.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.563 . . . . 0.0 110.617 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -68.7 -36.46 78.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.075 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.03 -41.42 86.59 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.659 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 83' ' ' LEU . 41.0 pt -69.56 -36.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.517 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.555 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.24 -52.93 51.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.759 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.54 -33.58 57.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.044 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.2 -40.08 84.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.577 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.84 -44.07 19.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.397 0.618 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -69.85 -35.12 74.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.849 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -72.04 -14.34 61.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.016 0.436 . . . . 0.0 109.988 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.85 149.86 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.083 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.79 107.61 19.48 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.53 -41.92 93.07 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.93 -178.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 34.3 Cg_exo -61.69 -33.96 84.89 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.185 1.923 . . . . 0.0 112.815 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.98 -39.51 85.93 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.55 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 mt -104.91 -19.76 13.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 69.83 16.99 72.89 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 ttp -108.04 145.77 33.51 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.634 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -103.04 144.46 31.25 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.122 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.484 HG23 ' CE2' ' A' ' 56' ' ' PHE . 70.6 m -110.7 132.06 54.52 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -128.88 156.44 43.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 116.22 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.914 0.387 . . . . 0.0 110.544 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.9 t -70.63 -30.69 67.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.602 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.64 156.14 8.37 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.37 132.18 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.692 0.282 . . . . 0.0 110.846 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -127.17 137.84 53.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.176 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtt -109.86 143.71 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.8 t -77.29 151.09 35.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.117 0.484 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -60.97 -31.05 70.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.939 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' C ' ' N ' ' A' ' 48' ' ' ALA . 89.6 m-20 -83.17 -3.62 57.55 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.43 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 58.87 11.07 1.73 Allowed 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 46' ' ' ASP . . . -75.02 -36.02 61.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -150.76 166.66 29.77 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.56 141.83 43.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -101.04 125.47 47.66 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.34 133.55 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 120.944 0.402 . . . . 0.0 110.476 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 98' ' ' PHE . 22.1 m -130.42 149.37 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 121.248 0.547 . . . . 0.0 111.095 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 m -133.27 135.64 45.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 36' ' ' THR . 35.4 m-85 -123.06 153.13 40.29 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.3 tp -72.26 -35.71 68.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.632 0.73 . . . . 0.0 110.397 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -81.27 8.13 9.76 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.8 p30 -60.96 -20.13 61.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 25.8 pttm -68.99 -30.04 68.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -90.7 117.2 29.15 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.31 -34.87 74.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.714 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.02 -38.81 89.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.455 0.645 . . . . 0.0 109.576 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.75 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' ILE . 74.8 t -69.12 -38.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -66.37 -45.67 79.33 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.489 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.97 -43.01 72.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.823 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.6 28.58 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.589 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.09 -37.63 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.719 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.09 -35.9 78.91 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.876 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.4 78.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.002 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' SER . 79.8 mt -71.22 -36.35 71.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.533 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.38 -45.55 75.92 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.291 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -71.18 -37.11 72.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.28 -3.55 57.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.392 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 72' ' ' LEU . 22.9 t -55.44 -51.16 67.83 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.899 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.56 92.64 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -63.04 -43.87 97.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.581 -0.309 . . . . 0.0 111.275 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.8 -40.21 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.372 0.606 . . . . 0.0 110.787 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.77 -46.02 89.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.048 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.5 m -70.48 -36.95 74.14 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.571 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -69.31 -37.94 78.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.542 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 19' ' ' ILE . 8.7 tt -68.27 -42.41 79.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.879 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.91 -41.9 71.01 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -66.21 -39.41 89.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.289 -0.956 . . . . 0.0 112.128 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.18 87.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.247 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.1 mtm -97.69 -5.39 35.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.44 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.9 mtm180 49.31 41.98 21.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 110.056 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.9 tp -92.04 140.32 29.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.416 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.491 ' C ' ' H ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -95.09 -41.29 9.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.7 pt -71.43 29.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.601 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 90' ' ' ARG . 88.6 t -73.45 114.2 29.47 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.276 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 160.62 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.5 1.467 . . . . 0.0 110.838 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.38 127.27 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.9 mt -94.2 131.02 40.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.207 0.527 . . . . 0.0 111.512 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.9 m -120.18 130.5 54.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.201 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -104.74 127.32 52.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.938 0.399 . . . . 0.0 110.752 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 39.9 t80 -132.23 151.72 51.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.002 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 51.0 p90 -105.61 132.51 51.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.969 0.414 . . . . 0.0 111.191 -179.54 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.09 -37.71 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.254 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.0 t -58.08 -40.04 75.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.09 93.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.083 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -63.83 -39.23 93.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.333 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.84 -36.3 80.77 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.8 mtt -72.84 -39.93 66.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.534 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.59 -47.41 79.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.774 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -66.49 -36.87 83.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.229 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -65.48 -41.69 93.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.67 -41.28 87.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.28 86.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.299 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.2 tp -60.92 -51.89 67.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.209 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.58 -34.44 65.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.24 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.4 tt -59.17 -40.85 86.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.841 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -82.24 -41.31 20.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.354 0.597 . . . . 0.0 111.481 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -70.59 -41.57 72.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.04 -15.74 61.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.173 0.511 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 23' ' ' LEU . 16.3 tt -114.42 148.2 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.75 119.4 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 30.9 t0 -78.89 -35.68 1.09 Allowed Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 47.4 Cg_exo -56.52 -34.49 95.15 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.766 1.644 . . . . 0.0 112.763 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -60.07 -38.01 81.58 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.267 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.81 -20.88 45.07 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.78 88.62 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.662 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 57' ' ' LEU . 47.5 ttm -171.94 154.8 3.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.593 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -79.48 140.98 37.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.7 p -89.18 165.51 14.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.2 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -127.14 156.2 42.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -107.57 125.41 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.966 0.413 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -67.54 -34.08 76.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.41 159.94 9.53 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.51 148.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.933 0.396 . . . . 0.0 111.262 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -124.08 138.09 54.48 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.748 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 mmm -113.14 142.33 45.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -73.85 150.76 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.734 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -60.6 -33.52 72.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.248 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.99 -3.54 57.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.408 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.0 mt 60.19 30.57 19.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.61 -48.21 3.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.888 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.6 144.36 44.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.953 0.406 . . . . 0.0 110.952 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.64 142.03 45.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.549 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -122.06 125.43 46.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.28 134.46 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 97.4 m-85 -107.69 139.71 41.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.061 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.47 146.32 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.266 0.555 . . . . 0.0 111.467 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -133.6 139.39 46.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.318 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -149.2 143.9 26.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.96 0.41 . . . . 0.0 110.026 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 1.2 pt? -77.66 -12.15 59.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.834 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.78 3.22 20.15 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -61.5 -16.53 48.27 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -69.64 -36.76 76.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 63' ' ' ASP . 65.2 t0 -90.84 114.01 26.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.722 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.26 -35.03 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.73 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 3.4 p30 -67.01 -33.52 75.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.133 0.492 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -67.98 -37.15 81.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.74 -44.7 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.341 0.591 . . . . 0.0 109.986 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.46 -41.0 85.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.018 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.48 -46.16 64.3 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.688 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.98 -51.73 27.35 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.472 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 mm -59.14 -37.79 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.567 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.39 -39.84 92.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.68 -41.81 74.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.939 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.1 tp -70.38 -36.52 74.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.67 -45.0 69.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.308 0.575 . . . . 0.0 110.386 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -36.86 74.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.028 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.38 -7.86 55.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 t -55.07 -50.55 68.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.11 -39.04 93.89 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -66.94 -40.33 87.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.41 -41.43 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 109.833 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.9 -47.19 81.58 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.535 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -70.93 -36.23 72.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.821 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.81 -34.56 76.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.063 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.36 -46.08 74.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.545 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -66.52 -36.93 92.17 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.985 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.58 -43.55 89.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.72 -0.74 . . . . 0.0 111.714 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.26 -43.73 66.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.798 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.7 mtt -80.65 -17.96 49.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 84' ' ' GLY . 40.5 ttp180 61.47 29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.487 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.58 141.66 35.04 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.217 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -97.38 -11.91 23.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.094 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -84.03 24.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 92' ' ' VAL . 1.2 m -72.33 119.13 73.11 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.34 161.48 31.78 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.447 1.432 . . . . 0.0 111.882 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.04 134.11 56.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.6 mt -99.76 131.04 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.085 0.469 . . . . 0.0 110.883 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -118.6 123.13 44.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -102.69 131.11 49.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 54.4 t80 -119.03 141.92 48.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.603 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.412 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 43.2 p90 -106.87 134.53 49.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 -179.817 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.639 0.256 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -60.31 -43.31 96.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 p -65.6 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.721 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.09 79.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.45 -40.42 95.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.24 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -38.38 87.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 91.1 mmm -70.66 -40.13 73.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.513 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -55.32 -43.21 74.69 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.551 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -62.73 -45.35 93.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.182 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.59 -34.66 78.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.788 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.5 mt -70.5 -42.3 78.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.69 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.77 85.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.034 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.53 -53.06 61.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.641 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.5 mt -69.81 -33.94 58.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.503 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.7 tp -56.67 -41.56 77.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.813 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 60.0 tt0 -82.11 -42.8 18.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.285 0.564 . . . . 0.0 111.267 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.39 -36.62 76.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.94 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -71.81 -17.05 62.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.214 0.53 . . . . 0.0 109.909 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.2 pt -119.44 150.54 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.067 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.2 120.52 24.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -73.13 -39.09 4.89 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.4 Cg_exo -52.91 -38.35 78.94 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.012 1.808 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -63.93 -37.73 88.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 mt -99.7 -9.79 22.68 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.719 0.295 . . . . 0.0 110.514 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 81.01 17.88 71.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.3 ttp 60.61 3.01 0.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.334 0.588 . . . . 0.0 109.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 33' ' ' GLY . 64.9 mtt -58.29 -28.02 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.781 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -65.98 129.42 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -131.39 148.39 52.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.898 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -91.93 117.75 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 0.0 109.788 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 m -66.48 -35.9 81.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.508 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 160.58 10.04 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -127.14 152.78 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -132.79 139.9 47.75 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.42 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.2 mtt -97.16 140.3 31.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.7 p -73.66 160.14 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.955 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.8 ttm105 -58.01 -32.78 68.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.507 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -82.6 -3.88 56.81 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.271 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.0 mt 59.17 15.26 4.03 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.13 -36.79 8.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.901 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.6 146.25 41.95 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.724 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.19 141.75 47.17 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.787 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -108.88 128.08 54.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.299 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.1 133.38 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.292 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.44 130.16 56.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.14 148.68 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.007 0.432 . . . . 0.0 110.94 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 t -135.43 151.55 50.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -144.63 141.85 29.69 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.275 0.56 . . . . 0.0 111.037 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.9 tp -68.74 -22.49 64.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -80.3 5.57 14.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 53.7 p30 -61.85 -17.43 56.41 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 48.1 mtmt -68.88 -35.85 77.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.339 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -89.73 118.57 29.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.011 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.1 -35.49 75.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.907 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.78 -39.57 93.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.608 0.718 . . . . 0.0 109.275 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.53 80.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.588 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 69' ' ' ILE . 68.2 t -65.44 -42.83 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.679 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.15 -47.68 70.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.258 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.45 69.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.826 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -51.27 37.34 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.857 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 65' ' ' VAL . 16.5 tt -59.03 -40.98 81.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.223 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' ILE . 68.1 mttm -68.79 -35.02 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.951 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.4 76.82 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.335 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.11 -36.82 72.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.198 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.02 -45.38 67.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.347 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.67 -37.06 73.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.487 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.62 -12.06 60.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.345 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.5 p -55.66 -50.2 70.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.503 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.83 95.06 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.485 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.72 -41.44 92.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.39 -39.84 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.321 0.582 . . . . 0.0 110.622 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.36 -47.74 80.84 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.023 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.1 m -71.45 -38.37 71.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.211 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.5 tp -68.07 -37.79 81.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.311 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.35 -41.33 80.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.73 -36.04 74.52 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -70.05 -43.68 70.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.529 -0.835 . . . . 0.0 111.614 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.61 89.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.522 . . . . 0.0 109.909 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.409 ' O ' HD23 ' A' ' 89' ' ' LEU . 62.8 mtt -84.9 -17.69 37.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.15 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' GLY . 39.7 mmm-85 59.52 25.32 14.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 87' ' ' MET . 2.7 mm? -100.99 141.77 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.108 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.71 -10.45 19.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.413 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 91' ' ' ILE . 11.1 pt -75.21 7.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.353 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 92' ' ' VAL . 31.2 m -72.55 122.21 86.92 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.75 163.68 28.72 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.616 1.544 . . . . 0.0 111.749 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.02 133.47 56.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.31 129.73 44.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -119.38 127.96 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.51 129.85 52.5 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.181 0.515 . . . . 0.0 111.468 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -119.11 138.69 52.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.568 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 24.6 p90 -102.69 128.69 49.29 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.935 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.46 0.059 0 CA-C-O 120.771 0.319 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -58.93 -37.63 77.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' SD ' ' A' ' 15' ' ' MET . 66.3 t -58.57 -41.01 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.762 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.26 90.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.063 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.86 -39.2 93.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.116 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.73 -36.52 81.21 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -73.06 -41.1 64.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.035 178.494 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.11 -45.62 92.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -67.25 -41.1 86.16 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.24 -41.9 89.37 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.772 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.23 -41.35 86.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.281 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 -37.65 88.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.122 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.458 HD11 ' NE ' ' A' ' 25' ' ' ARG . 42.5 tp -62.53 -52.32 63.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.34 -32.78 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.305 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.36 -40.96 71.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.478 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ILE . 83.1 mt-30 -82.51 -43.73 16.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.696 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NE ' HD11 ' A' ' 21' ' ' LEU . 87.3 mtt180 -70.83 -32.68 69.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -71.7 -16.54 62.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.45 0.643 . . . . 0.0 109.343 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.6 pt -118.69 149.34 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -95.0 123.92 38.75 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -47.39 -59.7 5.13 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -52.11 -23.23 16.81 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.966 1.777 . . . . 0.0 113.513 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.45 -38.11 76.81 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.559 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -100.33 -12.24 19.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.85 61.42 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 mtt -146.71 163.91 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.542 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.6 mtp -96.19 148.08 23.08 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.807 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -114.35 152.5 31.37 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.131 0.491 . . . . 0.0 111.004 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.0 m -129.03 145.7 51.19 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 38' ' ' VAL . 32.7 m -92.73 124.08 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.5 p -78.33 -23.19 47.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.744 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.95 155.09 6.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.46 153.53 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -135.12 142.51 46.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 mmt -103.36 142.36 34.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.778 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 88.3 p -73.54 161.6 30.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.186 0.517 . . . . 0.0 110.5 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -59.55 -35.16 73.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -83.68 -2.94 57.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp 59.89 22.48 11.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.71 -37.53 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.46 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.426 ' O ' ' OG ' ' A' ' 44' ' ' SER . 89.9 m-85 -116.19 143.66 45.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.42 141.97 46.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -115.93 125.72 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.301 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.65 134.77 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.087 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -109.54 131.95 54.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 m -131.59 149.53 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.062 0.458 . . . . 0.0 111.04 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -140.96 152.01 44.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.285 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CG ' ' OD1' ' A' ' 59' ' ' ASP . 19.2 p90 -151.98 161.07 43.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.474 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -27.76 68.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.486 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 60' ' ' LYS . 15.9 t-20 -80.56 2.03 27.2 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.529 ' OD1' ' CG ' ' A' ' 56' ' ' PHE . 3.3 m-20 -61.53 -15.48 38.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 58' ' ' ASN . 48.9 mtmt -67.64 -37.13 82.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -90.52 114.46 26.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.778 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.34 -33.26 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.64 -38.88 92.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.48 0.657 . . . . 0.0 109.486 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.65 84.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.763 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.61 -39.53 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.212 0.529 . . . . 0.0 109.977 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -65.86 -41.22 91.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.07 70.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.38 -51.39 52.89 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.254 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.6 -38.83 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.203 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.43 -39.98 95.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.254 0.55 . . . . 0.0 109.634 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.82 71.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.325 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 tp -70.32 -37.57 74.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -69.35 -44.76 70.93 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.09 -37.03 78.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.936 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.86 -10.14 59.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.9 p -57.76 -49.6 76.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.63 -36.79 87.29 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.09 -45.38 85.46 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.425 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.2 mt -60.72 -39.23 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.468 0.651 . . . . 0.0 110.608 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -61.43 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.84 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -70.4 -35.65 73.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.478 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -63.67 -40.58 97.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.113 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.63 -51.11 45.72 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.88 -44.31 94.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.176 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.58 -42.63 70.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.33 92.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtm -89.19 -17.15 29.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.12 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 84' ' ' GLY . 48.1 mmm-85 54.42 37.61 28.01 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 tp -93.9 139.87 30.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.689 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -89.35 -38.56 14.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -77.76 21.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.673 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.2 p -72.35 114.8 32.91 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -83.24 168.61 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.903 1.735 . . . . 0.0 112.284 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -74.32 142.46 45.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 95' ' ' LEU . 9.6 mp -98.15 128.13 44.48 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.189 0.518 . . . . 0.0 111.324 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 m -110.24 118.95 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 130.25 44.66 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 112.334 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.37 138.67 52.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.095 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -105.71 133.81 49.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.731 0.301 . . . . 0.0 110.653 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.98 0.419 . . . . 0.0 110.184 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo . . . . . 0 N--CA 1.498 1.745 0 CA-C-O 120.792 0.247 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -58.5 -37.07 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -60.72 -40.49 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.326 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.18 -40.68 86.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.86 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.2 83.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.46 -42.1 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.188 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.81 -38.54 88.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.9 mtt -71.13 -38.6 72.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.971 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.72 -44.61 73.66 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -64.28 -45.93 85.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.499 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -63.25 -34.06 76.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.376 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.83 80.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.741 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.75 85.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.812 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.93 -53.16 58.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.068 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.8 -34.87 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.747 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.0 tp -58.89 -43.47 90.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.245 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -83.23 -40.5 19.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.591 . . . . 0.0 111.684 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -69.85 -41.86 74.32 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -72.94 -15.62 61.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.145 0.498 . . . . 0.0 110.442 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 23' ' ' LEU . 18.8 tt -115.35 142.21 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.547 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -83.58 113.71 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -67.87 -38.62 14.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.787 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 60.0 Cg_exo -52.68 -31.78 51.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.878 1.719 . . . . 0.0 112.616 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -60.5 -37.26 80.51 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.891 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.9 mt -79.85 -20.1 46.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 109.856 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.47 5.45 82.12 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.401 ' SD ' HD23 ' A' ' 57' ' ' LEU . 25.2 ttt -167.07 154.8 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.65 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.55 142.91 33.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.034 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 157.17 16.27 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.0 m -121.15 143.28 49.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.23 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.33 118.08 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 110.131 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -63.32 -36.16 82.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.313 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.63 161.52 10.44 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.64 151.35 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.812 0.339 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.17 142.59 48.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.0 mtt -102.2 142.28 33.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.003 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.7 t -73.79 152.2 40.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.087 0.47 . . . . 0.0 110.588 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -55.98 -31.75 63.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.993 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.71 -3.87 57.05 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.326 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.8 mt 58.8 20.11 7.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.06 -41.37 6.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.945 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.62 147.28 40.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 141.31 49.18 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.94 0.4 . . . . 0.0 110.474 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -109.04 127.55 54.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.81 133.11 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -112.84 130.46 56.08 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.91 147.65 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.892 0.377 . . . . 0.0 110.716 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -126.37 125.7 42.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.96 131.6 55.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' SD ' ' A' ' 34' ' ' MET . 30.5 tp -70.89 -25.93 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.436 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 60' ' ' LYS . 19.6 m120 -81.09 2.57 26.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -60.75 -16.85 44.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 58' ' ' ASN . 14.7 mtpp -69.0 -35.56 76.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -89.71 119.32 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.378 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.71 -32.31 70.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.75 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.7 -40.24 76.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.308 0.575 . . . . 0.0 110.415 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.09 74.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.955 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.83 -34.37 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.257 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -64.69 -42.92 94.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 109.641 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.64 75.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.343 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.37 51.66 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.997 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.58 HD13 ' CZ ' ' A' ' 99' ' ' TYR . 5.5 mm -57.98 -42.93 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.666 0.27 . . . . 0.0 111.038 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.01 -35.73 80.57 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.04 -45.2 71.01 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.106 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 tp -70.98 -36.68 72.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.416 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.6 -45.46 71.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.43 -37.08 74.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.43 59.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.28 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 t -55.67 -51.07 68.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.241 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.09 93.22 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -65.94 -41.27 91.54 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.11 -41.43 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.342 0.592 . . . . 0.0 109.969 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 93' ' ' PRO . 37.4 ttt85 -62.9 -47.15 84.51 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.42 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 t -70.95 -36.45 72.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.707 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.46 -39.91 77.44 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.787 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.35 -49.22 51.62 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.43 -42.26 99.73 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.407 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -68.8 -39.86 79.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.375 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.851 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.08 -14.07 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 93.7 mtt-85 56.91 35.78 26.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.52 141.35 34.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.782 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -102.12 -10.94 19.22 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.498 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 91' ' ' ILE . 36.8 pt -88.4 13.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -73.09 121.94 86.39 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 94.7 Cg_endo -78.06 166.06 25.32 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.701 1.601 . . . . 0.0 111.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.01 138.41 58.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.4 mm? -97.56 128.31 44.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.074 0.464 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.4 m -118.57 129.35 55.29 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.67 129.12 49.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.198 0.523 . . . . 0.0 111.498 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.1 t80 -123.25 144.97 49.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.738 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 21.4 m-85 -109.22 132.56 54.0 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.932 0.396 . . . . 0.0 110.241 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.936 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo . . . . . 0 N--CA 1.501 1.951 0 CA-C-O 120.592 0.164 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.2 -37.87 81.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.73 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -62.02 -43.06 99.64 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.65 -37.74 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.164 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.96 81.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -64.67 -41.78 95.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.29 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.57 -38.75 88.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 90.4 mtp -71.1 -38.8 72.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.71 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.5 -42.38 78.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.537 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -63.0 -45.42 92.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.11 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.13 -34.85 78.49 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.708 0.766 . . . . 0.0 109.715 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.63 -41.51 77.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.485 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.51 84.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.194 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.56 -52.99 62.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.577 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.9 mt -69.87 -34.26 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.395 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 27' ' ' ILE . 36.8 tp -56.33 -41.96 76.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.016 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' ILE . 59.4 tt0 -82.92 -41.64 18.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 111.442 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -70.35 -38.81 74.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.122 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -72.39 -14.86 61.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.071 0.462 . . . . 0.0 110.336 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.9 tt -119.9 141.64 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.554 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -86.54 113.06 22.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -67.77 -38.75 15.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.489 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.59 -28.69 46.93 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.012 1.808 . . . . 0.0 112.559 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -59.38 -38.2 79.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.527 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 mt -88.37 -19.45 26.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.138 0.494 . . . . 0.0 109.8 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.71 5.0 89.84 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 90.7 mmm -143.74 162.22 36.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.838 0.351 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.6 ttp -96.79 134.54 39.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.952 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.0 p -92.0 158.04 16.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 t -135.56 159.66 40.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p -108.17 127.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.999 0.428 . . . . 0.0 110.085 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 m -72.19 -34.2 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.42 157.44 8.48 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.76 150.69 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.074 0.464 . . . . 0.0 111.488 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.1 141.86 50.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.074 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.1 mtt -108.11 142.07 38.87 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 p -75.47 152.84 37.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.058 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -63.06 -34.81 78.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.443 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.92 -3.11 57.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.376 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.4 mt 62.03 13.67 5.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.11 58.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.177 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.2 165.49 29.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.256 0.55 . . . . 0.0 111.764 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.54 142.3 35.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.257 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -112.41 120.01 40.19 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.208 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.8 133.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.907 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -109.67 136.19 49.41 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.79 146.98 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 0.0 111.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 t -144.65 152.48 40.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 11.0 p90 -150.24 159.73 44.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.123 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.18 -27.03 68.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.02 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.412 ' C ' ' N ' ' A' ' 60' ' ' LYS . 73.5 m-20 -80.23 5.78 13.67 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 68.9 m-20 -61.02 -16.71 46.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 58' ' ' ASN . 63.9 tttp -68.87 -39.97 79.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.82 114.12 26.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.167 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -60.46 -33.0 71.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.04 -38.72 89.09 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.447 0.641 . . . . 0.0 109.386 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.55 83.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 69' ' ' ILE . 82.6 t -68.76 -37.87 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.913 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.4 -45.47 79.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.595 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.27 -44.55 68.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.496 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.85 41.38 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.484 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.0 tt -59.8 -34.5 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.214 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -66.4 -41.31 89.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.38 0.61 . . . . 0.0 109.506 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.36 75.09 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.95 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -69.62 -36.63 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -68.48 -44.49 74.67 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.192 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -69.35 -37.07 77.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.091 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.72 -10.52 59.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.333 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.8 p -58.67 -49.41 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.243 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.7 91.88 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -64.49 -43.6 93.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.623 0.249 . . . . 0.0 111.452 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.73 -42.84 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 110.808 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -63.11 -47.1 84.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.48 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.1 t -70.98 -37.76 72.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.866 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -66.45 -37.8 85.95 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.778 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.75 -43.32 76.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.956 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.0 -38.4 74.21 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -66.26 -43.12 87.36 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -0.726 . . . . 0.0 111.921 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.58 83.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.7 mtt -84.29 -17.21 40.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' GLY . 41.3 ttt85 59.44 35.35 22.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.656 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.35 142.05 33.32 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.034 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.58 -10.54 19.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.668 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 pt -82.62 18.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.201 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.97 122.5 87.81 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.91 158.97 31.09 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.545 1.496 . . . . 0.0 111.374 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.81 128.7 37.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.5 mt -95.58 131.37 41.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.228 0.537 . . . . 0.0 111.313 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -115.61 127.25 55.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.98 126.9 52.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -119.11 141.64 48.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.768 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 23.3 p90 -106.83 132.02 53.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.905 0.383 . . . . 0.0 110.337 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.341 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.497 1.722 0 CA-C-O 120.746 0.227 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -63.31 -43.2 98.52 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.016 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.07 -37.1 78.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.291 0.567 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.8 -39.54 83.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -71.59 -46.42 59.32 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.519 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.37 -37.15 84.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 57.3 mtt -71.62 -40.72 69.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.982 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -54.49 -42.33 70.63 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -63.3 -46.79 85.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.366 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.35 -33.48 75.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.608 0.718 . . . . 0.0 109.824 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.26 -42.92 78.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.962 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.17 86.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.58 -51.82 65.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.389 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.27 -34.1 64.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.7 -41.02 97.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -82.65 -27.8 31.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -82.83 -45.26 14.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.773 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.05 -17.39 62.02 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 72' ' ' LEU . 35.5 mt -112.24 133.92 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.009 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.97 121.96 28.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 10.7 t70 -46.14 -58.48 6.36 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.302 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.61 -22.93 18.24 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.805 1.67 . . . . 0.0 113.13 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.18 -38.36 76.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.763 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.8 mt -100.7 -13.79 18.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.05 0.453 . . . . 0.0 109.801 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.66 5.68 89.68 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.3 tpt -160.88 158.75 28.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.404 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.442 ' SD ' ' OD1' ' A' ' 29' ' ' ASP . 94.1 mmm -80.45 137.93 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 p -86.08 150.33 24.52 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.872 0.368 . . . . 0.0 111.029 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.4 m -125.98 141.71 51.84 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.911 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -100.24 120.97 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.012 0.434 . . . . 0.0 110.169 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -68.84 -33.94 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.17 158.19 8.79 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 m -127.16 148.62 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 111.193 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -126.1 138.29 53.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.952 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.487 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -113.73 143.24 44.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 94.7 p -73.2 156.4 38.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.233 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.953 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 55.3 p30 -83.91 -0.86 53.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.5 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.27 31.94 21.57 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' A' ' 46' ' ' ASP . . . -105.56 -46.44 4.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.79 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -116.02 145.55 42.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.829 0.347 . . . . 0.0 110.641 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.88 142.17 40.69 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -122.05 127.49 50.28 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.5 134.74 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -109.96 133.17 53.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.74 149.85 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.167 0.508 . . . . 0.0 111.55 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -143.36 151.77 40.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.41 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 7.2 p90 -156.03 158.52 37.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 111.397 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.01 -14.67 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.75 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.6 3.42 21.94 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.519 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 64.6 m-20 -61.88 -16.64 52.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.37 -39.43 85.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.135 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.62 117.26 29.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.037 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -60.3 -36.57 78.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.427 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.06 -37.92 89.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.471 0.653 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.84 84.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.1 -44.32 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -66.83 -39.83 87.78 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.47 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.83 76.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.59 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.42 -51.2 38.78 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.41 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.37 -41.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.612 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.46 -35.27 80.4 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.57 86.21 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.936 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' CD2' HD11 ' A' ' 27' ' ' ILE . 84.7 mt -70.35 -35.89 73.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.851 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -67.78 -45.96 73.33 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.47 -37.18 71.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.5 -3.97 54.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.286 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -55.24 -50.3 69.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.317 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.76 93.02 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.232 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -66.41 -42.65 87.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.32 -39.52 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.638 0.732 . . . . 0.0 110.087 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -63.74 -45.02 91.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.09 -36.95 78.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.521 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.52 -38.77 90.63 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.935 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.87 -49.5 57.74 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.515 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -59.45 -43.0 97.83 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.692 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.053 0.454 . . . . 0.0 111.824 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.65 98.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.474 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -94.5 -9.17 36.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 89.5 mtm-85 55.13 36.67 27.49 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.72 141.2 33.93 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.977 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -99.22 -14.69 19.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 pt -86.91 29.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 92' ' ' VAL . 35.9 m -72.57 118.36 67.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.91 160.82 27.25 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.547 1.498 . . . . 0.0 111.61 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.29 136.2 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.8 mt -100.84 130.76 46.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 110.947 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -119.65 124.88 47.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.996 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.73 129.11 47.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.452 . . . . 0.0 111.231 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 37.7 t80 -119.64 139.8 51.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 44.6 p90 -104.67 133.6 49.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.964 0.412 . . . . 0.0 110.484 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.502 1.986 0 CA-C-O 120.758 0.232 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.37 -34.4 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.288 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -59.77 -43.21 94.47 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 m -65.5 -36.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.847 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.33 85.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.811 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.33 -40.71 96.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.3 -37.62 83.89 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.55 -42.18 68.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.886 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.36 -43.74 79.43 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -63.52 -48.14 78.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.069 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.83 -32.25 72.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.246 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.03 -41.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.86 85.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.8 tp -64.34 -52.01 60.5 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.22 -33.92 60.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 27' ' ' ILE . 56.4 tp -57.96 -42.21 84.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.4 mt-30 -82.46 -41.87 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.384 0.611 . . . . 0.0 111.358 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -70.54 -37.6 74.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.827 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -72.12 -17.42 61.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.176 0.512 . . . . 0.0 110.125 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.2 tt -118.7 141.09 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.815 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -66.52 -38.69 21.0 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.437 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.5 Cg_exo -55.28 -31.91 78.7 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.004 1.802 . . . . 0.0 112.521 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.51 -38.22 80.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.704 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.9 -20.02 28.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.951 0.405 . . . . 0.0 110.002 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 7.39 87.19 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.8 mtt -138.85 167.15 22.64 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.962 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.8 mtp -98.29 151.2 20.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.444 ' CG2' ' CE1' ' A' ' 56' ' ' PHE . 88.0 m -109.09 142.36 39.94 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -122.41 157.36 32.05 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.732 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p -105.54 116.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.152 0.501 . . . . 0.0 110.2 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -34.46 78.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.006 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.11 152.59 6.37 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 52' ' ' VAL . 32.5 t -126.09 137.92 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.679 0.276 . . . . 0.0 110.454 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -128.23 140.35 51.95 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.993 0.425 . . . . 0.0 110.779 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.6 mtt -111.36 142.47 43.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.475 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.1 p -73.44 155.31 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.822 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.25 -32.54 71.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.565 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.57 -3.54 56.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.377 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.31 27.12 16.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.37 -41.29 5.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -118.07 142.75 47.07 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.872 0.367 . . . . 0.0 110.885 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.07 141.73 48.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.13 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.97 129.13 55.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 41' ' ' VAL . 97.0 t -117.77 133.36 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.415 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -118.74 128.76 54.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.33 149.73 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.225 0.536 . . . . 0.0 111.452 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -123.7 134.68 53.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 36' ' ' THR . 97.6 m-85 -121.39 146.55 46.76 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.426 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.3 mt -76.03 -12.06 60.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 81.9 m-20 -80.68 -2.43 46.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.834 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 100' ' ' ASP . 98.4 m-20 -62.94 -21.2 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.88 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -69.88 -38.43 76.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.562 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -99.1 109.51 22.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.03 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.11 -38.17 82.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.05 -38.03 89.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.84 82.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.51 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' ILE . 76.7 t -66.43 -35.53 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -66.2 -43.75 85.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.228 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.81 72.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.346 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -50.4 32.18 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.717 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.22 -36.74 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.682 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -68.35 -38.05 81.09 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.551 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.35 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.61 -36.88 76.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.658 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.76 -44.95 72.65 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.09 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.75 -36.95 79.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.236 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.26 -12.16 60.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.0 -49.53 76.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.461 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.15 86.02 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.161 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.09 -44.63 88.24 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.333 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.44 -39.6 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.543 0.687 . . . . 0.0 110.501 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -63.48 -45.02 92.7 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.736 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.56 -36.55 76.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.0 mt -66.43 -36.49 82.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.237 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.12 -48.6 64.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.909 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.17 -43.1 65.08 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.603 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.86 -43.11 80.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.258 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.14 83.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.429 ' HB3' HD23 ' A' ' 89' ' ' LEU . 56.6 mtt -84.54 -21.38 30.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 84' ' ' GLY . 49.0 ttp85 64.21 37.15 8.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.992 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.6 mm? -90.28 141.46 28.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.984 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -98.7 -14.56 19.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.422 ' CG1' HD12 ' A' ' 89' ' ' LEU . 34.8 pt -97.7 34.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 92' ' ' VAL . 34.2 m -73.25 119.87 78.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.98 160.35 30.37 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.418 1.412 . . . . 0.0 111.352 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.37 132.67 54.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.05 126.82 51.47 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.819 0.342 . . . . 0.0 110.304 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 m -117.11 133.68 55.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.512 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.28 128.52 54.52 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -119.58 137.53 53.79 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 38.3 p90 -109.63 123.59 49.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.932 0.396 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.417 ' O ' ' OD2' ' A' ' 59' ' ' ASP . 60.4 t0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.497 1.721 0 CA-C-O 121.028 0.345 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -65.03 -29.81 70.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.632 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -58.71 -41.57 86.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.53 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.2 -39.38 78.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.757 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.07 96.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.914 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -61.38 -39.37 90.41 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.379 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.56 -37.33 83.44 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.32 -41.87 69.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.599 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HG2' HG22 ' A' ' 41' ' ' VAL . 94.7 mt-30 -60.66 -41.5 95.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.574 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -64.63 -51.33 63.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.215 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.74 -34.92 79.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.941 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.0 mt -71.07 -39.96 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.109 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -36.85 85.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.25 -53.31 46.18 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.81 -34.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.76 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 27' ' ' ILE . 37.0 tp -59.35 -38.96 81.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.945 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 27' ' ' ILE . 48.5 tt0 -81.88 -44.46 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.988 0.423 . . . . 0.0 111.15 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -71.15 -36.64 72.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -73.27 -14.31 61.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.291 0.567 . . . . 0.0 109.906 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 23' ' ' LEU . 15.0 tt -121.67 149.47 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -76.03 113.02 13.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -70.14 -38.55 9.02 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.86 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 46.0 Cg_exo -56.57 -37.4 97.56 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.078 1.852 . . . . 0.0 112.781 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -59.94 -37.43 79.5 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.121 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 61.7 mt -92.45 -3.88 54.54 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.76 0.314 . . . . 0.0 110.6 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.05 5.39 70.65 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ttt 65.46 0.38 1.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mmm -79.32 10.29 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.692 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.3 m -78.75 130.68 36.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.067 0.46 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.9 m -131.27 145.91 52.09 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.3 t -94.47 119.11 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.379 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.98 163.68 11.3 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 16' ' ' GLN . 2.2 m -127.42 148.8 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.637 0.256 . . . . 0.0 110.386 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.93 130.55 56.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 58.3 mmm -100.65 142.27 32.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -73.52 151.27 41.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 0.0 110.585 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -57.92 -36.12 72.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.428 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -83.92 -0.14 50.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.421 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 59.38 30.17 19.83 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.61 -47.41 4.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.187 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -118.19 145.02 45.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.903 0.383 . . . . 0.0 111.055 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.4 141.79 46.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.06 130.13 56.27 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.14 133.47 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.593 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -116.51 128.9 55.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.722 0.296 . . . . 0.0 110.355 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.82 147.34 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.83 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -132.61 144.2 50.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 5.5 p90 -150.3 150.17 31.12 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.159 0.504 . . . . 0.0 111.058 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.08 -33.75 75.01 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 17.0 m120 -80.89 -2.46 47.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 36.0 t0 -61.68 -14.83 34.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -67.6 -38.2 83.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.28 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.09 126.71 35.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.068 0.461 . . . . 0.0 110.428 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.3 -35.41 75.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.136 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.9 -40.28 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 109.976 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.66 81.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.054 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.74 -39.27 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 0.0 109.279 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HZ3' ' CE ' ' A' ' 70' ' ' LYS . 22.0 tptp -64.31 -43.32 95.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.534 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.9 62.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.804 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.64 -52.08 32.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.747 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.34 -36.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.568 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' CE ' ' HZ3' ' A' ' 66' ' ' LYS . 3.1 ttmp? -66.03 -39.94 90.62 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.43 -42.06 83.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.834 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.11 -36.24 74.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.116 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -69.0 -45.5 70.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.59 -36.96 73.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.227 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.13 -8.78 59.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.218 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -57.15 -49.06 77.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.293 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.36 87.09 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.07 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -66.08 -44.52 84.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.464 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.29 -40.37 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 110.149 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -63.46 -45.55 90.32 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -68.88 -37.09 78.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.44 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.11 -38.36 90.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.254 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.92 -47.24 66.27 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.67 -42.15 72.53 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.722 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.43 -43.01 78.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.351 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.32 87.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.008 0.432 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 39.8 mtt -86.21 -17.6 34.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 70.8 mtp85 53.51 37.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -94.64 139.44 31.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.412 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -86.65 -39.0 16.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.033 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.9 pt -76.22 33.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -72.59 114.61 31.61 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -80.33 162.13 22.61 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.694 1.596 . . . . 0.0 112.036 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.67 133.29 50.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.19 131.41 44.57 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.104 0.478 . . . . 0.0 110.882 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.6 m -120.88 131.79 54.6 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.389 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.74 127.28 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.004 0.431 . . . . 0.0 110.98 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -126.04 146.16 50.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.0 p90 -109.54 132.48 54.1 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.788 0.328 . . . . 0.0 111.313 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.89 178.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.982 0.326 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.55 -33.37 74.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.314 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -59.24 -39.85 84.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.995 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.1 t -58.02 -39.74 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.69 95.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.86 -40.35 96.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.697 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.97 -36.46 81.52 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.47 -40.96 63.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.47 -47.91 82.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.135 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -67.48 -37.83 83.46 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -64.19 -42.37 96.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.311 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.78 -40.65 86.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.33 87.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.082 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.59 -51.88 65.59 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.32 -34.41 68.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.766 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 72' ' ' LEU . 13.3 tp -60.34 -40.42 90.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.383 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -83.07 -27.57 30.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.783 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -79.61 -46.45 17.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.38 -15.39 61.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 24' ' ' GLN . 31.7 mt -114.15 133.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -84.48 112.73 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -65.93 -39.15 27.88 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.235 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.2 Cg_exo -55.28 -34.39 88.21 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.021 1.814 . . . . 0.0 112.36 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.49 -37.89 79.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.445 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.7 mt -80.91 -20.26 42.54 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.89 4.27 90.1 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.644 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 57.1 mtt -151.62 167.15 29.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.833 0.349 . . . . 0.0 110.513 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -92.06 139.8 30.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.0 p -87.17 152.02 22.69 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 110.965 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -126.81 141.8 51.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.286 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.11 122.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -66.2 -35.22 79.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.237 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.67 160.69 10.02 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.34 146.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 111.1 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -121.43 139.4 53.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.609 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.3 mmm -109.39 139.97 43.68 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.3 p -73.99 153.64 39.64 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.964 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.418 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 56.9 t0 -82.45 -3.3 55.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.058 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 47' ' ' LEU . 9.3 mp 56.38 23.31 7.2 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.42 -37.01 9.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.45 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -123.14 150.79 42.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.21 141.9 35.9 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.305 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -119.63 125.09 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.598 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.26 134.58 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.285 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -108.8 135.8 49.42 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.57 147.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.255 0.55 . . . . 0.0 111.464 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 t -146.32 152.04 38.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.34 151.32 24.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.209 0.528 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.58 -25.55 68.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.833 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.644 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 9.5 m120 -79.91 5.26 14.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.9 p30 -64.5 -15.4 60.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 15.2 ptpt -70.03 -33.88 72.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -90.22 116.67 28.38 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.82 -33.4 71.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.385 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.5 -39.12 91.5 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.448 0.642 . . . . 0.0 109.619 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.93 87.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.98 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.72 -38.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -66.76 -47.03 73.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.044 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.58 77.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.473 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.53 -50.72 24.47 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.572 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.7 tt -59.67 -36.71 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.768 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -68.14 -37.51 81.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.24 92.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.241 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 23' ' ' LEU . 56.6 tp -68.35 -36.43 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.882 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -69.44 -45.81 68.25 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.3 -36.92 71.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.31 58.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.286 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 m -56.5 -50.05 72.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.69 93.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.252 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.22 -42.99 87.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.727 0.298 . . . . 0.0 111.506 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.42 -40.8 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.352 0.596 . . . . 0.0 110.783 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -64.27 -45.35 88.42 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.259 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -69.45 -36.84 76.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.632 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.01 -37.54 81.54 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.66 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.32 -50.49 53.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.578 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.41 -43.87 96.14 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.596 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -70.83 -42.22 70.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.8 98.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.25 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtm -89.5 -15.82 32.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.831 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' GLY . 96.8 mtt180 53.42 36.65 23.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -94.74 139.1 31.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.04 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -82.69 -44.7 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.531 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 pt -75.79 40.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.917 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.0 p -72.74 114.59 31.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 72.8 Cg_endo -79.91 157.64 24.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.643 1.562 . . . . 0.0 112.256 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.97 138.07 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -94.97 127.9 41.37 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.11 0.481 . . . . 0.0 110.753 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -115.72 120.85 40.7 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.86 132.05 44.5 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 0.0 111.727 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -119.14 138.86 52.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -102.43 115.87 31.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo . . . . . 0 N--CA 1.496 1.622 0 CA-C-O 120.848 0.27 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -35.9 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -59.79 -39.62 85.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.86 -40.8 83.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.08 94.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.024 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -60.9 -39.6 89.92 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.993 0.425 . . . . 0.0 110.328 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.62 -37.33 83.57 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.1 -40.9 67.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.824 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.1 -42.43 80.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.455 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -63.02 -47.56 82.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.925 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -61.99 -34.57 76.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.579 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.62 -40.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.795 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 -37.35 87.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.42 -52.22 62.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.654 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.94 -34.63 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.43 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.7 mt -64.39 -33.66 76.38 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.061 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.584 ' NE2' ' SD ' ' A' ' 35' ' ' MET . 94.8 mt-30 -82.76 -27.71 30.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 0.0 111.346 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -87.65 -46.19 9.74 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.48 -12.55 60.83 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.508 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.24 132.11 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.21 109.98 17.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 8.8 t0 -65.32 -36.63 15.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.398 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 31.9 Cg_exo -58.82 -38.55 88.01 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.497 1.465 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -61.89 -38.58 88.85 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.216 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.5 mt -87.63 -19.77 27.28 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.68 5.42 89.98 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.3 ttm -163.9 151.91 12.91 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.584 ' SD ' ' NE2' ' A' ' 24' ' ' GLN . 58.7 ttp -83.24 141.49 31.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.09 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -81.48 153.86 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 111.01 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.5 m -122.92 143.84 49.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.11 118.96 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.001 0.429 . . . . 0.0 110.589 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 m -66.51 -34.33 77.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.278 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.65 153.94 6.99 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 52' ' ' VAL . 29.3 t -126.59 135.78 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.774 0.321 . . . . 0.0 111.081 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.74 137.96 52.99 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.3 mtt -112.57 142.34 45.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.413 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 p -76.91 152.43 35.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.182 0.515 . . . . 0.0 110.388 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -64.08 -32.86 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.677 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.47 -3.25 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.404 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.42 14.36 5.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.82 62.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.84 164.28 35.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.514 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.12 35.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.486 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -104.11 127.57 51.7 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 41' ' ' VAL . 72.3 t -117.6 133.11 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.42 134.92 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -129.82 145.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 120.997 0.427 . . . . 0.0 110.537 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.0 m -139.9 137.44 34.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.057 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.35 149.37 29.25 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.892 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.66 -15.34 63.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.531 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -81.12 -2.31 47.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.07 -15.3 62.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.426 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.88 -36.05 77.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.76 115.74 28.08 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -34.0 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.517 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.65 -38.69 91.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.376 0.607 . . . . 0.0 109.49 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.54 83.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.878 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 69' ' ' ILE . 79.2 t -67.18 -41.05 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.84 -42.17 86.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.57 -46.12 64.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.65 -50.59 41.64 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.3 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.2 tt -59.48 -34.5 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -66.73 -41.18 88.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.81 78.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.802 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -69.48 -36.57 76.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.08 -45.01 71.37 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.212 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.51 -36.93 74.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.01 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.19 -7.05 56.61 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.141 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.8 t -55.57 -50.04 71.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.3 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -38.27 91.19 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.221 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -65.87 -43.58 87.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.593 0.235 . . . . 0.0 111.545 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.78 -39.72 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.56 0.695 . . . . 0.0 110.31 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -63.51 -46.26 86.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.272 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.1 t -70.22 -37.02 74.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.646 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.44 -37.45 86.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.345 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -68.45 -49.88 56.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -63.1 -43.88 98.07 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.349 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.67 -39.53 73.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 0.0 111.807 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.66 94.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.571 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.3 mtm -92.44 -13.55 29.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.485 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 30.9 mmt180 57.34 42.92 24.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.767 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.79 141.2 29.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.824 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -92.93 -16.86 24.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 pt -96.7 43.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.3 t -72.8 114.57 31.67 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 156.19 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.459 1.439 . . . . 0.0 111.433 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.47 125.99 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.3 mt -94.18 131.84 39.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.411 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -119.78 128.24 53.54 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.033 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.43 131.23 53.12 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 111.345 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.404 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.8 t80 -119.49 142.3 48.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.512 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 44.8 p90 -105.45 133.79 49.63 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.958 0.408 . . . . 0.0 110.292 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 120.868 0.278 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -59.47 -31.46 69.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -59.22 -38.8 80.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.398 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.62 -40.39 79.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.14 93.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.221 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -64.84 -40.07 94.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.6 -37.85 85.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.24 -42.87 68.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.81 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.71 -41.79 82.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -64.06 -50.23 69.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -63.29 -34.77 78.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.727 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.26 -42.19 78.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.132 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.94 85.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 ' HE ' ' A' ' 25' ' ' ARG . 42.9 tp -62.64 -52.92 61.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.53 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.33 -35.77 74.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.054 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.6 tt -63.13 -37.25 86.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.284 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -74.38 -41.15 61.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 111.038 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HE ' HD11 ' A' ' 21' ' ' LEU . 89.3 mtt-85 -75.19 -42.5 55.59 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -73.08 -16.23 61.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.748 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 23' ' ' LEU . 12.6 tt -107.19 134.01 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -86.15 108.78 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -66.68 -38.61 19.67 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 35.9 Cg_exo -58.02 -33.69 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.479 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -59.38 -37.87 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.579 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.5 mt -82.36 -20.4 37.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.137 0.494 . . . . 0.0 109.692 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.62 3.85 90.35 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.399 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 94.3 mmm -147.85 171.17 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.897 0.38 . . . . 0.0 109.995 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.1 mtt -94.99 157.15 16.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.7 t -125.05 150.24 46.98 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -129.45 148.81 51.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.844 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 t -94.0 123.91 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.8 p -73.27 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.92 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.4 157.37 8.13 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.37 151.97 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.374 . . . . 0.0 110.771 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -135.96 142.21 44.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.9 mtt -96.95 139.02 33.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.257 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.5 p -73.88 160.73 31.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.269 0.557 . . . . 0.0 110.782 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 45' ' ' ARG . 1.1 mpt_? -59.59 -32.35 70.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.694 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.2 m-20 -83.06 -4.34 58.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.098 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.8 mt 60.08 5.6 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -95.94 -22.94 17.1 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.972 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -124.13 143.96 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.65 141.94 49.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.09 120.15 37.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.74 133.68 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.251 0.548 . . . . 0.0 109.798 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.77 136.19 50.2 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.298 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.99 147.09 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.04 0.448 . . . . 0.0 111.141 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -140.29 151.33 45.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.273 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.65 160.77 42.48 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.182 0.515 . . . . 0.0 111.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.0 mm? -67.34 -18.91 65.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.643 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -80.96 1.96 28.86 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.1 p30 -64.33 -15.08 59.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 60.9 tttm -69.09 -39.97 78.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.334 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -93.43 115.96 28.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.449 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.99 -35.95 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.29 -39.17 93.38 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.1 83.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.73 -39.14 83.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.16 -45.54 91.36 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.95 -36.38 77.86 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.3 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.44 52.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.737 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.7 -39.98 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.299 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.52 -36.96 83.98 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.907 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.9 77.53 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.53 -36.45 73.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.207 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.57 -45.64 68.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.155 0.502 . . . . 0.0 110.475 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.24 -37.01 74.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.244 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.48 -12.83 60.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -49.16 77.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.56 86.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.245 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -66.61 -44.57 81.73 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.535 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.29 -40.81 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.556 0.693 . . . . 0.0 110.559 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.523 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 62.3 ttt180 -63.88 -46.6 84.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.551 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 t -68.7 -37.29 79.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.646 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 27.6 mt -65.58 -35.98 82.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.493 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.3 -48.44 64.93 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.831 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.92 -41.2 73.04 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -70.72 -43.76 68.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.391 -0.904 . . . . 0.0 112.173 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' LEU . . . -63.21 -43.37 98.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.7 mtt -85.42 -15.42 43.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 81.4 mtm180 59.95 26.1 15.33 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.531 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.37 150.31 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.382 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' A' ' 92' ' ' VAL . 70.5 mtp85 -100.87 -9.58 21.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.248 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 tt -59.07 -2.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 92' ' ' VAL . 27.3 m -70.36 116.09 41.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 172.5 14.45 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.841 1.694 . . . . 0.0 111.942 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.523 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 77.2 mm-40 -59.85 134.53 57.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.9 mt -100.65 128.32 46.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.957 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -113.26 127.32 56.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.52 129.06 55.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.195 0.522 . . . . 0.0 112.097 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -118.53 137.32 53.29 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 46.1 p90 -110.27 132.78 53.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.421 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.87 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.493 1.489 0 CA-C-O 120.708 0.212 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HB2' ' HE ' ' A' ' 10' ' ' ARG . 99.2 mm-40 -55.37 -31.6 61.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.671 ' HE ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -59.93 -39.69 86.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.213 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.73 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.299 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.96 81.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.107 0.479 . . . . 0.0 110.338 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -70.78 -46.81 62.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.652 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.38 -36.87 85.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.054 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.5 mtt -71.93 -40.89 68.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.429 HE22 HG11 ' A' ' 38' ' ' VAL . 37.7 tp60 -54.86 -45.87 74.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.22 -45.8 86.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.26 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 85.2 tt0 -61.65 -33.89 74.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.2 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.97 -42.6 77.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.29 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -36.62 84.78 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.67 -52.94 54.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.076 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.0 mt -70.1 -35.03 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.4 tp -60.65 -41.74 95.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.779 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -82.58 -41.29 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.313 0.578 . . . . 0.0 111.286 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -70.3 -40.8 74.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.57 -16.71 61.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.333 0.587 . . . . 0.0 110.195 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 23' ' ' LEU . 17.8 tt -116.05 149.48 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.326 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -67.3 122.85 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 110.059 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.07 -61.87 4.33 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.956 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.17 -27.63 57.21 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.727 1.618 . . . . 0.0 112.814 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -59.5 -38.04 79.86 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.215 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 70.4 mt -103.79 -2.18 26.76 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.0 5.86 72.79 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.4 ttt 63.03 8.44 3.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.2 mmm -81.35 18.4 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.1 m -76.03 128.05 34.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.319 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -132.7 143.06 49.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.967 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.429 HG11 HE22 ' A' ' 16' ' ' GLN . 40.5 t -98.72 120.35 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.944 0.402 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 m -63.95 -36.14 82.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.256 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.72 155.84 7.45 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 m -127.39 152.27 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.957 0.408 . . . . 0.0 110.819 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -132.79 141.9 48.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.226 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.3 mtt -113.79 142.27 46.28 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.5 m -73.51 151.92 40.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -63.71 -29.58 70.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.337 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -83.6 -3.84 58.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 mt 60.38 24.54 14.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 -45.98 5.82 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.307 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -119.65 146.75 45.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.15 0.5 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.45 142.23 41.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.159 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.41 124.21 43.96 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.33 134.52 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.038 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -113.91 138.27 50.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.26 148.17 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.28 0.562 . . . . 0.0 111.187 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 m -141.67 132.8 26.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -135.93 146.44 47.31 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 178.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 57' ' ' LEU . 7.0 mp -64.29 -23.03 67.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 83.8 m-20 -81.13 -7.0 59.47 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.33 -16.03 51.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -66.65 -33.09 74.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -89.91 117.96 29.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.29 -39.75 94.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.482 0.658 . . . . 0.0 109.432 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.76 -36.01 81.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 69' ' ' ILE . 73.3 t -64.47 -39.7 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.5 -41.41 88.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.05 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -47.14 62.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.84 -50.46 41.44 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.274 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.7 tt -59.39 -34.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.493 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.79 -41.21 87.98 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.381 0.61 . . . . 0.0 109.522 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 -40.88 75.09 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.041 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -70.31 -37.67 74.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -68.64 -45.11 72.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.278 0.561 . . . . 0.0 110.163 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -69.79 -37.18 76.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.908 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -9.2 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.0 p -57.42 -50.67 72.26 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.89 93.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.52 -41.53 84.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.62 -39.72 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.645 0.736 . . . . 0.0 109.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -63.31 -46.01 88.68 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.6 t -68.37 -36.64 79.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.434 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.57 -38.75 87.71 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.094 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 mt -68.99 -50.46 48.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.709 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.81 -44.13 97.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.54 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -71.3 -42.2 68.95 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.81 97.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.96 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 63.4 mtm -87.29 -19.49 28.19 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 84' ' ' GLY . 50.9 ttm-85 61.61 41.84 11.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.479 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.5 mm? -90.9 141.16 29.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.994 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -88.22 -26.34 22.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.532 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -89.75 45.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.569 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 114.2 28.65 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.133 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 78.6 Cg_endo -80.61 163.31 21.47 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.613 1.542 . . . . 0.0 111.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -72.39 130.75 41.45 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 1.6 mm? -93.17 128.18 39.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.155 0.502 . . . . 0.0 110.894 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 m -114.98 121.28 42.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -101.02 129.71 46.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.086 0.47 . . . . 0.0 111.818 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -119.77 138.95 53.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.393 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -102.0 132.3 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.579 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 CA-C-O 120.809 0.254 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.0 mp0 -58.08 -35.16 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.384 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.25 -39.7 83.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.397 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.24 -40.84 84.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.54 86.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -65.88 -43.02 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.17 -37.37 84.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt -73.55 -36.04 65.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.9 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.03 -47.73 80.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -66.46 -37.34 84.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.984 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.4 tt0 -65.78 -40.39 91.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.28 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.35 -42.27 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 -38.12 89.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.282 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.07 -52.26 63.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.129 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.42 -33.48 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 60.7 tp -57.67 -36.33 71.77 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.375 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -84.4 -36.02 22.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -76.98 -47.74 19.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -75.45 -3.89 36.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.113 0.482 . . . . 0.0 110.346 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 47.5 mm -114.29 126.68 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.946 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -82.46 102.86 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 1.3 m-20 -78.34 -36.76 1.33 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.496 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 84.1 Cg_exo -48.47 -38.19 34.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.635 1.557 . . . . 0.0 113.323 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.41 -37.6 87.9 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.771 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.45 -20.18 34.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 109.795 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.55 84.84 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.2 mtt -147.89 156.25 42.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 110.313 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.2 mtm -97.69 148.04 23.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 p -87.63 156.05 19.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 p -124.13 160.93 26.71 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' GLY . 47.7 t -106.26 128.71 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.829 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t -88.54 -14.91 36.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' H ' HG12 ' A' ' 38' ' ' VAL . . . 157.7 148.54 5.16 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG13 HG12 ' A' ' 52' ' ' VAL . 22.0 t -124.58 128.84 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.43 139.98 53.38 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.979 0.418 . . . . 0.0 110.778 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.4 mtt -117.1 142.59 46.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.66 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.2 m -73.34 152.16 41.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -59.48 -31.67 69.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.528 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.4 -3.82 57.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.287 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.63 29.21 18.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.22 -49.17 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.031 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -117.17 144.48 44.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.924 0.392 . . . . 0.0 111.021 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.99 141.08 50.22 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.615 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -122.59 117.84 26.79 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.382 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 HG13 ' A' ' 41' ' ' VAL . 1.7 m -120.9 135.41 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 120.708 0.289 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.0 135.48 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 m -133.27 149.83 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.122 0.487 . . . . 0.0 111.379 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -131.35 156.43 45.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.948 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -157.5 153.57 27.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 111.814 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.65 -12.27 59.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -80.08 3.65 19.69 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -66.16 -15.6 63.27 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.87 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -67.87 -39.97 83.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.431 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -92.45 115.14 27.83 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.173 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.41 -34.54 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.57 -38.72 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.5 80.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.54 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.25 -46.15 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.601 . . . . 0.0 109.899 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -67.98 -47.77 67.65 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.86 -45.36 64.6 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.555 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -51.94 53.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.899 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.14 -34.84 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.021 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.35 -40.75 96.47 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.94 87.03 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.529 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.8 -36.78 81.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.358 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -68.15 -45.08 74.53 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.343 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.42 -36.99 74.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.254 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.06 -8.29 57.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.053 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -55.18 -48.64 73.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.426 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.37 -38.26 90.03 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.084 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.56 -42.17 92.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.604 0.24 . . . . 0.0 111.308 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.65 -42.62 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 63.3 ttt180 -63.12 -46.71 86.02 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.346 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 t -70.28 -36.94 74.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.375 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.63 -35.56 80.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.435 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -68.4 -50.4 53.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.97 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.5 -43.56 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.236 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.72 -40.84 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.179 0.514 . . . . 0.0 111.713 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.76 99.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.48 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 58.3 mtm -93.94 -8.89 38.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 91.9 mtt-85 54.86 36.03 25.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.62 141.13 32.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -97.73 -10.76 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.29 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -94.53 30.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -73.23 118.46 68.82 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 161.93 30.58 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.505 1.47 . . . . 0.0 111.834 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 78.1 mm-40 -60.08 136.17 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.53 130.85 47.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 0.0 111.059 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.3 m -120.79 128.39 52.84 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.87 126.25 54.9 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.994 0.426 . . . . 0.0 111.644 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -119.96 138.67 53.33 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -110.22 129.78 55.66 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.282 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.246 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 N--CA 1.495 1.566 0 CA-C-O 120.848 0.27 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -58.77 -33.23 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.09 -37.86 78.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.652 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -38.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 0.0 110.274 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.8 82.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.455 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -71.62 -46.38 59.29 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.952 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -62.64 -36.55 83.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.9 ttm -70.51 -40.57 73.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.09 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.03 -41.96 75.79 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -62.64 -45.04 94.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.018 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.61 -33.18 75.04 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.469 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.23 -42.41 78.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.413 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.79 85.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.098 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.92 -52.49 64.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.602 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.2 mt -68.67 -33.9 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.128 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.3 tp -56.17 -43.29 78.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.1 mt-30 -83.1 -40.05 20.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 111.809 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -70.05 -39.96 75.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -72.56 -14.99 61.76 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.076 0.465 . . . . 0.0 110.377 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -119.23 143.34 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -83.45 115.11 21.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -69.99 -38.19 8.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.58 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.42 -37.28 81.72 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.816 1.677 . . . . 0.0 112.242 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -59.94 -37.8 80.57 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.362 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -78.24 -20.93 50.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.38 5.34 87.18 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm -171.82 154.69 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.655 0.264 . . . . 0.0 110.475 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.9 mtp -83.24 138.11 33.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -88.42 158.07 18.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -122.87 143.7 49.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.543 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.52 122.76 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -65.39 -36.09 82.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.08 159.17 9.13 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.18 148.83 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.896 0.379 . . . . 0.0 110.925 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -122.91 142.1 51.17 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.1 mmm -109.42 142.29 40.6 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.86 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -73.11 155.01 40.14 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 110.372 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -58.31 -34.25 70.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.499 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -83.69 -4.57 58.72 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 110.807 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.61 32.99 21.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.84 -46.59 3.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.609 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.89 140.85 48.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.426 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.23 141.62 51.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.907 0.384 . . . . 0.0 110.801 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.29 130.59 55.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.169 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.66 134.34 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.002 0.429 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.05 133.87 53.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -131.14 147.17 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.345 0.593 . . . . 0.0 112.062 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -146.29 150.52 35.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.371 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.91 155.65 29.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.844 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.8 mt -72.85 -14.77 61.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.744 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -81.07 3.43 23.3 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 50.4 p30 -66.37 -15.85 63.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.115 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -68.62 -36.4 78.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.355 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -91.03 117.09 29.31 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.14 -34.94 74.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.35 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.07 -38.32 90.41 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.44 0.638 . . . . 0.0 109.454 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.45 83.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.842 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.69 -41.93 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 109.584 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.68 -42.7 86.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.584 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.7 -44.77 66.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.012 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.98 -51.11 48.1 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.185 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 -37.15 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.002 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -65.39 -40.03 92.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.57 -41.76 83.65 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.554 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.1 -36.43 81.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.397 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.95 -45.95 69.42 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.148 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -71.29 -37.11 71.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.261 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.2 -6.31 54.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.505 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.5 p -58.9 -52.52 65.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.193 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.64 92.88 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.643 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -66.79 -44.38 81.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -68.11 -38.21 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.116 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -64.21 -47.16 80.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.558 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -71.09 -37.85 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.814 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.66 -36.99 85.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.407 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 ' SD ' ' A' ' 87' ' ' MET . 6.2 tt -69.14 -48.52 62.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.806 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.67 -42.32 99.74 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.11 -40.38 74.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.051 0.453 . . . . 0.0 111.598 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.74 96.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.157 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.432 ' SD ' HD21 ' A' ' 83' ' ' LEU . 62.1 mtt -88.22 -17.35 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.482 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 84' ' ' GLY . 72.7 mtm180 54.18 36.99 26.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.09 139.62 30.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.012 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 92' ' ' VAL . 89.0 mtt180 -92.36 -38.53 11.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.91 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.9 pt -73.55 26.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 90' ' ' ARG . 60.0 t -73.22 114.13 28.42 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 119.289 -0.386 . . . . 0.0 109.975 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.4 159.63 25.89 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.54 1.493 . . . . 0.0 111.632 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.45 137.38 58.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.56 130.01 46.57 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.223 0.535 . . . . 0.0 111.001 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.4 m -123.78 135.38 53.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.85 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -117.08 139.79 50.29 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.452 0.644 . . . . 0.0 112.134 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -121.66 153.94 37.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.728 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -109.15 134.07 52.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.649 -179.324 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo . . . . . 0 N--CA 1.495 1.598 0 CA-C-O 120.925 0.302 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -60.08 -31.48 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -59.37 -37.9 79.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.099 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.92 -40.39 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.66 88.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.55 -39.94 94.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.484 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.57 -37.2 82.98 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.18 -42.76 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.525 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -55.75 -44.68 77.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.452 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -64.32 -46.8 81.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.542 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.71 -33.62 74.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.917 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.14 -42.44 79.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.61 84.87 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.106 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HH11 ' A' ' 25' ' ' ARG . 43.0 tp -61.15 -53.4 57.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.037 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.78 -33.52 56.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.455 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.52 -44.37 76.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.855 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.8 mt-30 -82.1 -40.91 21.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 111.686 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.541 HH11 HD11 ' A' ' 21' ' ' LEU . 24.7 ttm180 -69.65 -37.58 76.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.126 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 45.5 tp10 -71.99 -17.09 62.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.205 0.526 . . . . 0.0 109.974 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.7 pt -118.54 150.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.796 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -81.93 115.14 20.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -70.8 -37.85 6.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -179.08 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 44.2 Cg_exo -56.87 -38.15 96.53 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.839 1.693 . . . . 0.0 112.499 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -60.1 -37.54 80.3 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.14 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 64.9 mt -92.36 -8.02 46.16 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.558 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.79 28.61 50.39 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mtm 56.17 -126.21 2.01 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.464 -0.199 . . . . 0.0 110.464 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.409 ' SD ' HD12 ' A' ' 57' ' ' LEU . 71.8 mtm 45.24 48.2 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.618 0.247 . . . . 0.0 111.037 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.5 m -120.24 130.45 54.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.855 0.359 . . . . 0.0 110.386 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -132.94 145.15 50.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.6 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -92.78 118.64 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 55' ' ' THR . 44.2 m -65.75 -35.4 80.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.587 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.42 152.31 6.23 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 52' ' ' VAL . 43.3 t -125.47 134.41 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.922 0.392 . . . . 0.0 110.95 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.52 141.43 49.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.039 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.3 mmm -111.45 141.85 44.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.521 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.7 m -73.45 151.76 40.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.585 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -60.67 -30.46 69.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.322 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 57.7 t0 -82.62 -3.86 56.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 9.4 mp 56.57 29.75 16.09 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.31 -49.02 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.737 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -116.92 143.56 45.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.74 141.59 51.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.434 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -113.08 127.77 56.3 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 41' ' ' VAL . 55.2 t -118.21 132.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.309 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -119.77 127.38 52.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 150.71 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.246 0.546 . . . . 0.0 111.798 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.501 HG23 ' OG ' ' A' ' 39' ' ' SER . 22.2 p -131.01 149.87 52.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.895 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' A' ' 59' ' ' ASP . 6.3 p90 -156.2 155.34 32.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.358 0.599 . . . . 0.0 111.606 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.409 HD12 ' SD ' ' A' ' 35' ' ' MET . 64.7 mt -77.3 -13.58 59.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.602 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 71.3 m-20 -80.91 0.18 36.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 7.3 m-20 -61.93 -19.53 62.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -68.22 -34.94 77.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.103 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.78 115.74 27.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.048 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 51.0 mp0 -59.69 -34.27 72.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.35 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.97 -37.34 87.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.376 0.608 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.17 83.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.554 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 69' ' ' ILE . 78.1 t -69.72 -47.04 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.16 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.98 -46.33 71.64 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.357 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.06 -46.34 65.18 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.213 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.44 -51.41 48.86 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.455 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.5 tp -60.12 -34.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.473 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -67.1 -40.23 86.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.251 0.548 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.19 -41.86 76.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.843 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.3 -36.65 74.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.136 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -68.78 -45.38 71.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.243 0.544 . . . . 0.0 110.316 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -70.6 -37.08 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.35 -8.63 57.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.544 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.7 m -56.12 -50.46 71.02 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.036 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.69 94.31 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CE1' ' OE2' ' A' ' 26' ' ' GLU . 35.4 t80 -63.4 -43.15 98.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.64 -39.44 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.421 0.629 . . . . 0.0 110.359 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 74.2 ttt-85 -60.95 -46.16 91.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.937 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -70.21 -37.75 75.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.533 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.63 -37.84 76.97 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.82 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD21 ' CE ' ' A' ' 87' ' ' MET . 8.4 tt -68.78 -46.43 68.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.078 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -60.32 -42.48 98.83 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.99 -36.48 75.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.465 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.83 95.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.508 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 83' ' ' LEU . 66.0 mtm -101.52 -3.91 27.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 53.41 43.77 30.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.505 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.1 mt -100.55 141.07 33.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.142 0.496 . . . . 0.0 111.701 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -97.99 -10.82 23.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.95 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 91' ' ' ILE . 22.3 pt -98.56 21.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -72.7 116.46 50.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.05 160.63 26.84 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.713 1.608 . . . . 0.0 112.068 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' A' ' 80' ' ' ARG . 78.3 mm-40 -60.42 137.45 58.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.5 mt -100.37 130.15 46.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.961 0.41 . . . . 0.0 110.676 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.7 m -119.95 127.48 52.7 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -108.0 126.41 52.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.144 0.497 . . . . 0.0 111.308 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -120.93 138.26 54.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.333 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 99' ' ' TYR . 37.7 p90 -107.74 113.85 27.39 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.866 0.365 . . . . 0.0 110.318 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.9 t0 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.935 179.654 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.498 1.751 0 CA-C-O 120.793 0.247 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.58 -37.37 75.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -59.5 -39.93 85.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.53 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.56 -40.23 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.92 91.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.183 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -63.86 -39.9 95.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.368 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.5 -37.64 84.42 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.2 -43.77 66.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.925 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.31 -42.44 77.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.337 0.589 . . . . 0.0 109.842 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.92 -49.82 71.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.228 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.66 -35.34 80.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.306 0.574 . . . . 0.0 110.747 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.155 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.284 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.57 -53.36 58.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.345 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.3 mt -70.23 -34.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.442 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.8 tp -55.95 -45.53 78.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.785 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 12.5 pt20 -84.49 -42.03 15.97 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.973 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 24' ' ' GLN . 50.7 mtp180 -70.45 -33.76 71.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -72.25 -15.75 61.92 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.452 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.8 pt -119.4 149.68 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.669 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.36 117.26 29.85 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -74.12 -38.12 3.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.496 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.2 Cg_exo -55.61 -31.61 79.94 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.108 1.872 . . . . 0.0 112.554 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.54 -37.72 79.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.684 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 mt -81.51 -20.06 40.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.979 0.419 . . . . 0.0 109.918 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.35 5.52 89.51 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.3 mtt -143.95 168.78 19.17 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.2 mtp -113.02 158.08 20.74 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 55' ' ' THR . 13.2 t -128.74 153.71 47.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.529 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.6 m -127.57 148.04 50.35 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.84 118.59 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.4 p -67.8 -30.51 69.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.14 157.41 8.04 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.57 152.82 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -130.36 141.05 50.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -103.75 141.66 35.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.936 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 67.5 m -73.06 154.69 40.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.639 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -58.21 -32.47 68.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.572 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -82.93 -3.99 57.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.449 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 58.87 26.58 15.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -104.86 -47.91 3.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.849 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.418 ' O ' ' OG ' ' A' ' 44' ' ' SER . 87.5 m-85 -114.69 143.7 44.62 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.885 0.374 . . . . 0.0 110.541 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.22 141.39 51.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -108.41 128.57 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.991 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.33 133.39 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.6 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.86 132.26 55.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 22.0 t -131.13 148.03 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.345 0.593 . . . . 0.0 111.874 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 36' ' ' THR . 37.5 m -119.2 129.34 54.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.838 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CZ ' HG11 ' A' ' 54' ' ' VAL . 84.8 m-85 -119.67 142.01 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.897 0.379 . . . . 0.0 111.778 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.67 -13.54 57.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 82.1 m-20 -81.34 -0.41 41.04 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.9 p30 -66.03 -15.01 62.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.96 177.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 61.2 tttp -67.37 -39.86 85.7 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.544 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -109.28 117.7 34.78 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -58.34 -35.86 72.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.85 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.36 -38.0 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.685 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.0 -45.56 73.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.64 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 69' ' ' ILE . 7.4 p -73.35 -33.41 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.37 . . . . 0.0 111.149 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.08 -40.52 94.75 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.39 -46.1 64.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.35 -50.23 39.94 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.533 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.8 tt -59.26 -34.67 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.247 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.47 -41.52 88.88 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.86 76.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.909 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.04 -36.61 75.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.637 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.15 -44.34 76.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.218 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.85 -36.57 80.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.281 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.12 -9.0 58.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.256 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.4 m -55.82 -45.99 78.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.159 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.75 -38.29 91.67 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -64.87 -42.91 94.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.019 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -58.22 -39.62 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.592 0.71 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 94' ' ' GLU . 75.3 ttt-85 -61.42 -44.76 96.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.442 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 t -70.12 -36.75 75.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.617 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -69.37 -41.43 76.55 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.58 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 tt -69.05 -48.48 62.73 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.633 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -65.68 -44.02 93.25 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.553 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.72 -37.89 73.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 112.024 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' LEU . . . -60.94 -42.73 98.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 74.7 mtm -99.83 -5.95 27.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.836 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' GLY . 66.4 mtt85 49.52 40.88 20.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.43 138.7 31.37 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.626 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -92.49 -38.4 11.97 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.223 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 pt -78.46 19.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.519 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.9 p -72.67 114.42 30.05 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.98 157.88 30.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.501 1.468 . . . . 0.0 112.099 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 38.0 mp0 -60.96 139.87 57.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.99 132.81 46.22 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.014 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.2 m -119.0 128.03 54.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.91 127.32 51.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.282 0.563 . . . . 0.0 111.426 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 52.0 t80 -126.91 147.73 50.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 51.1 p90 -101.28 129.13 47.19 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.767 0.318 . . . . 0.0 110.223 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.791 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' O ' HG12 ' A' ' 11' ' ' VAL . 44.0 Cg_endo . . . . . 0 N--CA 1.498 1.754 0 CA-C-O 120.565 0.152 . . . . 0.0 112.101 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -51.04 -23.74 3.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -59.02 -37.24 76.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.298 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 8' ' ' PRO . 5.1 p -59.57 -40.51 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.042 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.54 87.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.592 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.85 -43.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.597 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.32 -39.32 92.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mmt -66.98 -42.17 85.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.442 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.88 -41.92 88.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.783 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -63.48 -47.36 82.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.095 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -62.96 -35.33 79.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.07 -42.88 79.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.58 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.41 84.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.471 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.7 tp -60.76 -53.38 58.11 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.26 -34.48 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.514 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.11 -45.87 79.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.905 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.3 mt-30 -83.23 -39.33 21.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.114 0.483 . . . . 0.0 112.068 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -69.79 -38.76 76.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.05 -16.1 62.03 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.907 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 24' ' ' GLN . 9.6 pt -116.58 149.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.304 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -86.61 125.8 34.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.51 -63.0 1.05 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.612 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -56.94 -23.82 53.53 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -58.94 -37.1 75.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.199 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -77.62 -20.55 53.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.43 5.09 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 62.4 mtt -146.73 167.8 22.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.812 0.339 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -104.9 152.49 22.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.625 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -130.68 155.29 46.85 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.798 0.332 . . . . 0.0 110.752 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -137.4 159.03 43.1 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.423 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 38' ' ' VAL . 11.7 p -98.12 123.11 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.7 p -69.93 -28.7 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.26 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.71 153.89 6.48 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.2 148.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.744 0.307 . . . . 0.0 110.454 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -129.26 139.69 51.72 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.5 mmt -105.81 142.41 35.58 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.8 t -73.76 151.94 40.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.136 0.493 . . . . 0.0 110.343 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.24 -29.99 66.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.623 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.7 -3.36 57.71 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.546 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? 56.51 29.9 16.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.79 -48.41 3.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.789 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -116.78 141.57 48.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.46 51.86 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.452 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.69 127.7 54.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.34 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.48 133.27 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.623 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.08 133.66 55.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.27 149.79 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.442 0.639 . . . . 0.0 111.84 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -129.67 135.98 49.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.49 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 65' ' ' VAL . 15.7 p90 -146.02 154.77 42.24 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.546 0.689 . . . . 0.0 112.22 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.3 mm? -80.08 -11.26 59.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.592 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.488 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 88.1 m-20 -79.49 -0.25 32.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.0 p30 -68.09 -14.84 63.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 35.1 ttpt -69.27 -38.51 78.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.541 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.59 119.03 38.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.018 0.437 . . . . 0.0 110.114 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 50.7 mp0 -59.48 -32.97 70.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.22 -39.02 75.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.254 0.549 . . . . 0.0 110.794 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.05 74.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.748 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 69' ' ' ILE . 14.5 p -69.93 -33.58 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.448 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.75 -44.51 85.7 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.22 -44.77 67.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.39 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.8 -50.73 39.76 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.485 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.3 tt -59.46 -34.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.922 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -66.1 -42.19 89.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -40.72 87.25 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.649 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.92 -36.26 79.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -68.92 -45.63 70.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.083 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.15 -37.08 72.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.95 -8.91 58.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.177 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -57.09 -50.09 73.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.122 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.38 90.78 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.33 -43.6 94.13 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.269 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -58.61 -41.57 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 109.744 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 94' ' ' GLU . 39.8 ttm180 -63.14 -46.76 85.7 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -70.64 -38.04 73.83 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.98 -38.58 79.41 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.002 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.94 -40.61 83.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.157 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.89 -34.54 71.52 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -67.53 -43.29 81.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.392 -0.904 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.19 85.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.594 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtt -85.68 -17.19 36.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.5 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 84' ' ' GLY . 73.9 mtp180 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.244 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 92' ' ' VAL . 86.3 mt -101.15 141.55 33.88 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.124 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -97.43 -14.95 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.559 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 91' ' ' ILE . 37.7 pt -86.69 21.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 89' ' ' LEU . 59.4 t -72.85 114.14 27.8 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.141 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 89.3 Cg_endo -77.66 161.59 30.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.298 1.332 . . . . 0.0 111.098 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 80' ' ' ARG . 79.0 mm-40 -64.62 136.49 57.04 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.249 -0.581 . . . . 0.0 109.521 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' PRO . 7.1 mp -98.94 129.87 45.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.062 0.458 . . . . 0.0 110.365 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -117.9 127.63 54.04 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.28 126.65 51.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.126 0.489 . . . . 0.0 111.157 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 48.1 t80 -126.17 146.14 50.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.475 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 47.9 p90 -99.8 129.02 45.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.855 0.36 . . . . 0.0 110.435 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 56.3 p-10 . . . . . 0 N--CA 1.474 0.772 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.378 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo . . . . . 0 N--CA 1.494 1.502 0 CA-C-O 120.878 0.282 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -60.01 -31.76 70.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.81 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -59.29 -38.18 79.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.152 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.77 -40.79 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.81 88.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.146 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.48 -40.88 96.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.607 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.44 -36.96 81.83 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.3 -39.09 65.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.268 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -49.11 76.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.548 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HG2' ' HZ3' ' A' ' 17' ' ' LYS . 1.5 ptpp? -67.18 -37.71 84.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.099 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.1 tt0 -68.76 -39.94 80.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.43 -42.78 97.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.36 86.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 HH11 ' A' ' 25' ' ' ARG . 27.9 tp -60.68 -52.92 63.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.25 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -69.14 -34.01 61.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.22 -42.31 85.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.577 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -82.43 -41.89 19.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.307 0.575 . . . . 0.0 111.337 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.523 HH11 HD11 ' A' ' 21' ' ' LEU . 24.6 ttm180 -70.23 -37.15 74.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.35 -177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.22 -15.28 61.94 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.181 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 27' ' ' ILE . 13.1 pt -113.89 150.42 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.18 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -78.5 130.52 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.028 0.442 . . . . 0.0 110.342 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.59 -62.0 3.31 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.962 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.74 -28.18 55.89 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.714 1.609 . . . . 0.0 112.725 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.31 -37.77 78.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.447 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 72.2 mt -99.02 -1.94 38.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.143 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.9 9.16 62.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm 58.97 60.79 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.571 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.423 ' SD ' HD23 ' A' ' 57' ' ' LEU . 62.2 mtt -150.6 72.8 1.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.555 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.4 p -126.04 140.92 52.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.6 m -139.71 142.78 36.85 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.208 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.2 p -95.76 117.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 m -68.21 -31.19 70.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.63 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.53 6.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 52' ' ' VAL . 17.1 t -125.41 133.0 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -131.73 141.25 49.48 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.6 mpt? -111.44 143.17 42.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.412 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.5 t -72.63 151.86 42.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.662 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -56.29 -35.01 67.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.383 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.07 -4.98 58.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.695 0.283 . . . . 0.0 110.757 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 91' ' ' ILE . 7.9 tp 60.01 34.45 21.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.61 -48.23 3.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.674 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -117.79 139.13 51.5 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.428 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.84 141.11 52.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.804 0.335 . . . . 0.0 110.226 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -119.58 118.79 31.94 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.96 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 41' ' ' VAL . 1.2 m -119.43 134.66 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.014 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -108.56 136.35 48.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.058 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.33 150.82 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.1 0.476 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -140.95 152.06 44.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.023 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -156.04 146.77 21.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.392 0.615 . . . . 0.0 111.646 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.423 HD23 ' SD ' ' A' ' 35' ' ' MET . 32.4 tp -66.05 -18.67 65.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.411 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 25.3 m120 -80.4 2.48 24.83 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.7 p30 -65.64 -15.12 62.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -70.22 -35.61 74.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.502 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -90.51 119.83 31.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.755 0.312 . . . . 0.0 110.368 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.6 -37.47 81.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.679 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -63.5 -38.92 92.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.483 0.658 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.08 82.33 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.96 -47.08 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.352 0.596 . . . . 0.0 109.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.52 -38.48 84.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.659 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.24 65.43 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.206 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.54 -52.71 15.02 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.045 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 99' ' ' TYR . 79.0 mt -59.91 -39.68 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.248 0.524 . . . . 0.0 112.064 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.37 -35.82 80.12 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.048 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.16 68.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.739 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.11 -36.99 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.765 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.25 -45.49 73.07 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.33 0.586 . . . . 0.0 110.261 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.95 -36.93 75.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.082 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.66 -7.24 59.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.655 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.5 m -55.55 -50.01 71.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.685 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.15 -35.62 85.02 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -64.93 -45.98 83.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.88 -39.54 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.512 0.673 . . . . 0.0 110.123 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -62.03 -45.07 95.2 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.526 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -71.01 -38.25 72.63 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 82' ' ' LEU . 1.1 tm? -69.28 -42.41 75.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.73 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.88 -39.72 83.66 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.763 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.77 -39.46 76.63 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -68.38 -38.02 80.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.189 -1.005 . . . . 0.0 111.347 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.9 99.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.558 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 69.0 mtm -98.34 -6.92 29.86 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 98.8 mtt180 49.59 38.27 14.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 109.316 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.1 tp -90.98 140.4 29.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.968 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -90.08 -38.59 13.45 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.731 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.412 HD12 ' CD2' ' A' ' 47' ' ' LEU . 25.8 pt -78.28 34.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.731 0.3 . . . . 0.0 111.744 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 89' ' ' LEU . 88.3 t -73.46 115.31 40.09 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.8 161.31 30.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.366 1.377 . . . . 0.0 111.884 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.27 138.36 58.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.24 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -122.23 131.23 53.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.397 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -108.54 130.33 55.29 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.048 0.451 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -119.43 141.23 49.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' HG23 ' A' ' 69' ' ' ILE . 2.9 m-85 -97.77 118.62 34.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 111.524 -179.014 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 11' ' ' VAL . 34.0 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.87 0.279 . . . . 0.0 111.818 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.74 -22.8 25.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.425 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -57.58 -37.23 72.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.215 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 8' ' ' PRO . 3.2 m -61.56 -38.82 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.612 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -63.05 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.99 -36.11 80.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.4 mtt -73.17 -38.99 66.0 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.987 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.4 -49.06 78.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.087 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -67.8 -40.77 83.85 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.071 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.98 -38.66 86.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.63 -44.06 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -37.04 86.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.3 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD11 HH11 ' A' ' 25' ' ' ARG . 31.8 tp -61.29 -53.32 58.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.043 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 83' ' ' LEU . 81.1 mt -69.71 -34.27 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.716 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.7 tp -57.99 -41.9 84.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -83.3 -38.16 22.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.209 0.528 . . . . 0.0 111.909 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.546 HH11 HD11 ' A' ' 21' ' ' LEU . 30.5 ttm180 -71.16 -43.87 66.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.1 -13.82 61.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.52 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -112.17 142.44 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -80.25 117.15 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 6.8 t70 -73.2 -35.6 2.83 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.8 Cg_exo -55.66 -29.82 72.46 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.966 1.778 . . . . 0.0 113.176 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -59.99 -36.64 77.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.742 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.36 -20.02 55.39 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.368 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.66 5.79 74.14 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.594 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 14.8 ptp -174.75 175.7 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.5 mtm -89.14 161.23 16.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.268 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -124.07 155.15 38.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.656 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.0 p -121.35 160.9 23.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.943 0.402 . . . . 0.0 110.96 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -108.43 123.75 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.828 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.436 ' CB ' ' OD2' ' A' ' 100' ' ' ASP . 23.2 t -68.31 -35.55 77.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.6 158.49 8.28 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.15 147.01 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 110.986 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -119.51 138.14 53.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.522 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.9 mmm -108.62 142.26 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 m -72.93 152.01 41.61 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -63.59 -30.5 71.61 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.409 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -83.68 -2.64 56.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.118 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.6 32.86 21.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -108.75 -47.66 3.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.174 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -117.28 139.02 51.34 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.0 0.428 . . . . 0.0 111.179 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.53 141.5 51.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -113.67 130.03 56.47 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.188 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.69 133.82 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.705 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.84 132.44 56.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.9 151.06 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.098 0.475 . . . . 0.0 111.857 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -144.19 149.86 37.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 59' ' ' ASP . 6.9 p90 -159.21 159.95 34.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.29 0.567 . . . . 0.0 111.577 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.95 -25.76 66.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.401 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.594 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 27.6 m120 -80.31 0.93 30.78 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.891 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 13.8 m-20 -63.43 -15.1 56.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -69.44 -36.7 76.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.049 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -91.09 113.9 26.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.19 -35.99 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.81 -38.1 89.85 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.42 0.629 . . . . 0.0 109.458 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.59 84.24 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 69' ' ' ILE . 69.9 t -67.51 -38.48 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -66.43 -40.75 89.7 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.03 66.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.72 -50.07 32.66 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.644 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.8 tp -58.67 -38.7 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.663 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.27 -36.18 79.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.58 80.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.719 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.35 -36.56 74.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.962 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -68.8 -45.36 71.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.138 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.9 -37.09 72.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.955 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.62 -7.8 57.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.067 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 t -57.85 -52.86 63.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.565 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.45 93.86 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.954 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.74 -44.56 85.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -68.86 -37.29 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.174 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.74 -46.45 88.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.666 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 t -67.62 -38.12 83.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.1 tp -68.93 -34.38 75.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.262 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 HD12 ' A' ' 22' ' ' ILE . 13.6 tp -66.83 -46.79 74.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.744 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -58.61 -40.97 95.36 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.851 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.58 -40.8 93.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.94 0.4 . . . . 0.0 111.212 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.77 99.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtt -82.21 -17.3 46.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' GLY . 83.1 mtp180 57.85 34.01 23.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.261 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.08 141.44 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.737 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -97.93 -10.23 24.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.453 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 91' ' ' ILE . 2.6 pp -106.96 34.21 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.4 p -73.27 124.77 90.89 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ALA . 88.8 Cg_endo -75.52 157.97 40.36 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.436 1.424 . . . . 0.0 112.304 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 39.3 mp0 -61.43 138.73 58.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.7 130.55 48.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.478 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 m -121.98 131.37 53.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.727 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.87 128.83 54.96 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.223 0.535 . . . . 0.0 111.015 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 41.5 t80 -129.64 152.28 49.32 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.7 p90 -104.81 132.43 51.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.658 0.266 . . . . 0.0 110.53 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' CB ' ' A' ' 39' ' ' SER . 56.3 p30 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' O ' HG12 ' A' ' 11' ' ' VAL . 57.8 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 CA-C-O 120.832 0.263 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -54.28 -24.03 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.468 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -58.29 -40.5 82.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.386 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 8' ' ' PRO . 4.4 p -59.41 -38.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.729 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' GLN . . . -62.13 -39.12 91.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -66.06 -42.66 89.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.15 -39.52 92.91 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 19' ' ' ILE . 58.5 mtt -74.06 -35.61 64.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.107 177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . 49.4 tt0 -57.33 -48.8 78.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.563 . . . . 0.0 110.617 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -68.7 -36.46 78.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.075 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.03 -41.42 86.59 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.659 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 83' ' ' LEU . 41.0 pt -69.56 -36.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.517 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.555 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.24 -52.93 51.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.759 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.54 -33.58 57.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.044 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.2 -40.08 84.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.577 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.84 -44.07 19.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.397 0.618 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -69.85 -35.12 74.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.849 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -72.04 -14.34 61.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.016 0.436 . . . . 0.0 109.988 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.85 149.86 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.083 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.79 107.61 19.48 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.53 -41.92 93.07 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.93 -178.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 34.3 Cg_exo -61.69 -33.96 84.89 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.185 1.923 . . . . 0.0 112.815 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.98 -39.51 85.93 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.55 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 mt -104.91 -19.76 13.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 69.83 16.99 72.89 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 ttp -108.04 145.77 33.51 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.634 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -103.04 144.46 31.25 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.122 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.484 HG23 ' CE2' ' A' ' 56' ' ' PHE . 70.6 m -110.7 132.06 54.52 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -128.88 156.44 43.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 116.22 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.914 0.387 . . . . 0.0 110.544 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.9 t -70.63 -30.69 67.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.602 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.64 156.14 8.37 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.37 132.18 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.692 0.282 . . . . 0.0 110.846 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -127.17 137.84 53.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.176 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtt -109.86 143.71 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.8 t -77.29 151.09 35.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.117 0.484 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -60.97 -31.05 70.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.939 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' C ' ' N ' ' A' ' 48' ' ' ALA . 89.6 m-20 -83.17 -3.62 57.55 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.43 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 58.87 11.07 1.73 Allowed 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 46' ' ' ASP . . . -75.02 -36.02 61.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -150.76 166.66 29.77 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.56 141.83 43.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -101.04 125.47 47.66 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.34 133.55 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 120.944 0.402 . . . . 0.0 110.476 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 98' ' ' PHE . 22.1 m -130.42 149.37 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 121.248 0.547 . . . . 0.0 111.095 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 m -133.27 135.64 45.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 36' ' ' THR . 35.4 m-85 -123.06 153.13 40.29 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.3 tp -72.26 -35.71 68.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.632 0.73 . . . . 0.0 110.397 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -81.27 8.13 9.76 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.8 p30 -60.96 -20.13 61.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 25.8 pttm -68.99 -30.04 68.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -90.7 117.2 29.15 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.31 -34.87 74.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.714 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.02 -38.81 89.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.455 0.645 . . . . 0.0 109.576 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.75 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' ILE . 74.8 t -69.12 -38.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -66.37 -45.67 79.33 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.489 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.97 -43.01 72.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.823 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.6 28.58 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.589 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.09 -37.63 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.719 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.09 -35.9 78.91 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.876 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.4 78.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.002 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' SER . 79.8 mt -71.22 -36.35 71.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.533 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.38 -45.55 75.92 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.291 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -71.18 -37.11 72.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.28 -3.55 57.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.392 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 72' ' ' LEU . 22.9 t -55.44 -51.16 67.83 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.899 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.56 92.64 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -63.04 -43.87 97.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.581 -0.309 . . . . 0.0 111.275 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.8 -40.21 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.372 0.606 . . . . 0.0 110.787 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.77 -46.02 89.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.048 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.5 m -70.48 -36.95 74.14 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.571 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -69.31 -37.94 78.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.542 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 19' ' ' ILE . 8.7 tt -68.27 -42.41 79.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.879 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.91 -41.9 71.01 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -66.21 -39.41 89.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.289 -0.956 . . . . 0.0 112.128 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.18 87.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.247 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.1 mtm -97.69 -5.39 35.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.44 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.9 mtm180 49.31 41.98 21.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 110.056 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.9 tp -92.04 140.32 29.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.416 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.491 ' C ' ' H ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -95.09 -41.29 9.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.7 pt -71.43 29.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.601 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 90' ' ' ARG . 88.6 t -73.45 114.2 29.47 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.276 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 160.62 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.5 1.467 . . . . 0.0 110.838 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.38 127.27 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.9 mt -94.2 131.02 40.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.207 0.527 . . . . 0.0 111.512 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.9 m -120.18 130.5 54.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.201 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -104.74 127.32 52.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.938 0.399 . . . . 0.0 110.752 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 39.9 t80 -132.23 151.72 51.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.002 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 51.0 p90 -105.61 132.51 51.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.969 0.414 . . . . 0.0 111.191 -179.54 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 120.854 0.272 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.386 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.09 -37.71 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.254 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.0 t -58.08 -40.04 75.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.09 93.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.083 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -63.83 -39.23 93.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.333 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.84 -36.3 80.77 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.8 mtt -72.84 -39.93 66.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.534 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.59 -47.41 79.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.774 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -66.49 -36.87 83.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.229 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -65.48 -41.69 93.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.67 -41.28 87.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.28 86.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.299 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.2 tp -60.92 -51.89 67.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.209 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.58 -34.44 65.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.24 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.4 tt -59.17 -40.85 86.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.841 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -82.24 -41.31 20.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.354 0.597 . . . . 0.0 111.481 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -70.59 -41.57 72.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.04 -15.74 61.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.173 0.511 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 23' ' ' LEU . 16.3 tt -114.42 148.2 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.75 119.4 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 30.9 t0 -78.89 -35.68 1.09 Allowed Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 47.4 Cg_exo -56.52 -34.49 95.15 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.766 1.644 . . . . 0.0 112.763 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -60.07 -38.01 81.58 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.267 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.81 -20.88 45.07 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.78 88.62 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.662 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 57' ' ' LEU . 47.5 ttm -171.94 154.8 3.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.593 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -79.48 140.98 37.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.7 p -89.18 165.51 14.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.2 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -127.14 156.2 42.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -107.57 125.41 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.966 0.413 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -67.54 -34.08 76.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.41 159.94 9.53 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.51 148.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.933 0.396 . . . . 0.0 111.262 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -124.08 138.09 54.48 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.748 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 mmm -113.14 142.33 45.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -73.85 150.76 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.734 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -60.6 -33.52 72.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.248 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.99 -3.54 57.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.408 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.0 mt 60.19 30.57 19.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.61 -48.21 3.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.888 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.6 144.36 44.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.953 0.406 . . . . 0.0 110.952 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.64 142.03 45.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.549 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -122.06 125.43 46.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.28 134.46 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 97.4 m-85 -107.69 139.71 41.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.061 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.47 146.32 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.266 0.555 . . . . 0.0 111.467 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -133.6 139.39 46.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.318 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -149.2 143.9 26.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.96 0.41 . . . . 0.0 110.026 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 1.2 pt? -77.66 -12.15 59.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.834 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.78 3.22 20.15 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -61.5 -16.53 48.27 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -69.64 -36.76 76.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 63' ' ' ASP . 65.2 t0 -90.84 114.01 26.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.722 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.26 -35.03 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.73 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 3.4 p30 -67.01 -33.52 75.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.133 0.492 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -67.98 -37.15 81.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.74 -44.7 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.341 0.591 . . . . 0.0 109.986 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.46 -41.0 85.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.018 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.48 -46.16 64.3 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.688 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.98 -51.73 27.35 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.472 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 mm -59.14 -37.79 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.567 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.39 -39.84 92.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.68 -41.81 74.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.939 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.1 tp -70.38 -36.52 74.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.67 -45.0 69.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.308 0.575 . . . . 0.0 110.386 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -36.86 74.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.028 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.38 -7.86 55.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 t -55.07 -50.55 68.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.11 -39.04 93.89 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -66.94 -40.33 87.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.41 -41.43 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 109.833 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.9 -47.19 81.58 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.535 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -70.93 -36.23 72.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.821 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.81 -34.56 76.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.063 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.36 -46.08 74.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.545 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -66.52 -36.93 92.17 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.985 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.58 -43.55 89.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.72 -0.74 . . . . 0.0 111.714 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.26 -43.73 66.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.798 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.7 mtt -80.65 -17.96 49.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 84' ' ' GLY . 40.5 ttp180 61.47 29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.487 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.58 141.66 35.04 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.217 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -97.38 -11.91 23.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.094 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -84.03 24.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 92' ' ' VAL . 1.2 m -72.33 119.13 73.11 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.34 161.48 31.78 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.447 1.432 . . . . 0.0 111.882 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.04 134.11 56.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.6 mt -99.76 131.04 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.085 0.469 . . . . 0.0 110.883 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -118.6 123.13 44.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -102.69 131.11 49.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 54.4 t80 -119.03 141.92 48.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.603 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.412 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 43.2 p90 -106.87 134.53 49.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 -179.817 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.5 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 121.057 0.357 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -64.4 -35.08 79.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.335 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -60.31 -43.31 96.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 8' ' ' PRO . 3.4 p -65.6 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.721 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.09 79.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.45 -40.42 95.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.24 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -38.38 87.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 91.1 mmm -70.66 -40.13 73.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.513 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -55.32 -43.21 74.69 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.551 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -62.73 -45.35 93.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.182 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.59 -34.66 78.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.788 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.5 mt -70.5 -42.3 78.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.69 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.77 85.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.034 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.53 -53.06 61.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.641 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.5 mt -69.81 -33.94 58.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.503 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.7 tp -56.67 -41.56 77.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.813 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 60.0 tt0 -82.11 -42.8 18.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.285 0.564 . . . . 0.0 111.267 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.39 -36.62 76.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.94 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -71.81 -17.05 62.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.214 0.53 . . . . 0.0 109.909 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.2 pt -119.44 150.54 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.067 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.2 120.52 24.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -73.13 -39.09 4.89 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.4 Cg_exo -52.91 -38.35 78.94 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.012 1.808 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -63.93 -37.73 88.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 mt -99.7 -9.79 22.68 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.719 0.295 . . . . 0.0 110.514 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 81.01 17.88 71.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.3 ttp 60.61 3.01 0.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.334 0.588 . . . . 0.0 109.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 33' ' ' GLY . 64.9 mtt -58.29 -28.02 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.781 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -65.98 129.42 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -131.39 148.39 52.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.898 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -91.93 117.75 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 0.0 109.788 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 m -66.48 -35.9 81.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.508 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 160.58 10.04 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -127.14 152.78 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -132.79 139.9 47.75 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.42 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.2 mtt -97.16 140.3 31.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.7 p -73.66 160.14 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.955 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.8 ttm105 -58.01 -32.78 68.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.507 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -82.6 -3.88 56.81 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.271 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.0 mt 59.17 15.26 4.03 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.13 -36.79 8.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.901 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.6 146.25 41.95 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.724 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.19 141.75 47.17 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.787 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -108.88 128.08 54.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.299 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.1 133.38 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.292 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.44 130.16 56.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.14 148.68 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.007 0.432 . . . . 0.0 110.94 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 t -135.43 151.55 50.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -144.63 141.85 29.69 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.275 0.56 . . . . 0.0 111.037 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.9 tp -68.74 -22.49 64.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -80.3 5.57 14.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 53.7 p30 -61.85 -17.43 56.41 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 48.1 mtmt -68.88 -35.85 77.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.339 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -89.73 118.57 29.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.011 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.1 -35.49 75.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.907 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.78 -39.57 93.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.608 0.718 . . . . 0.0 109.275 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.53 80.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.588 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 69' ' ' ILE . 68.2 t -65.44 -42.83 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.679 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.15 -47.68 70.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.258 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.45 69.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.826 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -51.27 37.34 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.857 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 65' ' ' VAL . 16.5 tt -59.03 -40.98 81.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.223 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' ILE . 68.1 mttm -68.79 -35.02 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.951 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.4 76.82 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.335 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.11 -36.82 72.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.198 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.02 -45.38 67.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.347 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.67 -37.06 73.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.487 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.62 -12.06 60.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.345 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.5 p -55.66 -50.2 70.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.503 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.83 95.06 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.485 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.72 -41.44 92.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.39 -39.84 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.321 0.582 . . . . 0.0 110.622 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.36 -47.74 80.84 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.023 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.1 m -71.45 -38.37 71.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.211 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.5 tp -68.07 -37.79 81.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.311 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.35 -41.33 80.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.73 -36.04 74.52 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -70.05 -43.68 70.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.529 -0.835 . . . . 0.0 111.614 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.61 89.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.522 . . . . 0.0 109.909 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.409 ' O ' HD23 ' A' ' 89' ' ' LEU . 62.8 mtt -84.9 -17.69 37.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.15 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' GLY . 39.7 mmm-85 59.52 25.32 14.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 87' ' ' MET . 2.7 mm? -100.99 141.77 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.108 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.71 -10.45 19.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.413 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 91' ' ' ILE . 11.1 pt -75.21 7.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.353 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 92' ' ' VAL . 31.2 m -72.55 122.21 86.92 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.75 163.68 28.72 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.616 1.544 . . . . 0.0 111.749 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.02 133.47 56.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.31 129.73 44.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -119.38 127.96 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.51 129.85 52.5 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.181 0.515 . . . . 0.0 111.468 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -119.11 138.69 52.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.568 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 24.6 p90 -102.69 128.69 49.29 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.935 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 CA-C-O 120.856 0.273 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -51.94 -23.72 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.797 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -58.93 -37.63 77.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' SD ' ' A' ' 15' ' ' MET . 66.3 t -58.57 -41.01 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.762 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.26 90.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.063 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.86 -39.2 93.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.116 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.73 -36.52 81.21 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -73.06 -41.1 64.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.035 178.494 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.11 -45.62 92.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -67.25 -41.1 86.16 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.24 -41.9 89.37 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.772 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.23 -41.35 86.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.281 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 -37.65 88.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.122 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.458 HD11 ' NE ' ' A' ' 25' ' ' ARG . 42.5 tp -62.53 -52.32 63.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.34 -32.78 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.305 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.36 -40.96 71.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.478 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ILE . 83.1 mt-30 -82.51 -43.73 16.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.696 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NE ' HD11 ' A' ' 21' ' ' LEU . 87.3 mtt180 -70.83 -32.68 69.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -71.7 -16.54 62.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.45 0.643 . . . . 0.0 109.343 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.6 pt -118.69 149.34 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -95.0 123.92 38.75 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -47.39 -59.7 5.13 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -52.11 -23.23 16.81 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.966 1.777 . . . . 0.0 113.513 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.45 -38.11 76.81 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.559 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -100.33 -12.24 19.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.85 61.42 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 mtt -146.71 163.91 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.542 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.6 mtp -96.19 148.08 23.08 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.807 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -114.35 152.5 31.37 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.131 0.491 . . . . 0.0 111.004 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.0 m -129.03 145.7 51.19 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 38' ' ' VAL . 32.7 m -92.73 124.08 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.5 p -78.33 -23.19 47.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.744 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.95 155.09 6.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.46 153.53 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -135.12 142.51 46.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 mmt -103.36 142.36 34.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.778 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 88.3 p -73.54 161.6 30.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.186 0.517 . . . . 0.0 110.5 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -59.55 -35.16 73.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -83.68 -2.94 57.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp 59.89 22.48 11.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.71 -37.53 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.46 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.426 ' O ' ' OG ' ' A' ' 44' ' ' SER . 89.9 m-85 -116.19 143.66 45.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.42 141.97 46.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -115.93 125.72 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.301 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.65 134.77 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.087 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -109.54 131.95 54.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 m -131.59 149.53 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.062 0.458 . . . . 0.0 111.04 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -140.96 152.01 44.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.285 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CG ' ' OD1' ' A' ' 59' ' ' ASP . 19.2 p90 -151.98 161.07 43.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.474 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -27.76 68.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.486 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 60' ' ' LYS . 15.9 t-20 -80.56 2.03 27.2 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.529 ' OD1' ' CG ' ' A' ' 56' ' ' PHE . 3.3 m-20 -61.53 -15.48 38.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 58' ' ' ASN . 48.9 mtmt -67.64 -37.13 82.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -90.52 114.46 26.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.778 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.34 -33.26 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.64 -38.88 92.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.48 0.657 . . . . 0.0 109.486 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.65 84.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.763 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.61 -39.53 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.212 0.529 . . . . 0.0 109.977 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -65.86 -41.22 91.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.07 70.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.38 -51.39 52.89 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.254 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.6 -38.83 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.203 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.43 -39.98 95.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.254 0.55 . . . . 0.0 109.634 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.82 71.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.325 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 tp -70.32 -37.57 74.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -69.35 -44.76 70.93 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.09 -37.03 78.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.936 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.86 -10.14 59.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.9 p -57.76 -49.6 76.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.63 -36.79 87.29 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.09 -45.38 85.46 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.425 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.2 mt -60.72 -39.23 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.468 0.651 . . . . 0.0 110.608 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -61.43 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.84 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -70.4 -35.65 73.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.478 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -63.67 -40.58 97.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.113 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.63 -51.11 45.72 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.88 -44.31 94.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.176 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.58 -42.63 70.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.33 92.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtm -89.19 -17.15 29.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.12 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 84' ' ' GLY . 48.1 mmm-85 54.42 37.61 28.01 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 tp -93.9 139.87 30.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.689 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -89.35 -38.56 14.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -77.76 21.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.673 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.2 p -72.35 114.8 32.91 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -83.24 168.61 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.903 1.735 . . . . 0.0 112.284 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -74.32 142.46 45.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 95' ' ' LEU . 9.6 mp -98.15 128.13 44.48 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.189 0.518 . . . . 0.0 111.324 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 m -110.24 118.95 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 130.25 44.66 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 112.334 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.37 138.67 52.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.095 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -105.71 133.81 49.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.731 0.301 . . . . 0.0 110.653 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.98 0.419 . . . . 0.0 110.184 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.645 0.259 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -60.72 -40.49 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.326 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.18 -40.68 86.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.86 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.2 83.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.46 -42.1 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.188 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.81 -38.54 88.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.9 mtt -71.13 -38.6 72.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.971 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.72 -44.61 73.66 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -64.28 -45.93 85.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.499 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -63.25 -34.06 76.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.376 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.83 80.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.741 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.75 85.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.812 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.93 -53.16 58.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.068 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.8 -34.87 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.747 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.0 tp -58.89 -43.47 90.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.245 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -83.23 -40.5 19.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.591 . . . . 0.0 111.684 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -69.85 -41.86 74.32 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -72.94 -15.62 61.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.145 0.498 . . . . 0.0 110.442 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 23' ' ' LEU . 18.8 tt -115.35 142.21 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.547 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -83.58 113.71 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -67.87 -38.62 14.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.787 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 60.0 Cg_exo -52.68 -31.78 51.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.878 1.719 . . . . 0.0 112.616 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -60.5 -37.26 80.51 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.891 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.9 mt -79.85 -20.1 46.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 109.856 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.47 5.45 82.12 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.401 ' SD ' HD23 ' A' ' 57' ' ' LEU . 25.2 ttt -167.07 154.8 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.65 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.55 142.91 33.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.034 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 157.17 16.27 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.0 m -121.15 143.28 49.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.23 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.33 118.08 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 110.131 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -63.32 -36.16 82.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.313 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.63 161.52 10.44 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.64 151.35 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.812 0.339 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.17 142.59 48.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.0 mtt -102.2 142.28 33.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.003 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.7 t -73.79 152.2 40.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.087 0.47 . . . . 0.0 110.588 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -55.98 -31.75 63.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.993 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.71 -3.87 57.05 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.326 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.8 mt 58.8 20.11 7.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.06 -41.37 6.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.945 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.62 147.28 40.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 141.31 49.18 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.94 0.4 . . . . 0.0 110.474 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -109.04 127.55 54.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.81 133.11 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -112.84 130.46 56.08 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.91 147.65 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.892 0.377 . . . . 0.0 110.716 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -126.37 125.7 42.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.96 131.6 55.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' SD ' ' A' ' 34' ' ' MET . 30.5 tp -70.89 -25.93 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.436 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 60' ' ' LYS . 19.6 m120 -81.09 2.57 26.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -60.75 -16.85 44.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 58' ' ' ASN . 14.7 mtpp -69.0 -35.56 76.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -89.71 119.32 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.378 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.71 -32.31 70.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.75 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.7 -40.24 76.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.308 0.575 . . . . 0.0 110.415 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.09 74.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.955 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.83 -34.37 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.257 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -64.69 -42.92 94.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 109.641 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.64 75.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.343 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.37 51.66 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.997 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.58 HD13 ' CZ ' ' A' ' 99' ' ' TYR . 5.5 mm -57.98 -42.93 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.666 0.27 . . . . 0.0 111.038 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.01 -35.73 80.57 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.04 -45.2 71.01 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.106 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 tp -70.98 -36.68 72.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.416 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.6 -45.46 71.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.43 -37.08 74.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.43 59.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.28 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 t -55.67 -51.07 68.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.241 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.09 93.22 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -65.94 -41.27 91.54 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.11 -41.43 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.342 0.592 . . . . 0.0 109.969 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 93' ' ' PRO . 37.4 ttt85 -62.9 -47.15 84.51 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.42 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 t -70.95 -36.45 72.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.707 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.46 -39.91 77.44 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.787 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.35 -49.22 51.62 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.43 -42.26 99.73 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.407 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -68.8 -39.86 79.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.375 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.851 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.08 -14.07 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 93.7 mtt-85 56.91 35.78 26.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.52 141.35 34.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.782 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -102.12 -10.94 19.22 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.498 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 91' ' ' ILE . 36.8 pt -88.4 13.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -73.09 121.94 86.39 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 94.7 Cg_endo -78.06 166.06 25.32 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.701 1.601 . . . . 0.0 111.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.01 138.41 58.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.4 mm? -97.56 128.31 44.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.074 0.464 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.4 m -118.57 129.35 55.29 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.67 129.12 49.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.198 0.523 . . . . 0.0 111.498 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.1 t80 -123.25 144.97 49.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.738 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 21.4 m-85 -109.22 132.56 54.0 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.932 0.396 . . . . 0.0 110.241 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.936 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -62.02 -43.06 99.64 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.65 -37.74 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.164 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.96 81.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -64.67 -41.78 95.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.29 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.57 -38.75 88.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 90.4 mtp -71.1 -38.8 72.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.71 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.5 -42.38 78.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.537 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -63.0 -45.42 92.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.11 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.13 -34.85 78.49 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.708 0.766 . . . . 0.0 109.715 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.63 -41.51 77.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.485 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.51 84.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.194 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.56 -52.99 62.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.577 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.9 mt -69.87 -34.26 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.395 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 27' ' ' ILE . 36.8 tp -56.33 -41.96 76.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.016 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.3 tt0 -82.92 -41.64 18.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 111.442 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -70.35 -38.81 74.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.122 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -72.39 -14.86 61.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.071 0.462 . . . . 0.0 110.336 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.9 tt -119.9 141.64 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.554 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -86.54 113.06 22.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -67.77 -38.75 15.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.489 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.59 -28.69 46.93 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.012 1.808 . . . . 0.0 112.559 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -59.38 -38.2 79.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.527 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 mt -88.37 -19.45 26.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.138 0.494 . . . . 0.0 109.8 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.71 5.0 89.84 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 90.7 mmm -143.74 162.22 36.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.838 0.351 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.6 ttp -96.79 134.54 39.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.952 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.0 p -92.0 158.04 16.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 t -135.56 159.66 40.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p -108.17 127.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.999 0.428 . . . . 0.0 110.085 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 m -72.19 -34.2 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.42 157.44 8.48 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.76 150.69 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.074 0.464 . . . . 0.0 111.488 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.1 141.86 50.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.074 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.1 mtt -108.11 142.07 38.87 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 p -75.47 152.84 37.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.058 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -63.06 -34.81 78.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.443 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.92 -3.11 57.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.376 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.4 mt 62.03 13.67 5.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.11 58.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.177 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.2 165.49 29.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.256 0.55 . . . . 0.0 111.764 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.54 142.3 35.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.257 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -112.41 120.01 40.19 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.208 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.8 133.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.907 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -109.67 136.19 49.41 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.79 146.98 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 0.0 111.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 t -144.65 152.48 40.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 11.0 p90 -150.24 159.73 44.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.123 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.18 -27.03 68.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.02 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.412 ' C ' ' N ' ' A' ' 60' ' ' LYS . 73.5 m-20 -80.23 5.78 13.67 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 68.9 m-20 -61.02 -16.71 46.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 58' ' ' ASN . 63.9 tttp -68.87 -39.97 79.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.82 114.12 26.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.167 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -60.46 -33.0 71.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.04 -38.72 89.09 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.447 0.641 . . . . 0.0 109.386 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.55 83.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 69' ' ' ILE . 82.6 t -68.76 -37.87 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.913 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.4 -45.47 79.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.595 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.27 -44.55 68.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.496 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.85 41.38 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.484 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.0 tt -59.8 -34.5 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.214 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -66.4 -41.31 89.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.38 0.61 . . . . 0.0 109.506 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.36 75.09 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.95 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -69.62 -36.63 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -68.48 -44.49 74.67 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.192 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -69.35 -37.07 77.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.091 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.72 -10.52 59.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.333 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.8 p -58.67 -49.41 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.243 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.7 91.88 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -64.49 -43.6 93.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.623 0.249 . . . . 0.0 111.452 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.73 -42.84 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 110.808 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -63.11 -47.1 84.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.48 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.1 t -70.98 -37.76 72.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.866 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -66.45 -37.8 85.95 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.778 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.75 -43.32 76.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.956 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.0 -38.4 74.21 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -66.26 -43.12 87.36 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -0.726 . . . . 0.0 111.921 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.58 83.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.7 mtt -84.29 -17.21 40.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' GLY . 41.3 ttt85 59.44 35.35 22.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.656 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.35 142.05 33.32 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.034 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.58 -10.54 19.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.668 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 pt -82.62 18.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.201 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.97 122.5 87.81 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.91 158.97 31.09 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.545 1.496 . . . . 0.0 111.374 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.81 128.7 37.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.5 mt -95.58 131.37 41.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.228 0.537 . . . . 0.0 111.313 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -115.61 127.25 55.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.98 126.9 52.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -119.11 141.64 48.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.768 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 23.3 p90 -106.83 132.02 53.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.905 0.383 . . . . 0.0 110.337 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.341 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -63.31 -43.2 98.52 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.016 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.07 -37.1 78.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.291 0.567 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.8 -39.54 83.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -71.59 -46.42 59.32 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.519 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.37 -37.15 84.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 57.3 mtt -71.62 -40.72 69.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.982 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -54.49 -42.33 70.63 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -63.3 -46.79 85.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.366 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.35 -33.48 75.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.608 0.718 . . . . 0.0 109.824 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.26 -42.92 78.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.962 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.17 86.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.58 -51.82 65.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.389 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.27 -34.1 64.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.7 -41.02 97.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -82.65 -27.8 31.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -82.83 -45.26 14.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.773 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.05 -17.39 62.02 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 72' ' ' LEU . 35.5 mt -112.24 133.92 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.009 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.97 121.96 28.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 10.7 t70 -46.14 -58.48 6.36 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.302 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.61 -22.93 18.24 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.805 1.67 . . . . 0.0 113.13 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.18 -38.36 76.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.763 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.8 mt -100.7 -13.79 18.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.05 0.453 . . . . 0.0 109.801 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.66 5.68 89.68 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.3 tpt -160.88 158.75 28.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.404 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.442 ' SD ' ' OD1' ' A' ' 29' ' ' ASP . 94.1 mmm -80.45 137.93 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 p -86.08 150.33 24.52 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.872 0.368 . . . . 0.0 111.029 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.4 m -125.98 141.71 51.84 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.911 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -100.24 120.97 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.012 0.434 . . . . 0.0 110.169 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -68.84 -33.94 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.17 158.19 8.79 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 m -127.16 148.62 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 111.193 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -126.1 138.29 53.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.952 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.487 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -113.73 143.24 44.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 94.7 p -73.2 156.4 38.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.233 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.953 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 55.3 p30 -83.91 -0.86 53.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.5 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.27 31.94 21.57 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' A' ' 46' ' ' ASP . . . -105.56 -46.44 4.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.79 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -116.02 145.55 42.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.829 0.347 . . . . 0.0 110.641 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.88 142.17 40.69 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -122.05 127.49 50.28 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.5 134.74 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -109.96 133.17 53.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.74 149.85 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.167 0.508 . . . . 0.0 111.55 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -143.36 151.77 40.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.41 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 7.2 p90 -156.03 158.52 37.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 111.397 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.01 -14.67 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.75 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -80.6 3.42 21.94 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.519 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 64.6 m-20 -61.88 -16.64 52.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.37 -39.43 85.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.135 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.62 117.26 29.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.037 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -60.3 -36.57 78.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.427 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.06 -37.92 89.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.471 0.653 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.84 84.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.1 -44.32 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -66.83 -39.83 87.78 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.47 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.83 76.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.59 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.42 -51.2 38.78 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.41 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.37 -41.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.612 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.46 -35.27 80.4 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.57 86.21 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.936 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' CD2' HD11 ' A' ' 27' ' ' ILE . 84.7 mt -70.35 -35.89 73.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.851 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -67.78 -45.96 73.33 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.47 -37.18 71.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.5 -3.97 54.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.286 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -55.24 -50.3 69.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.317 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.76 93.02 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.232 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -66.41 -42.65 87.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.32 -39.52 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.638 0.732 . . . . 0.0 110.087 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -63.74 -45.02 91.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.09 -36.95 78.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.521 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.52 -38.77 90.63 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.935 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.87 -49.5 57.74 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.515 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -59.45 -43.0 97.83 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.692 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.053 0.454 . . . . 0.0 111.824 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.65 98.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.474 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -94.5 -9.17 36.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 89.5 mtm-85 55.13 36.67 27.49 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.72 141.2 33.93 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.977 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -99.22 -14.69 19.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 pt -86.91 29.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 92' ' ' VAL . 35.9 m -72.57 118.36 67.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.91 160.82 27.25 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.547 1.498 . . . . 0.0 111.61 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.29 136.2 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.8 mt -100.84 130.76 46.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 110.947 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -119.65 124.88 47.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.996 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.73 129.11 47.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.452 . . . . 0.0 111.231 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 37.7 t80 -119.64 139.8 51.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 44.6 p90 -104.67 133.6 49.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.964 0.412 . . . . 0.0 110.484 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.56 0.219 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -59.77 -43.21 94.47 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 m -65.5 -36.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.847 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.33 85.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.811 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.33 -40.71 96.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.3 -37.62 83.89 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.55 -42.18 68.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.886 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.36 -43.74 79.43 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -63.52 -48.14 78.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.069 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.83 -32.25 72.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.246 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.03 -41.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.86 85.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.8 tp -64.34 -52.01 60.5 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.22 -33.92 60.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 27' ' ' ILE . 56.4 tp -57.96 -42.21 84.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.4 mt-30 -82.46 -41.87 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.384 0.611 . . . . 0.0 111.358 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -70.54 -37.6 74.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.827 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -72.12 -17.42 61.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.176 0.512 . . . . 0.0 110.125 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.2 tt -118.7 141.09 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.815 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -66.52 -38.69 21.0 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.437 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.5 Cg_exo -55.28 -31.91 78.7 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.004 1.802 . . . . 0.0 112.521 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.51 -38.22 80.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.704 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.9 -20.02 28.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.951 0.405 . . . . 0.0 110.002 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 7.39 87.19 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.8 mtt -138.85 167.15 22.64 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.962 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.8 mtp -98.29 151.2 20.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.444 ' CG2' ' CE1' ' A' ' 56' ' ' PHE . 88.0 m -109.09 142.36 39.94 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -122.41 157.36 32.05 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.732 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p -105.54 116.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.152 0.501 . . . . 0.0 110.2 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -34.46 78.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.006 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.11 152.59 6.37 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 52' ' ' VAL . 32.5 t -126.09 137.92 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.679 0.276 . . . . 0.0 110.454 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -128.23 140.35 51.95 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.993 0.425 . . . . 0.0 110.779 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.6 mtt -111.36 142.47 43.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.475 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.1 p -73.44 155.31 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.822 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.25 -32.54 71.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.565 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.57 -3.54 56.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.377 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.31 27.12 16.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.37 -41.29 5.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -118.07 142.75 47.07 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.872 0.367 . . . . 0.0 110.885 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.07 141.73 48.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.13 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.97 129.13 55.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 41' ' ' VAL . 97.0 t -117.77 133.36 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.415 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -118.74 128.76 54.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.33 149.73 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.225 0.536 . . . . 0.0 111.452 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -123.7 134.68 53.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 36' ' ' THR . 97.6 m-85 -121.39 146.55 46.76 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.426 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.3 mt -76.03 -12.06 60.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 81.9 m-20 -80.68 -2.43 46.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.834 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 100' ' ' ASP . 98.4 m-20 -62.94 -21.2 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.88 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -69.88 -38.43 76.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.562 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -99.1 109.51 22.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.03 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.11 -38.17 82.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.05 -38.03 89.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.84 82.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.51 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' ILE . 76.7 t -66.43 -35.53 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -66.2 -43.75 85.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.228 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.81 72.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.346 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -50.4 32.18 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.717 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.22 -36.74 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.682 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -68.35 -38.05 81.09 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.551 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.35 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.61 -36.88 76.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.658 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.76 -44.95 72.65 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.09 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.75 -36.95 79.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.236 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.26 -12.16 60.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.0 -49.53 76.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.461 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.15 86.02 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.161 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.09 -44.63 88.24 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.333 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.44 -39.6 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.543 0.687 . . . . 0.0 110.501 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -63.48 -45.02 92.7 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.736 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.56 -36.55 76.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.0 mt -66.43 -36.49 82.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.237 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.12 -48.6 64.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.909 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.17 -43.1 65.08 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.603 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.86 -43.11 80.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.258 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.14 83.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.429 ' HB3' HD23 ' A' ' 89' ' ' LEU . 56.6 mtt -84.54 -21.38 30.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 84' ' ' GLY . 49.0 ttp85 64.21 37.15 8.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.992 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.6 mm? -90.28 141.46 28.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.984 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -98.7 -14.56 19.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.422 ' CG1' HD12 ' A' ' 89' ' ' LEU . 34.8 pt -97.7 34.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 92' ' ' VAL . 34.2 m -73.25 119.87 78.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.98 160.35 30.37 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.418 1.412 . . . . 0.0 111.352 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.37 132.67 54.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.05 126.82 51.47 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.819 0.342 . . . . 0.0 110.304 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 m -117.11 133.68 55.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.512 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.28 128.52 54.52 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -119.58 137.53 53.79 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 38.3 p90 -109.63 123.59 49.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.932 0.396 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.417 ' O ' ' OD2' ' A' ' 59' ' ' ASP . 60.4 t0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 120.648 0.261 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -58.71 -41.57 86.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.53 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.2 -39.38 78.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.757 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.07 96.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.914 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -61.38 -39.37 90.41 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.379 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.56 -37.33 83.44 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.32 -41.87 69.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.599 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HG2' HG22 ' A' ' 41' ' ' VAL . 94.7 mt-30 -60.66 -41.5 95.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.574 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -64.63 -51.33 63.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.215 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.74 -34.92 79.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.941 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.0 mt -71.07 -39.96 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.109 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -36.85 85.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.25 -53.31 46.18 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.81 -34.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.76 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 27' ' ' ILE . 37.0 tp -59.35 -38.96 81.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.945 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 27' ' ' ILE . 48.5 tt0 -81.88 -44.46 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.988 0.423 . . . . 0.0 111.15 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -71.15 -36.64 72.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -73.27 -14.31 61.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.291 0.567 . . . . 0.0 109.906 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 23' ' ' LEU . 15.0 tt -121.67 149.47 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -76.03 113.02 13.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -70.14 -38.55 9.02 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.86 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 46.0 Cg_exo -56.57 -37.4 97.56 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.078 1.852 . . . . 0.0 112.781 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -59.94 -37.43 79.5 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.121 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 61.7 mt -92.45 -3.88 54.54 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.76 0.314 . . . . 0.0 110.6 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.05 5.39 70.65 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ttt 65.46 0.38 1.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mmm -79.32 10.29 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.692 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.3 m -78.75 130.68 36.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.067 0.46 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.9 m -131.27 145.91 52.09 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.3 t -94.47 119.11 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.379 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.98 163.68 11.3 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 16' ' ' GLN . 2.2 m -127.42 148.8 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.637 0.256 . . . . 0.0 110.386 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.93 130.55 56.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 58.3 mmm -100.65 142.27 32.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -73.52 151.27 41.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 0.0 110.585 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -57.92 -36.12 72.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.428 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -83.92 -0.14 50.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.421 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 59.38 30.17 19.83 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.61 -47.41 4.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.187 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -118.19 145.02 45.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.903 0.383 . . . . 0.0 111.055 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.4 141.79 46.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.06 130.13 56.27 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.14 133.47 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.593 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -116.51 128.9 55.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.722 0.296 . . . . 0.0 110.355 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.82 147.34 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.83 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -132.61 144.2 50.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 5.5 p90 -150.3 150.17 31.12 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.159 0.504 . . . . 0.0 111.058 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.08 -33.75 75.01 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 17.0 m120 -80.89 -2.46 47.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 36.0 t0 -61.68 -14.83 34.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -67.6 -38.2 83.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.28 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.09 126.71 35.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.068 0.461 . . . . 0.0 110.428 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.3 -35.41 75.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.136 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.9 -40.28 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 109.976 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.66 81.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.054 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.74 -39.27 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 0.0 109.279 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HZ3' ' CE ' ' A' ' 70' ' ' LYS . 22.0 tptp -64.31 -43.32 95.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.534 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.9 62.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.804 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.64 -52.08 32.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.747 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.34 -36.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.568 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' CE ' ' HZ3' ' A' ' 66' ' ' LYS . 3.1 ttmp? -66.03 -39.94 90.62 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.43 -42.06 83.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.834 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.11 -36.24 74.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.116 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -69.0 -45.5 70.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.59 -36.96 73.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.227 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.13 -8.78 59.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.218 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -57.15 -49.06 77.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.293 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.36 87.09 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.07 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -66.08 -44.52 84.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.464 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.29 -40.37 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 110.149 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -63.46 -45.55 90.32 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -68.88 -37.09 78.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.44 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.11 -38.36 90.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.254 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.92 -47.24 66.27 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.67 -42.15 72.53 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.722 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.43 -43.01 78.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.351 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.32 87.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.008 0.432 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 39.8 mtt -86.21 -17.6 34.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 70.8 mtp85 53.51 37.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -94.64 139.44 31.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.412 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -86.65 -39.0 16.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.033 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.9 pt -76.22 33.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -72.59 114.61 31.61 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -80.33 162.13 22.61 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.694 1.596 . . . . 0.0 112.036 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.67 133.29 50.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.19 131.41 44.57 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.104 0.478 . . . . 0.0 110.882 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.6 m -120.88 131.79 54.6 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.389 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.74 127.28 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.004 0.431 . . . . 0.0 110.98 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -126.04 146.16 50.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.0 p90 -109.54 132.48 54.1 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.788 0.328 . . . . 0.0 111.313 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.89 178.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.673 0.273 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -59.24 -39.85 84.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.995 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.1 t -58.02 -39.74 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.69 95.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.86 -40.35 96.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.697 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.97 -36.46 81.52 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.47 -40.96 63.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.47 -47.91 82.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.135 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -67.48 -37.83 83.46 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -64.19 -42.37 96.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.311 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.78 -40.65 86.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.33 87.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.082 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.59 -51.88 65.59 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.32 -34.41 68.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.766 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 72' ' ' LEU . 13.3 tp -60.34 -40.42 90.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.383 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -83.07 -27.57 30.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.783 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -79.61 -46.45 17.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.38 -15.39 61.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 24' ' ' GLN . 31.7 mt -114.15 133.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -84.48 112.73 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -65.93 -39.15 27.88 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.235 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.2 Cg_exo -55.28 -34.39 88.21 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.021 1.814 . . . . 0.0 112.36 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.49 -37.89 79.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.445 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 63.7 mt -80.91 -20.26 42.54 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.89 4.27 90.1 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 57.1 mtt -151.62 167.15 29.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.833 0.349 . . . . 0.0 110.513 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -92.06 139.8 30.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.0 p -87.17 152.02 22.69 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 110.965 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -126.81 141.8 51.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.286 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.11 122.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -66.2 -35.22 79.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.237 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.67 160.69 10.02 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.34 146.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 111.1 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -121.43 139.4 53.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.609 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.3 mmm -109.39 139.97 43.68 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.3 p -73.99 153.64 39.64 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.964 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.418 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 56.9 t0 -82.45 -3.3 55.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.058 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 47' ' ' LEU . 9.3 mp 56.38 23.31 7.2 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.42 -37.01 9.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.45 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -123.14 150.79 42.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.21 141.9 35.9 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.305 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -119.63 125.09 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.598 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.26 134.58 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.285 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -108.8 135.8 49.42 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.57 147.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.255 0.55 . . . . 0.0 111.464 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 t -146.32 152.04 38.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.34 151.32 24.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.209 0.528 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.58 -25.55 68.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.833 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.493 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 84.9 m-20 -79.91 5.26 14.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.9 p30 -64.5 -15.4 60.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 15.2 ptpt -70.03 -33.88 72.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -90.22 116.67 28.38 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.82 -33.4 71.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.385 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.5 -39.12 91.5 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.448 0.642 . . . . 0.0 109.619 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.93 87.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.98 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.72 -38.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -66.76 -47.03 73.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.044 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.58 77.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.473 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.53 -50.72 24.47 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.572 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.7 tt -59.67 -36.71 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.768 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -68.14 -37.51 81.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.24 92.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.241 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 23' ' ' LEU . 56.6 tp -68.35 -36.43 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.882 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -69.44 -45.81 68.25 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.3 -36.92 71.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.31 58.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.286 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 m -56.5 -50.05 72.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.69 93.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.252 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.22 -42.99 87.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.727 0.298 . . . . 0.0 111.506 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.42 -40.8 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.352 0.596 . . . . 0.0 110.783 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -64.27 -45.35 88.42 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.259 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -69.45 -36.84 76.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.632 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.01 -37.54 81.54 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.66 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.32 -50.49 53.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.578 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.41 -43.87 96.14 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.596 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -70.83 -42.22 70.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.8 98.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.25 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtm -89.5 -15.82 32.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.831 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' GLY . 96.8 mtt180 53.42 36.65 23.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -94.74 139.1 31.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.04 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -82.69 -44.7 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.531 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 pt -75.79 40.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.917 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.0 p -72.74 114.59 31.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 72.8 Cg_endo -79.91 157.64 24.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.643 1.562 . . . . 0.0 112.256 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.97 138.07 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -94.97 127.9 41.37 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.11 0.481 . . . . 0.0 110.753 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -115.72 120.85 40.7 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.86 132.05 44.5 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 0.0 111.727 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -119.14 138.86 52.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -102.43 115.87 31.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -59.79 -39.62 85.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.86 -40.8 83.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.08 94.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.024 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -60.9 -39.6 89.92 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.993 0.425 . . . . 0.0 110.328 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.62 -37.33 83.57 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.1 -40.9 67.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.824 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.1 -42.43 80.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.455 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -63.02 -47.56 82.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.925 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -61.99 -34.57 76.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.579 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.62 -40.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.795 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 -37.35 87.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.42 -52.22 62.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.654 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.94 -34.63 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.43 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.7 mt -64.39 -33.66 76.38 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.061 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.584 ' NE2' ' SD ' ' A' ' 35' ' ' MET . 94.8 mt-30 -82.76 -27.71 30.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 0.0 111.346 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -87.65 -46.19 9.74 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.48 -12.55 60.83 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.508 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.24 132.11 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.21 109.98 17.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 8.8 t0 -65.32 -36.63 15.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.398 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 31.9 Cg_exo -58.82 -38.55 88.01 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.497 1.465 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -61.89 -38.58 88.85 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.216 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.5 mt -87.63 -19.77 27.28 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.68 5.42 89.98 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.3 ttm -163.9 151.91 12.91 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.584 ' SD ' ' NE2' ' A' ' 24' ' ' GLN . 58.7 ttp -83.24 141.49 31.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.09 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -81.48 153.86 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 111.01 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.5 m -122.92 143.84 49.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.11 118.96 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.001 0.429 . . . . 0.0 110.589 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 m -66.51 -34.33 77.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.278 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.65 153.94 6.99 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 52' ' ' VAL . 29.3 t -126.59 135.78 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.774 0.321 . . . . 0.0 111.081 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.74 137.96 52.99 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.3 mtt -112.57 142.34 45.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.413 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 p -76.91 152.43 35.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.182 0.515 . . . . 0.0 110.388 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -64.08 -32.86 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.677 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.47 -3.25 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.404 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.42 14.36 5.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.82 62.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.84 164.28 35.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.514 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.12 35.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.486 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -104.11 127.57 51.7 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 41' ' ' VAL . 72.3 t -117.6 133.11 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.42 134.92 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -129.82 145.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 120.997 0.427 . . . . 0.0 110.537 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.0 m -139.9 137.44 34.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.057 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.35 149.37 29.25 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.892 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.66 -15.34 63.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.531 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -81.12 -2.31 47.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.07 -15.3 62.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.426 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.88 -36.05 77.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.76 115.74 28.08 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -34.0 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.517 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.65 -38.69 91.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.376 0.607 . . . . 0.0 109.49 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.54 83.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.878 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 69' ' ' ILE . 79.2 t -67.18 -41.05 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.84 -42.17 86.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.57 -46.12 64.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.65 -50.59 41.64 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.3 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.2 tt -59.48 -34.5 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -66.73 -41.18 88.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.81 78.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.802 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -69.48 -36.57 76.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.08 -45.01 71.37 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.212 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.51 -36.93 74.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.01 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.19 -7.05 56.61 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.141 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.8 t -55.57 -50.04 71.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.3 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -38.27 91.19 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.221 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -65.87 -43.58 87.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.593 0.235 . . . . 0.0 111.545 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.78 -39.72 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.56 0.695 . . . . 0.0 110.31 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -63.51 -46.26 86.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.272 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.1 t -70.22 -37.02 74.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.646 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.44 -37.45 86.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.345 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -68.45 -49.88 56.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -63.1 -43.88 98.07 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.349 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.67 -39.53 73.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 0.0 111.807 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.66 94.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.571 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.3 mtm -92.44 -13.55 29.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.485 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 30.9 mmt180 57.34 42.92 24.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.767 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.79 141.2 29.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.824 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -92.93 -16.86 24.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 pt -96.7 43.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.3 t -72.8 114.57 31.67 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 156.19 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.459 1.439 . . . . 0.0 111.433 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.47 125.99 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.3 mt -94.18 131.84 39.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.411 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -119.78 128.24 53.54 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.033 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.43 131.23 53.12 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 111.345 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.404 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.8 t80 -119.49 142.3 48.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.512 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 44.8 p90 -105.45 133.79 49.63 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.958 0.408 . . . . 0.0 110.292 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.79 0.329 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -59.22 -38.8 80.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.398 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.62 -40.39 79.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.14 93.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.221 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -64.84 -40.07 94.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.6 -37.85 85.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.24 -42.87 68.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.81 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.71 -41.79 82.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -64.06 -50.23 69.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -63.29 -34.77 78.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.727 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.26 -42.19 78.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.132 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.94 85.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 ' HE ' ' A' ' 25' ' ' ARG . 42.9 tp -62.64 -52.92 61.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.53 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.33 -35.77 74.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.054 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.6 tt -63.13 -37.25 86.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.284 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -74.38 -41.15 61.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 111.038 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HE ' HD11 ' A' ' 21' ' ' LEU . 89.3 mtt-85 -75.19 -42.5 55.59 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -73.08 -16.23 61.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.748 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 23' ' ' LEU . 12.6 tt -107.19 134.01 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -86.15 108.78 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -66.68 -38.61 19.67 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 35.9 Cg_exo -58.02 -33.69 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.479 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -59.38 -37.87 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.579 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.5 mt -82.36 -20.4 37.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.137 0.494 . . . . 0.0 109.692 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.62 3.85 90.35 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.399 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 94.3 mmm -147.85 171.17 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.897 0.38 . . . . 0.0 109.995 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.1 mtt -94.99 157.15 16.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.7 t -125.05 150.24 46.98 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -129.45 148.81 51.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.844 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 t -94.0 123.91 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.8 p -73.27 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.92 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.4 157.37 8.13 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.37 151.97 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.374 . . . . 0.0 110.771 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -135.96 142.21 44.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.9 mtt -96.95 139.02 33.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.257 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.5 p -73.88 160.73 31.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.269 0.557 . . . . 0.0 110.782 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 45' ' ' ARG . 1.1 mpt_? -59.59 -32.35 70.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.694 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.2 m-20 -83.06 -4.34 58.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.098 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.8 mt 60.08 5.6 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -95.94 -22.94 17.1 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.972 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -124.13 143.96 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.65 141.94 49.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.09 120.15 37.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.74 133.68 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.251 0.548 . . . . 0.0 109.798 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.77 136.19 50.2 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.298 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.99 147.09 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.04 0.448 . . . . 0.0 111.141 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -140.29 151.33 45.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.273 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.65 160.77 42.48 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.182 0.515 . . . . 0.0 111.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.0 mm? -67.34 -18.91 65.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.643 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -80.96 1.96 28.86 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.1 p30 -64.33 -15.08 59.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 60.9 tttm -69.09 -39.97 78.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.334 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -93.43 115.96 28.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.449 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.99 -35.95 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.29 -39.17 93.38 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.1 83.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.73 -39.14 83.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.16 -45.54 91.36 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.95 -36.38 77.86 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.3 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.44 52.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.737 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.7 -39.98 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.299 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.52 -36.96 83.98 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.907 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.9 77.53 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.53 -36.45 73.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.207 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.57 -45.64 68.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.155 0.502 . . . . 0.0 110.475 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.24 -37.01 74.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.244 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.48 -12.83 60.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -49.16 77.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.56 86.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.245 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -66.61 -44.57 81.73 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.535 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.29 -40.81 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.556 0.693 . . . . 0.0 110.559 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.523 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 62.3 ttt180 -63.88 -46.6 84.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.551 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 t -68.7 -37.29 79.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.646 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 27.6 mt -65.58 -35.98 82.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.493 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.3 -48.44 64.93 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.831 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.92 -41.2 73.04 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -70.72 -43.76 68.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.391 -0.904 . . . . 0.0 112.173 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' LEU . . . -63.21 -43.37 98.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.7 mtt -85.42 -15.42 43.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 81.4 mtm180 59.95 26.1 15.33 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.531 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.37 150.31 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.382 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' A' ' 92' ' ' VAL . 70.5 mtp85 -100.87 -9.58 21.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.248 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 tt -59.07 -2.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 92' ' ' VAL . 27.3 m -70.36 116.09 41.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 172.5 14.45 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.841 1.694 . . . . 0.0 111.942 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.523 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 77.2 mm-40 -59.85 134.53 57.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.9 mt -100.65 128.32 46.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.957 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -113.26 127.32 56.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.52 129.06 55.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.195 0.522 . . . . 0.0 112.097 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -118.53 137.32 53.29 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 46.1 p90 -110.27 132.78 53.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.421 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HB2' ' HE ' ' A' ' 10' ' ' ARG . 99.2 mm-40 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.528 0.204 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.671 ' HE ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -59.93 -39.69 86.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.213 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.73 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.299 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.96 81.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.107 0.479 . . . . 0.0 110.338 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.78 -46.81 62.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.652 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.38 -36.87 85.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.054 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.5 mtt -71.93 -40.89 68.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.429 HE22 HG11 ' A' ' 38' ' ' VAL . 37.7 tp60 -54.86 -45.87 74.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.22 -45.8 86.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.26 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 85.2 tt0 -61.65 -33.89 74.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.2 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.97 -42.6 77.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.29 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -36.62 84.78 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.67 -52.94 54.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.076 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.0 mt -70.1 -35.03 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.4 tp -60.65 -41.74 95.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.779 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -82.58 -41.29 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.313 0.578 . . . . 0.0 111.286 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -70.3 -40.8 74.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.57 -16.71 61.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.333 0.587 . . . . 0.0 110.195 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 23' ' ' LEU . 17.8 tt -116.05 149.48 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.326 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -67.3 122.85 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 110.059 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.07 -61.87 4.33 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.956 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.17 -27.63 57.21 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.727 1.618 . . . . 0.0 112.814 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -59.5 -38.04 79.86 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.215 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 70.4 mt -103.79 -2.18 26.76 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.0 5.86 72.79 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.4 ttt 63.03 8.44 3.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.2 mmm -81.35 18.4 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.1 m -76.03 128.05 34.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.319 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -132.7 143.06 49.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.967 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.429 HG11 HE22 ' A' ' 16' ' ' GLN . 40.5 t -98.72 120.35 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.944 0.402 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 m -63.95 -36.14 82.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.256 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.72 155.84 7.45 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 m -127.39 152.27 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.957 0.408 . . . . 0.0 110.819 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -132.79 141.9 48.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.226 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.3 mtt -113.79 142.27 46.28 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.5 m -73.51 151.92 40.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -63.71 -29.58 70.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.337 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -83.6 -3.84 58.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 mt 60.38 24.54 14.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 -45.98 5.82 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.307 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -119.65 146.75 45.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.15 0.5 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.45 142.23 41.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.159 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.41 124.21 43.96 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.33 134.52 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.038 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -113.91 138.27 50.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.26 148.17 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.28 0.562 . . . . 0.0 111.187 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 m -141.67 132.8 26.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -135.93 146.44 47.31 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 178.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 57' ' ' LEU . 7.0 mp -64.29 -23.03 67.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 83.8 m-20 -81.13 -7.0 59.47 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.33 -16.03 51.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -66.65 -33.09 74.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -89.91 117.96 29.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.29 -39.75 94.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.482 0.658 . . . . 0.0 109.432 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.76 -36.01 81.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 69' ' ' ILE . 73.3 t -64.47 -39.7 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.5 -41.41 88.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.05 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -47.14 62.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.84 -50.46 41.44 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.274 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.7 tt -59.39 -34.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.493 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.79 -41.21 87.98 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.381 0.61 . . . . 0.0 109.522 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 -40.88 75.09 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.041 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -70.31 -37.67 74.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -68.64 -45.11 72.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.278 0.561 . . . . 0.0 110.163 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -69.79 -37.18 76.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.908 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -9.2 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.0 p -57.42 -50.67 72.26 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.89 93.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.52 -41.53 84.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.62 -39.72 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.645 0.736 . . . . 0.0 109.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -63.31 -46.01 88.68 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.6 t -68.37 -36.64 79.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.434 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.57 -38.75 87.71 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.094 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 mt -68.99 -50.46 48.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.709 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.81 -44.13 97.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.54 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -71.3 -42.2 68.95 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.81 97.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.96 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 63.4 mtm -87.29 -19.49 28.19 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 84' ' ' GLY . 50.9 ttm-85 61.61 41.84 11.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.479 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.5 mm? -90.9 141.16 29.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.994 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -88.22 -26.34 22.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.532 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -89.75 45.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.569 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 114.2 28.65 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.133 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 78.6 Cg_endo -80.61 163.31 21.47 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.613 1.542 . . . . 0.0 111.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -72.39 130.75 41.45 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 1.6 mm? -93.17 128.18 39.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.155 0.502 . . . . 0.0 110.894 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 m -114.98 121.28 42.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -101.02 129.71 46.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.086 0.47 . . . . 0.0 111.818 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -119.77 138.95 53.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.393 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -102.0 132.3 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.579 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.78 0.324 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.25 -39.7 83.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.397 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.24 -40.84 84.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.54 86.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -65.88 -43.02 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.17 -37.37 84.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt -73.55 -36.04 65.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.9 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.03 -47.73 80.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -66.46 -37.34 84.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.984 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.4 tt0 -65.78 -40.39 91.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.28 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.35 -42.27 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 -38.12 89.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.282 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.07 -52.26 63.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.129 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.42 -33.48 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 60.7 tp -57.67 -36.33 71.77 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.375 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -84.4 -36.02 22.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -76.98 -47.74 19.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -75.45 -3.89 36.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.113 0.482 . . . . 0.0 110.346 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 47.5 mm -114.29 126.68 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.946 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -82.46 102.86 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 1.3 m-20 -78.34 -36.76 1.33 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.496 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 84.1 Cg_exo -48.47 -38.19 34.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.635 1.557 . . . . 0.0 113.323 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.41 -37.6 87.9 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.771 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.45 -20.18 34.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 109.795 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.55 84.84 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.2 mtt -147.89 156.25 42.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 110.313 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.2 mtm -97.69 148.04 23.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 p -87.63 156.05 19.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 p -124.13 160.93 26.71 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' GLY . 47.7 t -106.26 128.71 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.829 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t -88.54 -14.91 36.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' H ' HG12 ' A' ' 38' ' ' VAL . . . 157.7 148.54 5.16 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG13 HG12 ' A' ' 52' ' ' VAL . 22.0 t -124.58 128.84 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.43 139.98 53.38 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.979 0.418 . . . . 0.0 110.778 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.4 mtt -117.1 142.59 46.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.66 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.2 m -73.34 152.16 41.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -59.48 -31.67 69.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.528 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.4 -3.82 57.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.287 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.63 29.21 18.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.22 -49.17 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.031 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -117.17 144.48 44.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.924 0.392 . . . . 0.0 111.021 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.99 141.08 50.22 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.615 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -122.59 117.84 26.79 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.382 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 HG13 ' A' ' 41' ' ' VAL . 1.7 m -120.9 135.41 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 120.708 0.289 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.0 135.48 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 m -133.27 149.83 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.122 0.487 . . . . 0.0 111.379 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -131.35 156.43 45.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.948 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -157.5 153.57 27.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 111.814 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.65 -12.27 59.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -80.08 3.65 19.69 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -66.16 -15.6 63.27 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.87 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -67.87 -39.97 83.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.431 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -92.45 115.14 27.83 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.173 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.41 -34.54 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.57 -38.72 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.5 80.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.54 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.25 -46.15 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.601 . . . . 0.0 109.899 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -67.98 -47.77 67.65 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.86 -45.36 64.6 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.555 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -51.94 53.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.899 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.14 -34.84 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.021 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.35 -40.75 96.47 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.94 87.03 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.529 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.8 -36.78 81.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.358 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -68.15 -45.08 74.53 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.343 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.42 -36.99 74.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.254 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.06 -8.29 57.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.053 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -55.18 -48.64 73.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.426 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.37 -38.26 90.03 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.084 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.56 -42.17 92.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.604 0.24 . . . . 0.0 111.308 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.65 -42.62 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 63.3 ttt180 -63.12 -46.71 86.02 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.346 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 t -70.28 -36.94 74.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.375 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.63 -35.56 80.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.435 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -68.4 -50.4 53.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.97 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.5 -43.56 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.236 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.72 -40.84 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.179 0.514 . . . . 0.0 111.713 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.76 99.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.48 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 58.3 mtm -93.94 -8.89 38.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 91.9 mtt-85 54.86 36.03 25.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.62 141.13 32.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -97.73 -10.76 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.29 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -94.53 30.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -73.23 118.46 68.82 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 161.93 30.58 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.505 1.47 . . . . 0.0 111.834 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 78.1 mm-40 -60.08 136.17 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.53 130.85 47.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 0.0 111.059 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.3 m -120.79 128.39 52.84 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.87 126.25 54.9 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.994 0.426 . . . . 0.0 111.644 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -119.96 138.67 53.33 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -110.22 129.78 55.66 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.282 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.246 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.625 0.25 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.09 -37.86 78.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.652 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -38.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 0.0 110.274 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.8 82.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.455 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -71.62 -46.38 59.29 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.952 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -62.64 -36.55 83.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.9 ttm -70.51 -40.57 73.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.09 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.03 -41.96 75.79 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -62.64 -45.04 94.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.018 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.61 -33.18 75.04 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.469 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.23 -42.41 78.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.413 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.79 85.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.098 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.92 -52.49 64.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.602 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.2 mt -68.67 -33.9 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.128 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.3 tp -56.17 -43.29 78.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.1 mt-30 -83.1 -40.05 20.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 111.809 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -70.05 -39.96 75.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -72.56 -14.99 61.76 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.076 0.465 . . . . 0.0 110.377 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -119.23 143.34 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -83.45 115.11 21.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -69.99 -38.19 8.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.58 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.42 -37.28 81.72 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.816 1.677 . . . . 0.0 112.242 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -59.94 -37.8 80.57 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.362 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -78.24 -20.93 50.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.38 5.34 87.18 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm -171.82 154.69 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.655 0.264 . . . . 0.0 110.475 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.9 mtp -83.24 138.11 33.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -88.42 158.07 18.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -122.87 143.7 49.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.543 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.52 122.76 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -65.39 -36.09 82.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.08 159.17 9.13 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.18 148.83 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.896 0.379 . . . . 0.0 110.925 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -122.91 142.1 51.17 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.1 mmm -109.42 142.29 40.6 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.86 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -73.11 155.01 40.14 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 110.372 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -58.31 -34.25 70.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.499 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -83.69 -4.57 58.72 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 110.807 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.61 32.99 21.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.84 -46.59 3.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.609 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.89 140.85 48.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.426 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.23 141.62 51.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.907 0.384 . . . . 0.0 110.801 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.29 130.59 55.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.169 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.66 134.34 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.002 0.429 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.05 133.87 53.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -131.14 147.17 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.345 0.593 . . . . 0.0 112.062 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -146.29 150.52 35.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.371 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.91 155.65 29.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.844 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.8 mt -72.85 -14.77 61.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.744 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -81.07 3.43 23.3 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 50.4 p30 -66.37 -15.85 63.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.115 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -68.62 -36.4 78.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.355 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -91.03 117.09 29.31 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.14 -34.94 74.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.35 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.07 -38.32 90.41 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.44 0.638 . . . . 0.0 109.454 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.45 83.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.842 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.69 -41.93 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 109.584 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.68 -42.7 86.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.584 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.7 -44.77 66.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.012 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.98 -51.11 48.1 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.185 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 -37.15 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.002 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -65.39 -40.03 92.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.57 -41.76 83.65 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.554 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.1 -36.43 81.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.397 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.95 -45.95 69.42 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.148 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -71.29 -37.11 71.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.261 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.2 -6.31 54.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.505 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.5 p -58.9 -52.52 65.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.193 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.64 92.88 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.643 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -66.79 -44.38 81.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -68.11 -38.21 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.116 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -64.21 -47.16 80.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.558 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -71.09 -37.85 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.814 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.66 -36.99 85.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.407 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 ' SD ' ' A' ' 87' ' ' MET . 6.2 tt -69.14 -48.52 62.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.806 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.67 -42.32 99.74 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.11 -40.38 74.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.051 0.453 . . . . 0.0 111.598 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.74 96.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.157 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.432 ' SD ' HD21 ' A' ' 83' ' ' LEU . 62.1 mtt -88.22 -17.35 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.482 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 84' ' ' GLY . 72.7 mtm180 54.18 36.99 26.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.09 139.62 30.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.012 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 92' ' ' VAL . 89.0 mtt180 -92.36 -38.53 11.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.91 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.9 pt -73.55 26.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 90' ' ' ARG . 60.0 t -73.22 114.13 28.42 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 119.289 -0.386 . . . . 0.0 109.975 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.4 159.63 25.89 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.54 1.493 . . . . 0.0 111.632 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.45 137.38 58.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.56 130.01 46.57 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.223 0.535 . . . . 0.0 111.001 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.4 m -123.78 135.38 53.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.85 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -117.08 139.79 50.29 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.452 0.644 . . . . 0.0 112.134 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -121.66 153.94 37.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.728 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -109.15 134.07 52.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.649 -179.324 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.898 0.38 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -59.37 -37.9 79.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.099 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.92 -40.39 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.66 88.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.55 -39.94 94.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.484 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.57 -37.2 82.98 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.18 -42.76 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.525 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -55.75 -44.68 77.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.452 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -64.32 -46.8 81.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.542 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.71 -33.62 74.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.917 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.14 -42.44 79.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.61 84.87 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.106 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HH11 ' A' ' 25' ' ' ARG . 43.0 tp -61.15 -53.4 57.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.037 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.78 -33.52 56.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.455 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.52 -44.37 76.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.855 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.8 mt-30 -82.1 -40.91 21.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 111.686 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.541 HH11 HD11 ' A' ' 21' ' ' LEU . 24.7 ttm180 -69.65 -37.58 76.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.126 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 45.5 tp10 -71.99 -17.09 62.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.205 0.526 . . . . 0.0 109.974 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.7 pt -118.54 150.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.796 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -81.93 115.14 20.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -70.8 -37.85 6.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -179.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 44.2 Cg_exo -56.87 -38.15 96.53 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.839 1.693 . . . . 0.0 112.499 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -60.1 -37.54 80.3 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.14 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.526 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 64.9 mt -92.36 -8.02 46.16 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.558 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.79 28.61 50.39 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mtm 56.17 -126.21 2.01 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.464 -0.199 . . . . 0.0 110.464 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.409 ' SD ' HD12 ' A' ' 57' ' ' LEU . 71.8 mtm 45.24 48.2 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.618 0.247 . . . . 0.0 111.037 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.5 m -120.24 130.45 54.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.855 0.359 . . . . 0.0 110.386 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -132.94 145.15 50.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.6 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -92.78 118.64 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 55' ' ' THR . 44.2 m -65.75 -35.4 80.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.587 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.42 152.31 6.23 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 52' ' ' VAL . 43.3 t -125.47 134.41 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.922 0.392 . . . . 0.0 110.95 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.52 141.43 49.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.039 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.3 mmm -111.45 141.85 44.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.521 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.7 m -73.45 151.76 40.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.585 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -60.67 -30.46 69.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.322 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 57.7 t0 -82.62 -3.86 56.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 9.4 mp 56.57 29.75 16.09 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.31 -49.02 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.737 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -116.92 143.56 45.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.74 141.59 51.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.434 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -113.08 127.77 56.3 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 41' ' ' VAL . 55.2 t -118.21 132.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.309 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -119.77 127.38 52.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 150.71 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.246 0.546 . . . . 0.0 111.798 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.501 HG23 ' OG ' ' A' ' 39' ' ' SER . 22.2 p -131.01 149.87 52.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.895 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' A' ' 59' ' ' ASP . 6.3 p90 -156.2 155.34 32.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.358 0.599 . . . . 0.0 111.606 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.409 HD12 ' SD ' ' A' ' 35' ' ' MET . 64.7 mt -77.3 -13.58 59.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.602 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 71.3 m-20 -80.91 0.18 36.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 7.3 m-20 -61.93 -19.53 62.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -68.22 -34.94 77.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.103 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.78 115.74 27.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.048 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 51.0 mp0 -59.69 -34.27 72.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.35 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.97 -37.34 87.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.376 0.608 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.17 83.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.554 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 69' ' ' ILE . 78.1 t -69.72 -47.04 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.16 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.98 -46.33 71.64 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.357 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.06 -46.34 65.18 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.213 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.44 -51.41 48.86 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.455 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.5 tp -60.12 -34.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.473 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -67.1 -40.23 86.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.251 0.548 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.19 -41.86 76.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.843 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.3 -36.65 74.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.136 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -68.78 -45.38 71.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.243 0.544 . . . . 0.0 110.316 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -70.6 -37.08 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.35 -8.63 57.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.544 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.7 m -56.12 -50.46 71.02 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.036 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.69 94.31 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CE1' ' OE2' ' A' ' 26' ' ' GLU . 35.4 t80 -63.4 -43.15 98.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.64 -39.44 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.421 0.629 . . . . 0.0 110.359 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 74.2 ttt-85 -60.95 -46.16 91.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.937 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -70.21 -37.75 75.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.533 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.63 -37.84 76.97 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.82 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD21 ' CE ' ' A' ' 87' ' ' MET . 8.4 tt -68.78 -46.43 68.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.078 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -60.32 -42.48 98.83 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.99 -36.48 75.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.465 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.83 95.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.508 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 83' ' ' LEU . 66.0 mtm -101.52 -3.91 27.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 53.41 43.77 30.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.505 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.1 mt -100.55 141.07 33.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.142 0.496 . . . . 0.0 111.701 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -97.99 -10.82 23.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.95 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 91' ' ' ILE . 22.3 pt -98.56 21.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -72.7 116.46 50.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.05 160.63 26.84 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.713 1.608 . . . . 0.0 112.068 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' A' ' 80' ' ' ARG . 78.3 mm-40 -60.42 137.45 58.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.5 mt -100.37 130.15 46.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.961 0.41 . . . . 0.0 110.676 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.7 m -119.95 127.48 52.7 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -108.0 126.41 52.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.144 0.497 . . . . 0.0 111.308 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -120.93 138.26 54.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.333 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 99' ' ' TYR . 37.7 p90 -107.74 113.85 27.39 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.866 0.365 . . . . 0.0 110.318 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.9 t0 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.935 179.654 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.756 0.312 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -59.5 -39.93 85.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.53 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.56 -40.23 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.92 91.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.183 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -63.86 -39.9 95.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.368 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.5 -37.64 84.42 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.2 -43.77 66.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.925 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.31 -42.44 77.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.337 0.589 . . . . 0.0 109.842 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.92 -49.82 71.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.228 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.66 -35.34 80.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.306 0.574 . . . . 0.0 110.747 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.155 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.284 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.57 -53.36 58.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.345 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.3 mt -70.23 -34.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.442 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.8 tp -55.95 -45.53 78.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.785 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 12.5 pt20 -84.49 -42.03 15.97 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.973 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 24' ' ' GLN . 50.7 mtp180 -70.45 -33.76 71.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -72.25 -15.75 61.92 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.452 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.8 pt -119.4 149.68 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.669 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.36 117.26 29.85 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -74.12 -38.12 3.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.496 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.2 Cg_exo -55.61 -31.61 79.94 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.108 1.872 . . . . 0.0 112.554 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.54 -37.72 79.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.684 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 mt -81.51 -20.06 40.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.979 0.419 . . . . 0.0 109.918 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.35 5.52 89.51 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.3 mtt -143.95 168.78 19.17 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.2 mtp -113.02 158.08 20.74 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 55' ' ' THR . 13.2 t -128.74 153.71 47.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.529 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.6 m -127.57 148.04 50.35 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.84 118.59 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.4 p -67.8 -30.51 69.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.14 157.41 8.04 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.57 152.82 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -130.36 141.05 50.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -103.75 141.66 35.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.936 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 67.5 m -73.06 154.69 40.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.639 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -58.21 -32.47 68.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.572 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -82.93 -3.99 57.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.449 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 58.87 26.58 15.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -104.86 -47.91 3.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.849 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.418 ' O ' ' OG ' ' A' ' 44' ' ' SER . 87.5 m-85 -114.69 143.7 44.62 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.885 0.374 . . . . 0.0 110.541 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.22 141.39 51.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -108.41 128.57 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.991 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.33 133.39 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.6 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.86 132.26 55.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 22.0 t -131.13 148.03 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.345 0.593 . . . . 0.0 111.874 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 36' ' ' THR . 37.5 m -119.2 129.34 54.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.838 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CZ ' HG11 ' A' ' 54' ' ' VAL . 84.8 m-85 -119.67 142.01 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.897 0.379 . . . . 0.0 111.778 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.67 -13.54 57.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 82.1 m-20 -81.34 -0.41 41.04 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.9 p30 -66.03 -15.01 62.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.96 177.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 61.2 tttp -67.37 -39.86 85.7 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.544 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -109.28 117.7 34.78 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -58.34 -35.86 72.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.85 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.36 -38.0 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.685 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.0 -45.56 73.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.64 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 69' ' ' ILE . 7.4 p -73.35 -33.41 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.37 . . . . 0.0 111.149 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.08 -40.52 94.75 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.39 -46.1 64.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.35 -50.23 39.94 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.533 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.8 tt -59.26 -34.67 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.247 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.47 -41.52 88.88 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.86 76.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.909 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.04 -36.61 75.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.637 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.15 -44.34 76.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.218 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.85 -36.57 80.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.281 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.12 -9.0 58.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.256 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.4 m -55.82 -45.99 78.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.159 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.75 -38.29 91.67 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -64.87 -42.91 94.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.019 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -58.22 -39.62 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.592 0.71 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 94' ' ' GLU . 75.3 ttt-85 -61.42 -44.76 96.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.442 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 t -70.12 -36.75 75.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.617 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -69.37 -41.43 76.55 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.58 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 tt -69.05 -48.48 62.73 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.633 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -65.68 -44.02 93.25 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.553 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.72 -37.89 73.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 112.024 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' LEU . . . -60.94 -42.73 98.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 74.7 mtm -99.83 -5.95 27.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.836 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' GLY . 66.4 mtt85 49.52 40.88 20.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.43 138.7 31.37 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.626 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -92.49 -38.4 11.97 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.223 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 pt -78.46 19.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.519 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.9 p -72.67 114.42 30.05 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.98 157.88 30.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.501 1.468 . . . . 0.0 112.099 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 38.0 mp0 -60.96 139.87 57.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.99 132.81 46.22 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.014 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.2 m -119.0 128.03 54.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.91 127.32 51.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.282 0.563 . . . . 0.0 111.426 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 52.0 t80 -126.91 147.73 50.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 51.1 p90 -101.28 129.13 47.19 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.767 0.318 . . . . 0.0 110.223 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.791 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -59.02 -37.24 76.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.298 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.57 -40.51 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.042 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.54 87.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.592 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.85 -43.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.597 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.32 -39.32 92.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mmt -66.98 -42.17 85.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.442 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.88 -41.92 88.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.783 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -63.48 -47.36 82.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.095 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -62.96 -35.33 79.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.07 -42.88 79.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.58 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.41 84.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.471 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.7 tp -60.76 -53.38 58.11 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.26 -34.48 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.514 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.11 -45.87 79.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.905 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.3 mt-30 -83.23 -39.33 21.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.114 0.483 . . . . 0.0 112.068 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -69.79 -38.76 76.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.05 -16.1 62.03 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.907 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 24' ' ' GLN . 9.6 pt -116.58 149.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.304 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -86.61 125.8 34.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.51 -63.0 1.05 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.612 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -56.94 -23.82 53.53 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -58.94 -37.1 75.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.199 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -77.62 -20.55 53.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.43 5.09 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 62.4 mtt -146.73 167.8 22.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.812 0.339 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -104.9 152.49 22.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.625 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -130.68 155.29 46.85 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.798 0.332 . . . . 0.0 110.752 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -137.4 159.03 43.1 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.423 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 38' ' ' VAL . 11.7 p -98.12 123.11 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.7 p -69.93 -28.7 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.26 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.71 153.89 6.48 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.2 148.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.744 0.307 . . . . 0.0 110.454 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -129.26 139.69 51.72 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.5 mmt -105.81 142.41 35.58 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.8 t -73.76 151.94 40.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.136 0.493 . . . . 0.0 110.343 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.24 -29.99 66.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.623 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.7 -3.36 57.71 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.546 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? 56.51 29.9 16.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.79 -48.41 3.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.789 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -116.78 141.57 48.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.46 51.86 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.452 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.69 127.7 54.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.34 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.48 133.27 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.623 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.08 133.66 55.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.27 149.79 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.442 0.639 . . . . 0.0 111.84 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -129.67 135.98 49.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.49 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 65' ' ' VAL . 15.7 p90 -146.02 154.77 42.24 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.546 0.689 . . . . 0.0 112.22 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.3 mm? -80.08 -11.26 59.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.592 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.488 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 88.1 m-20 -79.49 -0.25 32.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.0 p30 -68.09 -14.84 63.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 35.1 ttpt -69.27 -38.51 78.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.541 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.59 119.03 38.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.018 0.437 . . . . 0.0 110.114 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 50.7 mp0 -59.48 -32.97 70.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.22 -39.02 75.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.254 0.549 . . . . 0.0 110.794 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.05 74.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.748 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 69' ' ' ILE . 14.5 p -69.93 -33.58 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.448 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.75 -44.51 85.7 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.22 -44.77 67.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.39 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.8 -50.73 39.76 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.485 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.3 tt -59.46 -34.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.922 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -66.1 -42.19 89.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -40.72 87.25 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.649 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.92 -36.26 79.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -68.92 -45.63 70.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.083 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.15 -37.08 72.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.95 -8.91 58.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.177 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -57.09 -50.09 73.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.122 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.38 90.78 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.33 -43.6 94.13 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.269 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -58.61 -41.57 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 109.744 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 94' ' ' GLU . 39.8 ttm180 -63.14 -46.76 85.7 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -70.64 -38.04 73.83 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.98 -38.58 79.41 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.002 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.94 -40.61 83.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.157 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.89 -34.54 71.52 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -67.53 -43.29 81.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.392 -0.904 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.19 85.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.594 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtt -85.68 -17.19 36.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.5 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 84' ' ' GLY . 73.9 mtp180 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.244 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 92' ' ' VAL . 86.3 mt -101.15 141.55 33.88 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.124 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -97.43 -14.95 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.559 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 91' ' ' ILE . 37.7 pt -86.69 21.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 89' ' ' LEU . 59.4 t -72.85 114.14 27.8 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.141 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 89.3 Cg_endo -77.66 161.59 30.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.298 1.332 . . . . 0.0 111.098 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 80' ' ' ARG . 79.0 mm-40 -64.62 136.49 57.04 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.249 -0.581 . . . . 0.0 109.521 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' PRO . 7.1 mp -98.94 129.87 45.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.062 0.458 . . . . 0.0 110.365 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -117.9 127.63 54.04 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.28 126.65 51.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.126 0.489 . . . . 0.0 111.157 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 48.1 t80 -126.17 146.14 50.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.475 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 47.9 p90 -99.8 129.02 45.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.855 0.36 . . . . 0.0 110.435 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 56.3 p-10 . . . . . 0 N--CA 1.474 0.772 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.378 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.823 0.344 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -59.29 -38.18 79.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.152 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.77 -40.79 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.81 88.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.146 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.48 -40.88 96.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.607 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.44 -36.96 81.83 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.3 -39.09 65.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.268 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -49.11 76.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.548 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HG2' ' HZ3' ' A' ' 17' ' ' LYS . 1.5 ptpp? -67.18 -37.71 84.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.099 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.1 tt0 -68.76 -39.94 80.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.43 -42.78 97.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.36 86.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 HH11 ' A' ' 25' ' ' ARG . 27.9 tp -60.68 -52.92 63.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.25 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -69.14 -34.01 61.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.22 -42.31 85.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.577 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -82.43 -41.89 19.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.307 0.575 . . . . 0.0 111.337 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.523 HH11 HD11 ' A' ' 21' ' ' LEU . 24.6 ttm180 -70.23 -37.15 74.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.35 -177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.22 -15.28 61.94 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.181 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 27' ' ' ILE . 13.1 pt -113.89 150.42 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.18 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -78.5 130.52 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.028 0.442 . . . . 0.0 110.342 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.59 -62.0 3.31 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.962 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.74 -28.18 55.89 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.714 1.609 . . . . 0.0 112.725 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.31 -37.77 78.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.447 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 72.2 mt -99.02 -1.94 38.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.143 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.9 9.16 62.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm 58.97 60.79 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.571 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.423 ' SD ' HD23 ' A' ' 57' ' ' LEU . 62.2 mtt -150.6 72.8 1.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.555 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.4 p -126.04 140.92 52.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.6 m -139.71 142.78 36.85 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.208 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.2 p -95.76 117.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 m -68.21 -31.19 70.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.63 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.53 6.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 52' ' ' VAL . 17.1 t -125.41 133.0 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -131.73 141.25 49.48 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.6 mpt? -111.44 143.17 42.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.412 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.5 t -72.63 151.86 42.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.662 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -56.29 -35.01 67.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.383 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.07 -4.98 58.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.695 0.283 . . . . 0.0 110.757 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 91' ' ' ILE . 7.9 tp 60.01 34.45 21.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.61 -48.23 3.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.674 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -117.79 139.13 51.5 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.428 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.84 141.11 52.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.804 0.335 . . . . 0.0 110.226 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -119.58 118.79 31.94 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.96 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 41' ' ' VAL . 1.2 m -119.43 134.66 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.014 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -108.56 136.35 48.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.058 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.33 150.82 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.1 0.476 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -140.95 152.06 44.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.023 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -156.04 146.77 21.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.392 0.615 . . . . 0.0 111.646 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.423 HD23 ' SD ' ' A' ' 35' ' ' MET . 32.4 tp -66.05 -18.67 65.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.411 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 25.3 m120 -80.4 2.48 24.83 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.7 p30 -65.64 -15.12 62.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -70.22 -35.61 74.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.502 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -90.51 119.83 31.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.755 0.312 . . . . 0.0 110.368 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.6 -37.47 81.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.679 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -63.5 -38.92 92.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.483 0.658 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.08 82.33 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.96 -47.08 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.352 0.596 . . . . 0.0 109.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.52 -38.48 84.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.659 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.24 65.43 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.206 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.54 -52.71 15.02 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.045 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 99' ' ' TYR . 79.0 mt -59.91 -39.68 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.248 0.524 . . . . 0.0 112.064 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.37 -35.82 80.12 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.048 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.16 68.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.739 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.11 -36.99 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.765 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.25 -45.49 73.07 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.33 0.586 . . . . 0.0 110.261 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.95 -36.93 75.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.082 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.66 -7.24 59.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.655 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.5 m -55.55 -50.01 71.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.685 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.15 -35.62 85.02 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -64.93 -45.98 83.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.88 -39.54 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.512 0.673 . . . . 0.0 110.123 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -62.03 -45.07 95.2 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.526 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -71.01 -38.25 72.63 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 82' ' ' LEU . 1.1 tm? -69.28 -42.41 75.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.73 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.88 -39.72 83.66 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.763 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.77 -39.46 76.63 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -68.38 -38.02 80.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.189 -1.005 . . . . 0.0 111.347 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.9 99.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.558 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 69.0 mtm -98.34 -6.92 29.86 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 98.8 mtt180 49.59 38.27 14.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 109.316 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.1 tp -90.98 140.4 29.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.968 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -90.08 -38.59 13.45 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.731 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.412 HD12 ' CD2' ' A' ' 47' ' ' LEU . 25.8 pt -78.28 34.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.731 0.3 . . . . 0.0 111.744 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 89' ' ' LEU . 88.3 t -73.46 115.31 40.09 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.8 161.31 30.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.366 1.377 . . . . 0.0 111.884 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.27 138.36 58.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.24 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -122.23 131.23 53.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.397 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -108.54 130.33 55.29 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.048 0.451 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -119.43 141.23 49.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' HG23 ' A' ' 69' ' ' ILE . 2.9 m-85 -97.77 118.62 34.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 111.524 -179.014 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.679 0.276 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -57.58 -37.23 72.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.215 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.56 -38.82 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.612 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -63.05 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.99 -36.11 80.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.4 mtt -73.17 -38.99 66.0 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.987 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.4 -49.06 78.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.087 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -67.8 -40.77 83.85 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.071 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.98 -38.66 86.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.63 -44.06 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -37.04 86.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.3 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD11 HH11 ' A' ' 25' ' ' ARG . 31.8 tp -61.29 -53.32 58.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.043 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 83' ' ' LEU . 81.1 mt -69.71 -34.27 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.716 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.7 tp -57.99 -41.9 84.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -83.3 -38.16 22.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.209 0.528 . . . . 0.0 111.909 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.546 HH11 HD11 ' A' ' 21' ' ' LEU . 30.5 ttm180 -71.16 -43.87 66.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.1 -13.82 61.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.52 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -112.17 142.44 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -80.25 117.15 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 6.8 t70 -73.2 -35.6 2.83 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.8 Cg_exo -55.66 -29.82 72.46 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.966 1.778 . . . . 0.0 113.176 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -59.99 -36.64 77.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.742 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.36 -20.02 55.39 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.368 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.66 5.79 74.14 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.594 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 14.8 ptp -174.75 175.7 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.5 mtm -89.14 161.23 16.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.268 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -124.07 155.15 38.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.656 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.0 p -121.35 160.9 23.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.943 0.402 . . . . 0.0 110.96 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -108.43 123.75 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.828 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.436 ' CB ' ' OD2' ' A' ' 100' ' ' ASP . 23.2 t -68.31 -35.55 77.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.6 158.49 8.28 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.15 147.01 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 110.986 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -119.51 138.14 53.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.522 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.9 mmm -108.62 142.26 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 m -72.93 152.01 41.61 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -63.59 -30.5 71.61 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.409 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -83.68 -2.64 56.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.118 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.6 32.86 21.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -108.75 -47.66 3.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.174 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -117.28 139.02 51.34 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.0 0.428 . . . . 0.0 111.179 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.53 141.5 51.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -113.67 130.03 56.47 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.188 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.69 133.82 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.705 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.84 132.44 56.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.9 151.06 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.098 0.475 . . . . 0.0 111.857 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -144.19 149.86 37.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 59' ' ' ASP . 6.9 p90 -159.21 159.95 34.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.29 0.567 . . . . 0.0 111.577 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.95 -25.76 66.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.401 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.594 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 27.6 m120 -80.31 0.93 30.78 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.891 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 13.8 m-20 -63.43 -15.1 56.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -69.44 -36.7 76.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.049 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -91.09 113.9 26.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.19 -35.99 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.81 -38.1 89.85 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.42 0.629 . . . . 0.0 109.458 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.59 84.24 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 69' ' ' ILE . 69.9 t -67.51 -38.48 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -66.43 -40.75 89.7 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.03 66.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.72 -50.07 32.66 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.644 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.8 tp -58.67 -38.7 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.663 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.27 -36.18 79.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.58 80.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.719 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.35 -36.56 74.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.962 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -68.8 -45.36 71.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.138 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.9 -37.09 72.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.955 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.62 -7.8 57.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.067 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 t -57.85 -52.86 63.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.565 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.45 93.86 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.954 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.74 -44.56 85.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -68.86 -37.29 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.174 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.74 -46.45 88.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.666 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 t -67.62 -38.12 83.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.1 tp -68.93 -34.38 75.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.262 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 HD12 ' A' ' 22' ' ' ILE . 13.6 tp -66.83 -46.79 74.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.744 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -58.61 -40.97 95.36 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.851 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.58 -40.8 93.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.94 0.4 . . . . 0.0 111.212 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.77 99.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtt -82.21 -17.3 46.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' GLY . 83.1 mtp180 57.85 34.01 23.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.261 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.08 141.44 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.737 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -97.93 -10.23 24.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.453 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 91' ' ' ILE . 2.6 pp -106.96 34.21 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.4 p -73.27 124.77 90.89 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ALA . 88.8 Cg_endo -75.52 157.97 40.36 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.436 1.424 . . . . 0.0 112.304 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 39.3 mp0 -61.43 138.73 58.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.7 130.55 48.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.478 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 m -121.98 131.37 53.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.727 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.87 128.83 54.96 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.223 0.535 . . . . 0.0 111.015 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 41.5 t80 -129.64 152.28 49.32 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.7 p90 -104.81 132.43 51.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.658 0.266 . . . . 0.0 110.53 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' CB ' ' A' ' 39' ' ' SER . 56.3 p30 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.626 0.25 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -58.29 -40.5 82.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.386 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 p -59.41 -38.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.729 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' GLN . . . -62.13 -39.12 91.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -66.06 -42.66 89.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.15 -39.52 92.91 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 19' ' ' ILE . 58.5 mtt -74.06 -35.61 64.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.107 177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . 49.4 tt0 -57.33 -48.8 78.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.563 . . . . 0.0 110.617 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -68.7 -36.46 78.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.075 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.03 -41.42 86.59 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.659 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 83' ' ' LEU . 41.0 pt -69.56 -36.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.517 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.555 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.24 -52.93 51.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.759 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.54 -33.58 57.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.044 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.2 -40.08 84.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.577 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.84 -44.07 19.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.397 0.618 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -69.85 -35.12 74.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.849 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -72.04 -14.34 61.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.016 0.436 . . . . 0.0 109.988 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.85 149.86 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.083 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.79 107.61 19.48 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.53 -41.92 93.07 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.93 -178.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 34.3 Cg_exo -61.69 -33.96 84.89 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.185 1.923 . . . . 0.0 112.815 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.98 -39.51 85.93 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.55 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 mt -104.91 -19.76 13.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 69.83 16.99 72.89 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 ttp -108.04 145.77 33.51 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.634 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -103.04 144.46 31.25 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.122 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.484 HG23 ' CE2' ' A' ' 56' ' ' PHE . 70.6 m -110.7 132.06 54.52 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -128.88 156.44 43.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 116.22 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.914 0.387 . . . . 0.0 110.544 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.9 t -70.63 -30.69 67.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.602 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.64 156.14 8.37 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.37 132.18 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.692 0.282 . . . . 0.0 110.846 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -127.17 137.84 53.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.176 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtt -109.86 143.71 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.8 t -77.29 151.09 35.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.117 0.484 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -60.97 -31.05 70.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.939 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' C ' ' N ' ' A' ' 48' ' ' ALA . 89.6 m-20 -83.17 -3.62 57.55 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.43 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 58.87 11.07 1.73 Allowed 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 46' ' ' ASP . . . -75.02 -36.02 61.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -150.76 166.66 29.77 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.56 141.83 43.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -101.04 125.47 47.66 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.34 133.55 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 120.944 0.402 . . . . 0.0 110.476 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 98' ' ' PHE . 22.1 m -130.42 149.37 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 121.248 0.547 . . . . 0.0 111.095 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 m -133.27 135.64 45.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 36' ' ' THR . 35.4 m-85 -123.06 153.13 40.29 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.3 tp -72.26 -35.71 68.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.632 0.73 . . . . 0.0 110.397 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -81.27 8.13 9.76 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.8 p30 -60.96 -20.13 61.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 25.8 pttm -68.99 -30.04 68.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -90.7 117.2 29.15 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.31 -34.87 74.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.714 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.02 -38.81 89.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.455 0.645 . . . . 0.0 109.576 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.75 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' ILE . 74.8 t -69.12 -38.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -66.37 -45.67 79.33 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.489 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.97 -43.01 72.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.823 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.6 28.58 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.589 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.09 -37.63 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.719 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.09 -35.9 78.91 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.876 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.4 78.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.002 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' SER . 79.8 mt -71.22 -36.35 71.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.533 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.38 -45.55 75.92 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.291 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -71.18 -37.11 72.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.28 -3.55 57.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.392 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 72' ' ' LEU . 22.9 t -55.44 -51.16 67.83 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.899 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.56 92.64 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -63.04 -43.87 97.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.581 -0.309 . . . . 0.0 111.275 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.8 -40.21 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.372 0.606 . . . . 0.0 110.787 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.77 -46.02 89.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.048 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.5 m -70.48 -36.95 74.14 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.571 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -69.31 -37.94 78.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.542 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 19' ' ' ILE . 8.7 tt -68.27 -42.41 79.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.879 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.91 -41.9 71.01 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -66.21 -39.41 89.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.289 -0.956 . . . . 0.0 112.128 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.18 87.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.247 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.1 mtm -97.69 -5.39 35.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.44 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.9 mtm180 49.31 41.98 21.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 110.056 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.9 tp -92.04 140.32 29.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.416 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.491 ' C ' ' H ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -95.09 -41.29 9.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.7 pt -71.43 29.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.601 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 90' ' ' ARG . 88.6 t -73.45 114.2 29.47 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.276 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 160.62 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.5 1.467 . . . . 0.0 110.838 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.38 127.27 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.9 mt -94.2 131.02 40.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.207 0.527 . . . . 0.0 111.512 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.9 m -120.18 130.5 54.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.201 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -104.74 127.32 52.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.938 0.399 . . . . 0.0 110.752 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 39.9 t80 -132.23 151.72 51.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.002 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 51.0 p90 -105.61 132.51 51.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.969 0.414 . . . . 0.0 111.191 -179.54 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.944 0.402 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.09 -37.71 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.254 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.0 t -58.08 -40.04 75.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.09 93.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.083 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -63.83 -39.23 93.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.333 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.84 -36.3 80.77 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.8 mtt -72.84 -39.93 66.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.534 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.59 -47.41 79.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.774 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -66.49 -36.87 83.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.229 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -65.48 -41.69 93.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.67 -41.28 87.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.28 86.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.299 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.2 tp -60.92 -51.89 67.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.209 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.58 -34.44 65.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.24 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.4 tt -59.17 -40.85 86.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.841 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -82.24 -41.31 20.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.354 0.597 . . . . 0.0 111.481 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -70.59 -41.57 72.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.04 -15.74 61.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.173 0.511 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 23' ' ' LEU . 16.3 tt -114.42 148.2 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.75 119.4 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 30.9 t0 -78.89 -35.68 1.09 Allowed Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 47.4 Cg_exo -56.52 -34.49 95.15 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.766 1.644 . . . . 0.0 112.763 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -60.07 -38.01 81.58 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.267 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.81 -20.88 45.07 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.78 88.62 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.662 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 57' ' ' LEU . 47.5 ttm -171.94 154.8 3.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.593 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -79.48 140.98 37.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.7 p -89.18 165.51 14.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.2 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -127.14 156.2 42.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -107.57 125.41 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.966 0.413 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -67.54 -34.08 76.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.41 159.94 9.53 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.51 148.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.933 0.396 . . . . 0.0 111.262 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -124.08 138.09 54.48 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.748 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 mmm -113.14 142.33 45.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -73.85 150.76 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.734 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -60.6 -33.52 72.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.248 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.99 -3.54 57.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.408 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.0 mt 60.19 30.57 19.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.61 -48.21 3.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.888 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.6 144.36 44.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.953 0.406 . . . . 0.0 110.952 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.64 142.03 45.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.549 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -122.06 125.43 46.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.28 134.46 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 97.4 m-85 -107.69 139.71 41.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.061 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.47 146.32 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.266 0.555 . . . . 0.0 111.467 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -133.6 139.39 46.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.318 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -149.2 143.9 26.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.96 0.41 . . . . 0.0 110.026 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 1.2 pt? -77.66 -12.15 59.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.834 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.78 3.22 20.15 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -61.5 -16.53 48.27 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -69.64 -36.76 76.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 63' ' ' ASP . 65.2 t0 -90.84 114.01 26.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.722 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.26 -35.03 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.73 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 3.4 p30 -67.01 -33.52 75.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.133 0.492 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -67.98 -37.15 81.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.74 -44.7 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.341 0.591 . . . . 0.0 109.986 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.46 -41.0 85.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.018 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.48 -46.16 64.3 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.688 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.98 -51.73 27.35 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.472 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 mm -59.14 -37.79 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.567 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.39 -39.84 92.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.68 -41.81 74.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.939 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.1 tp -70.38 -36.52 74.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.67 -45.0 69.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.308 0.575 . . . . 0.0 110.386 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -36.86 74.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.028 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.38 -7.86 55.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 t -55.07 -50.55 68.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.11 -39.04 93.89 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -66.94 -40.33 87.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.41 -41.43 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 109.833 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.9 -47.19 81.58 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.535 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -70.93 -36.23 72.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.821 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.81 -34.56 76.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.063 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.36 -46.08 74.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.545 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -66.52 -36.93 92.17 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.985 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.58 -43.55 89.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.72 -0.74 . . . . 0.0 111.714 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.26 -43.73 66.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.798 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.7 mtt -80.65 -17.96 49.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 84' ' ' GLY . 40.5 ttp180 61.47 29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.487 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.58 141.66 35.04 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.217 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -97.38 -11.91 23.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.094 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -84.03 24.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 92' ' ' VAL . 1.2 m -72.33 119.13 73.11 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.34 161.48 31.78 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.447 1.432 . . . . 0.0 111.882 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.04 134.11 56.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.6 mt -99.76 131.04 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.085 0.469 . . . . 0.0 110.883 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -118.6 123.13 44.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -102.69 131.11 49.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 54.4 t80 -119.03 141.92 48.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.603 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.412 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 43.2 p90 -106.87 134.53 49.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 -179.817 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.639 0.256 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -60.31 -43.31 96.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 p -65.6 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.721 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.09 79.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.45 -40.42 95.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.24 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -38.38 87.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 91.1 mmm -70.66 -40.13 73.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.513 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.604 HE21 ' H ' ' A' ' 41' ' ' VAL . 51.2 tt0 -55.32 -43.21 74.69 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.551 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -62.73 -45.35 93.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.182 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.59 -34.66 78.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.788 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.5 mt -70.5 -42.3 78.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.69 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.77 85.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.034 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.53 -53.06 61.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.641 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.5 mt -69.81 -33.94 58.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.503 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.7 tp -56.67 -41.56 77.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.813 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.4 tt0 -82.11 -42.8 18.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.285 0.564 . . . . 0.0 111.267 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.39 -36.62 76.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.94 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -71.81 -17.05 62.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.214 0.53 . . . . 0.0 109.909 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.2 pt -119.44 150.54 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.067 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.2 120.52 24.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -73.13 -39.09 4.89 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.4 Cg_exo -52.91 -38.35 78.94 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.012 1.808 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -63.93 -37.73 88.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 mt -99.7 -9.79 22.68 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.719 0.295 . . . . 0.0 110.514 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 81.01 17.88 71.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.3 ttp 60.61 3.01 0.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.334 0.588 . . . . 0.0 109.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 33' ' ' GLY . 64.9 mtt -58.29 -28.02 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.781 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -65.98 129.42 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -131.39 148.39 52.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.898 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -91.93 117.75 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 0.0 109.788 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 m -66.48 -35.9 81.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.508 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 160.58 10.04 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.604 ' H ' HE21 ' A' ' 16' ' ' GLN . 5.4 m -127.14 152.78 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -132.79 139.9 47.75 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.42 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.2 mtt -97.16 140.3 31.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.7 p -73.66 160.14 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.955 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.8 ttm105 -58.01 -32.78 68.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.507 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -82.6 -3.88 56.81 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.271 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.0 mt 59.17 15.26 4.03 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.13 -36.79 8.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.901 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.6 146.25 41.95 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.724 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.19 141.75 47.17 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.787 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -108.88 128.08 54.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.299 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.1 133.38 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.292 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.44 130.16 56.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.14 148.68 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.007 0.432 . . . . 0.0 110.94 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 t -135.43 151.55 50.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -144.63 141.85 29.69 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.275 0.56 . . . . 0.0 111.037 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.9 tp -68.74 -22.49 64.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -80.3 5.57 14.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 53.7 p30 -61.85 -17.43 56.41 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 48.1 mtmt -68.88 -35.85 77.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.339 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -89.73 118.57 29.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.011 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.1 -35.49 75.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.907 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.78 -39.57 93.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.608 0.718 . . . . 0.0 109.275 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.53 80.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.588 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 69' ' ' ILE . 68.2 t -65.44 -42.83 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.679 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.15 -47.68 70.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.258 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.45 69.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.826 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -51.27 37.34 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.857 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 65' ' ' VAL . 16.5 tt -59.03 -40.98 81.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.223 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' ILE . 68.1 mttm -68.79 -35.02 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.951 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.4 76.82 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.335 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.11 -36.82 72.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.198 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.02 -45.38 67.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.347 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.67 -37.06 73.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.487 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.62 -12.06 60.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.345 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.5 p -55.66 -50.2 70.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.503 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.83 95.06 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.485 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.72 -41.44 92.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.39 -39.84 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.321 0.582 . . . . 0.0 110.622 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.36 -47.74 80.84 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.023 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.1 m -71.45 -38.37 71.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.211 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.5 tp -68.07 -37.79 81.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.311 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.35 -41.33 80.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.73 -36.04 74.52 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -70.05 -43.68 70.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.529 -0.835 . . . . 0.0 111.614 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.61 89.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.522 . . . . 0.0 109.909 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.409 ' O ' HD23 ' A' ' 89' ' ' LEU . 62.8 mtt -84.9 -17.69 37.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.15 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' GLY . 39.7 mmm-85 59.52 25.32 14.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 87' ' ' MET . 2.7 mm? -100.99 141.77 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.108 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.71 -10.45 19.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.413 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 91' ' ' ILE . 11.1 pt -75.21 7.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.353 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 92' ' ' VAL . 31.2 m -72.55 122.21 86.92 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.75 163.68 28.72 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.616 1.544 . . . . 0.0 111.749 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.02 133.47 56.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.31 129.73 44.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -119.38 127.96 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.51 129.85 52.5 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.181 0.515 . . . . 0.0 111.468 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -119.11 138.69 52.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.568 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 24.6 p90 -102.69 128.69 49.29 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.935 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.46 0.059 0 CA-C-O 120.771 0.319 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -58.93 -37.63 77.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' SD ' ' A' ' 15' ' ' MET . 66.3 t -58.57 -41.01 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.762 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.26 90.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.063 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.86 -39.2 93.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.116 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.73 -36.52 81.21 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -73.06 -41.1 64.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.035 178.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.11 -45.62 92.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -67.25 -41.1 86.16 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.24 -41.9 89.37 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.772 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.23 -41.35 86.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.281 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 -37.65 88.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.122 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.458 HD11 ' NE ' ' A' ' 25' ' ' ARG . 42.5 tp -62.53 -52.32 63.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.34 -32.78 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.305 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.36 -40.96 71.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.478 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ILE . 26.2 mt-30 -82.51 -43.73 16.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.696 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NE ' HD11 ' A' ' 21' ' ' LEU . 87.3 mtt180 -70.83 -32.68 69.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -71.7 -16.54 62.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.45 0.643 . . . . 0.0 109.343 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.6 pt -118.69 149.34 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -95.0 123.92 38.75 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -47.39 -59.7 5.13 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -52.11 -23.23 16.81 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.966 1.777 . . . . 0.0 113.513 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.45 -38.11 76.81 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.559 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -100.33 -12.24 19.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.85 61.42 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 mtt -146.71 163.91 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.542 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.6 mtp -96.19 148.08 23.08 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.807 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -114.35 152.5 31.37 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.131 0.491 . . . . 0.0 111.004 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.0 m -129.03 145.7 51.19 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 38' ' ' VAL . 32.7 m -92.73 124.08 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.5 p -78.33 -23.19 47.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.744 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.95 155.09 6.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.46 153.53 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -135.12 142.51 46.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 mmt -103.36 142.36 34.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.778 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 88.3 p -73.54 161.6 30.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.186 0.517 . . . . 0.0 110.5 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -59.55 -35.16 73.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -83.68 -2.94 57.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp 59.89 22.48 11.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.71 -37.53 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.46 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.426 ' O ' ' OG ' ' A' ' 44' ' ' SER . 89.9 m-85 -116.19 143.66 45.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.42 141.97 46.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -115.93 125.72 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.301 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.65 134.77 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.087 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -109.54 131.95 54.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 m -131.59 149.53 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.062 0.458 . . . . 0.0 111.04 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -140.96 152.01 44.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.285 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CG ' ' OD1' ' A' ' 59' ' ' ASP . 19.2 p90 -151.98 161.07 43.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.474 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -27.76 68.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.486 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 60' ' ' LYS . 15.9 t-20 -80.56 2.03 27.2 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.529 ' OD1' ' CG ' ' A' ' 56' ' ' PHE . 3.3 m-20 -61.53 -15.48 38.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 58' ' ' ASN . 48.9 mtmt -67.64 -37.13 82.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -90.52 114.46 26.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.778 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.34 -33.26 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.64 -38.88 92.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.48 0.657 . . . . 0.0 109.486 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.65 84.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.763 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.61 -39.53 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.212 0.529 . . . . 0.0 109.977 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -65.86 -41.22 91.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.07 70.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.38 -51.39 52.89 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.254 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.6 -38.83 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.203 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.43 -39.98 95.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.254 0.55 . . . . 0.0 109.634 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.82 71.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.325 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 tp -70.32 -37.57 74.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -69.35 -44.76 70.93 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.09 -37.03 78.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.936 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.86 -10.14 59.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.9 p -57.76 -49.6 76.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.63 -36.79 87.29 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.09 -45.38 85.46 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.425 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.2 mt -60.72 -39.23 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.468 0.651 . . . . 0.0 110.608 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -61.43 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.84 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -70.4 -35.65 73.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.478 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -63.67 -40.58 97.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.113 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.63 -51.11 45.72 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.88 -44.31 94.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.176 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.58 -42.63 70.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.33 92.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtm -89.19 -17.15 29.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.12 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 84' ' ' GLY . 48.1 mmm-85 54.42 37.61 28.01 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 tp -93.9 139.87 30.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.689 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -89.35 -38.56 14.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -77.76 21.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.673 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.2 p -72.35 114.8 32.91 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -83.24 168.61 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.903 1.735 . . . . 0.0 112.284 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -74.32 142.46 45.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 95' ' ' LEU . 9.6 mp -98.15 128.13 44.48 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.189 0.518 . . . . 0.0 111.324 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 m -110.24 118.95 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 130.25 44.66 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 112.334 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.37 138.67 52.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.095 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -105.71 133.81 49.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.731 0.301 . . . . 0.0 110.653 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.98 0.419 . . . . 0.0 110.184 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo . . . . . 0 N--CA 1.498 1.745 0 CA-C-O 120.792 0.247 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -58.5 -37.07 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -60.72 -40.49 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.372 . . . . 0.0 110.326 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -61.18 -40.68 86.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.86 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.2 83.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.46 -42.1 96.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.188 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.81 -38.54 88.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.9 mtt -71.13 -38.6 72.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.971 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -54.72 -44.61 73.66 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -64.28 -45.93 85.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.499 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -63.25 -34.06 76.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.376 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.78 -42.83 80.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.741 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.75 85.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.812 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.93 -53.16 58.39 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.068 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.6 mt -69.8 -34.87 62.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.747 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.0 tp -58.89 -43.47 90.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.245 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -83.23 -40.5 19.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.591 . . . . 0.0 111.684 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.4 ttt-85 -69.85 -41.86 74.32 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -72.94 -15.62 61.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.145 0.498 . . . . 0.0 110.442 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 23' ' ' LEU . 18.8 tt -115.35 142.21 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.547 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -83.58 113.71 21.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -67.87 -38.62 14.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.787 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 60.0 Cg_exo -52.68 -31.78 51.92 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.878 1.719 . . . . 0.0 112.616 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -60.5 -37.26 80.51 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.891 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.9 mt -79.85 -20.1 46.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 109.856 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.47 5.45 82.12 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.401 ' SD ' HD23 ' A' ' 57' ' ' LEU . 25.2 ttt -167.07 154.8 9.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 0.0 110.65 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.55 142.91 33.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.034 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.8 t -97.99 157.17 16.27 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.915 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.0 m -121.15 143.28 49.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.23 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.33 118.08 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 110.131 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -63.32 -36.16 82.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.313 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.63 161.52 10.44 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.64 151.35 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.812 0.339 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -133.17 142.59 48.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.0 mtt -102.2 142.28 33.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.003 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.7 t -73.79 152.2 40.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.087 0.47 . . . . 0.0 110.588 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -55.98 -31.75 63.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.993 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.71 -3.87 57.05 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.326 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.8 mt 58.8 20.11 7.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.06 -41.37 6.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.945 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.62 147.28 40.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.04 141.31 49.18 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.94 0.4 . . . . 0.0 110.474 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -109.04 127.55 54.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.81 133.11 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.303 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -112.84 130.46 56.08 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.91 147.65 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.892 0.377 . . . . 0.0 110.716 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.7 m -126.37 125.7 42.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.96 131.6 55.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' SD ' ' A' ' 34' ' ' MET . 30.5 tp -70.89 -25.93 63.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.436 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 60' ' ' LYS . 19.6 m120 -81.09 2.57 26.74 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -60.75 -16.85 44.58 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 58' ' ' ASN . 14.7 mtpp -69.0 -35.56 76.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.147 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -89.71 119.32 30.01 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.378 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.71 -32.31 70.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.75 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.7 -40.24 76.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.308 0.575 . . . . 0.0 110.415 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.64 -44.09 74.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.955 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -68.83 -34.37 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.257 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -64.69 -42.92 94.97 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 109.641 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -39.64 75.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.343 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.19 -50.37 51.66 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.997 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.58 HD13 ' CZ ' ' A' ' 99' ' ' TYR . 5.5 mm -57.98 -42.93 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.666 0.27 . . . . 0.0 111.038 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.01 -35.73 80.57 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.978 0.418 . . . . 0.0 110.264 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.04 -45.2 71.01 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.106 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 tp -70.98 -36.68 72.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.416 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.6 -45.46 71.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.43 -37.08 74.33 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.975 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.43 59.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.28 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 t -55.67 -51.07 68.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.419 -0.512 . . . . 0.0 112.241 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.09 93.22 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -65.94 -41.27 91.54 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.11 -41.43 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.342 0.592 . . . . 0.0 109.969 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 93' ' ' PRO . 37.4 ttt85 -62.9 -47.15 84.51 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.42 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.9 t -70.95 -36.45 72.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.707 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.46 -39.91 77.44 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.787 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.35 -49.22 51.62 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.43 -42.26 99.73 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.407 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -68.8 -39.86 79.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.375 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.48 99.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.851 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.08 -14.07 37.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 93.7 mtt-85 56.91 35.78 26.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.52 141.35 34.53 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.782 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -102.12 -10.94 19.22 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.498 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 91' ' ' ILE . 36.8 pt -88.4 13.03 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -73.09 121.94 86.39 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.526 ' O ' ' NH2' ' A' ' 80' ' ' ARG . 94.7 Cg_endo -78.06 166.06 25.32 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.701 1.601 . . . . 0.0 111.504 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.01 138.41 58.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 1.4 mm? -97.56 128.31 44.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.074 0.464 . . . . 0.0 110.536 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.4 m -118.57 129.35 55.29 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -102.67 129.12 49.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.198 0.523 . . . . 0.0 111.498 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.437 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.1 t80 -123.25 144.97 49.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.738 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 21.4 m-85 -109.22 132.56 54.0 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.932 0.396 . . . . 0.0 110.241 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.936 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo . . . . . 0 N--CA 1.501 1.951 0 CA-C-O 120.592 0.164 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.2 -37.87 81.37 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.73 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -62.02 -43.06 99.64 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.65 -37.74 80.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.164 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.96 81.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -64.67 -41.78 95.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.29 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.57 -38.75 88.66 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 90.4 mtp -71.1 -38.8 72.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.71 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.5 -42.38 78.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.537 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -63.0 -45.42 92.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.11 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.13 -34.85 78.49 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.708 0.766 . . . . 0.0 109.715 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.63 -41.51 77.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.485 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.51 84.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.194 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 tp -60.56 -52.99 62.82 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.577 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.9 mt -69.87 -34.26 59.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.395 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 27' ' ' ILE . 36.8 tp -56.33 -41.96 76.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.016 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.3 tt0 -82.92 -41.64 18.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 111.442 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -70.35 -38.81 74.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.122 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -72.39 -14.86 61.81 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.071 0.462 . . . . 0.0 110.336 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.9 tt -119.9 141.64 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.554 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -86.54 113.06 22.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -67.77 -38.75 15.64 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.489 -179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.59 -28.69 46.93 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.012 1.808 . . . . 0.0 112.559 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -59.38 -38.2 79.89 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.527 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.7 mt -88.37 -19.45 26.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.138 0.494 . . . . 0.0 109.8 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.71 5.0 89.84 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 90.7 mmm -143.74 162.22 36.56 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.838 0.351 . . . . 0.0 110.514 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.6 ttp -96.79 134.54 39.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.952 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.0 p -92.0 158.04 16.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 t -135.56 159.66 40.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.298 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.8 p -108.17 127.3 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 120.999 0.428 . . . . 0.0 110.085 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 m -72.19 -34.2 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.42 157.44 8.48 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.76 150.69 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.074 0.464 . . . . 0.0 111.488 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.1 141.86 50.66 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.074 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.1 mtt -108.11 142.07 38.87 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 75.7 p -75.47 152.84 37.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 110.058 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -63.06 -34.81 78.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.443 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.92 -3.11 57.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.376 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.4 mt 62.03 13.67 5.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.11 58.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.177 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.2 165.49 29.87 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.256 0.55 . . . . 0.0 111.764 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.54 142.3 35.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.257 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -112.41 120.01 40.19 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.208 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.8 133.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.907 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -109.67 136.19 49.41 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.829 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.6 t -130.79 146.98 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 0.0 111.069 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 t -144.65 152.48 40.53 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.792 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.536 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 11.0 p90 -150.24 159.73 44.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.123 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 30.3 tp -61.18 -27.03 68.12 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.02 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.412 ' C ' ' N ' ' A' ' 60' ' ' LYS . 73.5 m-20 -80.23 5.78 13.67 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 68.9 m-20 -61.02 -16.71 46.53 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 58' ' ' ASN . 63.9 tttp -68.87 -39.97 79.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.82 114.12 26.45 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.167 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -60.46 -33.0 71.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -66.04 -38.72 89.09 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.447 0.641 . . . . 0.0 109.386 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.55 83.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HG22 ' A' ' 69' ' ' ILE . 82.6 t -68.76 -37.87 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.913 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.4 -45.47 79.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.595 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.27 -44.55 68.19 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.496 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.85 41.38 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.484 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.0 tt -59.8 -34.5 55.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.214 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -66.4 -41.31 89.51 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.38 0.61 . . . . 0.0 109.506 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.36 75.09 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.95 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -69.62 -36.63 76.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -68.48 -44.49 74.67 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.192 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -69.35 -37.07 77.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.091 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.72 -10.52 59.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.333 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.8 p -58.67 -49.41 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.243 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.7 91.88 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -64.49 -43.6 93.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.623 0.249 . . . . 0.0 111.452 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.73 -42.84 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.326 0.584 . . . . 0.0 110.808 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -63.11 -47.1 84.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.48 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.1 t -70.98 -37.76 72.75 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.866 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -66.45 -37.8 85.95 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.778 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.75 -43.32 76.09 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.956 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.0 -38.4 74.21 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -66.26 -43.12 87.36 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.749 -0.726 . . . . 0.0 111.921 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.58 83.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.7 mtt -84.29 -17.21 40.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 84' ' ' GLY . 41.3 ttt85 59.44 35.35 22.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.656 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.1 mt -101.35 142.05 33.32 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.034 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -101.58 -10.54 19.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.668 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.7 pt -82.62 18.09 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.201 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -72.97 122.5 87.81 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.91 158.97 31.09 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.545 1.496 . . . . 0.0 111.374 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.81 128.7 37.82 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.5 mt -95.58 131.37 41.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.228 0.537 . . . . 0.0 111.313 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.2 m -115.61 127.25 55.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.98 126.9 52.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -119.11 141.64 48.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.768 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 23.3 p90 -106.83 132.02 53.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.905 0.383 . . . . 0.0 110.337 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.341 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.497 1.722 0 CA-C-O 120.746 0.227 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.27 -41.77 89.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -63.31 -43.2 98.52 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.705 -0.398 . . . . 0.0 112.016 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.07 -37.1 78.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.291 0.567 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.8 -39.54 83.98 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -71.59 -46.42 59.32 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.519 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -62.37 -37.15 84.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 57.3 mtt -71.62 -40.72 69.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.982 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -54.49 -42.33 70.63 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -63.3 -46.79 85.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.366 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.35 -33.48 75.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.608 0.718 . . . . 0.0 109.824 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.26 -42.92 78.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.962 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.17 86.61 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.9 tp -62.58 -51.82 65.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.389 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.27 -34.1 64.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.7 -41.02 97.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -82.65 -27.8 31.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -82.83 -45.26 14.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.773 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.05 -17.39 62.02 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 72' ' ' LEU . 35.5 mt -112.24 133.92 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.009 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.97 121.96 28.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' OD1' ' SD ' ' A' ' 35' ' ' MET . 10.7 t70 -46.14 -58.48 6.36 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.302 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -52.61 -22.93 18.24 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 121.805 1.67 . . . . 0.0 113.13 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.18 -38.36 76.54 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.763 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.8 mt -100.7 -13.79 18.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.05 0.453 . . . . 0.0 109.801 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.66 5.68 89.68 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.3 tpt -160.88 158.75 28.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.404 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.442 ' SD ' ' OD1' ' A' ' 29' ' ' ASP . 94.1 mmm -80.45 137.93 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.0 p -86.08 150.33 24.52 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.872 0.368 . . . . 0.0 111.029 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.4 m -125.98 141.71 51.84 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.911 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -100.24 120.97 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.012 0.434 . . . . 0.0 110.169 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -68.84 -33.94 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.85 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.17 158.19 8.79 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 m -127.16 148.62 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 111.193 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -126.1 138.29 53.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.952 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.487 ' O ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -113.73 143.24 44.95 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 94.7 p -73.2 156.4 38.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.218 0.532 . . . . 0.0 110.233 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.1 -34.87 75.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.953 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 48' ' ' ALA . 55.3 p30 -83.91 -0.86 53.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.5 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.27 31.94 21.57 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' A' ' 46' ' ' ASP . . . -105.56 -46.44 4.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.79 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -116.02 145.55 42.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 120.829 0.347 . . . . 0.0 110.641 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.88 142.17 40.69 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.723 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -122.05 127.49 50.28 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.525 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -119.5 134.74 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -109.96 133.17 53.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.74 149.85 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.167 0.508 . . . . 0.0 111.55 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 t -143.36 151.77 40.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.41 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' OD1' ' A' ' 59' ' ' ASP . 7.2 p90 -156.03 158.52 37.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.12 0.486 . . . . 0.0 111.397 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.01 -14.67 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.75 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -80.6 3.42 21.94 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.519 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 64.6 m-20 -61.88 -16.64 52.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.37 -39.43 85.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.135 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -90.62 117.26 29.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.037 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -60.3 -36.57 78.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.427 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.06 -37.92 89.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.471 0.653 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.8 -36.84 84.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.085 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.1 -44.32 84.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -66.83 -39.83 87.78 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.47 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.83 76.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.59 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.42 -51.2 38.78 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.41 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.37 -41.82 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.612 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.46 -35.27 80.4 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.57 86.21 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.936 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' CD2' HD11 ' A' ' 27' ' ' ILE . 84.7 mt -70.35 -35.89 73.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.851 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -67.78 -45.96 73.33 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -71.47 -37.18 71.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.01 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.5 -3.97 54.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.286 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -55.24 -50.3 69.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.317 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -38.76 93.02 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.232 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -66.41 -42.65 87.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.32 -39.52 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.638 0.732 . . . . 0.0 110.087 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -63.74 -45.02 91.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.09 -36.95 78.14 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.521 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.52 -38.77 90.63 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.935 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.87 -49.5 57.74 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.515 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -59.45 -43.0 97.83 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.692 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.053 0.454 . . . . 0.0 111.824 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.65 98.74 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.474 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.8 mtm -94.5 -9.17 36.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 89.5 mtm-85 55.13 36.67 27.49 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.614 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -100.72 141.2 33.93 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.977 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -99.22 -14.69 19.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 pt -86.91 29.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 92' ' ' VAL . 35.9 m -72.57 118.36 67.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.91 160.82 27.25 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.547 1.498 . . . . 0.0 111.61 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.29 136.2 57.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.8 mt -100.84 130.76 46.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 110.947 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m -119.65 124.88 47.37 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.996 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.73 129.11 47.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.452 . . . . 0.0 111.231 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 37.7 t80 -119.64 139.8 51.62 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 44.6 p90 -104.67 133.6 49.24 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.964 0.412 . . . . 0.0 110.484 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.502 1.986 0 CA-C-O 120.758 0.232 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.37 -34.4 77.87 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.288 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -59.77 -43.21 94.47 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 m -65.5 -36.87 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.847 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.33 85.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.811 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.33 -40.71 96.43 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.3 -37.62 83.89 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.8 mtt -71.55 -42.18 68.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.886 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.36 -43.74 79.43 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -63.52 -48.14 78.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.069 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.83 -32.25 72.56 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.246 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.03 -41.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.86 85.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.8 tp -64.34 -52.01 60.5 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.22 -33.92 60.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.621 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 27' ' ' ILE . 56.4 tp -57.96 -42.21 84.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.786 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.4 mt-30 -82.46 -41.87 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.384 0.611 . . . . 0.0 111.358 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -70.54 -37.6 74.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.827 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -72.12 -17.42 61.98 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.176 0.512 . . . . 0.0 110.125 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 23' ' ' LEU . 19.2 tt -118.7 141.09 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.815 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.92 110.87 20.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -66.52 -38.69 21.0 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.437 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.5 Cg_exo -55.28 -31.91 78.7 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.004 1.802 . . . . 0.0 112.521 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -59.51 -38.22 80.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.704 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.9 -20.02 28.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.951 0.405 . . . . 0.0 110.002 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.6 7.39 87.19 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.8 mtt -138.85 167.15 22.64 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.001 0.429 . . . . 0.0 110.962 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.8 mtp -98.29 151.2 20.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.444 ' CG2' ' CE1' ' A' ' 56' ' ' PHE . 88.0 m -109.09 142.36 39.94 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.759 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -122.41 157.36 32.05 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.732 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.7 p -105.54 116.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.152 0.501 . . . . 0.0 110.2 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -34.46 78.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.006 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.11 152.59 6.37 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG13 HG22 ' A' ' 52' ' ' VAL . 32.5 t -126.09 137.92 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.679 0.276 . . . . 0.0 110.454 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -128.23 140.35 51.95 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.993 0.425 . . . . 0.0 110.779 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.6 mtt -111.36 142.47 43.56 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.475 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.1 p -73.44 155.31 39.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.822 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.25 -32.54 71.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.565 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.57 -3.54 56.22 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.377 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.2 mt 59.31 27.12 16.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.37 -41.29 5.35 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -118.07 142.75 47.07 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.872 0.367 . . . . 0.0 110.885 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.07 141.73 48.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.13 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -116.97 129.13 55.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.358 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.451 HG22 HG13 ' A' ' 41' ' ' VAL . 97.0 t -117.77 133.36 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.415 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -118.74 128.76 54.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.33 149.73 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.225 0.536 . . . . 0.0 111.452 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -123.7 134.68 53.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 36' ' ' THR . 97.6 m-85 -121.39 146.55 46.76 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.426 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.3 mt -76.03 -12.06 60.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 81.9 m-20 -80.68 -2.43 46.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.834 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 100' ' ' ASP . 98.4 m-20 -62.94 -21.2 65.9 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.88 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -69.88 -38.43 76.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.562 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -99.1 109.51 22.22 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.03 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.11 -38.17 82.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.174 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -64.05 -38.03 89.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.84 82.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.51 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 69' ' ' ILE . 76.7 t -66.43 -35.53 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -66.2 -43.75 85.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.228 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.81 72.08 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.346 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -50.4 32.18 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.717 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.22 -36.74 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.682 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -68.35 -38.05 81.09 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.551 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.35 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.9 tp -69.61 -36.88 76.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.658 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.76 -44.95 72.65 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.09 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -68.75 -36.95 79.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.236 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.26 -12.16 60.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.428 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.0 -49.53 76.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.461 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.15 86.02 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.161 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.09 -44.63 88.24 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.333 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.44 -39.6 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.543 0.687 . . . . 0.0 110.501 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -63.48 -45.02 92.7 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.736 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.5 m -69.56 -36.55 76.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.0 mt -66.43 -36.49 82.93 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.237 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.12 -48.6 64.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.909 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -70.17 -43.1 65.08 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.603 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.86 -43.11 80.21 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.258 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.14 83.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.429 ' HB3' HD23 ' A' ' 89' ' ' LEU . 56.6 mtt -84.54 -21.38 30.52 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 84' ' ' GLY . 49.0 ttp85 64.21 37.15 8.95 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.992 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.6 mm? -90.28 141.46 28.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.984 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -98.7 -14.56 19.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.422 ' CG1' HD12 ' A' ' 89' ' ' LEU . 34.8 pt -97.7 34.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.641 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 92' ' ' VAL . 34.2 m -73.25 119.87 78.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.98 160.35 30.37 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.418 1.412 . . . . 0.0 111.352 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.37 132.67 54.64 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.1 tp -104.05 126.82 51.47 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.819 0.342 . . . . 0.0 110.304 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.3 m -117.11 133.68 55.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.512 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -107.28 128.52 54.52 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.98 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -119.58 137.53 53.79 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 99' ' ' TYR . 38.3 p90 -109.63 123.59 49.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.932 0.396 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.417 ' O ' ' OD2' ' A' ' 59' ' ' ASP . 60.4 t0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.497 1.721 0 CA-C-O 121.028 0.345 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -65.03 -29.81 70.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.632 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -58.71 -41.57 86.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.53 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.2 -39.38 78.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.757 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.07 96.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.914 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -61.38 -39.37 90.41 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.379 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.56 -37.33 83.44 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.1 mtt -71.32 -41.87 69.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.599 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.438 ' HG2' HG22 ' A' ' 41' ' ' VAL . 94.7 mt-30 -60.66 -41.5 95.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.574 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -64.63 -51.33 63.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.215 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.74 -34.92 79.46 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.941 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.0 mt -71.07 -39.96 75.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.109 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.57 -36.85 85.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.25 -53.31 46.18 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.81 -34.82 62.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.76 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 27' ' ' ILE . 37.0 tp -59.35 -38.96 81.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.945 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' O ' ' A' ' 27' ' ' ILE . 48.5 tt0 -81.88 -44.46 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.988 0.423 . . . . 0.0 111.15 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -71.15 -36.64 72.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -73.27 -14.31 61.3 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.291 0.567 . . . . 0.0 109.906 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 23' ' ' LEU . 15.0 tt -121.67 149.47 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.884 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -76.03 113.02 13.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.577 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -70.14 -38.55 9.02 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.86 -178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 46.0 Cg_exo -56.57 -37.4 97.56 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.078 1.852 . . . . 0.0 112.781 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -59.94 -37.43 79.5 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.121 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.419 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 61.7 mt -92.45 -3.88 54.54 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.76 0.314 . . . . 0.0 110.6 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.05 5.39 70.65 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ttt 65.46 0.38 1.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mmm -79.32 10.29 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.692 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.3 m -78.75 130.68 36.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.067 0.46 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.9 m -131.27 145.91 52.09 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.897 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.3 t -94.47 119.11 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.379 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.98 163.68 11.3 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 16' ' ' GLN . 2.2 m -127.42 148.8 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.637 0.256 . . . . 0.0 110.386 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.93 130.55 56.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 58.3 mmm -100.65 142.27 32.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.957 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 t -73.52 151.27 41.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.12 0.486 . . . . 0.0 110.585 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -57.92 -36.12 72.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.428 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.1 p30 -83.92 -0.14 50.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.421 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 59.38 30.17 19.83 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.61 -47.41 4.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.187 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -118.19 145.02 45.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.903 0.383 . . . . 0.0 111.055 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.4 141.79 46.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -113.06 130.13 56.27 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.171 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -118.14 133.47 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.593 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -116.51 128.9 55.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.722 0.296 . . . . 0.0 110.355 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.82 147.34 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.83 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 p -132.61 144.2 50.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 5.5 p90 -150.3 150.17 31.12 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.159 0.504 . . . . 0.0 111.058 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.08 -33.75 75.01 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 17.0 m120 -80.89 -2.46 47.58 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 36.0 t0 -61.68 -14.83 34.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -67.6 -38.2 83.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.28 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -89.09 126.71 35.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.068 0.461 . . . . 0.0 110.428 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.3 -35.41 75.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.136 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.9 -40.28 94.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.29 0.567 . . . . 0.0 109.976 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.33 -36.66 81.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.054 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.74 -39.27 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 0.0 109.279 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HZ3' ' CE ' ' A' ' 70' ' ' LYS . 22.0 tptp -64.31 -43.32 95.06 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.534 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -46.9 62.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.804 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.64 -52.08 32.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.747 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.34 -36.12 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.568 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' CE ' ' HZ3' ' A' ' 66' ' ' LYS . 3.1 ttmp? -66.03 -39.94 90.62 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.43 -42.06 83.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.834 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.11 -36.24 74.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.116 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -69.0 -45.5 70.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.234 0.54 . . . . 0.0 110.178 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.59 -36.96 73.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.227 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.13 -8.78 59.26 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.218 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.9 p -57.15 -49.06 77.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.293 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.36 87.09 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.07 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -66.08 -44.52 84.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.464 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.9 mt -61.29 -40.37 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 110.149 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -63.46 -45.55 90.32 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -68.88 -37.09 78.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.44 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.11 -38.36 90.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.254 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.92 -47.24 66.27 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.67 -42.15 72.53 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.722 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -68.43 -43.01 78.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.508 -0.846 . . . . 0.0 111.351 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.32 87.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.008 0.432 . . . . 0.0 110.417 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 39.8 mtt -86.21 -17.6 34.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 70.8 mtp85 53.51 37.29 25.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.8 tp -94.64 139.44 31.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.412 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -86.65 -39.0 16.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.033 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.9 pt -76.22 33.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.3 p -72.59 114.61 31.61 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -80.33 162.13 22.61 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.694 1.596 . . . . 0.0 112.036 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.67 133.29 50.79 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.19 131.41 44.57 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.104 0.478 . . . . 0.0 110.882 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.6 m -120.88 131.79 54.6 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.389 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -104.74 127.28 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.004 0.431 . . . . 0.0 110.98 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -126.04 146.16 50.02 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.0 p90 -109.54 132.48 54.1 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.788 0.328 . . . . 0.0 111.313 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.89 178.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.982 0.326 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.55 -33.37 74.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.314 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -59.24 -39.85 84.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.995 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.1 t -58.02 -39.74 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.69 95.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.199 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -63.86 -40.35 96.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.697 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.97 -36.46 81.52 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.47 -40.96 63.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.603 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.47 -47.91 82.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.135 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -67.48 -37.83 83.46 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -64.19 -42.37 96.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.311 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.78 -40.65 86.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.33 87.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.082 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.59 -51.88 65.59 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.32 -34.41 68.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.766 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 72' ' ' LEU . 13.3 tp -60.34 -40.42 90.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.383 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -83.07 -27.57 30.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.898 0.38 . . . . 0.0 111.783 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -79.61 -46.45 17.23 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.38 -15.39 61.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 24' ' ' GLN . 31.7 mt -114.15 133.9 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.191 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -84.48 112.73 20.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -65.93 -39.15 27.88 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.235 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.2 Cg_exo -55.28 -34.39 88.21 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.021 1.814 . . . . 0.0 112.36 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -59.49 -37.89 79.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.445 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 63.7 mt -80.91 -20.26 42.54 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.89 4.27 90.1 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 57.1 mtt -151.62 167.15 29.01 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.833 0.349 . . . . 0.0 110.513 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -92.06 139.8 30.28 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.0 p -87.17 152.02 22.69 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.855 0.359 . . . . 0.0 110.965 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -126.81 141.8 51.72 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.286 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.11 122.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -66.2 -35.22 79.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.237 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.67 160.69 10.02 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.34 146.15 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.103 0.478 . . . . 0.0 111.1 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -121.43 139.4 53.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.609 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 38.3 mmm -109.39 139.97 43.68 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 89.3 p -73.99 153.64 39.64 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.964 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.418 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 56.9 t0 -82.45 -3.3 55.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.058 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 47' ' ' LEU . 9.3 mp 56.38 23.31 7.2 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.42 -37.01 9.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.45 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -123.14 150.79 42.83 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.21 141.9 35.9 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.305 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -119.63 125.09 47.9 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.598 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.26 134.58 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.285 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -108.8 135.8 49.42 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -130.57 147.05 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.255 0.55 . . . . 0.0 111.464 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.9 t -146.32 152.04 38.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.816 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.34 151.32 24.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.209 0.528 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.58 -25.55 68.14 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.833 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.493 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 84.9 m-20 -79.91 5.26 14.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.9 p30 -64.5 -15.4 60.77 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 15.2 ptpt -70.03 -33.88 72.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -90.22 116.67 28.38 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.82 -33.4 71.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.385 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -65.5 -39.12 91.5 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.448 0.642 . . . . 0.0 109.619 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.93 87.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.98 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.72 -38.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.155 0.502 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -66.76 -47.03 73.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.044 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.58 77.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.473 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.53 -50.72 24.47 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.572 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.7 tt -59.67 -36.71 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.768 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -68.14 -37.51 81.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.24 92.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.241 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.402 HD13 HD11 ' A' ' 23' ' ' LEU . 56.6 tp -68.35 -36.43 79.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.882 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -69.44 -45.81 68.25 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.198 0.523 . . . . 0.0 110.345 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.3 -36.92 71.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.629 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.07 -9.31 58.5 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.286 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 m -56.5 -50.05 72.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.5 -39.69 93.42 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.252 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -66.22 -42.99 87.91 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.727 0.298 . . . . 0.0 111.506 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.42 -40.8 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.352 0.596 . . . . 0.0 110.783 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -64.27 -45.35 88.42 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.259 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -69.45 -36.84 76.99 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.632 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.6 mt -68.01 -37.54 81.54 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.66 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.32 -50.49 53.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.578 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.41 -43.87 96.14 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.596 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -70.83 -42.22 70.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.65 -42.8 98.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.25 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.7 mtm -89.5 -15.82 32.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.831 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' GLY . 96.8 mtt180 53.42 36.65 23.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -94.74 139.1 31.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.04 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -82.69 -44.7 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.531 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 pt -75.79 40.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.917 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.0 p -72.74 114.59 31.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 72.8 Cg_endo -79.91 157.64 24.06 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.643 1.562 . . . . 0.0 112.256 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.97 138.07 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -94.97 127.9 41.37 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.11 0.481 . . . . 0.0 110.753 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 m -115.72 120.85 40.7 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.86 132.05 44.5 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.2 0.524 . . . . 0.0 111.727 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -119.14 138.86 52.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -102.43 115.87 31.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.471 0.582 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.27 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo . . . . . 0 N--CA 1.496 1.622 0 CA-C-O 120.848 0.27 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -55.93 -35.9 67.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.762 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -59.79 -39.62 85.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.86 -40.8 83.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.08 94.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.024 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -60.9 -39.6 89.92 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 120.993 0.425 . . . . 0.0 110.328 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.62 -37.33 83.57 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.1 -40.9 67.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.824 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.1 -42.43 80.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.455 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -63.02 -47.56 82.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.925 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -61.99 -34.57 76.43 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.579 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.62 -40.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.795 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.46 -37.35 87.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.42 -52.22 62.49 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.654 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.0 mt -67.94 -34.63 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.43 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 36.7 mt -64.39 -33.66 76.38 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.061 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.584 ' NE2' ' SD ' ' A' ' 35' ' ' MET . 94.8 mt-30 -82.76 -27.71 30.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.915 0.388 . . . . 0.0 111.346 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -87.65 -46.19 9.74 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -73.48 -12.55 60.83 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.508 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.24 132.11 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.21 109.98 17.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 8.8 t0 -65.32 -36.63 15.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.398 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 31.9 Cg_exo -58.82 -38.55 88.01 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.497 1.465 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -61.89 -38.58 88.85 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.216 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.5 mt -87.63 -19.77 27.28 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.68 5.42 89.98 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 45.3 ttm -163.9 151.91 12.91 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.668 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.584 ' SD ' ' NE2' ' A' ' 24' ' ' GLN . 58.7 ttp -83.24 141.49 31.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.09 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -81.48 153.86 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.926 0.393 . . . . 0.0 111.01 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.5 m -122.92 143.84 49.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -98.11 118.96 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.001 0.429 . . . . 0.0 110.589 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.0 m -66.51 -34.33 77.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.278 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.65 153.94 6.99 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 52' ' ' VAL . 29.3 t -126.59 135.78 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.774 0.321 . . . . 0.0 111.081 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -118.74 137.96 52.99 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 52.3 mtt -112.57 142.34 45.27 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.413 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 p -76.91 152.43 35.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.182 0.515 . . . . 0.0 110.388 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -64.08 -32.86 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.677 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.47 -3.25 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.404 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.1 mt 61.42 14.36 5.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.82 62.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.84 164.28 35.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.514 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.12 35.92 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.486 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -104.11 127.57 51.7 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG22 HG13 ' A' ' 41' ' ' VAL . 72.3 t -117.6 133.11 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -114.42 134.92 54.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -129.82 145.76 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 120.997 0.427 . . . . 0.0 110.537 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.0 m -139.9 137.44 34.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.057 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.35 149.37 29.25 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.056 0.455 . . . . 0.0 110.892 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.7 mt -68.66 -15.34 63.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.531 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -81.12 -2.31 47.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.07 -15.3 62.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.426 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -68.88 -36.05 77.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -90.76 115.74 28.08 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -34.0 72.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.517 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.65 -38.69 91.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.376 0.607 . . . . 0.0 109.49 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.25 -36.54 83.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.878 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 69' ' ' ILE . 79.2 t -67.18 -41.05 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.84 -42.17 86.21 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.57 -46.12 64.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.695 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.65 -50.59 41.64 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.3 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.2 tt -59.48 -34.5 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.694 -0.403 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -66.73 -41.18 88.29 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.81 78.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.802 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -69.48 -36.57 76.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.546 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.08 -45.01 71.37 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.212 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.51 -36.93 74.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.01 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.19 -7.05 56.61 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.141 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.8 t -55.57 -50.04 71.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.3 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.64 -38.27 91.19 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.221 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -65.87 -43.58 87.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.593 0.235 . . . . 0.0 111.545 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.78 -39.72 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.56 0.695 . . . . 0.0 110.31 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -63.51 -46.26 86.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.272 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.1 t -70.22 -37.02 74.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.646 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.44 -37.45 86.93 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.345 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -68.45 -49.88 56.6 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -63.1 -43.88 98.07 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.349 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.67 -39.53 73.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 0.0 111.807 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.66 94.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.571 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.3 mtm -92.44 -13.55 29.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.485 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' GLY . 30.9 mmt180 57.34 42.92 24.23 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.767 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.1 mt -95.79 141.2 29.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 111.824 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -92.93 -16.86 24.68 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 pt -96.7 43.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.3 t -72.8 114.57 31.67 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.78 156.19 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.459 1.439 . . . . 0.0 111.433 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -64.47 125.99 26.43 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.3 mt -94.18 131.84 39.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.411 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -119.78 128.24 53.54 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.033 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.43 131.23 53.12 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 111.345 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.404 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 55.8 t80 -119.49 142.3 48.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.512 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 44.8 p90 -105.45 133.79 49.63 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.68 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--N 1.333 -0.151 0 CA-C-O 120.958 0.408 . . . . 0.0 110.292 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 N--CA 1.496 1.624 0 CA-C-O 120.868 0.278 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -59.47 -31.46 69.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.72 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -59.22 -38.8 80.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.398 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.62 -40.39 79.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.14 93.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.221 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -64.84 -40.07 94.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.6 -37.85 85.44 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.0 mtt -71.24 -42.87 68.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.81 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.71 -41.79 82.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -64.06 -50.23 69.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.038 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -63.29 -34.77 78.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.727 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.6 mt -70.26 -42.19 78.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.132 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.94 85.92 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 ' HE ' ' A' ' 25' ' ' ARG . 42.9 tp -62.64 -52.92 61.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.53 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.33 -35.77 74.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.054 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.6 tt -63.13 -37.25 86.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.284 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -74.38 -41.15 61.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 111.038 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HE ' HD11 ' A' ' 21' ' ' LEU . 89.3 mtt-85 -75.19 -42.5 55.59 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -73.08 -16.23 61.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.748 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 23' ' ' LEU . 12.6 tt -107.19 134.01 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -86.15 108.78 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.586 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -66.68 -38.61 19.67 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 35.9 Cg_exo -58.02 -33.69 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.164 1.909 . . . . 0.0 112.479 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -59.38 -37.87 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.579 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.5 mt -82.36 -20.4 37.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.137 0.494 . . . . 0.0 109.692 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . 82.62 3.85 90.35 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.399 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 33' ' ' GLY . 94.3 mmm -147.85 171.17 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.897 0.38 . . . . 0.0 109.995 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.1 mtt -94.99 157.15 16.02 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.062 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.7 t -125.05 150.24 46.98 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -129.45 148.81 51.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.844 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.3 t -94.0 123.91 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 82.8 p -73.27 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.92 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.4 157.37 8.13 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.37 151.97 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.884 0.374 . . . . 0.0 110.771 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -135.96 142.21 44.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.103 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.9 mtt -96.95 139.02 33.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.257 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.5 p -73.88 160.73 31.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.269 0.557 . . . . 0.0 110.782 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 45' ' ' ARG . 1.1 mpt_? -59.59 -32.35 70.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.694 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 48' ' ' ALA . 89.2 m-20 -83.06 -4.34 58.24 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.098 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.8 mt 60.08 5.6 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' ASP . . . -95.94 -22.94 17.1 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.972 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -124.13 143.96 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.881 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.65 141.94 49.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.646 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -117.09 120.15 37.44 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.928 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.74 133.68 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 121.251 0.548 . . . . 0.0 109.798 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.77 136.19 50.2 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.298 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.9 t -130.99 147.09 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.04 0.448 . . . . 0.0 111.141 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -140.29 151.33 45.0 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.273 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.65 160.77 42.48 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.182 0.515 . . . . 0.0 111.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 2.0 mm? -67.34 -18.91 65.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.643 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -80.96 1.96 28.86 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.1 p30 -64.33 -15.08 59.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 60.9 tttm -69.09 -39.97 78.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.334 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -93.43 115.96 28.5 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.449 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.99 -35.95 76.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.29 -39.17 93.38 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.416 0.627 . . . . 0.0 109.522 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.1 83.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.73 -39.14 83.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.16 -45.54 91.36 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.208 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.95 -36.38 77.86 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.3 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.44 52.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.737 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.7 -39.98 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.299 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -66.52 -36.96 83.98 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.907 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.07 -43.9 77.53 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.808 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.53 -36.45 73.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.207 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.57 -45.64 68.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.155 0.502 . . . . 0.0 110.475 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.24 -37.01 74.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.244 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.48 -12.83 60.32 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -49.16 77.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.07 -37.56 86.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.245 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -66.61 -44.57 81.73 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.535 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.29 -40.81 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.556 0.693 . . . . 0.0 110.559 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.523 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 62.3 ttt180 -63.88 -46.6 84.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.551 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 t -68.7 -37.29 79.42 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.646 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ALA . 27.6 mt -65.58 -35.98 82.41 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.493 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 mt -68.3 -48.44 64.93 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.831 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.92 -41.2 73.04 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -70.72 -43.76 68.29 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.391 -0.904 . . . . 0.0 112.173 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' LEU . . . -63.21 -43.37 98.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.7 mtt -85.42 -15.42 43.1 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' GLY . 81.4 mtm180 59.95 26.1 15.33 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.531 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.37 150.31 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.382 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' A' ' 92' ' ' VAL . 70.5 mtp85 -100.87 -9.58 21.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.248 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.4 tt -59.07 -2.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 92' ' ' VAL . 27.3 m -70.36 116.09 41.43 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 172.5 14.45 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 121.841 1.694 . . . . 0.0 111.942 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.523 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 77.2 mm-40 -59.85 134.53 57.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.9 mt -100.65 128.32 46.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.957 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -113.26 127.32 56.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.52 129.06 55.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.195 0.522 . . . . 0.0 112.097 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -118.53 137.32 53.29 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 46.1 p90 -110.27 132.78 53.87 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.421 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.493 1.489 0 CA-C-O 120.708 0.212 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HB2' ' HE ' ' A' ' 10' ' ' ARG . 99.2 mm-40 -55.37 -31.6 61.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.859 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.671 ' HE ' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -59.93 -39.69 86.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 110.213 179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.73 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.299 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.86 -36.96 81.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.107 0.479 . . . . 0.0 110.338 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -70.78 -46.81 62.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.652 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -65.38 -36.87 85.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.054 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.5 mtt -71.93 -40.89 68.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.429 HE22 HG11 ' A' ' 38' ' ' VAL . 37.7 tp60 -54.86 -45.87 74.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.22 -45.8 86.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.26 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 85.2 tt0 -61.65 -33.89 74.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.2 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.97 -42.6 77.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.29 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.52 -36.62 84.78 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.1 tp -64.67 -52.94 54.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.076 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.0 mt -70.1 -35.03 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.953 0.406 . . . . 0.0 111.098 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 27' ' ' ILE . 58.4 tp -60.65 -41.74 95.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.779 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.7 mt-30 -82.58 -41.29 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.313 0.578 . . . . 0.0 111.286 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -70.3 -40.8 74.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.57 -16.71 61.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.333 0.587 . . . . 0.0 110.195 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 23' ' ' LEU . 17.8 tt -116.05 149.48 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.326 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -67.3 122.85 18.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.017 0.437 . . . . 0.0 110.059 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -67.07 -61.87 4.33 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.956 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.17 -27.63 57.21 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.727 1.618 . . . . 0.0 112.814 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -59.5 -38.04 79.86 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.215 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 70.4 mt -103.79 -2.18 26.76 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.0 5.86 72.79 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.4 ttt 63.03 8.44 3.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.2 mmm -81.35 18.4 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.1 m -76.03 128.05 34.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 111.319 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.0 m -132.7 143.06 49.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.967 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.429 HG11 HE22 ' A' ' 16' ' ' GLN . 40.5 t -98.72 120.35 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.944 0.402 . . . . 0.0 109.972 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 m -63.95 -36.14 82.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.256 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.72 155.84 7.45 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 m -127.39 152.27 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.957 0.408 . . . . 0.0 110.819 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -132.79 141.9 48.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.226 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 62.3 mtt -113.79 142.27 46.28 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.5 m -73.51 151.92 40.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.955 0.407 . . . . 0.0 110.012 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -63.71 -29.58 70.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.337 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -83.6 -3.84 58.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 mt 60.38 24.54 14.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -98.81 -45.98 5.82 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.307 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -119.65 146.75 45.29 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.15 0.5 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.45 142.23 41.58 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.159 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.41 124.21 43.96 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.33 134.52 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.038 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -113.91 138.27 50.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.26 148.17 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.28 0.562 . . . . 0.0 111.187 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 m -141.67 132.8 26.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -135.93 146.44 47.31 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.086 178.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 57' ' ' LEU . 7.0 mp -64.29 -23.03 67.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 83.8 m-20 -81.13 -7.0 59.47 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.33 -16.03 51.75 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 ttpm? -66.65 -33.09 74.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.404 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -89.91 117.96 29.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -64.29 -39.75 94.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.482 0.658 . . . . 0.0 109.432 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.76 -36.01 81.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.738 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 69' ' ' ILE . 73.3 t -64.47 -39.7 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.5 -41.41 88.91 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.05 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.44 -47.14 62.13 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.84 -50.46 41.44 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.274 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 65' ' ' VAL . 14.7 tt -59.39 -34.86 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.493 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.79 -41.21 87.98 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.381 0.61 . . . . 0.0 109.522 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 -40.88 75.09 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.041 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.7 tt -70.31 -37.67 74.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.15 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -68.64 -45.11 72.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.278 0.561 . . . . 0.0 110.163 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -69.79 -37.18 76.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.908 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -9.2 59.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.28 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.0 p -57.42 -50.67 72.26 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -38.89 93.85 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.52 -41.53 84.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.62 -39.72 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.645 0.736 . . . . 0.0 109.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -63.31 -46.01 88.68 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.07 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.6 t -68.37 -36.64 79.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.434 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.57 -38.75 87.71 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.094 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 mt -68.99 -50.46 48.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.709 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.81 -44.13 97.92 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.54 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -71.3 -42.2 68.95 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.81 97.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.96 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 63.4 mtm -87.29 -19.49 28.19 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 84' ' ' GLY . 50.9 ttm-85 61.61 41.84 11.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.479 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 87' ' ' MET . 1.5 mm? -90.9 141.16 29.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.994 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -88.22 -26.34 22.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.532 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -89.75 45.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.569 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.98 114.2 28.65 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 119.263 -0.399 . . . . 0.0 110.133 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' O ' ' CD2' ' A' ' 95' ' ' LEU . 78.6 Cg_endo -80.61 163.31 21.47 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.613 1.542 . . . . 0.0 111.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -72.39 130.75 41.45 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 95' ' ' LEU . 1.6 mm? -93.17 128.18 39.02 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.155 0.502 . . . . 0.0 110.894 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 m -114.98 121.28 42.66 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -101.02 129.71 46.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.086 0.47 . . . . 0.0 111.818 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -119.77 138.95 53.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.393 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -102.0 132.3 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.579 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 N--CA 1.462 0.165 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.494 1.515 0 CA-C-O 120.809 0.254 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.476 ' CD ' ' H ' ' A' ' 9' ' ' GLN . 27.0 mp0 -58.08 -35.16 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.384 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.25 -39.7 83.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.397 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.3 t -60.24 -40.84 84.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.54 86.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -65.88 -43.02 89.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.039 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.17 -37.37 84.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt -73.55 -36.04 65.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.9 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.03 -47.73 80.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.372 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -66.46 -37.34 84.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.984 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.4 tt0 -65.78 -40.39 91.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.28 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.35 -42.27 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 -38.12 89.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.282 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.3 tp -63.07 -52.26 63.45 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.129 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.42 -33.48 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' O ' ' CG1' ' A' ' 27' ' ' ILE . 60.7 tp -57.67 -36.33 71.77 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.375 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -84.4 -36.02 22.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -76.98 -47.74 19.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -75.45 -3.89 36.43 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.113 0.482 . . . . 0.0 110.346 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 23' ' ' LEU . 47.5 mm -114.29 126.68 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.946 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -82.46 102.86 11.6 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 1.3 m-20 -78.34 -36.76 1.33 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.496 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 84.1 Cg_exo -48.47 -38.19 34.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.635 1.557 . . . . 0.0 113.323 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -63.41 -37.6 87.9 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.771 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.4 mt -83.45 -20.18 34.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 109.795 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.55 84.84 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.2 mtt -147.89 156.25 42.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 110.313 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.2 mtm -97.69 148.04 23.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 p -87.63 156.05 19.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 p -124.13 160.93 26.71 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.702 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 40' ' ' GLY . 47.7 t -106.26 128.71 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.829 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.7 t -88.54 -14.91 36.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' H ' HG12 ' A' ' 38' ' ' VAL . . . 157.7 148.54 5.16 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG13 HG12 ' A' ' 52' ' ' VAL . 22.0 t -124.58 128.84 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -124.43 139.98 53.38 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.979 0.418 . . . . 0.0 110.778 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.4 mtt -117.1 142.59 46.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.66 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.2 m -73.34 152.16 41.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -59.48 -31.67 69.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.528 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -83.4 -3.82 57.9 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.287 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 59.63 29.21 18.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.22 -49.17 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.031 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -117.17 144.48 44.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.924 0.392 . . . . 0.0 111.021 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.99 141.08 50.22 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.615 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -122.59 117.84 26.79 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.382 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG12 HG13 ' A' ' 41' ' ' VAL . 1.7 m -120.9 135.41 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 120.708 0.289 . . . . 0.0 110.87 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.0 135.48 51.44 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.3 m -133.27 149.83 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.122 0.487 . . . . 0.0 111.379 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -131.35 156.43 45.53 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.948 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -157.5 153.57 27.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.361 0.601 . . . . 0.0 111.814 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.0 mt -76.65 -12.27 59.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -80.08 3.65 19.69 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -66.16 -15.6 63.27 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.87 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -67.87 -39.97 83.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.431 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -92.45 115.14 27.83 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.173 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.41 -34.54 72.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.236 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.57 -38.72 92.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.1 -35.5 80.68 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.54 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.25 -46.15 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.363 0.601 . . . . 0.0 109.899 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -67.98 -47.77 67.65 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.86 -45.36 64.6 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.555 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -51.94 53.37 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.899 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.14 -34.84 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.021 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.35 -40.75 96.47 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.94 87.03 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.529 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -67.8 -36.78 81.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.358 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -68.15 -45.08 74.53 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.343 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.42 -36.99 74.36 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.254 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.06 -8.29 57.19 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.053 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.7 t -55.18 -48.64 73.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.426 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.37 -38.26 90.03 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.084 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.56 -42.17 92.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.604 0.24 . . . . 0.0 111.308 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.65 -42.62 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.542 0.687 . . . . 0.0 110.521 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' A' ' 94' ' ' GLU . 63.3 ttt180 -63.12 -46.71 86.02 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.346 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.0 t -70.28 -36.94 74.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.375 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.63 -35.56 80.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.435 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 mt -68.4 -50.4 53.21 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.97 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -62.5 -43.56 98.85 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.236 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.72 -40.84 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.179 0.514 . . . . 0.0 111.713 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.76 99.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.48 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 58.3 mtm -93.94 -8.89 38.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 91.9 mtt-85 54.86 36.03 25.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.94 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -99.62 141.13 32.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -97.73 -10.76 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.29 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -94.53 30.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -73.23 118.46 68.82 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 161.93 30.58 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.505 1.47 . . . . 0.0 111.834 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' A' ' 80' ' ' ARG . 78.1 mm-40 -60.08 136.17 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.53 130.85 47.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 0.0 111.059 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.3 m -120.79 128.39 52.84 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.87 126.25 54.9 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.994 0.426 . . . . 0.0 111.644 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -119.96 138.67 53.33 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -110.22 129.78 55.66 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.282 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.246 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 N--CA 1.495 1.566 0 CA-C-O 120.848 0.27 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.77 -33.23 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.904 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.09 -37.86 78.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.652 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.06 -38.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 0.0 110.274 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.17 -39.8 82.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.455 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -71.62 -46.38 59.29 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.952 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -62.64 -36.55 83.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.9 ttm -70.51 -40.57 73.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.09 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.03 -41.96 75.79 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -62.64 -45.04 94.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.018 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.61 -33.18 75.04 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 0.0 109.469 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.23 -42.41 78.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.413 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.79 85.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.098 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.92 -52.49 64.8 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.602 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.2 mt -68.67 -33.9 62.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.128 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.3 tp -56.17 -43.29 78.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.848 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.1 mt-30 -83.1 -40.05 20.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.252 0.549 . . . . 0.0 111.809 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -70.05 -39.96 75.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -72.56 -14.99 61.76 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.076 0.465 . . . . 0.0 110.377 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -119.23 143.34 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -83.45 115.11 21.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.569 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -69.99 -38.19 8.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.58 -179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.4 Cg_exo -53.42 -37.28 81.72 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.816 1.677 . . . . 0.0 112.242 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -59.94 -37.8 80.57 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.362 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -78.24 -20.93 50.71 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.38 5.34 87.18 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm -171.82 154.69 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.655 0.264 . . . . 0.0 110.475 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.9 mtp -83.24 138.11 33.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -88.42 158.07 18.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -122.87 143.7 49.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.543 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.52 122.76 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.5 m -65.39 -36.09 82.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.487 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.08 159.17 9.13 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.18 148.83 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.896 0.379 . . . . 0.0 110.925 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -122.91 142.1 51.17 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.116 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 40.1 mmm -109.42 142.29 40.6 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.86 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -73.11 155.01 40.14 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 110.372 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -58.31 -34.25 70.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.499 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -83.69 -4.57 58.72 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 110.807 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp 59.61 32.99 21.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.84 -46.59 3.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.609 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -116.89 140.85 48.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.426 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.23 141.62 51.08 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.907 0.384 . . . . 0.0 110.801 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.29 130.59 55.52 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.169 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.66 134.34 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.002 0.429 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.05 133.87 53.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.1 t -131.14 147.17 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.345 0.593 . . . . 0.0 112.062 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 t -146.29 150.52 35.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.371 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -157.91 155.65 29.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.844 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.8 mt -72.85 -14.77 61.57 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.744 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -81.07 3.43 23.3 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 50.4 p30 -66.37 -15.85 63.61 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.115 176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -68.62 -36.4 78.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.355 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -91.03 117.09 29.31 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.14 -34.94 74.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.35 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.07 -38.32 90.41 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.44 0.638 . . . . 0.0 109.454 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.45 83.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.842 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.69 -41.93 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 109.584 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -66.68 -42.7 86.12 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.584 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.7 -44.77 66.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.012 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.98 -51.11 48.1 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.185 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 -37.15 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.002 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -65.39 -40.03 92.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.57 -41.76 83.65 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.554 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.1 -36.43 81.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.397 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.95 -45.95 69.42 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.148 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -71.29 -37.11 71.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.261 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.2 -6.31 54.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.505 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.5 p -58.9 -52.52 65.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.193 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.64 92.88 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.643 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -66.79 -44.38 81.47 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -68.11 -38.21 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.116 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 22.5 ttp-105 -64.21 -47.16 80.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.558 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.6 t -71.09 -37.85 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.814 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.66 -36.99 85.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.407 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 ' SD ' ' A' ' 87' ' ' MET . 6.2 tt -69.14 -48.52 62.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.806 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -61.67 -42.32 99.74 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.443 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -70.11 -40.38 74.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.051 0.453 . . . . 0.0 111.598 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.74 96.6 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.157 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.432 ' SD ' HD21 ' A' ' 83' ' ' LEU . 62.1 mtt -88.22 -17.35 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.482 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 84' ' ' GLY . 72.7 mtm180 54.18 36.99 26.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.2 tp -94.09 139.62 30.76 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.012 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 92' ' ' VAL . 89.0 mtt180 -92.36 -38.53 11.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.91 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.9 pt -73.55 26.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 90' ' ' ARG . 60.0 t -73.22 114.13 28.42 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 119.289 -0.386 . . . . 0.0 109.975 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.4 159.63 25.89 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.54 1.493 . . . . 0.0 111.632 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -60.45 137.38 58.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.2 mt -100.56 130.01 46.57 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.223 0.535 . . . . 0.0 111.001 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 79.4 m -123.78 135.38 53.78 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.375 -0.829 . . . . 0.0 108.85 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -117.08 139.79 50.29 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.452 0.644 . . . . 0.0 112.134 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -121.66 153.94 37.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.728 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -109.15 134.07 52.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.649 -179.324 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo . . . . . 0 N--CA 1.495 1.598 0 CA-C-O 120.925 0.302 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -60.08 -31.48 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.463 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -59.37 -37.9 79.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.099 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -58.92 -40.39 80.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.66 88.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.98 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.55 -39.94 94.68 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.484 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.57 -37.2 82.98 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.2 mtt -71.18 -42.76 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.525 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -55.75 -44.68 77.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.452 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -64.32 -46.8 81.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.542 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.71 -33.62 74.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.917 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.3 mt -70.14 -42.44 79.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.61 84.87 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.106 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HH11 ' A' ' 25' ' ' ARG . 43.0 tp -61.15 -53.4 57.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.037 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.78 -33.52 56.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.455 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.4 tp -55.52 -44.37 76.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.855 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.8 mt-30 -82.1 -40.91 21.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 111.686 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.541 HH11 HD11 ' A' ' 21' ' ' LEU . 24.7 ttm180 -69.65 -37.58 76.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.126 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 45.5 tp10 -71.99 -17.09 62.07 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.205 0.526 . . . . 0.0 109.974 -178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.7 pt -118.54 150.22 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.796 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -81.93 115.14 20.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -70.8 -37.85 6.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.791 -179.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 44.2 Cg_exo -56.87 -38.15 96.53 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.839 1.693 . . . . 0.0 112.499 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -60.1 -37.54 80.3 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.14 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 64.9 mt -92.36 -8.02 46.16 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.558 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.79 28.61 50.39 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.7 mtm 56.17 -126.21 2.01 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 110.464 -0.199 . . . . 0.0 110.464 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.409 ' SD ' HD12 ' A' ' 57' ' ' LEU . 71.8 mtm 45.24 48.2 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.618 0.247 . . . . 0.0 111.037 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.5 m -120.24 130.45 54.52 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 120.855 0.359 . . . . 0.0 110.386 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -132.94 145.15 50.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.6 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -92.78 118.64 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 55' ' ' THR . 44.2 m -65.75 -35.4 80.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.587 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.42 152.31 6.23 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.515 HG13 HG22 ' A' ' 52' ' ' VAL . 43.3 t -125.47 134.41 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.922 0.392 . . . . 0.0 110.95 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.52 141.43 49.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.039 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 53.3 mmm -111.45 141.85 44.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.521 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.7 m -73.45 151.76 40.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.29 0.567 . . . . 0.0 110.585 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -60.67 -30.46 69.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.322 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 46' ' ' ASP . 57.7 t0 -82.62 -3.86 56.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 47' ' ' LEU . 9.4 mp 56.57 29.75 16.09 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.31 -49.02 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.737 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -116.92 143.56 45.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.74 141.59 51.27 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.434 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -113.08 127.77 56.3 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 HG13 ' A' ' 41' ' ' VAL . 55.2 t -118.21 132.79 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.309 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -119.77 127.38 52.76 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 150.71 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.246 0.546 . . . . 0.0 111.798 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.501 HG23 ' OG ' ' A' ' 39' ' ' SER . 22.2 p -131.01 149.87 52.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.895 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' A' ' 59' ' ' ASP . 6.3 p90 -156.2 155.34 32.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.358 0.599 . . . . 0.0 111.606 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.409 HD12 ' SD ' ' A' ' 35' ' ' MET . 64.7 mt -77.3 -13.58 59.91 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.602 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 32' ' ' LEU . 71.3 m-20 -80.91 0.18 36.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 7.3 m-20 -61.93 -19.53 62.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -68.22 -34.94 77.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.103 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.78 115.74 27.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.048 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 51.0 mp0 -59.69 -34.27 72.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.35 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.97 -37.34 87.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.376 0.608 . . . . 0.0 109.662 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -38.17 83.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.554 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 69' ' ' ILE . 78.1 t -69.72 -47.04 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.16 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.98 -46.33 71.64 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.357 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.06 -46.34 65.18 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.213 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.44 -51.41 48.86 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.455 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.498 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.5 tp -60.12 -34.8 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.473 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -67.1 -40.23 86.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.251 0.548 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.19 -41.86 76.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.843 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.3 -36.65 74.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.136 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -68.78 -45.38 71.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.243 0.544 . . . . 0.0 110.316 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -70.6 -37.08 73.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.244 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.35 -8.63 57.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.544 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.7 m -56.12 -50.46 71.02 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.036 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -38.69 94.31 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CE1' ' OE2' ' A' ' 26' ' ' GLU . 35.4 t80 -63.4 -43.15 98.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.846 0.355 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.64 -39.44 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.421 0.629 . . . . 0.0 110.359 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 74.2 ttt-85 -60.95 -46.16 91.83 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.937 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -70.21 -37.75 75.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.533 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.63 -37.84 76.97 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.82 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD21 ' CE ' ' A' ' 87' ' ' MET . 8.4 tt -68.78 -46.43 68.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.078 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -60.32 -42.48 98.83 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -69.99 -36.48 75.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.465 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.83 95.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.508 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.425 ' CE ' HD21 ' A' ' 83' ' ' LEU . 66.0 mtm -101.52 -3.91 27.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER 53.41 43.77 30.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.505 179.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.1 mt -100.55 141.07 33.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.142 0.496 . . . . 0.0 111.701 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -97.99 -10.82 23.81 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.515 -0.766 . . . . 0.0 108.95 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 91' ' ' ILE . 22.3 pt -98.56 21.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.6 p -72.7 116.46 50.08 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.05 160.63 26.84 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.713 1.608 . . . . 0.0 112.068 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' A' ' 80' ' ' ARG . 78.3 mm-40 -60.42 137.45 58.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.5 mt -100.37 130.15 46.43 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.961 0.41 . . . . 0.0 110.676 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 53.7 m -119.95 127.48 52.7 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -108.0 126.41 52.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.144 0.497 . . . . 0.0 111.308 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -120.93 138.26 54.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.333 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 99' ' ' TYR . 37.7 p90 -107.74 113.85 27.39 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.866 0.365 . . . . 0.0 110.318 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.9 t0 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.935 179.654 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.498 1.751 0 CA-C-O 120.793 0.247 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -58.58 -37.37 75.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.8 ttp85 -59.5 -39.93 85.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.53 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.56 -40.23 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.92 91.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.183 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -63.86 -39.9 95.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.368 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.5 -37.64 84.42 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.2 -43.77 66.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.925 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.31 -42.44 77.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.337 0.589 . . . . 0.0 109.842 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -63.92 -49.82 71.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.228 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.66 -35.34 80.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.306 0.574 . . . . 0.0 110.747 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 74.5 mt -68.51 -45.2 82.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.155 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.284 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.57 -53.36 58.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.345 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.3 mt -70.23 -34.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.442 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.8 tp -55.95 -45.53 78.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.785 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 12.5 pt20 -84.49 -42.03 15.97 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.973 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.401 ' N ' ' CG ' ' A' ' 24' ' ' GLN . 50.7 mtp180 -70.45 -33.76 71.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -178.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -72.25 -15.75 61.92 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.452 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.8 pt -119.4 149.68 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.669 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.36 117.26 29.85 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -74.12 -38.12 3.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.496 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.2 Cg_exo -55.61 -31.61 79.94 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.108 1.872 . . . . 0.0 112.554 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.54 -37.72 79.14 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.684 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.6 mt -81.51 -20.06 40.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.979 0.419 . . . . 0.0 109.918 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.35 5.52 89.51 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 63.3 mtt -143.95 168.78 19.17 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.718 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.2 mtp -113.02 158.08 20.74 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.16 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 55' ' ' THR . 13.2 t -128.74 153.71 47.09 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.529 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.6 m -127.57 148.04 50.35 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.84 118.59 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.4 p -67.8 -30.51 69.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.928 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.14 157.41 8.04 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.57 152.82 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -130.36 141.05 50.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.146 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -103.75 141.66 35.7 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.936 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 67.5 m -73.06 154.69 40.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.639 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -58.21 -32.47 68.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.572 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -82.93 -3.99 57.69 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.449 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.4 mt 58.87 26.58 15.04 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -104.86 -47.91 3.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.849 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.418 ' O ' ' OG ' ' A' ' 44' ' ' SER . 87.5 m-85 -114.69 143.7 44.62 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.885 0.374 . . . . 0.0 110.541 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.22 141.39 51.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -108.41 128.57 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.991 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.33 133.39 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.6 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.86 132.26 55.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 22.0 t -131.13 148.03 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 121.345 0.593 . . . . 0.0 111.874 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 36' ' ' THR . 37.5 m -119.2 129.34 54.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.838 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CZ ' HG11 ' A' ' 54' ' ' VAL . 84.8 m-85 -119.67 142.01 48.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.897 0.379 . . . . 0.0 111.778 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.67 -13.54 57.76 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 82.1 m-20 -81.34 -0.41 41.04 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 57.9 p30 -66.03 -15.01 62.67 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.96 177.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 61.2 tttp -67.37 -39.86 85.7 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.544 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -109.28 117.7 34.78 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -58.34 -35.86 72.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.85 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -69.36 -38.0 77.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.685 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.0 -45.56 73.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.64 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 69' ' ' ILE . 7.4 p -73.35 -33.41 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.878 0.37 . . . . 0.0 111.149 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.08 -40.52 94.75 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.39 -46.1 64.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.35 -50.23 39.94 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.533 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.8 tt -59.26 -34.67 54.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.247 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.47 -41.52 88.88 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.86 76.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.909 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.04 -36.61 75.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.637 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.15 -44.34 76.24 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.218 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.85 -36.57 80.53 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.281 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.12 -9.0 58.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.256 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.4 m -55.82 -45.99 78.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.159 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.75 -38.29 91.67 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -64.87 -42.91 94.44 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.019 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -58.22 -39.62 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.592 0.71 . . . . 0.0 109.92 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 94' ' ' GLU . 75.3 ttt-85 -61.42 -44.76 96.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.442 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 t -70.12 -36.75 75.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.617 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -69.37 -41.43 76.55 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.58 -178.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 tt -69.05 -48.48 62.73 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.633 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -65.68 -44.02 93.25 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.553 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.72 -37.89 73.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.0 112.024 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' LEU . . . -60.94 -42.73 98.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.398 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 74.7 mtm -99.83 -5.95 27.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.836 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' GLY . 66.4 mtt85 49.52 40.88 20.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.007 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.7 tp -91.43 138.7 31.37 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.626 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -92.49 -38.4 11.97 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.223 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 pt -78.46 19.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.519 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.9 p -72.67 114.42 30.05 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.98 157.88 30.76 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.501 1.468 . . . . 0.0 112.099 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 38.0 mp0 -60.96 139.87 57.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -100.99 132.81 46.22 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.014 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.2 m -119.0 128.03 54.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -103.91 127.32 51.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.282 0.563 . . . . 0.0 111.426 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 52.0 t80 -126.91 147.73 50.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 51.1 p90 -101.28 129.13 47.19 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.767 0.318 . . . . 0.0 110.223 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.791 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' O ' HG12 ' A' ' 11' ' ' VAL . 44.0 Cg_endo . . . . . 0 N--CA 1.498 1.754 0 CA-C-O 120.565 0.152 . . . . 0.0 112.101 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -51.04 -23.74 3.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.792 0.329 . . . . 0.0 111.105 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -59.02 -37.24 76.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.298 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 8' ' ' PRO . 5.1 p -59.57 -40.51 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.042 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.54 87.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.592 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -66.85 -43.43 83.67 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.597 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -62.32 -39.32 92.66 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mmt -66.98 -42.17 85.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.442 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.88 -41.92 88.27 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.783 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -63.48 -47.36 82.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.095 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -62.96 -35.33 79.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.444 0.64 . . . . 0.0 110.128 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.07 -42.88 79.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.58 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -36.41 84.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.471 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.7 tp -60.76 -53.38 58.11 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.26 -34.48 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.514 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.11 -45.87 79.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.905 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 27' ' ' ILE . 94.3 mt-30 -83.23 -39.33 21.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.114 0.483 . . . . 0.0 112.068 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -69.79 -38.76 76.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.05 -16.1 62.03 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.907 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 24' ' ' GLN . 9.6 pt -116.58 149.95 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.304 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -86.61 125.8 34.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.51 -63.0 1.05 Allowed Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.612 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -56.94 -23.82 53.53 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.0 1.8 . . . . 0.0 112.968 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -58.94 -37.1 75.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.199 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 1.7 mm? -77.62 -20.55 53.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.43 5.09 85.33 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 58' ' ' ASN . 62.4 mtt -146.73 167.8 22.93 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.812 0.339 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -104.9 152.49 22.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.625 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -130.68 155.29 46.85 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.798 0.332 . . . . 0.0 110.752 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.3 t -137.4 159.03 43.1 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.423 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 38' ' ' VAL . 11.7 p -98.12 123.11 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 86.7 p -69.93 -28.7 65.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.26 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.71 153.89 6.48 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -127.2 148.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.744 0.307 . . . . 0.0 110.454 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -129.26 139.69 51.72 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.5 mmt -105.81 142.41 35.58 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.8 t -73.76 151.94 40.5 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.136 0.493 . . . . 0.0 110.343 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -58.24 -29.99 66.18 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.623 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -83.7 -3.36 57.71 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.546 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.7 mm? 56.51 29.9 16.22 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.79 -48.41 3.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.789 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -116.78 141.57 48.04 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.59 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.46 51.86 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.452 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.69 127.7 54.76 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.34 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.48 133.27 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.623 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.08 133.66 55.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.27 149.79 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.442 0.639 . . . . 0.0 111.84 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 m -129.67 135.98 49.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.49 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.401 ' CE1' HG23 ' A' ' 65' ' ' VAL . 15.7 p90 -146.02 154.77 42.24 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.546 0.689 . . . . 0.0 112.22 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 57' ' ' LEU . 2.3 mm? -80.08 -11.26 59.78 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.592 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.488 ' OD1' ' SD ' ' A' ' 34' ' ' MET . 88.1 m-20 -79.49 -0.25 32.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.0 p30 -68.09 -14.84 63.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.474 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 35.1 ttpt -69.27 -38.51 78.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.541 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -105.59 119.03 38.08 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.018 0.437 . . . . 0.0 110.114 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 62' ' ' GLU . 50.7 mp0 -59.48 -32.97 70.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.628 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.22 -39.02 75.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.254 0.549 . . . . 0.0 110.794 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.05 74.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.748 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 69' ' ' ILE . 14.5 p -69.93 -33.58 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.448 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.75 -44.51 85.7 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.37 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.22 -44.77 67.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.39 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.8 -50.73 39.76 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.485 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 65' ' ' VAL . 15.3 tt -59.46 -34.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.922 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -66.1 -42.19 89.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -40.72 87.25 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.649 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.2 tp -67.92 -36.26 79.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -68.92 -45.63 70.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.083 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.15 -37.08 72.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.372 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.95 -8.91 58.23 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.177 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 t -57.09 -50.09 73.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.122 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.89 -37.38 90.78 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.33 -43.6 94.13 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.269 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -58.61 -41.57 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 109.744 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' ' OE1' ' A' ' 94' ' ' GLU . 39.8 ttm180 -63.14 -46.76 85.7 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.899 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -70.64 -38.04 73.83 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.101 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.98 -38.58 79.41 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.002 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.94 -40.61 83.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.157 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.89 -34.54 71.52 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -67.53 -43.29 81.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.392 -0.904 . . . . 0.0 111.342 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.19 85.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.594 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 mtt -85.68 -17.19 36.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.5 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 84' ' ' GLY . 73.9 mtp180 55.99 39.27 30.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.244 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 92' ' ' VAL . 86.3 mt -101.15 141.55 33.88 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.124 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -97.43 -14.95 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.559 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 91' ' ' ILE . 37.7 pt -86.69 21.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.773 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 89' ' ' LEU . 59.4 t -72.85 114.14 27.8 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.141 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 95' ' ' LEU . 89.3 Cg_endo -77.66 161.59 30.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.298 1.332 . . . . 0.0 111.098 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 80' ' ' ARG . 79.0 mm-40 -64.62 136.49 57.04 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.249 -0.581 . . . . 0.0 109.521 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 93' ' ' PRO . 7.1 mp -98.94 129.87 45.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.062 0.458 . . . . 0.0 110.365 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.6 m -117.9 127.63 54.04 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.28 126.65 51.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.126 0.489 . . . . 0.0 111.157 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 48.1 t80 -126.17 146.14 50.08 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.475 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 47.9 p90 -99.8 129.02 45.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.855 0.36 . . . . 0.0 110.435 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 56.3 p-10 . . . . . 0 N--CA 1.474 0.772 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.378 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo . . . . . 0 N--CA 1.494 1.502 0 CA-C-O 120.878 0.282 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -60.01 -31.76 70.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.81 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -59.29 -38.18 79.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.152 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.77 -40.79 80.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.81 88.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.146 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.48 -40.88 96.5 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.607 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.44 -36.96 81.83 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.4 mtt -73.3 -39.09 65.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.268 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -56.79 -49.11 76.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.548 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HG2' ' HZ3' ' A' ' 17' ' ' LYS . 1.5 ptpp? -67.18 -37.71 84.17 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.099 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.493 ' OE1' ' SD ' ' A' ' 87' ' ' MET . 84.1 tt0 -68.76 -39.94 80.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.43 -42.78 97.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.36 86.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 HH11 ' A' ' 25' ' ' ARG . 27.9 tp -60.68 -52.92 63.08 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.25 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -69.14 -34.01 61.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 tp -58.22 -42.31 85.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.577 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -82.43 -41.89 19.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.307 0.575 . . . . 0.0 111.337 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.523 HH11 HD11 ' A' ' 21' ' ' LEU . 24.6 ttm180 -70.23 -37.15 74.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 0.0 113.35 -177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.22 -15.28 61.94 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.181 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 27' ' ' ILE . 13.1 pt -113.89 150.42 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.18 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -78.5 130.52 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.028 0.442 . . . . 0.0 110.342 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.59 -62.0 3.31 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.962 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.74 -28.18 55.89 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 121.714 1.609 . . . . 0.0 112.725 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.31 -37.77 78.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.447 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 72.2 mt -99.02 -1.94 38.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.143 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.9 9.16 62.74 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 44.2 ttm 58.97 60.79 2.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.571 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.423 ' SD ' HD23 ' A' ' 57' ' ' LEU . 62.2 mtt -150.6 72.8 1.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.555 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.4 p -126.04 140.92 52.21 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.6 m -139.71 142.78 36.85 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.208 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.2 p -95.76 117.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.2 m -68.21 -31.19 70.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.63 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.19 150.53 6.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 52' ' ' VAL . 17.1 t -125.41 133.0 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -131.73 141.25 49.48 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.994 0.426 . . . . 0.0 111.047 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.6 mpt? -111.44 143.17 42.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.412 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.5 t -72.63 151.86 42.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.662 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -56.29 -35.01 67.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.383 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -83.07 -4.98 58.92 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.695 0.283 . . . . 0.0 110.757 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 91' ' ' ILE . 7.9 tp 60.01 34.45 21.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.61 -48.23 3.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.674 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -117.79 139.13 51.5 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.428 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.84 141.11 52.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 120.804 0.335 . . . . 0.0 110.226 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -119.58 118.79 31.94 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.96 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 41' ' ' VAL . 1.2 m -119.43 134.66 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 120.991 0.424 . . . . 0.0 110.014 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -108.56 136.35 48.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.058 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.33 150.82 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 121.1 0.476 . . . . 0.0 111.534 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -140.95 152.06 44.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.023 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -156.04 146.77 21.98 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.392 0.615 . . . . 0.0 111.646 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.423 HD23 ' SD ' ' A' ' 35' ' ' MET . 32.4 tp -66.05 -18.67 65.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.411 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 32' ' ' LEU . 25.3 m120 -80.4 2.48 24.83 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 54.7 p30 -65.64 -15.12 62.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 18.9 pttp -70.22 -35.61 74.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.502 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -90.51 119.83 31.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.755 0.312 . . . . 0.0 110.368 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.6 -37.47 81.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.679 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -63.5 -38.92 92.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.483 0.658 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.08 82.33 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.742 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -67.96 -47.08 80.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.352 0.596 . . . . 0.0 109.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -67.52 -38.48 84.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.659 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.24 65.43 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.206 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.54 -52.71 15.02 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.045 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 99' ' ' TYR . 79.0 mt -59.91 -39.68 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.248 0.524 . . . . 0.0 112.064 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -67.37 -35.82 80.12 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.048 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.16 68.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.739 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.11 -36.99 72.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.765 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.25 -45.49 73.07 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.33 0.586 . . . . 0.0 110.261 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.95 -36.93 75.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.082 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.66 -7.24 59.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.655 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.5 m -55.55 -50.01 71.16 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.685 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.15 -35.62 85.02 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -64.93 -45.98 83.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.573 -0.313 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.88 -39.54 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-O 121.512 0.673 . . . . 0.0 110.123 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -62.03 -45.07 95.2 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.526 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -71.01 -38.25 72.63 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.09 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 82' ' ' LEU . 1.1 tm? -69.28 -42.41 75.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.73 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tt -67.88 -39.72 83.66 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.763 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.77 -39.46 76.63 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -68.38 -38.02 80.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.189 -1.005 . . . . 0.0 111.347 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.9 99.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.558 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.493 ' SD ' ' OE1' ' A' ' 18' ' ' GLU . 69.0 mtm -98.34 -6.92 29.86 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 84' ' ' GLY . 98.8 mtt180 49.59 38.27 14.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.437 0.637 . . . . 0.0 109.316 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.1 tp -90.98 140.4 29.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.968 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -90.08 -38.59 13.45 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.731 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.412 HD12 ' CD2' ' A' ' 47' ' ' LEU . 25.8 pt -78.28 34.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.731 0.3 . . . . 0.0 111.744 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 89' ' ' LEU . 88.3 t -73.46 115.31 40.09 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.8 161.31 30.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.366 1.377 . . . . 0.0 111.884 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.27 138.36 58.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.24 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.029 0.442 . . . . 0.0 110.759 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -122.23 131.23 53.83 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.397 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -108.54 130.33 55.29 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.048 0.451 . . . . 0.0 111.4 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -119.43 141.23 49.3 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.609 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' HG23 ' A' ' 69' ' ' ILE . 2.9 m-85 -97.77 118.62 34.72 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.2 t0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.873 0.368 . . . . 0.0 111.524 -179.014 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 11' ' ' VAL . 34.0 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.87 0.279 . . . . 0.0 111.818 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.74 -22.8 25.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.425 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -57.58 -37.23 72.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.215 -178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 8' ' ' PRO . 3.2 m -61.56 -38.82 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.612 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.9 89.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -63.05 -39.95 96.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.99 -36.11 80.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.4 mtt -73.17 -38.99 66.0 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.987 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.4 -49.06 78.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.087 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -67.8 -40.77 83.85 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.071 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -66.98 -38.66 86.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.63 -44.06 99.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -37.04 86.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.3 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD11 HH11 ' A' ' 25' ' ' ARG . 31.8 tp -61.29 -53.32 58.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.043 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 83' ' ' LEU . 81.1 mt -69.71 -34.27 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.716 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 27' ' ' ILE . 40.7 tp -57.99 -41.9 84.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -83.3 -38.16 22.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.209 0.528 . . . . 0.0 111.909 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.546 HH11 HD11 ' A' ' 21' ' ' LEU . 30.5 ttm180 -71.16 -43.87 66.66 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.1 -13.82 61.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.52 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 23' ' ' LEU . 20.1 tt -112.17 142.44 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.53 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -80.25 117.15 20.78 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 6.8 t70 -73.2 -35.6 2.83 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 52.8 Cg_exo -55.66 -29.82 72.46 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.966 1.778 . . . . 0.0 113.176 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -59.99 -36.64 77.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.742 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.36 -20.02 55.39 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.368 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.66 5.79 74.14 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.594 ' SD ' ' ND2' ' A' ' 58' ' ' ASN . 14.8 ptp -174.75 175.7 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 72.5 mtm -89.14 161.23 16.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.268 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -124.07 155.15 38.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.656 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.0 p -121.35 160.9 23.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.943 0.402 . . . . 0.0 110.96 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 38' ' ' VAL . 7.5 p -108.43 123.75 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.828 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.436 ' CB ' ' OD2' ' A' ' 100' ' ' ASP . 23.2 t -68.31 -35.55 77.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.047 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.6 158.49 8.28 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.15 147.01 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 110.986 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -119.51 138.14 53.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.522 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.9 mmm -108.62 142.26 39.36 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.8 m -72.93 152.01 41.61 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -63.59 -30.5 71.61 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.409 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 56.4 p30 -83.68 -2.64 56.62 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.118 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.2 mt 59.6 32.86 21.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' O ' ' OE1' ' A' ' 94' ' ' GLU . . . -108.75 -47.66 3.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.174 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -117.28 139.02 51.34 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.0 0.428 . . . . 0.0 111.179 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.53 141.5 51.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -113.67 130.03 56.47 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.188 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.69 133.82 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.705 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.84 132.44 56.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.9 151.06 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.098 0.475 . . . . 0.0 111.857 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -144.19 149.86 37.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' ' OD1' ' A' ' 59' ' ' ASP . 6.9 p90 -159.21 159.95 34.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.29 0.567 . . . . 0.0 111.577 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.95 -25.76 66.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.401 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.594 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 27.6 m120 -80.31 0.93 30.78 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.891 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 13.8 m-20 -63.43 -15.1 56.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -69.44 -36.7 76.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.049 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -91.09 113.9 26.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.19 -35.99 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.181 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.81 -38.1 89.85 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.42 0.629 . . . . 0.0 109.458 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.59 84.24 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.845 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 69' ' ' ILE . 69.9 t -67.51 -38.48 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -66.43 -40.75 89.7 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.03 66.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.72 -50.07 32.66 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.644 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.8 tp -58.67 -38.7 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.663 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.27 -36.18 79.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.58 80.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.719 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.35 -36.56 74.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.962 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -68.8 -45.36 71.46 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.138 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.9 -37.09 72.98 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.955 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.62 -7.8 57.98 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.067 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.1 t -57.85 -52.86 63.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.565 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.45 93.86 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.954 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.74 -44.56 85.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -68.86 -37.29 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.174 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -62.74 -46.45 88.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.666 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 t -67.62 -38.12 83.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.1 tp -68.93 -34.38 75.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.262 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.607 HD12 HD12 ' A' ' 22' ' ' ILE . 13.6 tp -66.83 -46.79 74.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.744 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -58.61 -40.97 95.36 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.851 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.58 -40.8 93.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.94 0.4 . . . . 0.0 111.212 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -42.77 99.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.5 mtt -82.21 -17.3 46.62 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' GLY . 83.1 mtp180 57.85 34.01 23.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.261 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -101.08 141.44 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.737 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -97.93 -10.23 24.9 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.453 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.45 HD12 ' C ' ' A' ' 91' ' ' ILE . 2.6 pp -106.96 34.21 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.4 p -73.27 124.77 90.89 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ALA . 88.8 Cg_endo -75.52 157.97 40.36 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.436 1.424 . . . . 0.0 112.304 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 39.3 mp0 -61.43 138.73 58.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.7 130.55 48.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.478 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 m -121.98 131.37 53.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.727 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -107.87 128.83 54.96 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.223 0.535 . . . . 0.0 111.015 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 41.5 t80 -129.64 152.28 49.32 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.517 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 99' ' ' TYR . 50.7 p90 -104.81 132.43 51.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.658 0.266 . . . . 0.0 110.53 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' CB ' ' A' ' 39' ' ' SER . 56.3 p30 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 121.007 0.432 . . . . 0.0 110.646 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' O ' HG12 ' A' ' 11' ' ' VAL . 57.8 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 CA-C-O 120.832 0.263 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -54.28 -24.03 17.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.468 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -58.29 -40.5 82.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.386 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 8' ' ' PRO . 4.4 p -59.41 -38.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.729 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 16' ' ' GLN . . . -62.13 -39.12 91.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -66.06 -42.66 89.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.15 -39.52 92.91 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 19' ' ' ILE . 58.5 mtt -74.06 -35.61 64.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.107 177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ALA . 49.4 tt0 -57.33 -48.8 78.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.563 . . . . 0.0 110.617 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -68.7 -36.46 78.5 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.075 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.03 -41.42 86.59 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.659 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 83' ' ' LEU . 41.0 pt -69.56 -36.77 72.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.517 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.37 87.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.555 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.24 -52.93 51.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.759 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.1 mt -69.54 -33.58 57.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.044 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 mt -59.2 -40.08 84.66 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.577 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.84 -44.07 19.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.397 0.618 . . . . 0.0 111.093 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -69.85 -35.12 74.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.935 -1.029 . . . . 0.0 112.849 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -72.04 -14.34 61.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.016 0.436 . . . . 0.0 109.988 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.85 149.86 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.083 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -93.79 107.61 19.48 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -57.53 -41.92 93.07 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.93 -178.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 34.3 Cg_exo -61.69 -33.96 84.89 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.185 1.923 . . . . 0.0 112.815 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -59.98 -39.51 85.93 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.55 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 mt -104.91 -19.76 13.77 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 69.83 16.99 72.89 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 ttp -108.04 145.77 33.51 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.634 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 64.8 mtt -103.04 144.46 31.25 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.122 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.484 HG23 ' CE2' ' A' ' 56' ' ' PHE . 70.6 m -110.7 132.06 54.52 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -128.88 156.44 43.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.238 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.31 116.22 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.914 0.387 . . . . 0.0 110.544 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.9 t -70.63 -30.69 67.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.602 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.64 156.14 8.37 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.37 132.18 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.692 0.282 . . . . 0.0 110.846 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -127.17 137.84 53.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.176 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 64.4 mtt -109.86 143.71 39.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.8 t -77.29 151.09 35.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.117 0.484 . . . . 0.0 110.271 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -60.97 -31.05 70.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.939 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' C ' ' N ' ' A' ' 48' ' ' ALA . 89.6 m-20 -83.17 -3.62 57.55 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.43 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt 58.87 11.07 1.73 Allowed 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 46' ' ' ASP . . . -75.02 -36.02 61.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -150.76 166.66 29.77 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.56 141.83 43.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -101.04 125.47 47.66 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.34 133.55 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 120.944 0.402 . . . . 0.0 110.476 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 98' ' ' PHE . 22.1 m -130.42 149.37 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 121.248 0.547 . . . . 0.0 111.095 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 m -133.27 135.64 45.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 36' ' ' THR . 35.4 m-85 -123.06 153.13 40.29 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 34.3 tp -72.26 -35.71 68.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.632 0.73 . . . . 0.0 110.397 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -81.27 8.13 9.76 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 51.8 p30 -60.96 -20.13 61.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 25.8 pttm -68.99 -30.04 68.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.857 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -90.7 117.2 29.15 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.31 -34.87 74.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.714 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.02 -38.81 89.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.455 0.645 . . . . 0.0 109.576 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.75 84.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' ILE . 74.8 t -69.12 -38.78 78.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.314 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -66.37 -45.67 79.33 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.489 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.97 -43.01 72.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.823 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -50.6 28.58 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.589 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 tp -59.09 -37.63 69.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.719 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.09 -35.9 78.91 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.876 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.84 -46.4 78.68 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.002 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 76' ' ' SER . 79.8 mt -71.22 -36.35 71.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.533 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.38 -45.55 75.92 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.291 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -71.18 -37.11 72.18 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.006 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.28 -3.55 57.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.392 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 72' ' ' LEU . 22.9 t -55.44 -51.16 67.83 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.899 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.56 92.64 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -63.04 -43.87 97.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.581 -0.309 . . . . 0.0 111.275 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.8 -40.21 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.372 0.606 . . . . 0.0 110.787 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.77 -46.02 89.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.048 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.5 m -70.48 -36.95 74.14 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.571 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 tp -69.31 -37.94 78.03 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.542 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 19' ' ' ILE . 8.7 tt -68.27 -42.41 79.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.879 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.91 -41.9 71.01 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -66.21 -39.41 89.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.289 -0.956 . . . . 0.0 112.128 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.18 87.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.247 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 76.1 mtm -97.69 -5.39 35.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.44 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' GLY . 80.9 mtm180 49.31 41.98 21.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 110.056 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.9 tp -92.04 140.32 29.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.416 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.491 ' C ' ' H ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -95.09 -41.29 9.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.127 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.7 pt -71.43 29.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.601 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 90' ' ' ARG . 88.6 t -73.45 114.2 29.47 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 119.238 -0.41 . . . . 0.0 110.276 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.77 160.62 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.5 1.467 . . . . 0.0 110.838 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.38 127.27 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.9 mt -94.2 131.02 40.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.207 0.527 . . . . 0.0 111.512 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.9 m -120.18 130.5 54.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.201 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -104.74 127.32 52.48 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.938 0.399 . . . . 0.0 110.752 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 99' ' ' TYR . 39.9 t80 -132.23 151.72 51.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.002 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' O ' ' CE1' ' A' ' 98' ' ' PHE . 51.0 p90 -105.61 132.51 51.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.969 0.414 . . . . 0.0 111.191 -179.54 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 120.854 0.272 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.386 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.09 -37.71 77.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.254 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.0 t -58.08 -40.04 75.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.59 -39.09 93.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.083 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -63.83 -39.23 93.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.333 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.84 -36.3 80.77 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.8 mtt -72.84 -39.93 66.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.534 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -56.59 -47.41 79.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.774 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -66.49 -36.87 83.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.229 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -65.48 -41.69 93.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.357 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.67 -41.28 87.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.26 -37.28 86.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.299 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.2 tp -60.92 -51.89 67.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.209 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.1 mt -68.58 -34.44 65.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.24 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' ILE . 9.4 tt -59.17 -40.85 86.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.841 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -82.24 -41.31 20.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.354 0.597 . . . . 0.0 111.481 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -70.59 -41.57 72.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.04 -15.74 61.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.173 0.511 . . . . 0.0 110.512 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 23' ' ' LEU . 16.3 tt -114.42 148.2 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.75 119.4 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 30.9 t0 -78.89 -35.68 1.09 Allowed Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 47.4 Cg_exo -56.52 -34.49 95.15 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.766 1.644 . . . . 0.0 112.763 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -60.07 -38.01 81.58 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.267 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.81 -20.88 45.07 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.78 4.78 88.62 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.662 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 57' ' ' LEU . 47.5 ttm -171.94 154.8 3.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.593 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -79.48 140.98 37.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.7 p -89.18 165.51 14.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.2 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -127.14 156.2 42.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -107.57 125.41 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.966 0.413 . . . . 0.0 110.393 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -67.54 -34.08 76.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.933 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.41 159.94 9.53 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.51 148.34 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.933 0.396 . . . . 0.0 111.262 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -124.08 138.09 54.48 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.748 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 mmm -113.14 142.33 45.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -73.85 150.76 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.734 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -60.6 -33.52 72.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.248 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.99 -3.54 57.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.408 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.0 mt 60.19 30.57 19.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.61 -48.21 3.86 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.888 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.6 144.36 44.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.953 0.406 . . . . 0.0 110.952 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.64 142.03 45.12 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.549 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -122.06 125.43 46.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -119.28 134.46 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' VAL . 97.4 m-85 -107.69 139.71 41.84 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.061 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.0 t -129.47 146.32 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.266 0.555 . . . . 0.0 111.467 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -133.6 139.39 46.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.318 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -149.2 143.9 26.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.96 0.41 . . . . 0.0 110.026 179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.557 ' CD2' ' H ' ' A' ' 57' ' ' LEU . 1.2 pt? -77.66 -12.15 59.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.834 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.78 3.22 20.15 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -61.5 -16.53 48.27 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -69.64 -36.76 76.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.009 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 63' ' ' ASP . 65.2 t0 -90.84 114.01 26.31 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.722 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.26 -35.03 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.73 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 64' ' ' ALA . 3.4 p30 -67.01 -33.52 75.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.133 0.492 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 63' ' ' ASP . . . -67.98 -37.15 81.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.74 -44.7 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.341 0.591 . . . . 0.0 109.986 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -67.46 -41.0 85.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.018 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.48 -46.16 64.3 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.688 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.98 -51.73 27.35 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.472 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 mm -59.14 -37.79 70.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.567 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -65.39 -39.84 92.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.68 -41.81 74.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.939 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.1 tp -70.38 -36.52 74.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.006 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -69.67 -45.0 69.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.308 0.575 . . . . 0.0 110.386 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -36.86 74.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.028 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.38 -7.86 55.91 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.5 t -55.07 -50.55 68.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.11 -39.04 93.89 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -66.94 -40.33 87.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.41 -41.43 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 109.833 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.9 -47.19 81.58 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.535 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 t -70.93 -36.23 72.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.821 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.81 -34.56 76.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.063 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -67.36 -46.08 74.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.545 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -66.52 -36.93 92.17 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.985 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.58 -43.55 89.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.72 -0.74 . . . . 0.0 111.714 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.26 -43.73 66.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.798 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.7 mtt -80.65 -17.96 49.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 84' ' ' GLY . 40.5 ttp180 61.47 29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.487 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.58 141.66 35.04 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.217 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -97.38 -11.91 23.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.094 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -84.03 24.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.468 ' H ' HG22 ' A' ' 92' ' ' VAL . 1.2 m -72.33 119.13 73.11 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.34 161.48 31.78 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.447 1.432 . . . . 0.0 111.882 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.04 134.11 56.19 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.6 mt -99.76 131.04 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.085 0.469 . . . . 0.0 110.883 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 m -118.6 123.13 44.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -102.69 131.11 49.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.016 0.436 . . . . 0.0 111.057 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.412 ' CE2' ' O ' ' A' ' 99' ' ' TYR . 54.4 t80 -119.03 141.92 48.29 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.603 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.412 ' O ' ' CE2' ' A' ' 98' ' ' PHE . 43.2 p90 -106.87 134.53 49.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 110.039 -179.817 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.5 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 121.057 0.357 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -64.4 -35.08 79.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.335 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -60.31 -43.31 96.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 8' ' ' PRO . 3.4 p -65.6 -36.96 78.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 119.826 -0.749 . . . . 0.0 109.721 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.09 79.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.45 -40.42 95.69 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.24 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -38.38 87.11 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 91.1 mmm -70.66 -40.13 73.17 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.513 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.604 HE21 ' H ' ' A' ' 41' ' ' VAL . 51.2 tt0 -55.32 -43.21 74.69 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.551 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -62.73 -45.35 93.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.182 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.59 -34.66 78.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.788 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.5 mt -70.5 -42.3 78.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.69 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.77 85.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.034 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.53 -53.06 61.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.641 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.5 mt -69.81 -33.94 58.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.503 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.7 tp -56.67 -41.56 77.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.813 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ILE . 7.4 tt0 -82.11 -42.8 18.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.285 0.564 . . . . 0.0 111.267 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -69.39 -36.62 76.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.94 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -71.81 -17.05 62.18 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.214 0.53 . . . . 0.0 109.909 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 24' ' ' GLN . 6.2 pt -119.44 150.54 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.067 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -80.2 120.52 24.41 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -73.13 -39.09 4.89 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 29' ' ' ASP . 53.4 Cg_exo -52.91 -38.35 78.94 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.012 1.808 . . . . 0.0 113.003 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -63.93 -37.73 88.48 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.1 mt -99.7 -9.79 22.68 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.719 0.295 . . . . 0.0 110.514 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 81.01 17.88 71.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.3 ttp 60.61 3.01 0.54 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.334 0.588 . . . . 0.0 109.875 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 33' ' ' GLY . 64.9 mtt -58.29 -28.02 64.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.781 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -65.98 129.42 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 111.495 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -131.39 148.39 52.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.898 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 7.6 p -91.93 117.75 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 0.0 109.788 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.3 m -66.48 -35.9 81.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.508 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 160.58 10.04 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.604 ' H ' HE21 ' A' ' 16' ' ' GLN . 5.4 m -127.14 152.78 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.726 0.298 . . . . 0.0 110.679 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -132.79 139.9 47.75 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.42 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 63.2 mtt -97.16 140.3 31.87 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 97.7 p -73.66 160.14 32.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.955 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.8 ttm105 -58.01 -32.78 68.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.507 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -82.6 -3.88 56.81 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.271 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.0 mt 59.17 15.26 4.03 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.13 -36.79 8.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.901 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.6 146.25 41.95 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.724 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.19 141.75 47.17 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.787 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -108.88 128.08 54.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.299 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.1 133.38 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.292 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.44 130.16 56.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.14 148.68 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 121.007 0.432 . . . . 0.0 110.94 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.8 t -135.43 151.55 50.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.078 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -144.63 141.85 29.69 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.275 0.56 . . . . 0.0 111.037 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.9 tp -68.74 -22.49 64.31 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.773 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -80.3 5.57 14.39 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 53.7 p30 -61.85 -17.43 56.41 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 48.1 mtmt -68.88 -35.85 77.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.339 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -89.73 118.57 29.43 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.011 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.1 -35.49 75.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.907 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.78 -39.57 93.83 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.608 0.718 . . . . 0.0 109.275 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.45 -35.53 80.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.588 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 69' ' ' ILE . 68.2 t -65.44 -42.83 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.679 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.15 -47.68 70.29 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.258 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.94 -44.45 69.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.826 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -51.27 37.34 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.857 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 65' ' ' VAL . 16.5 tt -59.03 -40.98 81.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.223 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' ILE . 68.1 mttm -68.79 -35.02 76.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.951 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.4 76.82 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.335 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.11 -36.82 72.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.198 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.02 -45.38 67.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.347 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -70.67 -37.06 73.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.487 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.62 -12.06 60.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.345 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 92.5 p -55.66 -50.2 70.88 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.231 -0.588 . . . . 0.0 112.503 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.83 95.06 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.485 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -65.72 -41.44 92.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.39 -39.84 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.321 0.582 . . . . 0.0 110.622 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.36 -47.74 80.84 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.023 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.1 m -71.45 -38.37 71.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.211 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 33.5 tp -68.07 -37.79 81.65 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.311 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.35 -41.33 80.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.792 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -69.73 -36.04 74.52 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -70.05 -43.68 70.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.529 -0.835 . . . . 0.0 111.614 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.61 89.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.522 . . . . 0.0 109.909 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.409 ' O ' HD23 ' A' ' 89' ' ' LEU . 62.8 mtt -84.9 -17.69 37.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.15 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' GLY . 39.7 mmm-85 59.52 25.32 14.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 87' ' ' MET . 2.7 mm? -100.99 141.77 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.108 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.71 -10.45 19.97 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.413 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 91' ' ' ILE . 11.1 pt -75.21 7.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.353 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 92' ' ' VAL . 31.2 m -72.55 122.21 86.92 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.75 163.68 28.72 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.616 1.544 . . . . 0.0 111.749 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.02 133.47 56.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.4 mt -97.31 129.73 44.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.992 0.425 . . . . 0.0 110.821 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -119.38 127.96 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.51 129.85 52.5 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.181 0.515 . . . . 0.0 111.468 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -119.11 138.69 52.72 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.568 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 24.6 p90 -102.69 128.69 49.29 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.3 t0 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.935 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 CA-C-O 120.856 0.273 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -51.94 -23.72 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.797 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -58.93 -37.63 77.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.913 0.387 . . . . 0.0 110.151 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' SD ' ' A' ' 15' ' ' MET . 66.3 t -58.57 -41.01 80.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.762 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.26 90.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.063 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.86 -39.2 93.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.116 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.73 -36.52 81.21 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -73.06 -41.1 64.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.035 178.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -62.11 -45.62 92.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -67.25 -41.1 86.16 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.24 -41.9 89.37 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.772 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.23 -41.35 86.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.281 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.91 -37.65 88.34 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.122 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.458 HD11 ' NE ' ' A' ' 25' ' ' ARG . 42.5 tp -62.53 -52.32 63.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.34 -32.78 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.305 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.36 -40.96 71.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.478 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 27' ' ' ILE . 26.2 mt-30 -82.51 -43.73 16.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.696 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NE ' HD11 ' A' ' 21' ' ' LEU . 87.3 mtt180 -70.83 -32.68 69.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -71.7 -16.54 62.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.45 0.643 . . . . 0.0 109.343 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.422 ' O ' ' O ' ' A' ' 24' ' ' GLN . 10.6 pt -118.69 149.34 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.179 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -95.0 123.92 38.75 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -47.39 -59.7 5.13 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.318 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -52.11 -23.23 16.81 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 121.966 1.777 . . . . 0.0 113.513 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -58.45 -38.11 76.81 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.559 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -100.33 -12.24 19.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.85 61.42 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 62.5 mtt -146.71 163.91 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.858 0.361 . . . . 0.0 110.542 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 88.6 mtp -96.19 148.08 23.08 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.807 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.2 p -114.35 152.5 31.37 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.131 0.491 . . . . 0.0 111.004 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.0 m -129.03 145.7 51.19 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.626 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 38' ' ' VAL . 32.7 m -92.73 124.08 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 81.5 p -78.33 -23.19 47.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.744 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.95 155.09 6.97 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 m -127.46 153.53 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -135.12 142.51 46.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.842 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.3 mmt -103.36 142.36 34.35 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.778 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 49' ' ' TYR . 88.3 p -73.54 161.6 30.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.186 0.517 . . . . 0.0 110.5 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -59.55 -35.16 73.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.221 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -83.68 -2.94 57.27 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.417 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp 59.89 22.48 11.48 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.71 -37.53 7.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.46 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.426 ' O ' ' OG ' ' A' ' 44' ' ' SER . 89.9 m-85 -116.19 143.66 45.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.383 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.42 141.97 46.98 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.641 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -115.93 125.72 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.301 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.65 134.77 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.087 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -109.54 131.95 54.59 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 m -131.59 149.53 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.062 0.458 . . . . 0.0 111.04 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.9 t -140.96 152.01 44.63 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.285 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CG ' ' OD1' ' A' ' 59' ' ' ASP . 19.2 p90 -151.98 161.07 43.21 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.474 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.32 -27.76 68.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.486 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.401 ' C ' ' N ' ' A' ' 60' ' ' LYS . 15.9 t-20 -80.56 2.03 27.2 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.529 ' OD1' ' CG ' ' A' ' 56' ' ' PHE . 3.3 m-20 -61.53 -15.48 38.69 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 58' ' ' ASN . 48.9 mtmt -67.64 -37.13 82.0 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.874 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -90.52 114.46 26.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.778 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.34 -33.26 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.64 -38.88 92.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.48 0.657 . . . . 0.0 109.486 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.57 -36.65 84.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.763 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.61 -39.53 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.212 0.529 . . . . 0.0 109.977 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -65.86 -41.22 91.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.196 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.42 -43.07 70.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.38 -51.39 52.89 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.254 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.6 -38.83 77.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.203 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.43 -39.98 95.08 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.254 0.55 . . . . 0.0 109.634 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.16 -40.82 71.09 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.325 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 tp -70.32 -37.57 74.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.558 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -69.35 -44.76 70.93 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.415 0.626 . . . . 0.0 110.206 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.09 -37.03 78.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.936 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.86 -10.14 59.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.581 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.9 p -57.76 -49.6 76.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.63 -36.79 87.29 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -65.09 -45.38 85.46 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.425 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.2 mt -60.72 -39.23 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.468 0.651 . . . . 0.0 110.608 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -61.43 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.84 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.3 m -70.4 -35.65 73.59 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.478 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -63.67 -40.58 97.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.113 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.3 mt -68.63 -51.11 45.72 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 88' ' ' ARG . . . -64.88 -44.31 94.81 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.176 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.58 -42.63 70.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.33 92.91 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.564 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.4 mtm -89.19 -17.15 29.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.12 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 84' ' ' GLY . 48.1 mmm-85 54.42 37.61 28.01 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 tp -93.9 139.87 30.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.689 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -89.35 -38.56 14.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -77.76 21.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.673 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 92' ' ' VAL . 7.2 p -72.35 114.8 32.91 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -83.24 168.61 13.2 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.903 1.735 . . . . 0.0 112.284 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -74.32 142.46 45.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 95' ' ' LEU . 9.6 mp -98.15 128.13 44.48 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.189 0.518 . . . . 0.0 111.324 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 m -110.24 118.95 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 130.25 44.66 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.354 0.597 . . . . 0.0 112.334 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.37 138.67 52.92 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.095 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -105.71 133.81 49.84 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.731 0.301 . . . . 0.0 110.653 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.98 0.419 . . . . 0.0 110.184 -179.929 . . . . . . . . 0 0 . 1 stop_ save_